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Public health measures have been effective in many countries including New 
Zealand in reducing the prevalence of smoking, but smokers with co-existing 
problems, including mental illnesses, are now becoming a focus for reducing 
smoking rates further. A key clinical dilemma is the inter-relationship between 
smoking cessation, depression and weight gain, on which there is currently limited 
understanding.  
Aims and Objective 
This study was aimed to investigate the relationship between smoking cessation, 
depression and weight gain; and also to explore the experiences of participants 
attending a smoking cessation program in Christchurch through the Smoking 
Cessation, Mood and Eating Study (SCeMES). 
Methodology 
The SCeMES was a mixed method study involving the quantitative study (SCeMES-
QN) and the qualitative study (SCeMES-QL), conducted sequentially. Participants 
were recruited from an on-going clinical trial in Christchurch, the Zonnic and Patch 
Study (ZAP). Follow-up for SCeMES-QN were for one year and data collected at five 
separate occasions face-to-face. Information for depression, weight and both 
retention and abstinence rates were collected on all visits. Descriptive analysis was 
performed and where applicable univariate and multivariate analysis was conducted 
using the Statistical Package for Social Sciences (SPSS) version 20. Visits were 
grouped to baseline, EARLY and LATE. Participants for SCeMES-QL were recruited 
purposively from SCeMES-QN. Data was collected through individual and focus 
group interviews using a semi–structured interview guide. A general inductive 
approach was used for analysis with the assistance of the software NVivo. This study 
was approved by the local Ethics Committee. 
Results 
A total of 256 participants were recruited for SCeMES-QN and 25 for SCeMES-QL. 
The retention rate at EARLY follow-up (M = 94 days) was 48.4% and LATE follow-up 
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(M = 380) was 37.6%; and the quit rate was 14.5% and 14.8% respectively. Thirty-
five point seven percent reported a previous history of depression and current 
depression was low (2.3% and 6.6% using two different measures). The mean weight 
was 79.9kgs and the average BMI 27.4. Only 0.8% of the participants were 
considered to fulfil the criteria for food addiction at baseline with no significant cases 
detected at follow-ups. Overall, participants gained weight from baseline at EARLY 
and LATE follow-ups by 1.3kg and 5.1kg respectively (p <0.001) and those abstinent 
at follow up had gained more (p<0.01). There was no association between mood or 
eating variables, and smoking cessation, found in this analysis. For SCeMES-QL, 
‘smoking cessation’, ‘perceived prejudice’ and ‘unprecedented life event’ were the 
three major domains revealed by participants in their quit smoking journey. 
Discussion and Conclusion 
This study found lifetime prevalence of depression to be double the national average, 
however, current depression was lower. It was possible that the severity of illness 
affected participation in SCeMES and the findings were supported by the qualitative 
information where depression was barely mentioned as part of the smoking cessation 
journey. Abstinent participants gained more weight compared to those non-
abstinence at follow-up, in keeping with other studies. The role of food addiction 
causing weight gain was not seen in this study. Weight gain was likely the result of 
increasing consumption as evidenced by the qualitative findings of increased appetite 
post quitting. Similar to previous studies, this study found no relationship between 
smoking cessation, depression and weight gain when analysed together. The 
SCeMES-QL participants reported their smoking cessation journey to be influenced 
by the Christchurch earthquakes and the New Zealand endgame agenda. To 
conclude, more research is needed in this important field of work to ensure a 





It never occurred to her to give up. 
Kay Redfield Jamison, 
An Unquiet Mind: A Memoir of Moods and Madness 
 
I remember telling my sponsors in Malaysia when deciding to pursue my PhD studies 
in New Zealand: “Christchurch has no earthquakes,” when asked why I had chosen 
University of Otago, Christchurch to do my doctorate, having completed my medical 
degree from this same institution. How hollow those same words ring now. 
I completed my medical degree in 2002 after living in New Zealand for six years. I did 
not experience a major earthquake throughout that whole time. After graduation I 
returned to Malaysia and served with the Ministry of Health before joining the Ministry 
of Higher Education in 2005. Malaysia, the country where I am currently based, is not 
situated within the “ring of fire” and hence does not experience earthquakes (or any 
natural disaster apart from floods). In 2009, after obtaining my Masters degree, which 
is also the exit examination to becoming a psychiatrist, I worked for a year as a full-
fledged psychiatrist before enrolling to do a PhD in July 2010. 
I remember that episode on the 4th of September 2010 vividly (magnitude 7.1). I was 
awake at the time and experienced a fierce shaking around 4.30 in the morning, a 
mere three months after my arrival. It was like the whole earth was shaking and for a 
minute I remember asking myself, “is this an earthquake?” I recall standing in the 
living room, frozen to the spot, not knowing what to do or how to react. After the 
shaking stopped, I collected my nerves (which were on the floor by then) and braved 
it outside to see what had happened. The scene in front of me was utter chaos as the 
buildings surrounding my unit in the middle of town had toppled over. Yet luckily, no 
one was hurt that morning. This unfortunately was not the same a few months later 
during the February 22nd, 2011 earthquake (magnitude of 6.3). One hundred and 
eighty-five lives were lost that afternoon. In this incident I was at the National 
Addiction Centre on the 3rd Floor of Terrace House, and coincidentally had stepped 
out to the pantry (I’m usually at my own desk at that time on most days). Had I been 
in my office, reflecting back, it was possible that I would have sustained some major 
injuries as a result of displaced furniture. Each earthquake has left its mark on me 
and also for the people of this city. Within a year of arriving in New Zealand, I had 
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moved three times as a direct result of the earthquake and was displaced for 14 
weeks from both my home, and my place of work, due to infrastructure damage or 
building assessments. In fact, my first place of residence caught fire (seen on live 
television http://youtu.be/sNcS88eqMvs - the blue building next to the fire) and has 
since been demolished after additional damage from the second earthquake. The 
aftershocks were equally damaging and became a way of life in the ‘new’ 
Christchurch. We experienced more than 18,000 aftershock over the following 5 
years. Finally, to add to the experience, Christchurch experienced its worst snow 
storm in 50 years in 2012, and worse flooding for a century in 2013.  
My Masters thesis (titled: Depression and Myocardial Infarction) was on depression, 
and I was therefore interested in mood disorders. Weight and eating, on the other 
hand, were raised during my time with the National Addiction Centre (NAC). At the 
time, the NAC was doing research work in obesity which included the newly 
emerging concept: food addiction. My interest in looking at depression, and weight 
and eating, along with smoking cessation was partially coincidental. Although it was 
my aim to do work in smoking cessation, I was not a tobacco control researcher, 
clinician or advocate to begin with. I have since changed. Psychiatrists in Malaysia 
have never really been known to do work in smoking cessation, but surprisingly, as I 
later found out, the lack of involvement of psychiatrists in smoking cessation was not 
an isolated incident. My research revealed in general, that psychiatry has never 
taken smoking as seriously as other drugs of abuse although it is the most prevalent 
drug of abuse (A N Amer Siddiq, Adamson, & Sellman, 2015; Amer Nordin  Amer 
Siddiq & Farizah, 2013). Only recently has the tobacco control community revisited 
this issue, particularly in high income countries (HIC), as smoking prevalence has 
been found to plateau, as conveyed later in this thesis.    
For a country of 30 million, Malaysia has very few (< 50 people) tobacco control 
researchers. Amongst these, there are even fewer experts in smoking cessation (< 5 
people). My mentor, the past Director of University Malaya Centre on Addiction 
Sciences (UMCAS), Professor Dr. Mohd. Hussain Habil, had observed this gap in the 
country for some time. He therefore, encouraged me to join the addiction psychiatry 
team in 2008 with the aim of developing research in nicotine addiction to support the 
national agenda (Malaysia Drug Free by 2015). Thus in 2009, the nicotine addiction 
research group of UMCAS was formed to develop research expertise in this area. In 
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order for this new group to survive, he then encouraged me to apply for a PhD and 
this was subsequently supported by the University of Malaya, my employer.  
 
In all great endeavours, timing is everything 
Anonymous 
 
At around the same time, after making my PhD intentions known, Professor Sellman 
emailed to inform me that there was an opening in a smoking cessation research 
program in Christchurch. The project was the Zonnic™ and Patch study (ZAP). Little 
did I know at the time, New Zealand and Australia were the global tobacco control 
leaders in research and advocacy efforts. In the same year of my arrival, the New 
Zealand government announced an aspirational goal to become smoke-free as a 
nation as early as 2025 (Smoke-free 2025). This announcement further boosted 
tobacco control research in New Zealand, even more than what was already 
happening at the time.  
The Smoking Cessation, Mood and Eating Study (SCeMES) has provided me with 
the skills necessary in conducting a Mixed Method Research (MMR) and the 
appreciation of doing both quantitative and qualitative research together. It has also 
allowed me to appreciate the issues that surround both types of research work such 
as recruitment, follow-up, interviews and retention. The skills gleaned will assist me 
in future research work in the field. Conducting the research work in New Zealand, 
and being involved with tobacco control advocacy, has led me to be in a fortunate 








There are many people who need to be acknowledged for their part in the completion 
of this PhD thesis. First and foremost, I would like to thank my family who have been 
supporting me throughout this journey. My mother, Professor Dr Rahimah, and my 
father, Professor Amer Nordin, have both instilled in me since a young age the 
interest in doing academic work, including enrolling into a PhD. They have also 
supported me with their love and dedication to the cause over the past 5 years, 
always encouraging me to continue to finish the work despite the difficulties faced in 
New Zealand and the demanding challenges at the end of the journey in Malaysia. 
Together with my parents, I would like to thank the Amer family (all seven siblings) 
for their continuous love and support. In December 2012 I got married. I would 
therefore like to thank my wife, Doreen, who has had to endure a four-year long-term 
relationship, in which only one and a half years were as a married couple. I will 
forever be grateful for the sacrifice, and also the constant reminder to keep at it, 
although at times I wondered if it was all worth it. 
This work would not be possible without the continuous encouragement, support and 
dedication of experts, who have given me considerable help along the way. Most 
important, were my two supervisors, Professor Doug Sellman and Associate 
Professor Simon Adamson. Together with my supervisors, Dr Ria Schroder and 
Professor Chris Frampton, both qualitative and statistical qualitative expert within the 
NAC who has helped me the most with the qualitative section of the study, and I 
thank Ria for her time and dedication. More importantly, all of them were very 
approachable, and I always felt safe to ask numerous questions during our 
discussion sessions. 
A special thank you needs to be mentioned to the many sponsors that have funded 
my study and supported my work over the past 4 years. First are the University of 
Malaya (UM) management and human resource personnel who have allowed me to 
complete my PhD and have always been supportive and understanding. Among 
them are Tan Sri Professor Dr Ghauth Jasmon, the recently retired Vice Chancellor, 
Tan Sri Professor Dr Amin Jalaludin, the current Vice Chancellor, Professor Dr 
Ahmad Hatim Sulaiman, my Head of Department, and the staff in the Human 
Resource Unit of UM. The university supported me fully in my final year of study 
when all my scholarships had ended. Second is the University of Otago for the 
 viii
Postgraduate scholarship and research grant which helped me tremendously in my 
second and third years of study. A special mention is reserved for the NAC and 
Postgraduate Office staff in Christchurch, especially Lindsay Atkins, Lisa Andrews 
and Ruth Helms. Third is the Ministry of Higher Education, Malaysia, which funded 
the first year of my study in New Zealand.    
Finally, thanks goes to my colleagues and friends in New Zealand, especially Dr 
James Foulds from the NAC, and Professor Dr Chris Bullen from the University of 
Auckland, who have always provided me with encouragement. I would like to also 
acknowledge my ‘comrades’ who were completing their PhD’s with me, Ms Peshali 
Fernando and Dr. Deidre Richardson, both of whom spent days and nights writing 
with me, weekends inclusive! The Malaysian community here in Christchurch have 
really assisted me throughout the 4 years. There are so many of these beautiful 
people and I thank you all. However, there are four that require special mention: Dr 
Afida Sohana who helped me adjust back to New Zealand when I first arrived, was 
with me throughout the earthquake period and gave me shelter when my house was 
inhabitable; the brothers, Iskandar and Emir Roseley who lent me their home for a 
year when housing was difficult to find and rent was tremendously expensive; and 
finally Dr Norhasfazilah, who similarly housed me in my last month in New Zealand, 
when short term accommodation was difficult to find. 
This work would not have been able to be completed without the consent, support 
and understanding of the study participants. I hope that this work will be able to 
represent your trust in me during our time together. I also hope, as you did, that this 




Table of Contents 
Abstract ...................................................................................................................... ii 
Preface ...................................................................................................................... iv 
Acknowledgements ................................................................................................. vii 
List of Tables ........................................................................................................... xv 
List of Figures ......................................................................................................... xvi 
List of Publications and Presentations ............................................................... xvii 
Abbreviation List .................................................................................................. xviii 
 
INTRODUCTION 
CHAPTER 1 - Introduction ........................................................................................ 2 
1.1 Thesis Overview ............................................................................................. 2 
 
LITERATURE REVIEW 
CHAPTER 2 – Smoking ............................................................................................. 5 
2.1 Chapter Overview .......................................................................................... 5 
2.2 Smoking, Nicotine Addiction and Tobacco Use Disorder .......................... 5 
 Epidemiology ............................................................................................. 5 
 Framework Convention on Tobacco Control .............................................. 5 
 Smoking Harm ........................................................................................... 6 
 Benefits of Smoking ................................................................................... 8 
 Benefits of Quitting ..................................................................................... 9 
2.3 Smoking as an Addiction ............................................................................ 10 
 Tobacco Use as a Disorder ...................................................................... 10 
 The Role of Nicotine ................................................................................ 11 
 The Role of Genetics ............................................................................... 12 
 The Role of Psychology ........................................................................... 12 
 Nicotine Withdrawal ................................................................................. 13 
2.4 Psychiatry and Smoking ............................................................................. 13 
 Psychiatrists and Tobacco Control ........................................................... 15 
2.5 New Zealand and Tobacco Control ............................................................ 15 
 New Zealand Smoking Developments ..................................................... 15 
 New Zealand Smoking Cessation Services ............................................. 17 
2.6 Summary....................................................................................................... 19 
CHAPTER 3 - Literature Review: Smoking Cessation .......................................... 20 
3.1 Chapter Overview ........................................................................................ 20 
3.2 Definition and Overview .............................................................................. 20 
3.3 Predictors for smoking cessation .............................................................. 22 
 General Predictors ................................................................................... 22 
 x
 Tobacco Related Predictors ..................................................................... 24 
 Psychosocial Predictors ........................................................................... 25 
 Treatment Predictors ............................................................................... 27 
3.4 Usefulness of Smoking Cessation Programs ............................................ 27 
3.5 User Experience ........................................................................................... 28 
3.6 Provider Experience .................................................................................... 30 
3.7 Currently Available Cessation Treatments ................................................ 31 
 Self-Quitting ............................................................................................. 31 
 Behavioural .............................................................................................. 32 
 Pharmacological ...................................................................................... 34 
 Combination ............................................................................................. 38 
3.8 Barriers and Challenges for Smoking Cessation ...................................... 38 
3.9 Summary....................................................................................................... 40 
CHAPTER 4 - Literature Review: Smoking Cessation and Depression .............. 42 
4.1 Chapter Overview ........................................................................................ 42 
4.2 Depression ................................................................................................... 42 
 Epidemiology ........................................................................................... 42 
 Aetiology .................................................................................................. 43 
 Types of Depression ................................................................................ 44 
 Burden of Depression .............................................................................. 46 
4.3 Relationship between Depression and Smoking ...................................... 46 
 Epidemiology ........................................................................................... 46 
 Causality .................................................................................................. 55 
4.4 Depression and Smoking Cessation .......................................................... 58 
4.5 Relationship between Depression and Smoking Cessation .................... 62 
 Do People with Depression Want to Quit Smoking? ................................ 62 
 Does Depression Influence Outcomes for Smoking Cessation? .............. 62 
 Does Smoking Cessation Worsen Depression? ...................................... 64 
 Depression Predicting Smoking Cessation .............................................. 66 
4.6 Summary....................................................................................................... 67 
CHAPTER 5 - Literature Review: Smoking Cessation and Weight Gain............. 68 
5.1 Chapter Overview ........................................................................................ 68 
5.2 The Obesity Epidemic ................................................................................. 68 
 How is the Obesity Epidemic Related to Tobacco? ................................. 69 
5.3 Weight and Smoking ................................................................................... 70 
 The Relationship between Smoking and Weight ...................................... 70 
 Mechanism of Smoking in Weight Control ............................................... 70 
5.4 The Relationship between Weight and Smoking Cessation .................... 73 
5.5 Mechanism for Smoking Cessation Weight Gain ...................................... 74 
 Predictors of Weight Gain among Those Wanting to Quit ........................ 75 
 General Factors ....................................................................................... 75 
 Smoking Factors ...................................................................................... 76 
 Weight Factors ......................................................................................... 76 
5.6 Treatment Availability .................................................................................. 77 
5.7 New Zealand Studies ................................................................................... 80 
 xi
5.8 Summary....................................................................................................... 81 
CHAPTER 6 – Literature Review: Smoking Cessation, Depression and  
Weight Gain ............................................................................................................. 82 
6.1 Chapter Overview ........................................................................................ 82 
6.2 Overview ....................................................................................................... 82 
6.3 Does Weight Gain and Depression Influence Smoking Cessation 
Outcomes .................................................................................................... 85 
6.4 Study Rationale ............................................................................................ 87 
6.5 SCeMES Aims and Objectives .................................................................... 88 
 
METHODOLOGY 
CHAPTER 7 - Methodology: Introduction, Concept and Rationale of use ......... 90 
7.1 Chapter Overview ........................................................................................ 90 
7.2 Description of Mixed Methods Research ................................................... 90 
 Introduction .............................................................................................. 90 
 Definition of Mixed Method....................................................................... 91 
 Paradigm or World View .......................................................................... 92 
 Types of Mixed Method Research Designs ............................................. 94 
 Benefits .................................................................................................... 95 
 Controversies and Critiques ..................................................................... 95 
7.3 Applying Mixed Methods to the SCeMES .................................................. 97 
7.4 Research design .......................................................................................... 98 
 Areas of Mixing ........................................................................................ 98 
 Justification for Using Sequential Explanatory Mixed Method .................. 99 
 Ethics ....................................................................................................... 99 
7.5 The Researcher’s Role ................................................................................ 99 
 The Researcher ..................................................................................... 100 
 The Christchurch Earthquakes ............................................................... 100 
7.6 Mixed Method Purpose Statement ........................................................... 101 
CHAPTER 8 - Smoking Cessation, Mood and Eating Study Quantitative 
(SCeMES-QN) Methodology ................................................................................. 102 
8.1 Chapter Overview ...................................................................................... 102 
8.2 Research Design ........................................................................................ 102 
8.3 Zonnic™ and Patch (ZAP) Study .............................................................. 102 
8.4 Duration ...................................................................................................... 102 
8.5 Recruitment and Site ................................................................................. 103 
8.6 Inclusion and Exclusion criteria ............................................................... 103 
8.7 Measures .................................................................................................... 104 
 Objective Measurements: ...................................................................... 104 
 Questionnaires: ...................................................................................... 105 
8.8 Data Collection ........................................................................................... 109 
 Phase One ............................................................................................. 109 
 Phase Two ............................................................................................. 110 
 Phase Three .......................................................................................... 110 
 xii
8.9 Analysis ...................................................................................................... 112 
CHAPTER 9 - Smoking Cessation, Mood and Eating Study Qualitative 
(SCeMES-QL) Methodology .................................................................................. 114 
9.1 Chapter Overview ...................................................................................... 114 
9.2 Research Design ........................................................................................ 114 
9.3 Recruitment and Sampling ........................................................................ 114 
9.4 Data Collection ........................................................................................... 115 
 Technique .............................................................................................. 115 
 Data Collection Strategies...................................................................... 117 
 Development of Interview Guide ............................................................ 119 
 Data Collection Site ............................................................................... 121 
 Recording the Data ................................................................................ 122 
9.5 Ethical Considerations .............................................................................. 122 
9.6 Methods of Rigor ....................................................................................... 124 
9.7 Reliability .................................................................................................... 124 
9.8 Validation .................................................................................................... 125 
9.9 Analysis ...................................................................................................... 127 
 
RESULTS 
CHAPTER 10 - Quantitative Results (SCeMES-QN) ............................................ 130 
10.1 Chapter Overview ..................................................................................... 130 
10.2 General Sample Profile ............................................................................ 130 
10.3 Baseline Sample Description .................................................................. 131 
 Baseline Smoking Status ..................................................................... 131 
 Baseline Sample Demographic Profile ................................................. 132 
 Baseline Mood Status .......................................................................... 132 
 Baseline Eating Status ......................................................................... 132 
 The Association Between Variables ..................................................... 133 
10.4 Follow-up Sample Description ................................................................ 135 
 Follow-up Retention ............................................................................. 135 
 Characteristics of Participants Who Did Not Attend Any Follow-up  
(n =116) ................................................................................................ 136 
10.5 Retention in the Study ............................................................................. 137 
 Characteristics of Participants at EARLY Follow-up (n =124) .............. 137 
 Characteristics of Participants at LATE Follow-up (n =94) ................... 140 
 Predictors for EARLY and LATE Follow-up .......................................... 141 
 Stepwise Logistic Regression for EARLY Follow-up ............................ 142 
 Stepwise Logistic Regression for LATE Follow-up ............................... 144 
 Summary .............................................................................................. 144 
10.6 Smoking Cessation Outcome ................................................................. 145 
 Smoking Cessation Outcome on Follow-up ......................................... 145 
10.7 Mood ......................................................................................................... 145 
 Depression Diagnosis and Quit status ................................................. 146 
 Depression Diagnosis at EARLY and LATE Follow-up Visits ............... 146 
 xiii
 Baseline Mood and Smoking Cessation Outcomes ............................. 147 
9.6.4 Summary................................................................................................ 148 
10.8 Eating ........................................................................................................ 148 
 Weight Status on Follow-up ................................................................. 149 
 Baseline between Weight and Quit Smoking ....................................... 151 
 Association between Eating Variables and EARLY (n = 124) Quit  
Status ................................................................................................... 152 
 Food Addiction Status on Follow-up ..................................................... 153 
 Summary .............................................................................................. 154 
10.9 The Association between Mood, Weight and Smoking Cessation ...... 154 
 The Association between Depression, Eating and Quit Smoking 
Outcomes ............................................................................................. 154 
 Predictors between Depression and Weight towards Quit Smoking  
Outcomes ............................................................................................. 155 
 Summary .............................................................................................. 156 
10.10 Key Findings ........................................................................................... 156 
CHAPTER 11 - Qualitative Results (SCeMES-QL) .............................................. 159 
11.1 Chapter Overview ..................................................................................... 159 
11.2 Introduction .............................................................................................. 159 
11.3 Setting the Scene ..................................................................................... 159 
11.4 Participant Characteristics ...................................................................... 160 
11.5 Demographic Description Interview Type .............................................. 161 
11.6 Demographic Description of Focus Group ............................................ 162 
11.7 Demographic Description Based on Quit Smoking Outcomes ............ 163 
11.8 SCeMES-QL Interview Findings .............................................................. 164 
 Journey towards Smoking Cessation ................................................... 165 
a. The Outlook to Quitting ............................................................................... 165 
 Matched Expectations .......................................................................... 166 
 Mismatched Expectations .................................................................... 167 
b. The Process of Quitting .............................................................................. 171 
 The Particularities of Quitting Smoking ................................................ 171 
 The Undesired Spin-offs of quitting smoking ........................................ 176 
c. Support ....................................................................................................... 183 
 Summary for Smoking Cessation ......................................................... 189 
11.9 Prejudice ................................................................................................... 190 
11.10 Unprecedented Life Event ..................................................................... 196 
11.11 Summary of “Journey Towards Smoking Cessation” ........................ 200 
 
DISCUSSION, IMPLICATIONS FOR PRACTICE,  
FUTURE RESEARCH AND CONCLUSION 
CHAPTER 12 – Discussion ................................................................................... 203 
12.1 Chapter Overview ..................................................................................... 203 
12.2 Introduction .............................................................................................. 203 
12.3 Main Findings ........................................................................................... 203 
 xiv
 Outcome Measures .............................................................................. 203 
 Depression and Smoking Cessation Outcomes ................................... 204 
 Eating and Smoking Cessation ............................................................ 207 
 The Interrelationship between Depression, Weight and Smoking 
Cessation Outcomes ............................................................................ 211 
 The Experiences of Smoking Cessation in the SCeMES ..................... 211 
12.4 Limitations and Strengths ....................................................................... 216 
 Limitations ............................................................................................ 216 
 Strengths .............................................................................................. 218 
 Future Research .................................................................................. 219 
 Implications for Practice ....................................................................... 221 
12.5 Conclusion ................................................................................................ 222 
References ............................................................................................................. 224 
Appendix A - Publications and Presentations .................................................... 272 
Appendix B - Ethics .............................................................................................. 301 
Appendix C - Consent ........................................................................................... 303 





List of Tables 
Table 3.1 Predictors for Smoking Cessation ............................................................. 22 
Table 4.1: Major depressive disorder symptoms for diagnosis using DSM-IV-TR  
and ICD-10 ......................................................................................................... 45 
Table 4.2: Current smokers with previous history or lifetime depression ................... 49 
Table 4.3: Current smokers with current diagnosis of depression ............................. 53 
Table 4.4: Review article on depression and smoking cessation between 1980 – 
2012 .................................................................................................................... 60 
Table 8.1: Phases of Data Collection ...................................................................... 109 
Table 10.1: Reasons for exclusion from the ZAP Study (and SCEMES-QN) .......... 131 
Table 10.2: Correlation for smoking variables ......................................................... 134 
Table 10.3: Comparison between depression and eating variables for those  
attending baseline visit only (n =116) compared to any follow-up (n =140) ...... 137 
Table 10.4: Association between demographic and smoking variables for  
EARLY (n =124) and lost to follow-up (n = 132) ............................................... 139 
Table 10.5: Association between mood and eating variables for EARLY (n=124)  
and lost to follow-up (n = 132)........................................................................... 140 
Table 10.6: Association between demographic and smoking variables for LATE  
(n = 94) and lost to follow-up (n = 162) ............................................................. 141 
Table 10.7: Demographic predictors of follow-up .................................................... 142 
Table 10.8: Smoking predictors of follow-up ........................................................... 143 
Table 10.9: Mood predictors of follow-up ................................................................ 143 
Table 10.10: Eating predictors of follow-up ............................................................. 144 
Table 10.11: Prevalence of depression at four visits ............................................... 146 
Table 10.12: Prevalence of depression for EARLY and LATE follow-up ................. 146 
Table 10.13: Association between baseline mood variables and EARLY  
(n = 124) quit smoking outcome and LATE (n=94) ........................................... 148 
Table 10.14: Paired t-test Eating Variables Between Baseline and Follow-up ........ 149 
Table 10.15 Association between baseline eating variables and EARLY quit  
smoking outcome .............................................................................................. 153 
Table 10.16: Diagnosis of food addiction at each visit ............................................. 154 
Table 10.17: Logistic regression for mood and eating and EARLY quit smoking 
outcome ............................................................................................................ 155 
Table 10.18: Logistic regression for mood and eating and LATE quit smoking 
outcome ............................................................................................................ 156 
Table 11.1: Description of participants interviewed individually compared to  
those interviewed in FG .................................................................................... 162 
Table 11.2: Abstainers compared to smokers in SCeMES-QL ................................ 164 
Table 11.3: Matrix display for the theme ‘The Outlook to Quitting’ .......................... 170 
 xvi
Table 11.4: Matrix display for the theme Process of Quitting .................................. 182 
Table 11.5: Matrix display for the theme Support .................................................... 188 
Table 11.6: Matrix display for the theme Prejudice .................................................. 195 
Table 11.7: Matrix display for the theme Prejudice .................................................. 199 
 
 
List of Figures 
Figure 5.1: Arcuate POMC Neurons Integrate a Diverse Set of Excitatory and 
Inhibitory Signals Involved in the Central Regulation of Energy Balance ............ 72 
Figure 7.1: The Purposive-Mixed Probability Sampling Continuum ........................... 93 
Figure 7.2: Flow of MM Research Design ................................................................. 98 
Figure 8.1: Flow for the SCeMES-QN Data Collection ............................................ 110 
Figure 9.1 : Recruitment for SCeMES-QL ............................................................... 115 
Figure 10.1: HADSD mean score trend between baseline and follow-ups .............. 147 
Figure 10.2: Mean weight at baseline, EARLY and LATE follow-up ........................ 149 
Figure 10.3: Mean score QSCRF for baseline, EARLY and LATE follow-up ........... 150 
Figure 10.4: Mean score NEEDNT between baseline, EARLY and LATE  
follow-up ........................................................................................................... 151 
Figure 10.5: Baseline and EARLY weight (kgs) and quit smoking outcome ............ 152 




List of Publications and Presentations 
Publications 
1. Amer Nordin, A., Adamson, S., & Sellman, J. (2017). Food Addiction Does Not 
Explain Weight Gain in Smoking Cessation. Journal of Smoking Cessation, 1-
4. doi:10.1017/jsc.2017.4 
2. Amer Siddiq Amer Nordin, J D Sellman, S Adamson. The role of psychiatrists 
in tobacco dependence treatment. Asean Journal of Psychiatry, Volume 16, 
January to June 2015, issue No.1 
Presentations 
1. Weight, Food Addiction and Quitting Smoking., 18th Malaysian Conference on 
Psychological Medicine and the 1st Asian Federation of Psychiatrists 
Associations regional Meeting, 23 May 2014 to 24 May 2014, Malaysian 
Psychiatric Association 
2. Amer Siddiq Amer Nordin. Smoking Cessation, Depression and Weight. 
Addiction Treatment Research News (2011), Vol 15(1) pg 6  
3. Amer Siddiq Amer Nordin, Simon Adamson, Doug Sellman. A Mixed Method 
Approach in the Study of Depression in Patients Undergoing Tobacco 
Cessation Treatment. Addiction Research Symposium, 15 August 2011, 





BDNF  Brain Derived Neurotropic Factor 
BMI  Body Mass Index 
BRFSS  Behavioural Risk Factor Surveillance System 
CES-D  Centre for Epidemiology Depression Scale 
CHDS  Christchurch Health and Development Study 
CIDI  The World Mental Health Composite International Diagnostic 
Interview 
COI  Cost-of-illness 
COPD  Chronic Obstructive Pulmonary Disease 
CPD  Cigarettes per Day 
DHB  District Health Board 
DSM  Diagnostic Statistical Manual for Mental Illness  
FCTC  Framework Convention on Tobacco Control 
FDA  Food Drug Administration 
FTND  Fagestrom Test for Tobacco Dependence 
GDP  Gross Domestic Product 
HIC  High Income Countries 
ICD  International Classification for Disease 
ITC  International Tobacco Control 
LMIC  Low Middle Income Countries 
MASC  Māori Affairs Select Committee 
MC  Melanocortin System 
MDD  Major Depressive Disorder 
m-dep  Minor Depression 
mYFAS  Modified Yale Food Addiction Scale 
MI  Motivational Interviewing 
MM  Mixed Methods Study 
MSA  Master Settlement Agreement 
nAchR  nicotinic acetylcholine receptors 
NHANES  National Health and Nutrition Examination Survey 
NHES  National Health Examination Survey 
NHS  National Health Service 
NPY  Neuropeptide-Y 
NRT  Nicotine Replacement Therapy 
 xix
PET  Positron Emission Tomography  
PHO  Primary Health Organization 
POMC  Pro-opiomelanocortin 
POS  Point-of-Sale 
RCT  Randomized Controlled Trials 
RP  Relapse Prevention 
SCeMES  The Smoking Cessation, Mood and Eating Study 
SCeMES-QL  SCeMES – Qualitative Study 
SCeMES-QN  SCeMES – Quantitative Study 
SCID  Structural Clinical Interview for DSM-IV 
SFE  Smoke-Free Environment Act 
SHS  Second-hand smoking 
SSRI  Serotonin Selective Reuptake Inhibitor 
TTS  Tobacco Treatment Specialists 
UN  United Nations 
WHO  World Health Organization 
WMH  WHO World Mental Health Survey 













 CHAPTER 1 - Introduction 
1.1 Thesis Overview 
At a high level United Nations (UN) meeting in 2012 concerns were raised regarding 
non-communicable diseases (NCDs), only the second time a health issue was 
discussed by the UN (Bonita et al., 2013). Specifically mentioned during the meeting 
were the concerns for tobacco, unhealthy eating and alcohol as major risk factors for 
health complications such as cardiovascular disease, chronic pulmonary lung 
diseases, mental illness and cancers.  
The smoking epidemic is a crucial health problem today. The role of psychiatry and 
psychiatrists in the management of smoking was tenuous to say the least. It is 
important for tobacco control advocates to have a greater understanding on how 
tobacco use affects the mental health population. This is especially significant 
considering that New Zealand is one of the leading countries in tobacco control policy 
(Blakely, Thomson, Wilson, Edwards, & Gifford, 2010; Thomson, Edwards, Wilson, & 
Blakely, 2012). As more people become aware of the dangers of smoking and the 
benefits of quitting, they may also become motivated to quit.  
Quitting smoking has been reported to lead to mood changes and weight gain 
(Ministry of Health, 2007). Although detrimental in their own right, both conditions 
have been reported to negatively impact quit attempts (Flegal, 2012; Ziedonis et al., 
2008). More important was the relationship between quitting smoking, depression 
and weight gain and how these experiences affected, if any, those wanting to quit. 
Therefore a study was designed, using mixed methods research (MM), using both 
numbers and narrative, to investigate this observation in order to better understand 
this issue among smokers quitting in Christchurch. 
The research work for this thesis was a study termed the Smoking Cessation, Mood 
and Eating Study (SCeMES). This study involved 256 smokers who were attempting 
to quit smoking in a smoking cessation program. The study also involved 
investigating the impact of depression and weight on participants wanting to quit 
smoking. At the same time, unbeknown to many, the nation was also preparing itself 
for the Smoke-free 2025 project. In addition, the Christchurch earthquakes 
happened, and both of these events affected the participants in this study although 
this was not known at the time. 
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This thesis is divided into twelve chapters. The first chapter is the introduction. It 
introduces the chapters that will follow and the scope of each chapter.  
Chapter’s two to six consider the main literature on the variables of interest: smoking 
and nicotine addiction (Chapter 2), smoking cessation (Chapter 3), mood (Chapter 4) 
and eating (Chapter 5).The final chapter in this section examines the literature linking 
both mood and eating together with quitting smoking (Chapter 6). This chapter ends 
with an introduction to the general concept of the SCeMES. 
The next three chapters (seven to nine) are the methodology section. In chapter 
seven, the mixed method research (MM) is introduced. This chapter includes a brief 
description of MM, methods to apply MMR and the many MMR designs. This chapter 
describes the researchers’ perspectives or positions within the research context. At 
the end, the MM purpose statement is also presented. Chapters eight and nine are 
the methods chapters for both the SCeMES quantitative study (SCeMES-QN) and 
the SCeMES qualitative study (SCeMES-QL). This is followed by chapters ten and 
eleven which are the results of both SCeMES-QN and SCeMES-QL respectively.  
The final chapter (Chapter 12) include both the discussion and conclusion. This 
section attempts to make sense of the data and to determine whether the research 













 CHAPTER 2 – Smoking 
2.1 Chapter Overview 
This chapter introduces the epidemic of smoking and the impact it has to individuals 
who smoke which include both health and non-health harms. This chapter also 
provides an explanation on the reasons why people smoke and the justification on 
why smoking is an addiction. The role of nicotine will be introduced and its role in 
addiction is explored. The field of tobacco control is also introduced in this chapter 
and what New Zealand has contributed to the field of smoking cessation.  
2.2 Smoking, Nicotine Addiction and Tobacco Use Disorder 
 Epidemiology 
According to the World Health Organization (WHO), there are more than one billion 
smokers worldwide (World Health Organization, 2011c). This number will continue to 
grow as the tobacco industry moves its operations to the Asia-Pacific region (Thun, 
Peto, Boreham, & Lopez, 2012). Smoking is the most common form of tobacco use 
and is the number one public health problem in the world, being likened to an 
“epidemic of death” (Doll, Peto, Wheatley, Gray, & Sutherland, 1994). Six million 
people die yearly worldwide from tobacco related deaths, and this number is 
estimated to reach 10 million by 2030 (Michael; Eriksen, Mackay, Schluger, Islami, & 
Jeffrey., 2015). For every one death, a further 20 people are affected by smoking 
related health problems (Centers for Disease Control and Prevention, 2003). As a 
consequence of this harm to health and the cost that ensues, various tobacco control 
initiatives have been put in place by governments worldwide. Tobacco control 
activities include controlling tobacco use through prevention, and assistance in the 
treatment of those affected by tobacco use. 
 Framework Convention on Tobacco Control 
In 2004 the WHO ratified its first ever legally binding treaty: the Framework 
Convention on Tobacco Control (FCTC) (World Health Organization, 2003). One 
hundred and seventy-three countries worldwide are signatories to this document 
(World Health Organization, 2011c). Member countries of the FCTC are expected to 
play their role in reducing the prevalence of smoking in their respective countries. 
The FCTC, in its working document, produced a number of Articles to reach this 
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objective, with the core demands listed in Articles 6-17 of the document (World 
Health Organization, 2003). These core demands are summarised in the MPOWER 
measures produced by the same group, and include monitoring tobacco use and 
prevention policies;, protecting people from tobacco smoke;, offering help to people 
wanting to quit tobacco use; warning about the dangers of tobacco use; enforcing 
bans on tobacco advertising, promotion and sponsorship; and, finally, raising taxes 
on tobacco (World Health Organization, 2008). Using the measures of MPOWER and 
guided by the Articles within the FCTC document, member countries are able to 
standardise and improve existing policies, assist one another in tobacco control 
activities and apply best practice strategies. Although a number of countries are still 
trying to implement and enforce strategies within the FCTC, there are some, led by 
New Zealand, which hope to be smoke-free by 2025 and are starting to think about 
the end of tobacco use in their countries (Blakely et al., 2010; Thomson et al., 2012). 
 Smoking Harm 
2.2.3.1 Direct Harm 
The landmark study on British doctors by Doll and Hill (1956) linking smoking to lung 
cancer, and the influential report by the US Surgeon General (1964) comprised of 
studies on the many health consequences of cigarette smoking at the time, heralded 
the beginning of the rapid acceleration on tobacco control activities. Smoking kills 
half of its users when used as intended through the various toxins in tobacco 
(Eriksen, Mackay, & Ross, 2012). It has been found that 7000 toxins, such as 
butane, ammonia and others, are released during tobacco smoking, and of these, 69 
have been found to be carcinogenic (Eriksen et al., 2015). The main cause of health 
problems starts with the ‘tar’ within the smoke as a result of smoking tobacco. The 
main health burden and harm associated with smoking is cancer, particularly in the 
lung (Eriksen et al., 2015). Smokers have been estimated to die, as much as 10 
years earlier than non-smokers (Doll, Peto, Boreham, & Sutherland, 2004). There 
have been many other studies since, linking smoking with various other health 
problems. The US Surgeon General’s report (2004), for instance, highlighted 
substantially and conclusively evidence that smoking causes cardiovascular diseases 
such as myocardial infarction and atherosclerosis; respiratory diseases such as 
chronic obstructive pulmonary disease (COPD); and cancers, other than lung cancer, 
such as laryngeal and esophageal cancers. Smoking has also been linked to poorer 
mental health (Blakely et al., 2010), mental illnesses such as depression (Boden, 
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Fergusson, & Horwood, 2010), a decline in memory (Dregan, Stewart, & Gulliford, 
2012), and poorer outcomes in pregnancies (Cnattingius, 2004). Those with mental 
illness due to their higher smoking prevalence (Lawrence et al., 2009) and cigarette 
consumption (Lasser et al., 2000; Tobias, Templeton, & Collings, 2008) die even 
earlier (Parks, Svendsen, Singer, Foti, & Mauer, 2006). 
2.2.3.2 Indirect Harm 
Apart from direct harm to individuals who smoke, smokers also harm those around 
them. When non-smokers are exposed to cigarette smoke, they are technically 
involuntary smokers or engaged in second-hand smoking (SHS) (U.S. Department of 
Health and Human Services, 2006). SHS is reported to be as dangerous as first-
hand smoking and is thought to cause half as much harm to those exposed to it (U.S. 
Department of Health and Human Services, 2006). Of late, there are reports of third-
hand smoking (THS) (Sleiman et al., 2010). In this situation the residue of cigarette 
smoking is left behind on everyday items such as car upholstery, house curtains and 
bedding, and other furniture. Once enough smoking residue is available, it can either 
cause health problems on its own or by ‘off-gassing’ (Dreyfuss, 2010), whereby these 
residues are released back in the air as gases (Sleiman et al., 2010). Both modes of 
action lead to cigarette smoke causing harm long after the smoker has completed 
smoking. Once these gases are released into the air, they can interact with other 
gases and continue to cause harm. For example, when nitrous oxide interacts with 
third-hand smoking, nitrosamines, a known carcinogen, is created (Becquemin et al., 
2010; Sleiman et al., 2010).  
2.2.3.3 Economic Harm 
There is enough evidence to suggest that cigarette smoking has a causal relationship 
with adverse health outcomes, including cancer care (Health & Services, 2014). 
Smoking is costly to countries economically. Cancer care in the United States alone, 
for instance, costs USD120 billion in 2010 (Mariotto, Robin Yabroff, Shao, Feuer, & 
Brown, 2011). The cost in Europe, in terms of cost of medication to treat cancer, 
based on data from 19 selected European countries, is estimated to be 71 billion 
equivalent dollars (Jönsson, 2007). These costs can be expected to increase with 
population growth (Mariotto et al., 2011), especially with the expected increase in 
smoking prevalence in Asia-Pacific countries, including China and India, the two 
most populated nations on earth. Sadly, however, history has shown that there is a 
lag time of 30-40 years before tobacco related mortalities and morbidities peak (Thun 
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et al., 2012) and, therefore, health resources of the future will be increasingly 
strained. Apart from the economic cost as a result of increasing health costs, 
smoking also affects costs related to worker productivity. This was measured through 
either smoking breaks, time off work due to illness, or even early retirement due to 
smoking related illnesses (Allender, Balakrishnan, Scarborough, Webster, & Rayner, 
2009; Bunn III, Stave, Downs, Alvir, & Dirani, 2006; Halpern, Shikiar, Rentz, & Khan, 
2001; Neubauer et al., 2006). Equally important, were smoking related fires which 
were often not well studied (Leistikow, Martin, & Milano, 2000; Smith, Bullen, 
Laugesen, & Glover, 2009). It was estimated that 1% of fires worldwide and 10% of 
fire deaths were due to cigarette smoking (Leistikow et al., 2000). Transportation to 
healthcare providers; the care and cost to non-healthcare providers such as time off 
to care for sick family members due to smoking; cleaning cloths and air due to 
smoking for both personal property and corporations; business expenses for 
companies to replace or retrain replacement workers; and insurance premiums for 
both fire and accidents were also non-health related economic burdens of smoking 
(World Health Organization, 2011b). 
 Benefits of Smoking 
Although much had been mentioned regarding the harms of smoking, there are 
reports of possible benefits of smoking (Barbash et al., 1995). These findings were 
termed the “smoker’s paradox” (Barbash et al., 1995) after Nesbitt’s P, which has 
been described as a pool of inter-related data which did not make sense (Parrott, 
1998). Nicotine on its own has been shown to have some benefits such as assisting 
in weight control, normalizing irritable mood, enhancing of performance both physical 
(to an extent) and concentration; and improving certain health conditions, for 
example Parkinson’s disease and Alzheimer’s disease (Jarvik, 1991). Smoking 
cigarettes, however, has been found to be detrimental to human health as mentioned 
earlier. Despite the well documented harms of smoking, there are reports of smokers 
doing better compared to non-smokers. Areas where this has been reported are in 
acute myocardial infarct (AMI) recovery (Nakaji et al., 2003), the low development of 
colorectal cancers (Terry & Neugut, 1998) and in reducing pre-eclampsia incidences 
(Cnattingius, Mills, Yuen, Eriksson, & Salonen, 1997). These reports, however, have 
since been invalidated, as more recent evidence has suggested that there might be 
confounders, such as age, to explain the apparently positive effects of smoking 
(Dahabreh & Kent, 2011; A. C. Parrott, 1998). In one particular explanation for the 
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findings of an apparent positive outcome, for the lower mortality amongst AMI 
patients who were smokers versus non-smokers, it was found that smokers tended to 
develop AMI at a young age and therefore were more favourable towards treatment, 
which might have explained the more positive outcomes (Aune, Røislien, Mathisen, 
Thelle, & Otterstad, 2011). In conclusion, although there are reports suggesting that 
smoking might have some benefits in certain conditions, current evidence suggests 
the harms far outweighs any potential benefit to health (Health & Services, 2014). 
 Benefits of Quitting 
2.2.5.1 Health Benefits 
Quitting smoking undisputedly has many benefits. Although smoking is directly 
associated with many illnesses, some of these conditions are reversible, such as 
Crohn’s disease and coronary heart disease, where the risk to a smoker, after 
quitting smoking for one year and fifteen years respectively, is equal to a non-smoker 
(Fagerstrom, 2002). Taylor et al. (2002), in their analysis on data from the Cancer 
Prevention Study II in the US involving 1.2 million participants, reported that the 
earlier one quits smoking, the greater the benefits to health. Quitting before the age 
of 35 years improved life by an additional 7-8 years. Health gains were also noted at 
any time point on quitting. Short-term health benefits were noted in respiratory and 
cardiovascular improvements. Respiratory symptoms improved by 5% within a few 
months and this improvement was cumulative. For those with cardiovascular disease, 
a 50% risk reduction was observed after only one year of abstinence, and the risk for 
cardiovascular diseases became similar to non-smokers after 15 years of being 
abstinent. Cancer risk, however, never dropped to the level of non-smokers, though it 
was lowered.  
The benefit of lower death related to any cancer occurs as early as five years of 
abstinence (Kenfield, Stampfer, Rosner, & Colditz, 2008). Even for those with early 
diagnosis of lung cancer, quitting reduces mortality and recurrence compared with 
continued smokers (Parsons, Daley, Begh, & Aveyard, 2010). Other health benefits 
include an improvement in quality of life (Anthonisen et al., 2005; Mulder, Tijhuis, 
Smit, & Kromhout, 2001). 
2.2.5.2 Economic Benefits 
There is clear evidence that there are long-term economic benefits in quitting 
smoking as a result of improved health, and fewer smoking related complications in 
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the future. The short-term economic benefits of quitting smoking, however, can be 
more difficult to measure (Menzin, Lines, & Marton, 2009). One example of a short-
term benefit is work absenteeism. Studies examining smoking cessation and work 
productivity have shown that the cost of loss of productivity is similar for those who 
no longer smoke, as early as four years post-quitting, to non-smokers (Halpern et al., 
2001). Therefore, employers that encourage their workers to quit smoking will be 
able to gain cost benefits in the short term as a result of better work productivity. 
Apart from public health interventions mentioned earlier, the use of current available 
smoking cessation treatments overall have been shown to be cost effective 
compared to smokers quitting on their own (West et al., 2015). Studies examining the 
cost benefits of various treatments have also been positive (Howard, Knight, Boler, & 
Baker, 2008; Menzin et al., 2009; Song et al., 2002) with the latest treatment 
available, varenicline, predicted to surpass all the present treatments available 
(Howard et al., 2008). To conclude, quitting smoking is clearly beneficial both 
economically and for health.  
2.3 Smoking as an Addiction 
There has been considerable debate on whether smoking is an addiction or a habit, 
however, this was put to rest with the publication of the Surgeon General Report 
(Health & Services, 2014). Since then, there has been much research on the 
mechanism of addiction and its role in smoking. As explained in later sections of this 
chapter, nicotine is implicated as the main chemical of addiction leading to the 
maladaptive and repeated use of smoking, apart from the challenges to quit as a 
result of withdrawals (Henningfield, 2000). People who smoke were found to develop 
characteristics of addiction such as salient behaviour, dyscontrol, compulsive use 
and finally physiological changes (Sellman, 2007). Moreover, the availability and lack 
of restrictions on its use together with an industry that markets smoking to be 
desirable, increases its addictive potential through psychological processes, all of 
which will be elaborated further below. 
 Tobacco Use as a Disorder 
The use of tobacco was first considered a disorder with its introduction into the 
International Classification for Disease (ICD). The ICD is used to code and classify 
both morbidity and mortality data. The notion that smokers can have problems with 
their tobacco use was included in the ninth edition of the ICD as tobacco use disorder 
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(Slee, 1978). The Diagnostic and Statistical Manual (DSM), a manual that classifies 
and describes mental disorders, classified the same problem in its third edition 
(1980) as tobacco dependence (American Psychiatric Association, 1980). This was 
subsequently changed to nicotine dependence in the revised version in 1987 (Sees, 
1990). Both the ICD tenth edition and the DSM fourth edition use nicotine 
dependence as its terminology (American Psychiatric Association, 2000; World 
Health Organization, 1993). Both of these major classification systems described this 
disorder as an addiction; with characteristic symptoms of tolerance, withdrawal and 
salience. In 2013, the DSM-IV-TR was replaced with the DSM 5 which saw the 
introduction of nicotine use disorder as the diagnosis to denote an addiction to 
tobacco. For the DSM 5, the item ‘craving’ was reintroduced as a criterion for 
diagnosis, which is an essential feature in the understanding of nicotine dependence 
(Shmulewitz et al., 2013) and therefore much welcomed within the field.  
 The Role of Nicotine 
Cigarette smoking is the most common form of tobacco ingestion worldwide (Eriksen 
et al., 2015). Although tobacco contains a number of toxins, it is the nicotine within 
tobacco which is the main driver (positive reinforcement agent) for this addiction. 
Nicotine is rapidly absorbed by the lungs through smoking and reaches the brain as 
quickly as ten seconds post inhalation (Henningfield, 1995). The addictive properties 
of nicotine are thought to be related to the release of dopamine in the anterior 
midbrain when binding to nicotinic acetylcholine receptors (nAchR), particularly the 
α4β2 nAchR. The dopamine released then binds to receptors in the meso-limbic 
dopaminergic neuron system, thus signalling salience and pleasure. As nicotine is 
rapidly broken down, the effects are short. Unlike other receptors, which often down-
regulate when there is an increase in external substrate such as nicotine, in the case 
of smoking, the nAchR up-regulates in response to external nicotine ingestion 
(Wonnacott, 1990). As a result, more nicotine is required to produce the same 
positive effect when smoking, and in order to achieve this more cigarettes are 
needed. This phenomenon also illustrates how tolerance develops due to smoking. 
Subsequently, a lack of nicotine causes withdrawal symptoms to be experienced on 
smoking cessation (Laviolette & Van Der Kooy, 2004). In explaining addiction, 
O'Loughlin et al.,(2009) argued that one can possibly be addicted to nicotine from the 
first cigarette within 3 months, whereas Scragg, Wellman, Laugesen, and DiFranza 
(2008), found this to be true as early as 1 month. Russell (1990), on the other hand 
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reported that three to four cigarettes are required to result in dependence. All three 
studies were conducted among children (ages between 10- 13) using self-reported 
smoking status and levels of dependence using different questionnaires. What 
exactly constitutes “addiction” is not yet precisely defined neurophysiologically due to 
the manner in which tobacco is ingested, i.e. smoked. Its availability and the 
possibility to ingest multiple and frequent doses to the brain might influence its level 
of addictiveness. This has led some to describe tobacco use to be as addictive as 
heroin, cocaine or amphetamines (Stolerman & Jarvis, 1995). When paired with other 
pleasurable activities, such as eating and drinking alcohol, addiction is consolidated 
and therefore becomes even more difficult to give up. Advanced, real time imaging, 
using positron emission tomography (PET) has been able to show higher dopamine 
levels in living tissues in those addicted to nicotine, similar to those using drugs such 
as amphetamine or cocaine. The mechanism of action, however, may be different 
(Gerasimov, 2000; Volkow, Fowler, & Wang, 1999). 
 The Role of Genetics 
Genetics play an important role in the aetiology of nicotine addiction. Numerous 
studies using twin, adoption and other methods have found the role of genetics in 
nicotine dependence to be between 30-70% (Agrawal et al., 2012; Hall, 2005; Hall, 
Madden, & Lynskey, 2002; Li, 2006). Therefore, addiction is not merely a passive 
physiological process, but rather a complex and multifaceted condition (Gifford & 
Humphreys, 2007; Koob et al., 2013). In genetic research, researchers have 
identified candidate genes for nicotine dependence (Agrawal et al., 2012), the most 
robust being the chromosome 15 variant candidate gene (Agrawal et al., 2012). 
However, it is still thought that multiple genes interact collectively to produce a 
vulnerability to nicotine addiction in any one individual (Hall, 2005). 
 The Role of Psychology 
An understanding of the natural history of smoking might allow an understanding of 
the psychosocial factors in smoking. Lichtenstein (1982), summarised the natural 
history as having four stages: initiation, maintenance, cessation and resumption/ 
relapse. In his summary, the author emphasised the role of psychosocial factors as 
critical in initiating and stopping smoking. The initiation of smoking, although 
influenced by genetics, is largely a psychosocial process, an idea supported by social 
learning theory, especially expectancy, self-efficacy, coping and craving (Brandon, 
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Herzog, Irvin, & Gwaltney, 2004). Using this model, the authors argued that the 
expectation that the drug produces ‘pleasurable experiences’ has positive effects to 
initiate consumption. Both positive and negative reinforcement models (Eissenberg, 
2004; Glautier, 2004; Tiffany, Conklin, Shiffman, & Clayton, 2004) maintain addiction 
by frequent nicotine use producing both pleasurable experiences on consumption 
and negative withdrawal symptoms on stopping. This process is strengthened 
through an unconscious learning process involving cognitive processing and 
neurobiological changes (Gifford & Humphreys, 2007; Laviolette & Van Der Kooy, 
2004; Tiffany et al., 2004).  
 Nicotine Withdrawal 
Withdrawal symptoms are symptoms which manifest on ceasing the use of an 
addictive agent once neuroadaptation has occurred. According to the DSM, nicotine 
withdrawal symptoms include irritability, anxiety, problems concentrating, 
restlessness, decreased heart rate, increased appetite or weight gain, dysphoric 
mood, and difficulty in sleeping, which might occur following cessation after twelve 
months or more of use. These symptoms are associated with daily use of nicotine 
and are relieved or avoided by retaking nicotine (American Psychiatric Association, 
2000). These symptoms are also similar to those described in the ICD (World Health 
Organization, 1993). 
Most withdrawal symptoms last for a short period of time, whilst others might last 
longer and cause further complications such as a mood disorder or excessive weight 
gain (Ministry of Health, 2007). Current smoking cessation guidelines include 
suggestions to manage these complications, as many who attempt to quit smoking 
report being concerned about their mood changes and weight gain. Yet, some of 
these withdrawal symptoms, such as constipation and respiratory tract infection 
among others, have not been fully studied to date (Ministry of Health, 2007; West, 
Ussher, Evans, & Rashid, 2006). 
2.4 Psychiatry and Smoking 
Although addiction and its management are within the field of psychiatry, nicotine 
addiction has received little attention. Those with mental illness are two to three times 
more likely to smoke than those without (Lawrence et al., 2009; Ziedonis et al., 
2008). Conditions such as schizophrenia are associated with a smoking prevalence 
of up to 85% (Prochaska, Hall, & Bero, 2008; Ziedonis et al., 2008). Those with 
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schizophrenia also smoke heavily (defined as smoking more than 25 cigarettes per 
day) (Lasser et al., 2000; Ziedonis, Williams, & Smelson, 2003), have higher 
dependence or severity scores compared to the general public (Lohr & Flynn, 1992), 
and have also been found to be more “efficient smokers,” able to extract and absorb 
more nicotine from each cigarette puff (Olincy, Young, & Freedman, 1997). People 
with mental illness constitute 16% of the New Zealand population (Ministry of Health, 
2012), but smoke 33% of the cigarettes consumed in the country (Tobias et al., 
2008). In the United States, 44% to 58% (Grant, Hasin, Chou, Stinson, & Dawson, 
2004; Lasser et al., 2000) of all cigarette sold, are consumed by the estimated 25% 
of the population who have a mental illness (Center for Disease Control and 
Prevention, 2013).  
Although smoking is highly prevalent and the consequences very debilitating, 
psychiatry has generally neglected nicotine dependence and its relationship with 
people with mental illness (Moss et al., 2010). It is common for people with mental 
illness to be excluded from smoking cessation trials, and often excluded from quit 
smoking initiatives altogether (Hall, 2007; Hall & Prochaska, 2009). Some 
professionals refer to this group as the “underserved” population (Borrelli, 2010), 
together with other groups, such as the low-socioeconomic population. The 
underserved often report a higher prevalence of smoking compared to the general 
population, and more difficulties in quitting smoking (Borrelli, 2010). 
Tobacco use and its treatment are underemphasised in psychiatry. One obvious 
example is the slowness to establish smoke-free inpatient services. Despite many 
countries having environmental or similar laws to prevent smoking in closed buildings 
such as hospitals (Malone & Warner, 2012), not all inpatient psychiatric facilities are 
smoke-free (Lawn, 2007). Those in psychiatry also need to be better equipped with 
tobacco control strategies as recommended by the FCTC (such as increasing taxes 
and expansion of smoke free areas for example), (World Health Organization, 2003) 
to better protect the health of people with mental health who smoke. Moreover, 
quitting smoking improves mental health rather than worsen it (Taylor et al., 2014), 
contrary to what those in mental health think (Prochaska, 2011). In Christchurch, 
New Zealand, it has taken half a decade longer for all mental health services to be 
smoke-free, achieving this in 2010, compared to all other health services within the 
New Zealand public hospitals, which have been smoke-free since 2004 (Canterbury 
District Health Board, 2010; Ministry of Health, 2003). 
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 Psychiatrists and Tobacco Control 
Psychiatrists, although able to provide smoking cessation towards patients under 
their care who smoke have only recently begun to consider their possible 
contributions (Moss et al., 2010). A review of the literature identified a number of 
perceived barriers to action which include failure to inculcate interest to conduct 
smoking cessation among psychiatrists at the outset of their training, the lack of 
interested supporting staff, and/or the unavailability of appropriate infrastructure 
(Amer Siddiq et al., 2015). This review concluded that psychiatrists need to put 
tobacco dependence on par with other mental illnesses that they treat daily and also 
keep updated with the latest treatment modalities available so as to better equip 
themselves to provide assistance to their patients when opportunities arises. 
2.5 New Zealand and Tobacco Control 
 New Zealand Smoking Developments 
New Zealand has made a lot of progress in terms of tobacco control in recent 
decades, both within the country and globally. The history of this progress has been 
previously documented (Cancer Council New Zealand, 2008; George & Nicholas, 
1997). However, this section will briefly describe what has been done in the past, 
before describing current developments happening in New Zealand. 
Prior to the 1960s, tobacco control activity in New Zealand was almost non-existent. 
As scientific evidence on the harm of smoking emerged from the 1960s through the 
early 1980s, tobacco control activities started to take shape and have continued to 
evolve since. The increase in scientific evidence on the harm that smoking has on 
health, most likely affected the medical physician population at the time, as smoking 
prevalence amongst physicians was reported to be as high as 39.3% in 1963, but 
had reduced to 20% by 1976 (Cancer Council New Zealand, 2008). In 2012, this 
number was reported to be less than 5% (Edwards et al., 2012). In 1976, as a result 
of the awareness of the dangers of smoking, the health census included smoking 
status, probably the first time in the world that this information was captured in a 
national census. Since then, a number of initiatives were implemented until the early 
1990s, leading to a drop in the national smoking prevalence from 32% in 1984 (which 
had been > 30% since the 1970s) to 27% within a five year period.  
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The emerging evidence and awareness of the dangers of tobacco smoking, 
especially in public, was a significant factor in the success towards implementing the 
Smoke-Free Environment Act (SFE) 1990 in New Zealand. This Act was further 
amended to support more initiatives such as increasing the purchasing age from 16 
to 18 years of age (SFE 1999), smoke-free restaurants and bars (SFE 2003) and; the 
point-of-sale bans (POS) (SFE 2012) (Cancer Council New Zealand, 2008; Māori 
Affairs Select Committee, 2010). Also in the 1990s, two other leading developments 
occurred: the introduction of the first clinical guideline to manage tobacco 
dependence, and the establishment of the Quitline service. These two initiatives 
foreshadowed the beginning of cessation activities in New Zealand. Most of the 
previous activities were preventive in nature. The combination of both arms of 
tobacco control in New Zealand, both prevention and cessation activities, pushed the 
tobacco agenda forward further in the country. Aukati Kai Paipa, a smoking cessation 
initiative for Māori was also introduced during this period. Māori, unfortunately, had 
been over-represented in the New Zealand smoking epidemic and were reported as 
having serious health outcomes as a consequence (Stevens, Stevens, Kolbe, & Cox, 
2008). Similar information and concerns were precursors for the eventual Māori 
Affairs Select Committee (MASC) report (Blakely et al., 2010).  
The last 20 years have seen a greater shift in public opinion towards tobacco control 
issues in New Zealand. This shift has allowed for more support and is probably a 
major reason for successful regular SFC amendments to reduce the prevalence of 
smoking even further, despite opposition from business owners and other relevant 
stakeholders with interest (Edwards, Wilson, Thomson, Weerasekera, & Blakely, 
2009). This unwavering support has also allowed for further tax increases on tobacco 
from the early 2000s which are still on-going. The latest strategy for tax increases 
includes a progressive increase of 10% yearly for a three year period and 
reassessed every three years, as opposed to a yearly increase (Wilson & Thomson, 
2005; Wilson et al., 2010). A three-yearly incremental increase allows the tax raise 
agenda in MPOWER to be included consistently, as a means to further reduce 
smoking prevalence. The scientific evidence of health inequalities due to smoking 
has also led to the push of the MASC report, which has called for a Smoke-free New 
Zealand by 2025 (Smoke-free 2025) through objectives such as protecting children 
from tobacco exposure and marketing, reducing supply and demand of tobacco 
products and, finally, increasing quit attempts through successful evidence based 
treatments (Māori Affairs Select Committee, 2010). The MASC report 
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recommendation was the first report on smoking adopted by an elected government, 
and solidified New Zealand’s reputation as leader in tobacco control innovations and 
initiatives. 
The MASC report allowed tobacco control activities to increase in pace. Two of the 
immediate outcome measures were to halve smoking prevalence by 2015, and to 
aim for less than 5% prevalence by 2025 (Blakely et al., 2010). Since the 
implementation of the MASC report, increased tobacco control activities have shown 
progress, with the national smoking prevalence at 18% in 2012 (Ministry of Health, 
2012), the first drop below 20% for over two decades. The latest prevalence is 17%, 
five years after implementing the MASC report (Ministry of Health, 2015). Through 
the MASC report also, the government has committed to follow Australia towards 
plain packaging, together with the UK and Scotland (Beaglehole & Bonita, 2015; 
Canadian Cancer Society, 2015). 
 New Zealand Smoking Cessation Services 
Smoking cessation service provision has been slowly increasing in pace over the 
past decade (Ministry of Health, 2004). It has, however, had an added boost since 
the MASC Report was published (Blakely et al., 2010). Various smoking cessation 
initiatives have since been introduced, provided by a variety of health professionals. 
Service provision has been comprehensive and has included both the community 
based services through the primary health organizations (PHO), and hospital based 
services through the District Health Boards (DHB). Culturally appropriate services 
have also been developed to ensure inclusion of specific groups such as Māori and 
Pacific people. Furthermore, innovations such as services by the Quit Group, which 
include the national Quitline have also been made available, and this has included 
internet assisted programs to quit (Health Promotion Agency; Ministry of Health, 
2004; Smokefree Coalition, 2010). The variety of services have ensured that all 
levels of intensity and a wide sector of the population are being catered for. Multiple 
avenues and opportunities to access treatment have ensured that services have 
been utilised well. Pharmacological treatments such as NRTs have also been 
subsidised to reduce barriers in accessing these services, and therefore have 
enabled those in the low socioeconomic groups to seek and receive treatment 
(Smokefree Coalition, 2010).  
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To support and ensure quality service is provided, appropriate training has been 
warranted for all healthcare providers. The government has published the New 
Zealand smoking cessation guidelines, aimed at safeguarding training, and at 
ensuring treatment for smoking cessation is of a high standard (Ministry of Health, 
2007). This national guideline has been updated regularly since its inception in 1997, 
2001 and 2007. It has recently been updated a fourth time, whereby additional 
studies since 2007 have been reviewed and an added brochure developed to 
complement the current existing guidelines published in 2007 (Ministry of Health, 
2014). The New Zealand guidelines are also amongst the three more popular 
guidelines used by other countries as a major reference on which to model their 
respective guidelines (Piné-Abata et al., 2013). To ensure sustained awareness to 
treat smokers or referrals to available local services, future medical doctors and other 
health providers such as nurses and pharmacist have been provided training in 
smoking cessation during their medical school or equivalent studies (Ministry of 
Health, 2004). In addition, for those who have missed out or have required re-
training, there are local non-governmental organizations, such as the New Zealand 
Heart Foundation, which have provided regular training for smoking cessation to all 
interested healthcare providers (Heart Foundation, 2013). In response to the MASC 
report, two leading research groups (Turanga and ASPIRE2025) have been formed, 
thus strengthening and ensuring further that the country meets its target for a smoke 
free 2025 through innovations in smoking cessation (ASPIRE2025, 2013; Tobacco 
Control Research Turanga, 2010). 
Although there have been a number of achievements in tobacco control public policy 
in New Zealand, there are still areas for improvement (Blakely et al., 2010; Ministry of 
Health, 2004; Smokefree Coalition, 2010). This includes providing more options for 
treatment, both behavioural and pharmacological. At present, only the NRT gum, 
lozenges and patches are subsidized (Health Promotion Agency, 2013; Ministry of 
Health, 2007). Varenicline is subsidized only if the client has shown failure with two 
previous NRT treatments (Pharmaceutical Management Agency, 2010). There has 
also been a need to ensure services can be accessed by the hard to reach groups, 
who often have the highest levels of addiction to smoking. These include those with 
mental illness, those from low socioeconomic status, and minority populations such 
as Māori and Pacific people (Borrelli, 2010). Monitoring service usage and 
acceptability is also an area that needs more research. 
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2.6 Summary 
Tobacco smoking is a public health problem with grave consequences to health. 
Nicotine is a highly addictive substance which can result in dependence. It is a 
complex addiction process which is still not fully understood neurophysiologically. 
Although the benefits of quitting are undeniable, the consequences of quitting, such 
as mood and weight changes, are important sequelae to be aware of. 
The dangers of tobacco smoking and tobacco control measures have centred 
towards the general population, and accordingly the results of these measures are 
starting to be noticed with a drop in smoking prevalence. Nonetheless, in countries 
with mature tobacco control measures, there is an observed plateauing in smoking 
prevalence reduction, despite the many tobacco control activities implemented.  
The ‘underserved’ population, including those with mental illness, are often reported 
to have high smoking prevalence but have received minimal input till recently. 
Psychiatry and psychiatrists have been slow to respond to address the situation in 
their patients. As a result, tobacco control measures for those with mental illness 
have been disproportionate, and at times underequipped in terms of resources. The 
Smoking Cessation, Mood and Eating Study (SCeMES) attempts to add to the 
smoking cessation discussion in New Zealand in light of Smoke-free 2025. 
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 CHAPTER 3 - Literature Review: Smoking Cessation 
3.1 Chapter Overview 
This chapter attempts to provide an overview about the concept of smoking cessation 
and the many components of this activity. The term cessation in this chapter will take 
a more narrow view by emphasising cessation in the context of treatment rather than 
public health policy based approach to smoking cessation such as increased in 
cigarette process through taxation or rising the smoking age. The predictors of 
stopping smoking will be listed and how it affects a quit smoking attempt. The 
methods to quit smoking will also be highlighted in this chapter and an exploration of 
this will be undertaken from the perspective of the user and the provider. Finally, this 
chapter will end with thoughts on the barriers and challenges in providing a 
successful smoking cessation service. 
3.2 Definition and Overview 
The term ‘smoking cessation’ has been used interchangeably with ‘tobacco 
dependence treatment’ and is generally understood to mean the discontinuation of 
tobacco use. In the past, there have been efforts to remove cessation as a 
terminology and continue with tobacco dependence treatment as the main term to 
denote this. However, this process requires time, as professionals within the field 
need to agree on the need for a common language (Wolff, Hughes, & Woods, 2013). 
A search using ‘smoking cessation’ and ‘tobacco dependence treatment’ as trunk 
words on Medline found more than 16,155 versus 203 hits (February 2016) to 
illustrate this conundrum. Wolff et al. (2013) explained that ‘tobacco dependence 
treatment’ should be the terminology of choice as the word treatment leads to the 
assumption that nicotine dependence: 1) is an addiction and 2) requires assistance 
using the many evidence based treatments now available. Cessation, on the other 
hand, connotes the traditional idea that nicotine dependence is an issue regarding 
habit or personality (weak-willed) and that one can simply cease to be a smoker. 
Although in agreement with Wolff et al. (2013) for this thesis, ‘smoking cessation’ will 
be the choice term used throughout, as it is the most prevalent terminology used in 
the literature, including for the local guidelines (Ministry of Health, 2007), but it does 
have limitations when discussing a contemporary addiction and nicotine dependence. 
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Schwartz (1992) described smoking cessation to consist of three main phases: 
preparation, intervention and maintenance. In the stage of preparation, the smoker 
makes arrangements to quit smoking. Smokers who present for treatment are often 
motivated, but can be ambivalent about their attempt to quit, described by Prochaska 
and DiClemente (1983) as being in the pre-contemplative/contemplative stages of 
change. Motivational interviewing has been reported to assist increasing motivation 
to quit smoking in this stage of change (Miller & Rollnick, 2002). Increasing self-
esteem and confidence to quit is also helpful during the preparation stage. The 
second phase includes any form of intervention which is evidence based and assists 
the smoker to quit. Finally, in the maintenance stage, strategies to stay abstinent, 
such as psychologically-based relapse prevention (Marlatt & Donovan, 2005) or long 
term pharmacological treatments, were included. A survey in countries with smoking 
cessation guidelines reported these three stages in their respective programs. What 
often differed between guideline implementation was the available local resources in 
addition to individual country income (Piné-Abata et al., 2013). 
Smoking cessation programs, although effective, are different depending on whether 
they are public health based or clinical based (Tobacco Use and Dependence 
Guideline Panel, 2008). The former uses a population based approach and include 
smoking cessation programs such as Quitline (World Health Organization, 2011a), 
where smokers can call into a local number to receive assistance to quit smoking, 
whereas clinical based smoking cessation programs are conducted face-to-face in a 
clinic setting (Niaura & Abrams, 2002). The services mostly differ in the level of 
intensity, duration and the target population for the respective services (Niaura & 
Abrams, 2002). These differences might be noticed during the stage of preparation 
described by Schwartz (1992) earlier. Population based programs might have fewer 
‘contact hours’ during the intervention stage whereas clinical based programs might 
have more. Conversely, public health based programs might instead have more 
resources used for the preparation stage (Niaura & Abrams, 2002; Tobacco Use and 
Dependence Guideline Panel, 2008). Despite this, both types of programs have been 
found to be equally effective and their effectiveness has been studied on their own, 
separately or together (Niaura & Abrams, 2002). There are also studies which 
combine the two forms of programs with newer interventions such as, for example, 
internet based treatments or text-messaging to assist smokers to quit (Boal, Abroms, 
Simmens, Graham, & Carpenter, 2016; Niaura & Abrams, 2002; Torres et al., 2010). 
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Smoking cessation programs have also led to the development of dedicated 
practitioners to either initiate, co-ordinate or even manage these respective 
programmes (Hughes, 2007). These practitioners are known as tobacco treatment 
specialists (TTS) or, in some countries such as New Zealand, smoking cessation 
specialists (Berlin, 2009; Heart Foundation, 2013; Hughes, 2007; Pbert, Ockene, 
Ewy, Leicher, & Warner, 2000; Wolff et al., 2013). These TTS are practitioners who 
are referred to as having an extensive knowledge in the field, are often accredited or 
licensed and able to handle a wide variety of clients (Berlin, 2009; Hughes, 2007; 
Pbert et al., 2000). This includes difficult to treat smokers such as those with mental 
illness, pregnant mothers and those with medical co-morbidities such as cancers, 
cardiovascular diseases and others (Hughes, 2007; Wolff et al., 2013). TTS often 
receive more training compared to general smoking cessation providers and are 
often used as a source of reference (Berlin, 2009; Hughes, 2007; Pbert et al., 2000).  
3.3 Predictors for smoking cessation 
This section describes common predictors for cessation grouped into general 
demographic predictors, tobacco related predictors, psycho-social predictors and 
treatment. Depression predictors will be covered later in section 4.5.4. 
Table 3.1 Predictors for Smoking Cessation 
Items Predictors in outcomes for smoking cessation 
General Early age of initiation 
No gender difference 
Lower socioeconomic background 
Tobacco Related Increase levesl of addiction 
Presence of craving 
History of quit attempts 
Perceived reaction to withdrawal symptoms 
Psychosocial Motivation levels 
Presence of stress 
Cultural beliefs 
Treatment Follow-up attendance 
 
 General Predictors 
The most commonly referred to predictors are age of initiation, gender and socio-
economic status. Early age of initiation has been associated with poorer outcomes of 
treatment (Naomi Breslau, Fenn, & Peterson, 1993; Khuder, Dayal, & Mutgi, 1999). 
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In a study involving 1007 young adults, those who started smoking early were 
associated with a poorer outcome. In those who smoked after the age of 13, the 
success rate was significantly higher. Amongst those who started between the ages 
of 14-16 years old, the smoking cessation success was 1.6 times higher compared to 
those 13 years and younger. For those who started smoking after the age of 17, the 
rate of success was found to be doubled (Naomi Breslau & Peterson, 1996). In 
another study involving 1282 adult participants in a smoking cessation program, 
those who started earlier than 17 years were 1.5 times more likely to smoke 
compared to older participants (Iliceto, Fino, Pasquariello, D'Angelo Di Paola, & 
Enea, 2013). A study of nearly 10,000 participants of Asian origin found similar 
findings to those of Breslau and Peterson (1996) and Iliceto et al. (2013), where 
those who started smoking early (<20 years) were associated with difficulties in 
quitting (Honjo, Iso, Inoue, & Tsugane, 2010). An explanation for this finding includes 
a dose response situation. An early start to smoking could lead to greater addiction 
and also to an increase in cigarette use (Fergusson, Goodwin, & Horwood, 2003). 
Early initiators likewise were found to be at increased risk of chronic exposure of 
nicotine to the brain, which might lead to greater consolidation (Benwell, Balfour, & 
Anderson, 1988). The increasing addiction, greater cigarette consumption, chronic 
changes and subsequent consolidation may then affect successful smoking 
cessation.  
Hitsman, Borrelli, McChargue, Spring, and Niaura (2003) did not find any association 
between gender and smoking cessation, while Gierisch (2012) reported too small a 
sample for further analysis. Puente et al. (2011), in a one year study of participants 
attending smoking cessation in primary health care centres, also found no 
association between genders. Iliceto et al. (2013), however, reported that men 
tended to do better in smoking cessation studies, whilst women on the other hand 
were reported to have 1.5 times the risk of relapsing. Possible explanations for this 
difference included the higher rates of depression (Kessler & Bromet, 2013) and 
greater concerns with weight gain (Larsen et al., 2009) amongst women, both of 
which could increase relapse. Nonetheless, overall the studies reviewed did not 
favour any difference in successful quitting between genders.  
Those from low socioeconomic background were reported to have a higher 
prevalence of smoking and also lower successful quit rates (Hiscock, Bauld, Amos, 
Fidler, & Munafò, 2012). This population was also often less studied, as were 
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populations of those with depression and other mental illnesses (Borrelli, 2010). The 
International Tobacco Control (ITC) Four Country Survey found social inequalities at 
many stages of the quit attempt (Reid et al., 2010). This study involving four high 
income countries (HIC) – Canada, United States, United Kingdom and Australia - 
found that smokers with more income were more likely to want to attempt smoking 
cessation and were also more likely to be abstinent for at least a month compared to 
those with lesser income. Siahpush, Yong, Borland, Reid, and Hammond (2009), 
also found in their ITC study that smokers with financial difficulties wanted to quit, but 
were often less successful compared to those without similar difficulties, OR 0.53 CI 
(0.33-0.87). A Canadian longitudinal study of more than 8,000 respondents also 
found a strong association between poverty and reduced smoking cessation uptake. 
This scenario was noted to improve when those studied were able to remain out of 
poverty (Young-Hoon, 2012). One of the reasons why those from low socioeconomic 
status had poorer smoking cessation outcomes was the inability to sustain treatment 
cost (Aguiar et al., 2009; Siahpush et al., 2009). Poverty appears to be negatively 
associated with successful quitting in most studies reviewed. 
 Tobacco Related Predictors 
Smoking is an addiction (refer to 2.3). The greater the addiction to nicotine, the more 
difficult it is to quit smoking. This has been reported through various measurements 
of addictiveness to nicotine or cigarettes. Using the Fagerstrom Test for Cigarette 
Dependence (FTND), Breslau and Johnson (2000), reported a four-fold increase in 
difficulty to quit in those highly dependent on tobacco compared to those with low 
dependence. Increased cigarette use was also associated with lower likelihood of 
cessation (Hagimoto, Nakamura, Morita, Masui, & Oshima, 2009). Objective 
measurements implying greater dependence (salivary cotinine as a nicotine 
breakdown measure) (Powell, 2010) and carbon monoxide screening (a measure of 
tobacco smoke by-product) were also related to poorer outcome (Wee, West, 
Bulgiba, & Shahab, 2011).  
Craving for tobacco, often reported as a psychological withdrawal symptom can also 
affect a quit attempt (Franken, 2003). In a study of 2600 smokers, craving was 
associated with increased relapse rate compared to those reporting lower craving 
scores (32% vs.15%) (Killen & Fortmann, 1997). In another study of unaided quitters, 
men who identified with smoking to reduce craving were at greater risk for relapse at 
one year. This study was, however, limited by sample size and their use of unverified 
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quitters (Nakajima & al'Absi, 2012). Nevertheless, the presence of craving appears to 
influence smoking cessation negatively. 
Previous history of quit attempts were also found to be important (Hymowitz et al., 
1997). A systematic review using data from 17 studies reported that the number of 
previous quit attempts was highly predictive of another quit attempt (Vangeli, 
Stapleton, Smit, Borland, & West, 2011) and the more attempts made the greater the 
likelihood of success. A quit attempt lasting more than 5 days was also reported to be 
helpful in increasing successful quitting (Caponnetto & Polosa, 2008).  
Perceived reaction towards withdrawal symptoms was also found to affect success in 
smoking cessation. Smokers who perceived more difficult withdrawal symptoms were 
less successful compared to those without similar perceptions (Weinberger, 
Krishnan-Sarin, Mazure, & McKee, 2008). Smokers who related having a higher 
positive perceived cigarette benefit were also found to have poorer smoking 
cessation outcomes (Friedman-Wheeler, Ahrens, Haaga, McIntosh, & Thorndike, 
2007; Schleicher et al., 2009). 
In summary, a greater level of addiction to tobacco, the presence of craving and 
increased perception of withdrawal symptoms on quitting were associated with 
unsuccessful quitting. The more smoking quit attempts attempted, on the other hand, 
was found to be associated with better outcomes. 
 Psychosocial Predictors 
Adapting motivational interviewing to smoking cessation is useful, as greater 
motivation to quit has been found to increase successful quitting (Caponnetto & 
Polosa, 2008; Wee, West, et al., 2011). Self-efficacy, which is related to motivation, 
has also been reported to influence smoking cessation outcomes. Those with 
reduced self-efficacy are less successful compared to those with increased self-
efficacy. However, the findings are less robust than initially thought as many of the 
studies included overestimated the relationship with little consideration to control 
relevant confounding factors such as smoking behaviour (Gwaltney, Metrik, Kahler, & 
Shiffman, 2009).  
Smoking is believed to reduce stress (Nakajima & al'Absi, 2012), while the opposite 
has been reported by others (Leung, Gartner, Dobson, Lucke, & Hall, 2011). There 
are many relationships between stress and smoking in particular; stress and coping, 
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self-medication and the role of the HPA axis involvement (Kassel, Stroud, & Paronis, 
2003). A number of studies have found that stress, even perceived stress, was a 
factor in predicting smoking cessation outcomes with increasing stress, often leading 
to poorer outcomes (Buczek, Le, Wang, Stewart, & Shaham, 1999; McKee et al., 
2011; Park et al., 2009; Tsourtos et al., 2011). In their study investigating major 
depression and progression to nicotine dependence, Khaled, Bulloch, Williams, 
Lavorato, and Patten (2011), found that those who had a poor coping style often 
coped by smoking to reduce stress and to have a shorter time to first cigarette (an 
indicator of addiction to cigarettes), independent of the other predictors studied. 
Therefore, increasing stress with poor coping was associated with increased risk to 
first cigarettes and subsequent lapse or relapse in a quit attempt. Properties within 
tobacco, particularly nicotine, can enhance concentration and attention and might be 
implicated in assisting with stress; however, increase in stress might also lead to 
greater risk of relapse (Kassel et al., 2003; Prochaska, 2011). The relationship 
between stress, the HPA axis involvement and smoking cessation is more complex. 
Smoking produces the same physiological changes as a stressful event i.e. increase 
in heart rate, and heightened sense of arousal. However, clinically, smokers report a 
calming effect, often reported as the paradoxical effect of smoking (Parrott, 1994). An 
increase in stress results in individuals relapsing, based on the calming effects 
experienced, despite physiological changes showing otherwise (Kassel et al., 2003).  
There is a growing call to include cultural and contextual circumstances when 
proposing psychosocial interventions (Bernal & Sáez‐Santiago, 2006). Similarly, 
awareness of cultural beliefs may also play a role in successful quitting. The lack of 
awareness of certain cultures or superstitions may render current western based 
smoking cessation strategies to be ineffective when applied to a multicultural setting. 
One study investigating this idea included 140 African Americans, a group with 
greater tobacco complications, and found that the participants who had acculturated 
with the western values appeared to do better compared to those who had not 
(Hooper, Baker, de Ybarra, McNutt, & Ahluwalia, 2012). Many other researchers, 
though, used similar western based smoking cessation programs within their 
community and found no difference in the ease of use and effectiveness of these 
type of programs (Honjo et al., 2010; Tsai, Lin, & Tsai, 2012; Wee, West, et al., 2011) 
compared to the findings of Hooper et al. (2012). 
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To summarise, the role of stress and coping was a greater predictor compared to 
culture as a psychosocial cause to smoking cessation outcome. 
 Treatment Predictors 
Apart from the recommendation of aided versus unaided smoking cessation 
attempts, number and duration of treatment have been shown to be predictors of 
successful outcomes. Most guidelines recommend at least four or more follow-up 
sessions (Ministry of Health, 2007). The Tobacco Use and Dependence Guideline 
Panel (Tobacco Use and Dependence Guideline Panel, 2008) found no added 
advantage of more than eight follow-up sessions compared to 4-8 [OR 2.3, CI (2.1-3) 
vs. OR 1.9, CI (1.6-2.2)]. However, more sessions with longer durations might be 
needed for those who meet criteria for hardened smokers: those who are older, those 
who have smoked a greater number of cigarettes, have had a longer history of 
smoking, and have had more frequent unsuccessful smoking cessation attempts 
(Samokhvalov et al., 2013; Warner & Burns, 2003). More intensive sessions often 
require longer duration of contact time which might be achieved through multiple 
follow-up visits. Those who are living with other smokers, are less educated and 
come from a lower socioeconomic status are also at greater risk of relapse and 
therefore require more follow-up compared to smokers from the general population in 
their smoking cessation requirements (Samokhvalov et al., 2013). These increased 
visits are found to be equally more effective for both the general group and those with 
special needs in quitting smoking (Iliceto et al., 2013). 
3.4 Usefulness of Smoking Cessation Programs 
Smoking cessation programs, have been demonstrated to be effective, although 
effectiveness was dose dependent in terms of frequency of visits and duration of 
consultation (Anthonisen et al., 2005; Iliceto et al., 2013). Implementation of these 
programs, however, was often conducted at the policy level (World Health 
Organization, 2003) and they may not be in synchrony with the stakeholders, both 
smokers using the service (the users) and the smoking cessation providers. 
Information on the usefulness of these services are best collected through surveys 
but often useful information are beyond simple surveys and might require the ‘lived 
experience’ of the target population. This information could be collected through a 
qualitative research approach which may assist in explaining certain phenomena 
(Sandelowski, 1996). When this approach was combined with quantitative research, 
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these studies were known as mixed methods research (Tashakkori & Teddlie, 
2010b). This research approach has been proven to be useful in ‘blending’ both 
numbers and narratives which allows a holistic understanding of the issue being 
studied (Tashakkori & Creswell, 2008). Mixed method studies in smoking cessation 
are especially limited (Estabrooks et al., 2010). 
3.5 User Experience 
Most users of smoking cessation services studied were amenable towards programs 
in assisting them with smoking cessation, whether it was public health or clinical 
based interventions. In spite of this, smokers often reported wanting to quit on their 
own terms and at the time of their liking. Previous studies, though, have found that 
this approach was the least successful (Roddy, Antoniak, Britton, Molyneux, & Lewis, 
2006). A quit attempt was often tried when smokers believed they were in a period of 
stability with little or no stress. Most users nevertheless also reported receptiveness 
in taking smoking cessation treatments if they were available, but some did report 
scepticism on the need for these interventions (Roddy et al., 2006; Wiltshire, 
Bancroft, Parry, & Amos, 2003). This difference was found to be related to smokers’ 
expectations on how these interventions, in particular medications, worked and what 
help it could do towards their quit attempt (Hendricks, Wood, & Hall, 2009; Vogt, Hall, 
& Marteau, 2008). Misinformation, though, was commonly seen and might have 
influenced the smokers’ decision as to whether to use these effective treatments or 
not (Wiltshire et al., 2003).  
Smokers who were categorised as the ‘underserved’ population such as adolescents 
(MacDonald, Rothwell, & Moore, 2007), those with mental illness, and the elderly 
(Kerr, Watson, Tolson, Lough, & Brown, 2006), for example, were reported to require 
different needs as compared to the general population whereby a general smoking 
cessation program may not suit them as well. Adolescents in particular reported 
being unaware they were eligible to access smoking cessation services. In a 
purposively collected sample of twenty-five adolescent boys and girls from three 
youth-clubs and two schools in Wales, participants were unaware they could access 
these services as they were not meant to smoke in the first place. Also, smoking 
cessation services were often themed for adults, which strengthened this 
misconception. As they were not meant to smoke due to age, the adolescents 
interviewed reported concern to visit general practitioners for their smoking for fear of 
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a breech in confidentiality and that their parents would find out. Despite this, 
participants for this study would attempt quitting through a smoking cessation 
program if it was made available and their privacy was ensured (MacDonald et al., 
2007). Those with mental illness on the other hand, felt that smoking cessation 
providers should come from mental health practitioners so their needs would be 
better taken care of (Morris, Waxmonsky, May, & Giese, 2009). As it was, most of 
those interviewed reported difficulties to access normal health services as a result of 
discrimination towards their mental health situation (Morris et al., 2009). By the same 
token, ethnic minorities also preferred a provider of the same ethnic background or, 
at the least, a provider who understood their culture and worldview, in helping them 
to quit smoking (Fernandez & Wilson, 2008; Fu et al., 2007; Thompson-Evans, 
Glover, & Walker, 2011). 
With the strengthening of tobacco control policies worldwide, as discussed in chapter 
one, smokers have reported being discriminated against. Two studies exploring clean 
air policies in both the UK (Louka, Maguire, Evans, & Worrell, 2006) and Canada 
(Bell, McCullough, Salmon, & Bell, 2010) reported similar themes of increasing 
perceptions of stigmatization as a direct consequence of their smoking. For both 
studies, it appeared that the intention to protect the wider community from second 
hand smoking had resulted in present smokers within these two countries feeling 
disenfranchised from society at large. These findings might cause smoking cessation 
programs in countries with similar policies to be less popular as smokers feel 
‘targeted’ and may even rebel. Some of the interviewees concurred that instead of 
the intended intention of encouraging quitting, current tobacco control measures 
might do the opposite, although not all agreed. Some of those interviewed related 
that current policies worked as intended, and had assisted them to quit smoking (Bell 
et al., 2010; Louka et al., 2006). Contrary to these two studies, Lawn, Pols, and 
Barber (2002), reported in their study of twenty-four persons with mental illness, that 
smoking was said to reduce stigma rather than increase it. Those interviewed 
reported gaining autonomy from the cigarette instead of losing it. These individuals 
were purposively sampled from the general population and were those with mental 
illnesses living in the community. There were some, similar to the initial two studies 
(Bell et al., 2010; Louka et al., 2006), who also reported feeling fearful of increasing 
stigma due to their smoking, as clean air policies strengthened. Lawn et al. (2002) 
termed this as “double dosing” whereby for those with mental illness, discrimination 
would not only be for their mental health conditions but for their smoking as well.  
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3.6 Provider Experience 
Smoking cessation providers studied were generally willing to conduct smoking 
cessation programs assigned to them (Bonevski et al., 2011; Wye et al., 2010). 
Notwithstanding, there were activities for which these providers were willing to do 
more compared to others. In a study of providers for relapse prevention interventions 
for example, those interviewed were more inclined to provide face-to-face sessions 
as opposed to telephone counselling (Agboola, Coleman, & McNeill, 2009). Although 
repetitive advice to quit smoking was more effective and encouraged to be given by 
many groups of health providers (Ministry of Health, 2007; Tobacco Use and 
Dependence Guideline Panel, 2008), certain groups such as the general practitioners 
were reported as not being as keen to repeat themselves for fear of being perceived 
as “nagging” (Coleman, Cheater, & Murphy, 2004). General practitioners in this same 
study suggested that during their interviews they used a more emphatic or 
“confrontational” advice style, although this was not seen on video-recordings of their 
consultation sessions (Coleman et al., 2004). Health services without a smoking 
cessation program were also willing and interested in starting these programs and 
were receptive to policy changes to support such initiatives (Ashton, Lawn, & 
Hosking, 2010; Wye et al., 2010). This initiative in certain establishments had also 
encouraged staff, especially those implementing these policies, to quit smoking first 
as they understood their job and the need to become role models (Veny et al., 2011).  
There were, however, reports of providers of services being resistant to, or having 
difficulties in, providing adequate service due to various reasons such as time, work 
load, training and limited resources (Vogt, Hall, & Marteau, 2005). In their review, 
Vogt and colleagues (2005), examined nineteen studies and found eight negative 
attitudes by both general practitioners and family physicians as to why they were 
reluctant to discuss smoking cessation with their smoking patients. More importantly, 
and of concern, was that a third (33%) of participants reported that treatments were 
ineffective. This review was similar to another review on psychiatrists (Amer Siddiq et 
al., 2015), which found service implementation lacked impetus due to a lack of 
confidence amongst psychiatrists. Not surprisingly, a lack of confidence was also 
reported in nearly a quarter (22%) of the general practitioners and family physicians 
studied who did not provide adequate services (Vogt et al., 2005). Having an unclear 
definition of the terminology for treatment might also be at fault. In a study by 
Agboola et al. (2009), sixteen smoking cessation providers were interviewed and 
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none shared a common definition of relapse prevention intervention, which was the 
intervention studied. The definitions provided by the participants was based on their 
practice and how their respective organizations saw relapse prevention intervention. 
Therefore, for this group, relapse prevention meant anything from interventions to 
prevent lapses, to treat a lapse, or even to treat a relapsed smoker. The lack of a 
standard definition might affect current service provision and impact on future 
outcomes. These examples provide an understanding of the challenges faced within 
the field amongst providers. Better training conversely was shown to improve service 
provisions and might need further investigation (Carson et al., 2012). 
3.7 Currently Available Cessation Treatments 
 Self-Quitting 
Quitting without any aid or self-quitting has been around for many years, however, it 
is often not discussed and neglected (Smith & Chapman, 2014). This method of 
quitting can be understood as any method not using smoking cessation treatment 
such as taxation and smoke-free areas or only receiving brief advice or using quitline 
services without any follow-up or medication (Smith, Carter, Dunlop, Freeman, & 
Chapman, 2015). In their commentary, (Chapman & MacKenzie, 2010) argued more 
individuals quit through self-quitting rather than using any smoking cessation aids. 
One possible reason given for this oversight was the agenda to medicalise health 
(Chapman & MacKenzie, 2010), moreover, after the declaration that smoking was an 
addiction by the U.S. Surgeon General (U.S. Department  of  Health  and  Human  
Services, 1988). Although a greater number of individuals quit smoking each year on 
their own, emphasis has always been to quit with the various smoking cessation aids 
(section 3.7.3) due to the understanding that success is reported to be at least 
double compared to without any aid (Hatsukami, Stead, & Gupta, 2008). Although 
this may be true in clinical trial settings, real world data has been less optimistic. In a 
study of Australians, 54 % to 69% of ex-smokers quit on their own whilst 41% to 58% 
of current smokers have attempted to quit smoking unassisted (Smith, Chapman, & 
Dunlop, 2013). However, despite this popularity in unassisted quitting, not much has 
been researched about this group of people.  
As a result of this reduced interest in exploring self-quitting amongst researchers in 
smoking cessation, there is little information about this population. To better 
understand this phenomenon, (Smith et al., 2015) conducted a review comprising of 
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11 qualitative studies, which found three themes linked to self-quitting. These three 
were motivation, willpower and commitment. Interestingly, the theme motivation was 
found to relate to the reasons for quitting by the participants in this study. It was not 
clear to what extent the strength of motivation was considering that participants could 
not recall their motivation at the time of quitting. Commitment as a theme however 
appeared more convincing in successful quitting without assistance. The final theme 
of will-power in this study at least related to many things which appeared to provide 
an understanding closest to success. More studies, however are need to better 
understand people who use this method to quit in the future.  
Despite the evidence suggesting that assisted treatment has a greater outcome for 
success compared to self-quitting (Hatsukami et al., 2008), it is important that both 
be considered when advising smokers to quit their addiction due to popularity of self-
quitting. As a result of the complexities of smoking as seen in section 3.3 and 
similarly the complexities of quitting smoking (Smith, Carter, Dunlop, Freeman, & 
Chapman, 2017), it is wise that the tobacco treatment specialist be familiar with all 
methods to quit smoking to obtain greater success in their task. 
 Behavioural 
An extensive review of current behavioural treatments is provided in the US Clinical 
Practice Guideline (Tobacco Use and Dependence Guideline Panel, 2008). 
Essentially, the more intensive the treatment method, the greater the success; and 
combining one or more behavioural methods is shown to further increase success. 
Three newer forms of behavioural treatments, which were introduced for smoking 
cessation, were motivational interviewing, mindfulness therapy and relapse 
prevention. Both motivational interviewing and relapse prevention were mentioned in 
the guidelines by the Tobacco Use and Dependence Guideline Panel (Tobacco Use 
and Dependence Guideline Panel, 2008) and, although included in the New Zealand 
guideline (Ministry of Health, 2007), were not extensively elaborated on. Mindfulness 
was, however, not mentioned at all due to its novelty within the smoking cessation 
field. These three interventions are discussed briefly together with their treatment 
effectiveness.  
Motivational interviewing (MI) was introduced by Miller and Rollnick (2002) initially for 
the treatment of alcohol problems. It is a person-centred strategic treatment which 
elicits motivations for change. There are two published reviews by the Cochrane 
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Group (Lai, Cahill, Qin, & Tang, 2010; Lindson-Hawley, Thompson, & Begh, 2015) 
investigating its effectiveness for smoking cessation. The latest review reported 
similar modest benefit to the review conducted earlier (Lai et al., 2010) in smoking 
cessation, RR1.26 CI (1.16-1.36) after reviewing 28 studies involving 16,803 
participants. In the latest review, MI conducted by a physician was three times more 
effective, than MI conducted by other health care providers, RR 3.49 CI (1.53-7.94) 
(Lindson-Hawley et al., 2015). In another review with 35 studies and nearly 10,000 
participants, Heckman, Egleston, and Hofmann (2010), found similar benefits to 
Lindson-Hawley et al. (2015) for the use of MI in smoking cessation, but with a lesser 
magnitude, RR 1.45 CI (1.14-1.83). The main difference, however, in this same 
review was that it found no difference in MI effectiveness depending on who provided 
the intervention, and the MI effects were best seen between 10-12 weeks.  
Mindfulness training was first introduced by Kabat-Zinn (1982), for the care of 
patients with chronic pain. Mindfulness training was described as a way to train one’s 
attention to the present. There were two parts to mindfulness training, namely 
maintaining attention on the individual’s immediate state, and maintaining an attitude 
of acceptance towards these experiences, both physical and mental (for example 
breathing, thoughts and body sensations). Brewer et al. (2011), in a preliminary 
study, investigated mindfulness training compared with behaviour treatment involving 
a combination of behaviour modification, relaxation and relapse prevention. The 
investigators found mindfulness training assisted in helping participants to be 
abstinent at week 4 and effects were maintained at week 17. While the limitations of 
this study were a small sample size (n=88) and short end point (week 4), it 
nevertheless was the first in testing this treatment on its own. There has since been a 
meta-analysis of randomised controlled trials of mindfulness training and its 
effectiveness for smoking cessation conducted (Oikonomou, Arvanitis, & Sokolove, 
2016). This meta-analysis found that of the four studies included, the pooled results 
of 474 patients found mindfulness training to improve long-term smoking cessation (> 
4 months) compared to those who received usual care, RR 1.88 CI (1.04 – 3.40). 
Therefore, mindfulness training is a useful behavioural treatment alternative for 
smoking cessation.  
Relapse prevention was introduced by Marlett and Gordon to assist clients with 
alcohol and drug problems (Marlatt & Donovan, 2005). The mainstay of relapse 
prevention training is the ability to anticipate and resist high risk situations and 
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cognitive restructuring to deal with self-defeating attributes on a lapse (Marlatt & 
Donovan, 2005). Although there was much anticipation about its use in smoking 
cessation, a Cochrane review (Hajek, Stead, West, Jarvis, & Lancaster, 2009) which 
examined 36 trials found no benefit from relapse prevention. Evidence did not show 
any significant differences in using either skills training or other pharmacological 
interventions, apart from varenicline, to avoid relapse in this review RR 1.18 CI (1.03 
– 1.36).  
In summary, each behavioural treatment described has its own use and, apart from 
relapse prevention, may be beneficial for those addicted to nicotine and wanting to 
quit smoking. It is important that all treatment providers, especially the tobacco 
treatment specialists, be familiar with these newer forms of behavioural treatment, 
together with more established methods, to further assist their patients when 
providing smoking cessation. 
 Pharmacological 
There are currently seven pharmacological agents that have been approved by the 
US Food and Drugs Administration (FDA) (Elrashidi & Ebbert, 2014). These are 
divided into two types: nicotine replacement therapies (NRT) and non-NRTs. NRTs 
are the most commonly used for tobacco dependence, and treatments available 
include patches, gum, lozenges, inhalers and nasal sprays. These agents act by 
replacing nicotine, thereby reducing withdrawal symptoms. The dose of nicotine is 
usually lower in NRTs compared to cigarettes as a result of its delivery method, and 
there is less peaking of plasma levels (as one would get from smoking tobacco) on 
use. Therefore smokers do not get the same ‘reward’ as they get from a cigarette, 
although peak plasma level can be reached more rapidly for inhalers and nasal 
sprays and provide much needed relief for the most severely addicted. Studies have 
shown that NRTs are effective and increase the quit rate by 50-70% irrespective of 
setting compared to placebo, are safe and the risk to develop dependence is low 
(Stead et al., 2012).  
The FDA has approved two non-NRT agents: bupropion and varenicline (Elrashidi & 
Ebbert, 2014). Bupropion was initially marketed as an antidepressant but was found 
to be useful in quitting smoking. The mechanism of action for smoking cessation, 
however, is not fully understood (Holm & Spencer, 2000). It is thought to inhibit the 
neuronal uptake of dopamine and noradrenaline together, and also have a weak 
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nAchR antagonist effect (Berrettini & Lerman, 2005; Caponnetto, Russo, & Polosa, 
2012). Bupropion doubles the quit rate over placebo (Hartmann-Boyce, Stead, Cahill, 
& Lancaster, 2014). A meta-analysis by Wu, Wilson, Dimoulas, and Mills (2006) 
reported that bupropion was effective at both three months and one year compared 
to placebo, OR 2.13 CI (1.72-2.64) and OR 1.56 CI (1.10-2.21) respectively from 11 
studies. Varenicline was the latest medication approved by the FDA for tobacco 
dependence treatment in 2006. Varenicline is a partial nAchR agonist. It acts at the 
receptor by both partially stimulating the receptor and at the same time acting as an 
antagonist for nicotine from tobacco on the same receptor. In the same meta-
analysis by Wu et al. (2006), using four available placebo controlled trials, varenicline 
was found to be effective at three months and one year and was also superior to 
bupropion. Varenicline was reported to be the most effective treatment available, 
tripling the quit rate compared to no treatment (Anthenelli et al., 2016).  
Although included in most guidelines (Ministry of Health, 2007; Tobacco Use and 
Dependence Guideline Panel, 2008), two other pharmacological treatments, namely 
nortriptyline and clonidine, are yet to be approved by the FDA for tobacco 
dependence treatments. Nortriptyline is a similar antidepressant to bupropion. As 
with bupropion, the method of action is not yet well understood. However, it has been 
theorized that its antidepressant effects and action on the noradrenergic system are 
the mode of action (Caponnetto et al., 2012). Neither of these antidepressants are 
serotonin selective receptor inhibitor (SSRI) class antidepressants, which have been 
found to be ineffective for smoking cessation (Hughes et al., 2007). Clonidine on the 
other hand was marketed as an antihypertensive medication. It is a α-adrenergic 
agonist drug and acts in the central nervous system to reduce sympathetic outflow. 
The mechanism of action in smoking cessation is believed to be primarily through its 
ability to counteract symptoms of withdrawal. The efficacy of both these agents is 
roughly similar; both double the quit rate compared to placebo (Gourlay, Stead, & 
Benowitz, 2004; Hughes, Stead, & Lancaster, 2005). Both medications have been 
considered as second-line treatment, utilized after the others have failed, but have 
required due diligence in their use due to their possible effects on the cardiovascular 
system (Hartmann-Boyce & Aveyard, 2016). 
Despite the efficacy of current treatments, the rate of reinstatement or relapse after a 
quit attempt is still significant, with rates reported at 30 – 50% in clinical settings (Lee, 
Hassali, & Shafie, 2013). Despite this, relapse rates have not often been measured 
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(Hughes, Keely, & Naud, 2004). Most of the NRT treatments reported did not reach 
the brain as quickly as nicotine from cigarettes, and therefore patients still reported 
withdrawal symptoms (Balfour & Fagerström, 1996). Newer pharmacological agents 
were needed which might have different properties, different delivery devices or 
which acted on different receptors or pathways. Some newer medications have 
included inhaled nicotine formulation, monoamine oxidase inhibitors, the use of 
natural nicotinic ligands with partial agonist activities, cannabinoid receptor 1 
antagonists, and dopamine D3 receptor antagonists (Caponnetto et al., 2012). One 
medication which holds promise is cystisine, having had a randomised clinical trial 
completed (Walker et al., 2014). This medication was initially reported to being used 
in Eastern European countries, particularly Poland and Bulgaria, to treat smoking. It 
was not considered seriously until Walker et al. (2014) reported the benefits of its use 
for smoking cessation. In this study, cystisine was found to be superior to the NRTs 
(patches and gums) when used with behavioural support (40% vs. 31%). However, 
participants in the cystisine arm complained of more side effects from their 
treatments compared to those on NRTs. Other treatments which were initially 
promising have since been withdrawn, such as tarabant and rimonobant; (both 
cannabinoid type 1 receptor antagonists) due to safety concerns over particular 
neuropsychiatric complications such as depression, anxiety and suicidal behaviour 
(Cahill, Lancaster, & Perera, 2011). Prior to rimonobant being withdrawn, there were 
positive indications that it might also assist in weight gain after quitting (Cahill et al., 
2011). 
 In addition to looking at the receptors that bind with nicotine, another novel approach 
was to target the nicotine from tobacco smoking itself. Vaccines for nicotine addiction 
were developed for this purpose and there were at least four long-term clinical trials 
involving 2642 participants (Hartmann-Boyce, Cahill, Hatsukami, & Cornuz, 2012). 
Through the use of vaccines, less nicotine reached the brain and therefore there was 
less of a ‘reward’ effect to initiate or maintain this addiction. As nicotine molecules 
are very small, the vaccine development required the combination of the nicotine 
molecule with a larger protein, usually from a bacterium or virus. In theory the 
vaccines appeared feasible with promising animal studies in support yet, in clinical 
practice, it has not materialised, and therefore no vaccines are recommended at 
present for smoking cessation (Hartmann-Boyce et al., 2012). The development and 
subsequent use of vaccines was also not without its controversies. The main 
mechanism was to develop an immune response towards nicotine, and this led to 
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identified ethical issues which were not thought of, or expected, at the onset 
(Wolters, Wert, Schayck, & Horstman, 2014).  
Another recent innovation is the use of electronic cigarettes. These are electronic 
devices which are similar in shape and, at times, colour to cigarettes but do not 
combust tobacco. Instead, these electronic gadgets vaporise liquid (termed e-liquid, 
a mixture of several constituents including nicotine) in order to deliver its dose of 
nicotine. The electronic cigarette was first introduced in China in 2006, and has since 
been widely sold with little regulation till recently (Etter & Bullen, 2011). Bullen et al. 
(2013), published the first study which used the electronic cigarette as a treatment 
aid. In this study, the authors concluded that electronic cigarettes were no different 
from NRT patches in assisting patients to quit smoking. This study, however, had a 
small sample size and significant drop-out, and therefore their conclusions need to 
be interpreted cautiously. A Cochrane review of two studies, however, found that 
there was inconclusive evidence to suggest that electronic cigarettes were effective 
as a smoking cessation aid for the long-term. An updated Cochrane review did not 
find additional studies to include in the analysis to answer whether electronic 
cigarettes were effective for smoking cessation, and therefore maintained the same 
conclusions as the previous review (Hartmann‐Boyce et al., 2016). The review, 
however, did find that participants using these devices did reduce their cigarette 
consumption compared to abstinence (McRobbie, Bullen, Hartmann-Boyce, & Hajek, 
2014), which is often the goal for smoking cessation. Among the proclaimed benefits 
by users of electronic cigarettes was the possibility to assist in the behavioural 
aspects, particularly the handling, holding and puffing a cigarette which is often 
lacking in currently available NRTs (Caponnetto et al., 2012). 
In summary, current available pharmacological agents are effective to aid in smoking 
cessation compared to no treatment. However, rates of relapse can still be high. 
Available treatments which deliver nicotine, such as NRTs, are still unable to deliver 
nicotine to the system as rapidly as cigarettes, resulting in periodic withdrawal 
symptoms still present. Non-NRT medications work differently and have been shown 
to be more effective compared to NRTs. However, both bupropion and varenicline 
need time to work. Therefore, there is a need to further innovate through the many 
pharmaceutical agents in various phases of development. Electronic cigarettes, 
although able to deliver nicotine more rapidly compared to current available 
treatments, have not been found to be effective, and have in some studies found to 
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have other harmful results in its use (Kalkhoran & Glantz, 2016; McNeill et al., 2015; 
West et al., 2015)  
 Combination 
Despite the effectiveness of both behavioural and pharmacological methods to quit 
smoking independently, the current recommendations are to use them together. 
Stead, Koilpillai, Fanshawe, and Lancester (2016) in their review found that 
combination was better compared to individual forms of treatment in smoking 
cessation. Moreover, in this review it was found that combination was particularly 
better for those in a healthcare setting compared to community, RR 1.97 CI (1.79 to 
2.18) compared to RR 1.53 CI (1.33 to 1.76). A total of 52 publications were included 
in this analysis and quit outcomes were measured at six month or more. Therefore, 
current guidelines recommend the use of combination treatment where possible 
(Ministry of Health, 2014). 
3.8 Barriers and Challenges for Smoking Cessation 
In countries where smoking cessation treatments are not funded, financial costs 
appear to be a major barrier for smokers to initiate and continue quitting smoking 
(Krist et al., 2010). This has also been reported in larger population studies (M. 
Siahpush et al., 2009). Where there was consideration to incentivise, users of 
smoking cessation programs were reported to be more positive than their providers 
when interviewed (Bonevski, Bryant, & Paul, 2011). In another qualitative in-depth 
interview of 14 clients of an incentivised service, Allan, Radley, and Williams (2012) 
reported on the Scotland experience where providing incentives did not achieve its 
objective. Instead, incentivising caused increased stigma and reduced self-efficacy in 
the smokers who were utilising such services. These interviews were supported by a 
recent extensive review which found that despite ‘incentivising’, particularly 
financially, there was still insufficient evidence to show that it led to increasing quit 
smoking rates. Improvement in other areas of smoking cessation such as recording 
smoking status, visitations to quit clinics and referrals was seen to increase 
(Hamilton, Greaves, Majeed, & Millett, 2013). 
For certain individuals, accessing services is also a barrier. Most smoking cessation 
programs are structured services with set rules and standards, such as the National 
Health Service (NHS) in the United Kingdom (Bauld, Bell, McCullough, Richardson, & 
Greaves, 2010). These services often include standard visiting hours, treatment 
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provision and location (Allan et al., 2012). For certain populations, these structured 
services might be difficult to access, such as those with financial difficulties (Bryant, 
Bonevski, Paul, O'Brien, & Oakes, 2010), adolescent smokers still in schools 
(MacDonald et al., 2007), or those with mental illness (Morris et al., 2009). At times, 
these services and their respective policies are also found to affect providers. Some 
of the concerns which have been reported by service providers have been mentioned 
earlier (refer to 3.5). This includes training or lack of it, financial reimbursement for 
services provided (Krist et al., 2010), and health system issues, for example, whether 
a service is a referral centre or not (Wilson et al., 2010).  
The awareness of the benefits of quitting and reach of services has also been seen 
as an issue for some. In support of larger epidemiological studies, a number of 
qualitative studies reported adolescent participants continuing to initiate smoking 
through peer pressure (Green & Clarke, 2005) despite the various tobacco control 
measures put in place. One possible reason given is that current measures were not 
targeting adolescents as well as it was hoped for (Staten & Ridner, 2007). In this 
study, adolescents reported to ignore advice if the campaign or message did not 
appeal to them. One participant summed the feeling of those involved: “If the 
message doesn’t speak to me, I don’t hear it”. This statement indicated frustration, 
defiance, and also hope to access available treatment facilities.  
The lack of positive coping skills with life situations appears to be a major factor for 
smoking, lapse and relapse (Khaled et al., 2011). Poor coping skills and boredom 
was especially raised by almost all smokers studied, who experienced mental illness 
(Morris et al., 2009; Snyder, McDevitt, & Painter, 2008; Tsourtos et al., 2011; 
Wiltshire et al., 2003). Those with mental illness reported the need to smoke to 
control stress (Lawn et al., 2002). For the successful quitters and non-smokers 
studied, those who succeeded in abstaining from smoking reported using other 
mechanisms of coping in times of stress (Tsourtos et al., 2011). Therefore, brief 
intervention, a form of behavioural treatment, is important and might make the 
difference, particularly for the disadvantaged groups. Resilience in response to stress 
was also raised by two studies (Lin & Ward, 2012; Tsourtos et al., 2011), however, 
more research is needed to investigate this observation. 
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3.9 Summary 
The term smoking cessation has been used interchangeably with tobacco 
dependence treatment to describe the treatment of smoking. For this thesis, 
however, the former is preferred due to its established use within the literature. 
Population types of smoking cessation programmes such as Quitline, or clinical 
based programmes such as face-to-face or group treatments, are both useful. The 
introduction of smoking cessation programmes has led to the development of 
tobacco treatment specialist, health care providers with extensive experience and 
knowledge in providing smoking cessation. Often, these same clinicians are adept at 
the many smoking cessation treatments available using both behavioural and 
pharmacological techniques, and are experienced at treating a wide variety of 
smokers both from the general population, and from special populations such as 
those with mental illness, those from lower socio-economic backgrounds, or those 
with co-morbid physical health problems.  
In spite of the many treatments available to assist people to stop smoking, the 
relapse rate is still unsatisfactory. A number of predictors have been identified which 
increase one’s risk to relapse. These predictors include demographic predictors like 
age and gender; tobacco related predictors such as duration of smoking and number 
of quit attempts; psychosocial predictors such as stress; and treatment predictors 
such as duration or frequency of treatment sessions. However, there are still gaps 
within the literature on further investigations into smoking cessation predictors. 
This chapter highlights what smoking cessation is dependent on, whether the 
understanding is from the user’s perspective or the treatment provider’s perspective. 
The two perspectives can be very different, with different outcome expectations. An 
area which is lacking in smoking cessation research is the combined qualitative and 
mixed method research. Both types of research are useful in further exploring and 
understanding smoking cessation from both user and provider perspectives. This will 
allow a better understanding of the individual’s or group’s impact towards quitting 
smoking in New Zealand. There is also a difference between treating the general 
population of smokers, and those with special needs, such as mental illness, the 
latter requiring more intensive treatments, for example. 
Finally, this chapter highlights the barriers to treatment. Among barriers identified 
were the cost of treatment for some populations, access to treatment for others, and 
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the awareness of these treatments being made available. However, more information 
is needed to better understand barriers present for New Zealand smokers wishing to 





 CHAPTER 4 - Literature Review: Smoking Cessation and 
Depression 
4.1 Chapter Overview 
This chapter will endeavour to bring together the literature on depression, smoking, 
and smoking cessation in order to better understand the relationship between the 
three main issues at hand. It will start with an outline on depression, and continue by 
connecting it with smoking and, eventually, smoking cessation. This chapter will end 




Depression is among the most prevalent mental health conditions worldwide and one 
of the most debilitating (Murray & Lopez, 1997b; Üstün, Ayuso-Mateos, Chatterji, 
Mathers, & Murray, 2004). The World Health Organization (WHO) ranks depression 
as the fourth leading cause of global burden of illness (Murray & Lopez, 1997b), and 
it is expected to move to first place by 2030 (World Health Organization, 2004). 
According to an alternative analysis, for developing nations, depression will be the 
leading cause of global burden of illness a decade earlier (Murray & Lopez, 1997a).  
Epidemiological studies vary in their estimation of mental health prevalence between 
countries. However, there is a general agreement that depression is the most 
common mental health condition after anxiety disorders (Kessler & Zhao, 2010; 
Ministry of Health, 2012; Slade, Johnston, Oakley Browne, Andrews, & Whiteford, 
2009). Kessler and Bromet (2013), using the WHO World Mental Health Survey 
(WMH), reported a study of 18 countries across all continents in which the 
prevalence of depression (major depressive disorder) in high income countries 
nations was found to be 14.2% compared to 11.1% in low to lower middle income 
countries. In response to previous limitations in other studies, this study utilised the 
WHO CIDI version 3, a common instrument and standardised protocol to generate 
findings. Although lifetime prevalence differed between high income countries and 
low to lower middle income countries, when current depression was studied, the 
prevalence was nearly the same between the two categories (5.5% vs. 5.9%). Age of 
onset was during early adulthood, and risk factors were similar in terms of gender, 
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age and marital status. Females were two times more likely to suffer depression then 
men. These findings, from all of the world’s continents, confirm that depression is 
very similar in both the form of occurrence, and presentation, despite differences in 
culture and socio-economic status. 
In New Zealand, a national health survey of 12,370 adults aged 15 and older, 
reported that 16% of the country’s population was suffering from mental illness 
(Ministry of Health, 2012). This same report found that 14% of those with mental 
illness had depression. Similar to findings by Kessler and Bromet (2013), women 
were doubly affected. Peak ages of onset were between 16 to 34 years of age. In this 
study, similar to the WHO World Mental Health Survey looking at high income 
countries, those with depression more often came from a lower socioeconomic 
group. In the national survey, those with European ancestries had higher mental 
health prevalence than Māori, 19% vs. 16%. However, it was difficult to ascertain a 
more accurate diagnosis of the data, as mental health classifications (depression, 
anxiety disorder and bipolar disorder) were grouped together and not broken down 
into individual diagnoses (Ministry of Health, 2012). 
The New Zealand Mental Health Survey 2006 was the first national survey 
attempting to specifically gather information on the mental health situation in the 
country (Oakley, Wells, & Scott, 2006). This study involved 12,992 participants of 
which 20% (n = 2,595) were Māori, the largest survey in which ethnic minorities were 
overrepresented. Lifetime prevalence of depression was 15.7% and current 
depression, 6.9%. Their risk of developing a mood disorder, compared to other 
groups in the countries, was also higher OR 1.5 CI (1.4-1.7).  
 Aetiology 
Clinical observations of depression occurring within families are consistent with 
genetic studies using twin and adoption studies (Kendler, Gatz, Gardner, & 
Pedersen, 2006; Levinson, 2006). Linking depression to the human genome using 
linkage studies, though, has been less convincing (Goodwin, 2009; Levinson, 2006). 
Linkage studies have been used to test hypotheses that a linkage relationship exists 
between known genetic markers and an identified trait. Temperament might also be 
implicated in the aetiology of depression (Goodwin, 2009). Although linked to some 
extent with genetics, temperament has been harder to prove (Goodwin, 2009). Early 
adversity was also found to be related to the development of depression and may be 
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associated with both genetic risk and temperament (Saveanu & Nemeroff, 2012). 
The relationship between the three – genetics, temperament and early adversity – 
might indeed have a part in the predisposition, precipitation and maintenance of 
depression (Goodwin, 2009).  
Neurobiologically, the monoamine oxidase system (MAO) is implicated in the 
aetiology for depression (Hamon & Blier, 2013; Saveanu & Nemeroff, 2012). 
Although serotonin, noradrenaline and dopamine are all involved with the MAO, 
serotonin is thought to have a larger role in depression (Saveanu & Nemeroff, 2012). 
Tryptophan, the precursor of serotonin, is reduced in depressed individuals and they 
are often found to have abnormalities in both production and utilisation of this 
neurotransmitter. Post-mortem and imaging studies have also reported reduced 
serotonin transporter binding sites in various parts of the brain (Goodwin, 2009; 
Saveanu & Nemeroff, 2012). Moreover, challenging depressed individuals with 
serotonin, using antidepressants such as the serotonin selective reuptake inhibitor 
(SSRI), has been shown to reverse depressive symptoms. Those with the s allele of 
the promoter region of the SERT gene (SLC 6A4), a gene important in serotonin 
production in the central nervous system, have also been found to develop 
depression at an earlier age and noticed to be more susceptible to early adversity 
(Saveanu & Nemeroff, 2012). 
 Types of Depression 
Depression is essentially a clinical diagnosis made through careful history taking by 
an experienced clinician. Two major classifications used to make the diagnosis are 
the DSM and ICD (American Psychiatric Association, 2000; World Health 
Organization, 1993). Symptoms need to be present for two weeks or longer and 
cause impaired functioning in activities of daily living. The core symptoms are 
depressed mood and the inability to enjoy normal pleasurable activities; they also 
include other non-core symptoms (refer to Table 3.1). In both classifications, mood 
disorders encompass bipolar disorder, cyclothymia, dysthymia and major depressive 
disorder (MDD). When depressive symptoms are present but do not fulfil the full 
requirements for any of the mood disorders mentioned, they are classified differently. 
The DSM includes, for example, diagnoses such as depressive disorder not 
otherwise specified, depressive disorder due to a general medical condition, 
substance induced mood disorder, and mood disorder not otherwise specified. The 
ICD includes persistent mood disorder or unspecific mood disorder to classify those 
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with depressive symptoms which do not meet criteria for a major depressive disorder 
(American Psychiatric Association, 2000; World Health Organization, 1993). 
Minor depression, otherwise also known as subclinical, subthreshold or 
subsyndromal depression, is classified in the DSM-IV as a depressive disorder not 
otherwise specified, or as mild depression in the ICD. Minor depression is considered 
to be a clinical depressive disorder which does not meet the full criteria as per the 
DSM or ICD for MDD, but argued to be still within the continuum of what is 
considered depression (Judd, Akiskal, Zeller, & et al., 2000) (American Psychiatric 
Association, 2000; Judd et al., 2000; World Health Organization, 1993). Meanwhile, 
others argue that minor depression is a discrete entity and should not be linked to 
MDD (Borrelli et al., 1999). Similarities between minor depression and MDD include 
both aetiology and genetic risk (Pietrzak et al., 2013). Those with minor depression 
are at risk of developing full MDD, and have health disabilities similar to major 
depressive disorder (Pietrzak et al., 2013). Moreover, minor depression may linger 
after a severe episode of major depressive disorder; therefore clinicians need to 
monitor on-going residual symptoms which might meet criteria (Judd et al., 2000). 
For ease and clarity of subsequent sections of this chapter, the term ‘depression’ will 
be used throughout for both minor depression and major depressive disorder. Where 
a distinction needs to be made, the terms ‘minor depression’ and ‘major depressive 
disorder’ will be used respectively. 
Table 4.1: Major depressive disorder symptoms for diagnosis using DSM-IV-TR and 
ICD-10 
Core symptoms: 
1. Depressed mood 
2. Inability to enjoy pleasurable activities (anhedonia) 
Additional symptoms: 
1. Poor concentration, or difficulty in concentrating 
2. Reduced self-esteem or self-worth (ICD-10 only) 
3. Feelings of guilt or unworthiness 
4. Pessimistic view of the future (ICD-10 only) 
5. Poor or disturbed sleep 
6. Change in activity (psychomotor retardation) (DSM-IV only) 
7. Diminished appetite or weight change (5%) 
8. Fatigue or loss of energy 
9. Suicidal or self-harming thoughts 
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 Burden of Depression 
Depression increases both morbidity and mortality in those affected. Depression is 
associated with a variety of physical illnesses and is also a leading cause of suicide 
(Kessler & Bromet, 2013; Pietrzak et al., 2013). A recent review of twenty-eight 
papers, aimed at identifying risk factors for suicide, reported that those with severe 
depression were at twice the risk of suicide, OR 2.2 CI (1.05 – 4.60). In addition, 
hopelessness as a symptom was found to be the major risk factor in those who were 
depressed, OR 2.2 CI (1.49 - 3.23) (Hawton, Casañas i Comabella, Haw, & 
Saunders, 2013). Psychosocial disability also increased in those with depression 
compared to individuals without (Judd et al., 2000). Moreover, for every detected and 
diagnosed occurrences of depression, there were many more which were 
undiagnosed, untreated and therefore posed a risk for harm (Pierre, 2013). Cost-of-
illness (COI), which includes both direct and intangible costs, is estimated to be 
between USD2000 to USD3700 per person per year (Luppa, Heinrich, Angermeyer, 
König, & Riedel-Heller, 2007). This study, however, did not include many low to lower 
middle income countries and is therefore unlikely to be representative of depression 
globally. In New Zealand, the estimated cost-of-illness to the country has been 
reported at NZD 750 million per year (Ministry of Health, 2010). This figure was 
calculated using the United Kingdom as reference, where cost-of-illness was 
estimated at 0.6% of gross domestic product (GDP), and was based on GDP data in 
2006. 
4.3 Relationship between Depression and Smoking 
 Epidemiology 
The study by Hughes, Hatsukami, Mitchell, and Dahlgren (1986), was one of the 
earliest studies in reporting interest in depression among smokers, despite smoking 
having been present for hundreds of years. One possible reason for the lack of 
information until then was the previous low interest in psychiatry towards tobacco 
control (refer to section 2.4). In this study by Hughes et al. (1986), when comparing 
smoking rates between attendees of a psychiatric outpatient service and the general 
population, those with a psychiatric illness were 1.6 times more likely to smoke 
compared to general population controls. Even after controlling for multiple 
confounders, the association was still significant. Hughes et al. (1986) also found that 
those with schizophrenia smoked more than those with mania and depression, in that 
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order. In a smoking cessation trial looking at the effectiveness of clonidine for 
nicotine withdrawal, Glassman, Stetner, Walsh, & et al., (1988) observed that 61% of 
those with a previous history of depression smoked. More importantly, those without 
a history of depression, irrespective of medication assignment, did better. Both 
epidemiological (Boden et al., 2010; Brown, Lewinsohn, Seeley, & Wagner, 1996; 
Fergusson et al., 2003; John, Meyer, Rumpf, & Hapke, 2004; Johnson & Breslau, 
2006; Kendler et al., 1993) and clinical (Glassman, Covey, Stetner, & Rivelli, 2001; 
Japuntich et al., 2007) studies have since found an association between smoking 
and depression. 
In comparison to the Glassman et al. (1988) study, prevalence of lifetime or previous 
depression has been reported between 11-52.5% (refer to Table 4.2). This has often 
been reported to be higher than that of the general population; however, no studies 
have been able to replicate the prevalence reported by Glassman et al., (1988). 
Current depression prevalence among smokers has been studied less. Available 
studies reported prevalence between 2-34.3% (refer to Table 4.3). Leventhal, Kahler, 
Ray, and Zimmerman (2009), reported a current depression prevalence of 57.8% in 
their study. This study involved 1800 participants where 352 were nicotine 
dependent. However, participants were recruited from psychiatric outpatient services 
and therefore it was likely that more cases were detected. A variation in prevalence 
for both lifetime and current depression might be explained by the population 
sampled (clinical vs. general), measurements for depression (face-to-face vs. self-
report) and study design (cross-sectional vs. longitudinal vs. randomised controlled 
trials) (Refer to Tables 4.2 and 4.3). 
There are limited New Zealand studies to date. Tobias et al. (2008), using data from 
the 2003-4 New Zealand Mental Health Survey, found that in those with any mental 
illness, nearly a third (32.3%) were smokers, which was higher than the national 
average during the same period (32% versus 21%, p <0.05). This study included 
12,992 participants with an over sampling of at risk groups, namely Māori and Pacific 
people, and a 73% response rate. Thirty-four per cent of those with a current mood 
disorder were noted to smoke. The majority of these had depression. Although this 
study had a large sample size, limitations included the survey being done on those 
16 years and older, it did not include those in residential institutions, and the smoking 
information was based on a single item question. The findings, however, were 
supported by Fergusson et al. (2003), using the Christchurch Health and 
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Development Study (CHDS), a longitudinal study of 1265 children studied from birth 
to age 21. Using three time points (16, 18 and 21 years), Fergusson and colleagues 
(2003) were able to consistently show that those with depression at each time point 
were smoking more cigarettes and were more dependent on nicotine than those 
without depression (p< 0.001). In another study, Glover (2005) reported that over a 
third of smokers had a past history of depression. This study included only Māori 
participants, and depression was reported using the Māori worldview for defining 
depression. This definition includes the description of depression based on the 4 
realms provided by Te Whare Tapa Wha. In this Māori worldview, depression 
includes a physical element, feelings and thoughts, a spiritual component, and also 
how this condition affects relationships in the family. Participants were also sampled 
among attendees of a focus group. Both measurement for depression and population 
might have introduced bias in the result. This study, however, concurred with Tobias 
et al. (2008), where it was reported that those with depression smoked more 
compared to the general population in New Zealand, irrespective of ethnicity. 
To summarise, the literature suggests a relationship between depression and 
smoking whereby those with depression are found to have higher rates of smoking 
than those without depression. Despite this, local studies have been limited, and 
have often used very different methodologies. Therefore, there is an opportunity to 






Table 4.2: Current smokers with previous history or lifetime depression 







Prevalence Comments/ Predictors 
1 (Glassman et al., 1988)  USA RCT 80 adults SADS 61% - 
2 S. M. Hall, Munoz, & Reus, 1990 USA RCT 65 adults DIS 46% Secondary analysis 
3 S. M. Hall, Munoz, & Reus, 1991 USA RCT 149 adults DI 31% Depression + less likely abstinence 
4 Breslau, Kilbey, & Andreski, 1991 USA 
Cross-
sectional 1007 adults DIS 19.2 -39% 
Depression depending on severity 
of dependence 
5 K. Kendler et al., 1993 USA Co-twin control method 
1566 female 
twins SCID 31.5% 
Increase in lifetime depression with 
increasing cigarette use 24.9% NS 
vs. 51.7% in smokers 
6 Ginsberg, Hall, Reus, & Muñoz, 1995 USA RCT 62 adults DIS 44% 
Lifetime depression did not affect 
quitting at 52 weeks 
7 Brown et al., 1996 USA Longitudinal 1709 adolescents SADS 32% 
Depression predicted smoking 
onset by 2 times (adjusted). 




Schultz, Chilcoat, & 
Andreski, 1998 
USA Longitudinal 1007 adults DIS 22.4% 
3 times likely to smoke with history 
of depression but did not reduce 
rate of quitting. History of smoking 
at baseline increased risk for 
depression 












Prevalence Comments/ Predictors 
10 Glassman et al., 2001 USA RCT 100 adults SCID 57% All patients had recurrent depression 
11 L. S. Covey et al., 2002 USA RCT 134 adults SCID 47% 
Those who smoked developed 
depression (13% vs. 2%), OR 7.17 
12 Cinciripini et al., 2003 USA RCT 121 adults Self-report 14% All patients were recurrent depression 
13 
Kahler, Brown, Strong, 
Lloyd-Richardson, & 
Niaura, 2003 




& Varady, 2003 
USA RCT 224 adults SCID 20% 19.4% of these had recurrent depression 
15 
Michele D. Levine, 
Marcus, & Perkins, 
2003 
USA RCT 219 adult women IDD-L 52.5% 
Lifetime history associated with 
increased cognitive vulnerability to 
depression 
16 L. Cox et al., 2004 USA RCT 784 adults SCID 17% 
Lifetime depression associated 




Humfleet, Reus, & 
Hall, 2004 
USA RCT 549 adults DIS 28.2% 
Those with change in depressive 
symptoms were more likely to 
relapse OR 4.88 
18 John et al., 2004 Germany Longitudinal 4075 adults CIDI 13% 
Those with change in depressive 
symptoms were more likely to 
relapse 












Prevalence Comments/ Predictors 
20 Glover, 2005 New Zealand 
Focus group 
interview 
130 adult Māori Self-report 30% 78.1% of those with depression had recurrent history 
21 Johnson & Breslau, 2006 USA Longitudinal 4858 adults CIDI 16% 
More dependence score and 
withdrawals increased risk for 
depression 
22 Brown et al., 2007 USA RCT 524 adults SCID 17.6% No difference in treatment outcome with depression 
23 Japuntich et al., 2007 USA RCT 677 adults PRIME-MD 24.1% - 
24 Spring et al., 2007 USA RCT 247 adults SCID 44% Those with depression, 46.6% reported recurrent 











23.7% 3.1% of these had recurrent depression 








Those with history of depression 
were more likely to relapse early 
post quit (1 week) than late (6 
months) 





30% of these had recurrent 
depression. Those with history of 
depression and using treatment 
were 3.3 times more likely to 
relapse 




Longitudinal 3056 internet users MDE 18.1% 
Current smokers were 2.62 times 













Prevalence Comments/ Predictors 
29 Bolam, West, & Gunnell, 2011 UK Longitudinal 
1027 internet 
users Self-report 24% 
Depressive symptoms increased 
risk of smoking by 3.42 times 



























twins SCID 9.8% 
Depressives were 4 times more 
likely to quit smoking 
2 Salive & Blazer, 1993 USA Longitudinal 3,960 geriatric population CES-D 11.2% 
Depression group had higher 
FTND and withdrawal  
3 
Kinnunen, Doherty, 
Militello, & Garvey, 
1996 
USA RCT 269 adults CES-D 34.3% 
Depression related to lower self-
efficacy but depression also 




& Knekt, 2000 
Finland Cross-sectional 2,280 adults BDI 
M: 10% 
F: 5% 
Regular smoking increased 
depression 1.4 times 
5 Johnson & Breslau, 2006 USA Longitudinal 4,858 adults CIDI 5% 
Depressive symptoms were higher 
among males that continued to 
smoke than among former and 
non-smokers. Depression did not 
impact quitting 
6 Kinnunen et al., 2006 USA Longitudinal 2,280 adults male CMI 2% - 
7 Japuntich et al., 2007 USA RC 677 adults PRIME-MD 10.5% 
No difference in success rate 
between depressed and non-
depressed using NR 
8 
Kinnunen, Korhonen, 
Tellervo, & Garvey, 
2008 
USA RCT 608 adults CES-D 32% High rate of people with mental illness attending quit clinics 























Not stated 21.5% 
Quit rates lower in those with 
increasing depression withdrawal 
expectancy scores 




students BDI 29% 
Depressed smokers were 2 times 
more likely to be nicotine 
dependent 
11 Khaled et al., 2009 Canada Longitudinal 11,727 adults CIDI 10.6% - 
12 Leventhal et al., 2009 USA Cross-sectional 342 adults SCID 57.8% 
Those with depression were least 




& Zhu, 2011 
USA Longitudinal 844 adult using Quitline PHQ-9 24.2% 
Smoking associated with 
depression particularly female OR 
3.72 














There is still uncertainty and disagreement over the relationship between smoking 
and depression in terms of causality. Four hypotheses for causality were often 
reported in the literature: a) depression causes smoking, b) smoking causes 
depression, c) there is no relationship between the two i.e. other factors were 
involved, and d) the relationship is bi-directional. A fifth, more likely restricted to 
adolescent causality, postulates that depression is divided into subgroups and each 
group has a different relationship with smoking.  
a) Depression causes smoking 
This hypothesis has often been referred to as the ‘self-medication hypotheses’ 
(Markou, Kosten, & Koob, 1998). It suggests that individuals use substances to 
overcome or ‘treat’ an underlying condition. It has been commonly viewed as a 
motive to initiate drugs of abuse and dependence. Causality is supported by the high 
prevalence of lifetime depression among current smokers as seen in Table 4.2. 
These smokers are believed to smoke in order to alleviate their depression through a 
shared neurobiological mechanism (Laje, Berman, & Glassman, 2001; Markou et al., 
1998). 
During depression, the impaired MAO system leads to a reduction in 
neurotransmitters such as serotonin, noradrenaline and dopamine (Hamon & Blier, 
2013). Tobacco use leads to the opposite, the release of these needed 
neurotransmitters either through nicotine or other ‘toxins’ (Eriksen et al., 2012; 
Henningfield, 1995). In turn, it is thought this relationship regulates the chemical 
imbalance associated with depression. Smokers are compelled to continue smoking 
in order to maintain mood regulation and therefore continue to become dependent as 
a result. 
b) Smoking causes depression 
The second hypothesis posits that smoking causes depression. Chronic use of 
tobacco is thought to cause changes in the brain and lead to the development of 
depression (Breese et al., 1997). The earlier the individual starts smoking tobacco, 
the greater the risk as a result of the longer duration of exposure to the ‘toxins’ of 
tobacco smoking (Murphy, Horton, Monson, & Laird, 2003). Early smoking initiation is 
also associated with a higher likelihood of dependence and increasing difficulties for 
smoking cessation. Smokers in this category reported more severe withdrawal 
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symptoms on smoking cessation. Frequent withdrawal symptoms on the other hand 
are implicated to cause further impairment (Covey, Glassman, & Stetner, 1997; John 
et al., 2004; Laje et al., 2001). Longitudinal studies, including those following birth 
cohorts to adulthood or amongst adults followed over a period of time, reported a link 
between smoking and developing depression (Breslau, Kilbey, & Andreski, 1991; 
Brown et al., 1996; Fergusson et al., 2003; Pedersen & Von Soest, 2009; Wu & 
Anthony, 1999). Building on their previous work using the CDHS data (Fergusson et 
al., 2003), Boden et al., (2010) analysed data at the time point of 24 years of their 
longitudinal cohort and reported further evidence to support their position that 
smoking causes depression (B=0.18, S.E. = 0.05, p<0.001). Jamal, Van der Does, 
Penninx, and Cuijpers (2011) also found that early smoking onset might reduce the 
time to first depression. This study found that those smoking earlier were diagnosed 
with depression five years earlier than late onset-smokers. Therefore, the authors 
concluded that the earlier an individual started smoking the shorter the onset to 
developing depression.  
c) There is no relationship between the two 
A third hypothesis asserts that causality was the result of a third variable, a 
confounder which could include either a genetic or an environmental cause. Kendler 
et al. (1993), using their co-twin study consisting of 1566 twins (415 monozygotic, 
315 dizygotic) from the Virginia twin registry, demonstrated through co-twin control 
analysis that causality was most likely genetic. This study was supported by another 
study looking at genetic probands which also reported a possible common cause. 
Using data from 979 epidemiological cohort participants, Johnson, Rhee, Chase, and 
Breslau (2004) reported familial correlation of 75-93% of these participants. Other 
researchers had not found similar findings and the authors attributed their findings to 
differences in definition and method of analysis. An examination of Tables 4.2 and 
4.3 indicates differences in the definition of depression using a variety of 
measurement instruments. In their pioneering study, Audrain-McGovern, Lerman, 
Wileyto, Rodriguez, and Shields (2004), reported the possibility of the DRD2A1 allele 
role found in smokers as a possible explanation. They postulated that this gene, the 
DRD2A1 allele, might be activated by depression and therefore lead to increasing 
smoking levels amongst those already smoking. Meanwhile, Chaiton and Zhang 
(2007), using the Ontario Student Drug Use Survey, reported the possibility of 
environmental factors as the confounder. A major limitation of this study was the 
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cross-sectional design which was unsuitable to show causality. Holma, Holma, 
Melartin, Ketokivi, and Isometsä (2013), nevertheless, reported smoking to be 
strongly associated with alcohol use and personality traits, especially in samples 
already depressed. This study, using the Vantaa Depression study, included 214 
participants recruited from both out-patient and in-patient psychiatric services. 
Therefore, the findings might be implicated for a higher risk population as opposed to 
the general population. 
d) The relationship is bi-directional 
More recent work using longitudinal study designs have supported the bi-directional 
causation. Earlier hypotheses engaging in a unilateral direction to test causality 
appeared incomplete by not incorporating the possibility of both arguments for 
causality. In a systematic review investigating longitudinal studies over nearly two 
decades, Chaiton, Cohen, O'Loughlin, and Rehm (2009) reported the onset of 
smoking among a non-clinical sample was found to be bi-directional especially in 
those using clinical measures. An explanation for a bi-directional approach might well 
be the interplay between tobacco smoking causing neurobiological changes within 
the developing brain. These changes ironically require tobacco use to regulate once 
the damage has set in. Therefore, studies at a particular time point might provide 
only half the explanation. In support of this, others have found an independent 
association between depression and smoking and vice versa which might explain the 
bi-directionality (Holma et al., 2013). Also, bi-directionality for causation was 
supported in the relationship between poor mental health in general and smoking 
(Leung, Gartner, Hall, Lucke, & Dobson, 2012). 
Park and Romer (2007) reported the fifth hypothesis on causality from the work of 
Rodriguez, Moss, and Audrain-McGovern (2005). To our knowledge this has not 
been reported elsewhere. In their review, Park and Romer (2007) have elegantly 
summarised the relationship between depression and smoking as not being static 
across timelines, but rather as dynamic at different periods and at different levels of 
symptomatology (mild, moderate and severe). There appear to be similarities with the 
fourth hypothesis, the difference being that Rodriguez et al. (2005), studied 
depression using subtypes as opposed to a single entity. This study caveated 
limitations to restrict their findings to an adolescent aetiology for causality. 
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In summary, it is still not clear as to the exact mechanism of the relationship between 
depression and smoking. Nonetheless, there appears to be an inclination for a bi-
directional explanation to support this causal relationship. 
4.4 Depression and Smoking Cessation 
There were fourteen reviews on this topic (Table 4.4); seven were from the United 
States, three from Australia, two from Europe and one each from the United Kingdom 
and Sweden. All were published in the last ten years. Four attempted a systematic 
review (Fagerström & Aubin, 2009; Gierisch, 2012; Hitsman et al., 2003; John R. 
Hughes, 2007a) and of these, two provided a meta-analysis (Gierisch, 2012; Hitsman 
et al., 2003). All articles provided advice on managing smoking in those with 
depression; however, only two scrutinised the evidence and provided a conclusion 
(Gierisch, 2012; Hitsman et al., 2003). One systematic review examined the 
incidence of developing depression on smoking cessation (Hughes, 2007a), and one 
other provided guidance for future developments within the field (Wilhelm, 
Wedgewood, Niven, & Kay-Lambskin, 2006). 
The meta-analysis by Hitsman et al. (2003), was the earliest review investigating the 
association of lifetime depression and smoking cessation outcomes. Using data up 
until 2000, they found only 15 studies at the time, the majority of which were clinical 
samples. They concluded that there was no association between a history of 
depression and smoking cessation in both the short (≤ 3 months) and long term (≥ 6 
months), or between genders. These findings created much discussion at the time 
(Covey, 2004; Hall, 2004; Hitsman, Spring, Borrelli, McChargue, & Niaura, 2004). 
Covey, Andrew Bomback, and Yan (2006), reported that a recurrent history of 
depression, as opposed to a single history of depression, might be associated with 
poor cessation outcomes. Hitsman et al., (2013) recently conducted a re-analysis on 
their previous publication (Hitsman et al., 2003) using updated studies until 2009. 
This study reported a small but modest effect of lifetime depression and reduced 
abstinence on short term cessation (17%) OR 0.83 CI (0.72-0.95, p = 0.009) and long 
term cessation (19%) OR 0.81 CI (0.67-0.91, p = 0.023). The researchers, however, 
did not include the sole varenicline study in their final analysis due to the 
antidepressant properties of the medication.  
Current understanding is based on information from clinical trials rather than 
naturalistic, observational and cohort studies (Ziedonis et al., 2008). The latter three 
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types of study have appeared less frequently in the literature. Moreover, Gierisch 
(2012), reported using only RCTs in her analysis of 16 studies. This review also 
reported insufficient studies to examine gender and current depression moderators, 
and thus was only able to answer one of her three research questions. These 
reviews highlighted the lack of studies involving current depression, although newer 
studies were more inclusive. These meta-analyses (Gierisch, 2012; Hitsman et al., 
2003; Hitsman et al., 2013) also reported smoking cessation outcomes in those with 
lifetime depression as opposed to current depression due to the lack of studies.  
The over-representation of clinical studies meant that findings were not as 
generalizable to the general population. Often, clinical studies included the more 
difficult to treat patients and had definitive inclusion criteria which might not represent 
the general population. This group is often referred to as ‘hardened’ smokers 
(Warner & Burns, 2003) although there are mixed reports on this theory. A study in 
Australia (Gartner, Scollo, Marquart, Mathews, & Hall, 2012) using three national 
surveys with > 50,000 participants found little to suggest a hardening hypothesis 
despite a falling smoking rate over a 7 to 10 year period. The analysis conducted on 
those from disadvantaged circumstances i.e. lower socioeconomic background, 
presence of psychological distress did not find any change between the two time 
points. Nevertheless, the hardening hypothesis maintained that remaining smokers 
were more addicted to nicotine and therefore harder to treat. This group was also 
considered by some to be a reason why prevalence has plateaued, especially in 
developed countries. It is thought that current policies have targeted the general 
population well, but have missed out on a certain segment of the population, who 
have more needs in their dependence to nicotine (Costa et al., 2010; Hughes, 2011; 





Table 4.4: Review article on depression and smoking cessation between 1980 – 2012 
No. Authors Year (published) 
Country of 
Origin 
Date range of 
articles Aim of Review 
1. (Hitsman et al.) 2003 USA 1966-2000 
Meta-analysis to evaluate a history of depression is 
associated with failure to quit smoking, and to investigate 
factors that moderate the relationship between a history of 
depression and cessation outcomes 
2.  (Paperwalla, Levin, Weiner, & Saravay) 2004 USA NS 
Review of the interaction between smoking and depression, 
focussing on biological and behavioural research 
3.  (Wilhelm, Arnold, Niven, & Richmond) 2004 Australia NS 
Overview of the relationship between depression and 
smoking.; andto provide recommendations on how to treat 
these individuals 
4.  (Wilhelm et al.) 2006 Australia NS Review research on the association between smoking cessation and depression, emphasising future research 
5. (Morrell & Cohen) 2006 USA NS Review of anxiety and depression as they relate to stages of the cigarette smoking cycle 
6. (John R. Hughes) 2007 USA 1990-2004 To test whether the incidence of depression after smoking is greater than expected 
7. (Lembke, Johnson, & DeBattista) 2007 USA NS 
Review of the clinical evidence on depression and smoking 
cessation, and support for current psychiatric practices 
8. (Ziedonis et al.) 2008 USA NS 
Review of tobacco use. dependence and smoking cessation 
among those with mental illness especially anxiety disorder, 
depression and schizophrenia 
9. (Campion) 2008 UK NS 
Review of literature on smoking cessation in those with 
mental health problems with the emphasis on depression 
and schizophrenia 




No. Authors Year (published) 
Country of 
Origin 
Date range of 
articles Aim of Review 
10. (Ischaki & Gratziou) 2009 Greece NS 
Review of the relationship between smoking and 
depression, the influence of depression and smoking 
cessation trials, and the available treatment for this group 
11. (Fagerström & Aubin) 2009 Sweden 1990-2008 Review of the relationship between smoking and psychiatric disorder, emphasising depression and schizophrenia 
12. (Molina-Linde) 2011 Spain NS Review of effective strategies for smoking cessation to assist adults with depression, schizophrenia and psychosis 
13 (Gierisch) 2011 USA Till 2010 
Systematic review of smoking cessation interventions for 
patients with history of depression or current depressive 
symptoms 
14. (Mendelsohn) 2012 Australia NS 
Review of the relationship between smoking and 
depression, and the evidence on certain treatments used in 
general practice 




4.5 Relationship between Depression and Smoking Cessation 
 Do People with Depression Want to Quit Smoking? 
One of the explanations for the reluctance to treat smokers with mental illness is the 
notion that these smokers are unwilling and do not want to quit (Prochaska, 2011). 
This reluctance also extends to those with depression. There appears to be little 
evidence that depression is worsened by smoking cessation and, since a greater 
number of them are at risk for tobacco related harm, it is considered that every effort 
should be made to assist them to quit smoking (Ministry of Health, 2007; Tobacco 
Use and Dependence Guideline Panel, 2008). The benefits for smoking cessation 
has been estimated to outweigh the risk of harm that is, if there is even any risk of 
harm to begin with (U.S. Department of Health and Human Services, 1990).  
Evidence from the National Institute Health Survey of 23,393 non-institutionalised 
adults in the US revealed that those with mental illness were as likely as those 
without to attempt smoking cessation (45.9% vs. 41.8%), although having more than 
one mental illness might reduce the likelihood to do so (Ziedonis et al., 2008). In their 
longitudinal study of 25 years, Kinnunen et al. (2006) reported that those with higher 
depressive scores were as likely to quit as those with lower scores. Another study of 
844 callers to Quitline identified that 40.7% of these callers who had symptoms 
suggestive of mild to major depression nonetheless also utilised the Quitline service 
to assist in their quitting (Hebert, Cummins, Hernández, Tedeschi, & Zhu, 2011). The 
findings from this observational study provided a glimpse of service utilisation for 
those with depression in the community. A more recent study with nearly 8000 
participants, where half were mental health patients with depression, provides further 
evidence of quit smoking attempts made by this population (Anthenelli et al., 2016). 
Therefore, there are indications that those with depression in the community are as 
likely to use smoking cessation services when available.  
From the available literature outline, there is evidence to suggest that people with 
depression are also willing to quit smoking using both clinical and community 
settings, irrespective of their depression status. 
 Does Depression Influence Outcomes for Smoking Cessation? 
Current understanding is based on data from clinical settings as opposed to 
community or epidemiological settings (Gierisch, 2012). The current understanding 
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on how depression interacts with smoking cessation outcomes is restricted to lifetime 
rather than current depression (Gierisch, 2012; Hitsman et al., 2013). Therefore, 
there is a need for more research, particularly in naturalistic studies, as the 
information on the impact of depression on smoking cessation is still unclear. 
The study by Glassman et al., (1988) was one of the early studies reporting a 
negative effect of lifetime depression on smoking cessation. Following this, the same 
authors conducted a test of association using participants of the St Louise 
Epidemiological Catchment Area Study (n = 3213) and found that those with lifetime 
depression were less likely to succeed in smoking cessation compared to those 
without (31% vs. 14%). Others have not found any significance in this relationship, 
especially for long term outcomes (Ginsberg, Hall, Reus, & Muñoz, 1995; Niaura et 
al., 1999). A meta-analysis of 15 publications found no association between lifetime 
depression and smoking cessation (Hitsman et al., 2003). A recent update, however, 
has reported modest negative association in both short (n = 35, OR = 0.83, 95% CI = 
0.72–0.95, P = 0.009) and long term outcomes (n = 38, OR = 0.81, 95% CI = 0.67–
0.97, P = 0.023) (Hitsman et al., 2013). Therefore, this most recent review suggests 
that the presence of lifetime depression is associated with poorer smoking cessation 
outcomes. This meta-analysis included 42 publications, including the previous 15, 
and analysis conducted excluded smoking cessation treatments which might have 
antidepressant effects, but still found the findings to be robust.  
The relationship between current depression and smoking cessation has been the 
subject of even fewer studies (Gierisch, 2012; Hitsman et al., 2003; Hitsman et al., 
2013; Wilhelm et al., 2006). One of the earlier studies investigating current depression 
and smoking cessation used a nationally representative survey (National Health and 
Nutrition Examination Survey, NHANES). In this study, Anda et al. (1990), defined 
depression using the CES-D (cut-off score ≥16) and found that those with depression 
were 40% more likely to fail in their quit attempt compared to those without 
depression (p<0.05). Another study of 296 participants found that those with 
depression were unlikely to abstain at 1 week compared to those without depression 
(37% vs. 56%). At 3 months, those with depression and on placebo fared the worst: 
only 12.5% of them managed to quit smoking. The results for those with depression 
and using NRT gum were similar to those without depression and on placebo (29.5% 
vs. 24.1%, p = 0.36). Those without depression and NRT did the best (37%). Overall, 
those who were non-depressed on active NRT gum did better than those who were 
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non-depressed and on placebo, or those who were depressed using active NRT gum 
(p<0.05) (Kinnunen, Doherty, Militello, & Garvey, 1996). This study, however, did not 
mention retention rate at 3-months which might have affected the outcome. In a 
meta-analysis of smoking cessation interventions of patients with depression 
(Gierisch, 2012), only three (Hall et al., 2006; MacPherson et al., 2010; Vickers et al., 
2009) of 16 articles were full RCTs which investigated current depression and 
smoking cessation. These were also the three of 49 articles identified in a recent 
Cochrane review (van der Meer, Willemsen, Smit, & Cuijpers, 2013). In this review 
which favoured abstinence outcomes of six months or longer, adding psychosocial 
interventions assisted current smoking cessation intervention in those with current 
and a history of depression. On their own, smoking cessation aids bupropion, RR 
1.37 CI (0.83 to 2.27) and NRTs RR 1.17 CI (0.85 to 1.60) showed positive results in 
treating those with current depression but the results are not statistically significant. 
There have not been enough studies evaluating the outcomes of smoking amongst 
people with current depression to provide a more conclusive result. 
A longitudinal study over 25 years, involving 2208 men recruited from the Veterans 
Administration Normative Aging Study, measured depression using three measures. 
None were found to be associated with reduced likelihood for smoking cessation. 
Also, the symptoms of those who were reported to have higher depressive symptoms 
over time did not appear to have an impact on their smoking cessation (Kinnunen et 
al., 2006). This was in contrast to Killen, Fortmann, Schatzberg, Hayward, and 
Varady (2003), which reported increasing symptoms of depression using the CES-D 
which was associated with lower likelihood of abstinence over a 26 week period. 
Therefore, it appears from the available literature that lifetime depression is 
associated with a poorer outcome, but there has not been enough research to 
confidently come to the same conclusion for those with current depression. 
 Does Smoking Cessation Worsen Depression? 
Relapse of the underlying psychiatric symptoms is another common concern 
expressed by those reluctant to treat smokers with mental illness (Prochaska, 2011). 
One of the earlier studies (Covey et al., 1997) included 126 participants who had 
completed a previous smoking cessation clinical trial and were followed up at 3-
months. Participants were abstinent and not depressed on recruitment. At follow-up, 
using DSM-IIR for assessment, the incidence of depression was 2% for those without 
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a history of depression, 17% for those with a previous single history, and 30% for 
those with recurrent history. Those with a history of depression, especially recurrent 
depression (p=0.008) and persistent withdrawal symptoms, were at greater risk 
(p<0.05) of developing a new episode of depression. Using a similar follow-up 
design, but at 6-months, participants in a clinical trial for smoking cessation using 
sertraline reported a higher incidence of depression in those who were abstainers 
compared to continued smokers, 31% vs. 2% (p=0.008) (Glassman et al., 2001). This 
study, however, did not follow-up on dropouts of the study (n=24) and had a small 
initial sample size (n=100). Dropouts were also more likely to continue smoking and 
this might affect the incidence of new depression at 6-months. Tsoh et al. (2000), 
using two trials for smoking cessation (n=304), also looked at the incidence of new 
depression using the Inventory to Diagnose Depression, a self-report questionnaire 
based on the DSM-IIIR. They found a 14.1% incidence of depression at 12-months 
follow-up, and there was no significant difference between those who were abstinent 
or continued smoking. Similar to findings by Covey et al. (1997), those with a history 
of depression were more likely to develop a subsequent episode. However, unlike 
Covey et al. (1997), those with a history of recurrent depression were not at greater 
risk. Using another study on smoking cessation, comparing NRT with paroxetine 
(20mg and 40mg) against NRT alone, Killen et al., (2003) reported a depression 
incidence of 4% (10/224) using the Structural Clinical Interview for DSM-IV (SCID). 
Of the ten participants, 80% resumed smoking at the end of treatment at 26 weeks 
and of these, two had a history of lifetime depression. In a study of adolescents, with 
a mean age 17, the incidence for depression was 1% (2/211) using the SCID. The 
authors concluded that incidences were similar in both adolescents and adults and 
therefore warranted awareness. In this study, however, only one of the two had a 
history of previous depression (Killen et al., 2004). A review of seven clinical studies, 
however, did not conclude that abstainers were more likely to develop new onset 
depression (Hughes, 2007a). 
Although clinical studies have found new incidences of depression post smoking 
cessation, there have been no similar findings from community based studies. The 
limited studies available have not reported smoking cessation to worsen depression. 
In the ATTEMPT cohort, a longitudinal study recruiting community samples from the 
internet (n=3645), an analysis of 1027 of them, who were free from depression at 
baseline, found no difference in depression symptoms at 6 to 9 months between 
those who were abstinent and those who continued to smoke OR= 1.03 CI (0.41 to 
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2.56) (Bolam, West, & Gunnell, 2011). Another analysis conducted using the same 
data set, but comparing those who quit for at least 3-months or less than 3-months at 
the 12-month follow-up, found a similar conclusion whereby quitting smoking was not 
associated with an increase in depression but might actually instead have reduced it 
(Shahab, Andrew, & West, 2013). Both studies used the internet to recruit 
participants and therefore depression was assessed by self-report using single 
statement questions on depression over the past 30 days; this may have limited 
finding validity. 
Therefore, from the literature reviewed, there was little evidence of their being a risk 
of developing depression after quitting smoking in those in clinical samples without 
recurrent depression or severe withdrawal symptoms. Similarly for those in 
community samples, there was little evidence to suggest quitting smoking increases 
the risk of depression.  
 Depression Predicting Smoking Cessation 
In two studies elucidated to earlier (Covey et al., 1997; Tsoh et al., 2000), although a 
history of depression was predictive of new onset depression, those with recurrent 
depression were at even greater risk. Recurrent depression has been associated 
with higher levels of nicotine dependence. Increased dependence has been shown to 
affect outcomes negatively. In their secondary analysis of 179 participants attending 
a smoking cessation study, Cohn, Strong, Abrantes, and Brown (2010) reported 
those with recurrent depression to be associated also with reduced self-efficacy. 
Also, their analysis found those with recurrent depression were more unlikely to be 
abstinent on their quit day (OR = 4.44, P<0.05). The authors, however, did not find 
an increased risk for early relapse amongst those with recurrent depression (β=0.45, 
p>0.05). Strong et al. (2010), in their study of 1560 participants, reported that those 
with recurrent depression also had a reduced number of quit attempts compared to 
those with single episode or no history of depression. The main limitation of this 
study, however, was the cross-sectional design. 
A recent review, looking at all published articles on smokers with depression and 
smoking cessation identified 190 articles and concluded that there was still much 
work to do in understanding this relationship between depression and smoking 
cessation (Weinberger, Mazure, Morlett, & McKee, 2013). There has been little 
research on current depression, and even less on dysthymia and minor depression. 
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Minor depression has been associated with similar burden as MDD (Pietrzak et al., 
2013). Increasing symptoms of depression, but not necessarily meeting full criteria, 
have been found to affect outcomes (Killen et al., 2003) and this, too, is a potential 
area of study.  
There is one other published study looking at predictors of depression in New 
Zealand. This used secondary data from an RCT on NRT (Williman, Parag, Walker, 
& Bullen, 2011). The authors reported that those with lifetime depression at baseline 
were more likely to be depressed at six months; however, those who managed to 
abstain for the duration were noted to have fewer symptoms. This study, however, 
was not primarily designed to investigate this matter.   
4.6 Summary 
Depression is a serious medical illness which was initially believed to be associated 
with smoking and to complicate smoking cessation. Available studies, have found 
that the relationship between depression and smoking is still inconclusive. There is, 
however, increasing evidence that the causal relationship between depression and 
smoking may be bi-directional in nature whereby depression can lead to smoking and 
continuous smoking may precipitate depression.  
Most of the current information on depression in relation to smoking is related to 
lifetime depression rather than current depression. Information on depression and 
smoking cessation, however, is mainly limited to clinical trial settings as opposed to 
the community, and may limit the findings. Similarly, there is little information to show 
that smoking cessation leads to new incidence of depression and what information 
there is was obtained from clinical settings as opposed to community based settings. 
Nevertheless, one recognised predictor of future depression during smoking 
cessation was a history of recurrent depression.  
Although there are a number of studies investigating the relationship between 
depression and smoking, and depression and smoking cessation, these studies have 
their limitations. There is still an opportunity to revisit this relationship and provide 
more information to the current pool of knowledge. 
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 CHAPTER 5 - Literature Review: Smoking Cessation and 
Weight Gain 
5.1 Chapter Overview 
This chapter will investigate the role of weight gain and obesity and its relationship to 
smoking and smoking cessation. Mechanisms for weight gain on quitting smoking will 
be addressed and treatments to prevent or reduce the weight gained will be 
reviewed. The chapter will end with a review of available studies conducted in New 
Zealand, before ending with the research gaps in this area of interest. 
5.2 The Obesity Epidemic 
Obesity is defined by the WHO as abnormal or excessive accumulation of fat which 
impairs health (James, Leach, Kalamara, & Shayeghi, 2001). Obesity has also been 
reported as overweight grade 2 (WHO Expert Committee, 1995). Both definitions can 
be measured by using the body mass index (BMI), which is represented by the 
formula current weight in kilograms divided by the square of current height in meters 
(kg/m2). Those with a body mass index of equal to or greater than 25 are considered 
overweight and those equal to or greater than 30 are obese. However, variability 
between ethnicities has also been considered. An alternative BMI scoring for Asians 
has been published with lower cut-offs scores (James et al., 2001).  
The consequences of being overweight and obese are major risk factors for various 
health conditions, including increasing the risk of developing diabetes, various 
cardiovascular diseases and also cancer (Hedley et al., 2004). The WHO estimates 
that three million lives are lost yearly as a result of obesity (Consultation, 2000). 
Compared to individuals of normal weight, those with obesity have shorter life spans. 
Obese individuals have been reported to die 13 years earlier than those who are not 
obese (Fontaine, Redden, Wang, Westfall, & Allison, 2003; Peeters et al., 2003). 
The past four decades have recorded a noticeable increase in worldwide obesity. It 
affects both high income countries and lower middle income countries However, it is 
increasingly being recognised as a problem of high income countries, but more 
noticeably affecting the poor within these countries (James et al., 2001). It is 
projected that by 2030, obesity will affect an estimated 576 million people compared 
to 396 million in 2005 (Kelly, Yang, Chen, Reynolds, & He, 2008). In 2008, however, 
it was already estimated that 502 million people were considered to be obese 
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(Swinburn et al., 2011). Others have reported the obesity rates to have increased by 
1% each year in the countries surveyed, making statistics meaningless rather quickly 
as national databases need to be updated regularly to reduce the risk of being 
obsolete and unable to cater to the current required demands in both policies and 
treatment practices (Prentice, 2006). 
 How is the Obesity Epidemic Related to Tobacco? 
Amongst the reported withdrawal symptoms of nicotine dependence is increased 
appetite and/or weight gain. Some researchers have postulated that the cost of 
population level smoking cessation has contributed towards the current obesity 
situation. An early study by Chou, Grossman, and Saffer (2004), reported trends from 
the National Health Examination Survey (NHES) and NHANES I,II,III and 99 which 
clearly showed an increasing trend in BMI from 24.91 in the late 1950s to 27.85 in 
2000. This was accompanied by an increasing proportion of obesity from 12% to 
nearly 30% during the same time. At the same time as the prevalence of obesity was 
climbing, smoking rates were dropping. This was postulated most likely as a 
consequence of the 1964 US Surgeon General’s report on the dangers of cigarettes 
released during that time period. Chou et al. (2004), using repeated cross-sections of 
the Behavioural Risk Factor Surveillance System (BRFSS) data for the years 1984-
1999, found a positive correlation between increasing cigarette prices and increasing 
obesity. However, the authors also stated a caveat that, despite their positive 
findings, cigarette prices were actually similar for the two decades from 1960s to 
1978 without any spike in obesity during that period. Nonnemaker, Finkelstein, 
Engelen, Hoerger, and Farrelly (2009) replicated the study by Chou et al. (2004) 
using the BRFSS, but divided smokers into current smokers, former smokers and 
non-smokers. They found that the largest BMI change was in the non-smoker group 
compared to the other groups; however, this observation was not significant (p>0.05). 
When analysed further, the authors found further discrepancies and concluded there 
was no support for the claim of increasing cigarette taxes causing the obesity rise. In 
another study using the NHANES 99 dataset for both weight and smoking, Flegal 
(2007) reported a very small effect of less than 1% of the role of smoking cessation 
on the population level rise in obesity. Similarly, Kasteridis and Yen (2012) in their 
study also found that if there was any effect of smoking cessation on the obesity 
epidemic, it probably was very modest. All these studies have indicated that smoking 
cessation may lead to obesity, although at the population level this rise was most 
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likely negligible. There are likely other factors involved unrelated to smoking 
cessation, such as the reduction in processing one’s own food and the rise of 
restaurants, particularly fast food outlets, during the same period (Chou et al., 2004). 
5.3 Weight and Smoking 
 The Relationship between Smoking and Weight 
Weight control is amongst the more commonly cited reasons for initiating and 
continuing smoking, and a significant reason cited for finding it difficult to quit 
smoking (Borrelli & Mermelstein, 1998; Pomerleau & Kurth, 1996; Pomerleau, 
Zucker, & Steward, 2001). The fear of weight gain was reported by both men and 
women alike (Larsen et al., 2009). However, more women than men endorsed weight 
control as a reason to start smoking (Spring et al., 2009). Similarly, this was also 
found among adolescents as a reason to continue smoking (Larsen et al., 2009). 
More women than men also increasingly used smoking as an appetite suppressant. 
These participants reported smoking assisted them to control their eating and that 
smoking cessation led to an increase in weight (French & Jeffery, 1995). Pomerleau 
and Kurth (1996) reported that among the 87 women studied, younger women in 
their study were more likely to report not wanting to gain any weight compared to 
senior women (57% vs. 9%). Of those who reported being willing for any weight gain, 
they were found to be only agreeable for a gain of less than 2.3kg (75%). Post-
cessation weight gain was also reported as the main reason for half of women not 
wanting to quit smoking. In the same study, just over a quarter (26%) of the men 
reported not wanting to quit due to post-cessation weight gain (Clark et al., 2006). 
Recent work by Siahpush et al. (2013) reported that in spite of weight gain, the 
benefits of quitting for health outweighs the consequences to health as a result of 
weight gain. The findings by Siahpush et al., (2013) provided further reassurance on 
the benefits of quitting. 
 Mechanism of Smoking in Weight Control 
The relationship between smoking and weight is complex and multi-factorial. The 
actual mechanism of action for tobacco smoking to control weight is still not yet fully 
understood. Studies have consistently reported smokers having lower BMIs 
compared to both recent quitters and also former smokers (Audrain-McGovern & 
Benowitz, 2011). There is increasing evidence to support the actions of nicotine in 
tobacco as an important factor in weight control (Audrain-McGovern & Benowitz, 
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2011; Jarvik, 1991). Nicotine has been shown to assist in weight control, mainly 
through two mechanisms: 1) increasing resting metabolic rate or thermogenesis and 
2) reducing appetite. 
Nicotine acts by binding to nicotine acetylcholine receptors (nAchR). This action 
results in the release of various neurotransmitters such as dopamine, serotonin and 
noradrenaline. It is the latter which is believed to be responsible for the increase in 
resting metabolic rate (Jarvik, 1991). In a study by Perkins, Epstein, Stiller, Marks, 
and Jacob (1989), acute nicotine use has been shown to increase resting metabolic 
rate above baseline by 6% compared to 3% in placebo. This study, using zero, low 
and moderate nicotine preparations administered through a nasal spray, was 
designed to separate nicotine action on resting metabolic rate from the action of 
smoking itself. The findings of an increase in resting metabolic rate by placebo 
means that there is still some interaction through the administration of nicotine. 
The role of nicotine in reducing appetite is more complex. The melanocortin system 
(MC) within the brainstem, the role of the MC4 receptor in particular, has been 
implicated in regulating appetite (Seeley & Sandoval, 2011). The pro-
opiomelanocortin (POMC) neurons located in the central nervous system at the 
hypothalamus are responsible for synthesising several molecules which act on the 
MC4 (Schwartz, Woods, Porte, Seeley, & Baskin, 2000). Action on the MC4 
produces appetite suppression.  
Nicotine interacts with the POMC through a number of systems as shown in Figure 1. 
Indirectly, acute nicotine intake has been shown to increase ghrelin, one of two 
hormones implicated in appetite regulation (Cowley et al., 2001; Rubinstein & Low, 
2011). Ghrelin particularly interacts with neuropeptide-Y (NPY), a neurotransmitter 
associated with inhibiting the actions of POMC. Through the action of ghrelin, the 
inhibitory role of NPY is disrupted and therefore POMC is able to increase its action. 
Nicotine has also been shown to increase leptin, another hormone involved with 
regulating appetite (Cowley et al., 2001). Leptin binds to receptors at the POMC to 
stimulate its action leading to appetite suppression.  
Apart from nicotine’s action on hormones, it is also involved in the release of 
serotonin (Pomerleau, Pomerleau, Morrell, & Lowenbergh, 1991). Similar to the 
actions of leptin, serotonin binds to serotonin receptors at the POMC to increase 
MC4 binding molecules. Recently, Mineur et al. (2011) reported on the direct 
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relationship between nicotine and the POMC. Nicotine was shown to bind with the 
α2β3 receptor which was shown to stimulate the POMC directly. This study was 
unique in that it incorporated a number of methodologies to come to the researchers’ 
conclusion. These studies were, however, conducted mainly on rats and, although 
they gave an indication of the mechanism of nicotine’s action towards appetite, this 
might not easily be translated in the clinical setting. Kroemer, Guevara, Vollstädt-
Klein, and Smolka (2013) nevertheless undertook this work on a small group of 26 
healthy participants through a pharmacological challenge and found supporting 
evidence of the work previously conducted on rats. Despite these initial findings, 
more studies are needed, preferably in larger populations, before a definitive 
conclusion can be reached on whether nicotine is indeed implicated in appetite. 
 
Figure 5.1: Arcuate POMC Neurons Integrate a Diverse Set of Excitatory and Inhibitory 
Signals Involved in the Central Regulation of Energy Balance (Cowley et al., 2001) 
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5.4 The Relationship between Weight and Smoking Cessation 
Williamson et al. (1991), were the first to report accurate weight gain on smoking 
cessation. Using the NHANES I, they measured weight at two time points for 1885 
smokers between 1971-75 and 1982-84. Of interest, 41% (409 men and 359 women) 
of the participants quit smoking within a year. They found that for those who were 
abstinent, their weight gain, after adjusting for confounders, was 2.8kg for men and 
3.8kg for women. Also, they reported more than 9.8% of men and 13.4% of women 
gained more than 13kg. This study also found smokers at baseline were lighter than 
non-smokers; however, at follow-up measurements, their weights were nearly the 
same. The main strength of this study is that both height and weight were measured 
objectively, as opposed to previous studies which had used self-reports. Using the 
Lung Health Study, O'Hara et al. (1998) studied 5,887 participants measured at five 
years apart. Some participants for this study were older by 10 years, than those in 
Williamson et al.’s (1991) study (35-60 years vs. 25-74 years). O’Hara and 
colleagues found a 5kg weight gain in both sexes at year one, and less weight gain 
thereafter. At both time points, women were noted to gain more weight than men. 
Weight gains of >10kg were reported for 33% of the sample who were abstinent for a 
year compared to 6% in smokers. Both studies were unable to quantify the 
mechanism of weight gain, due to the non-recording of caloric intake, but were 
important studies due to the sample size of both cohorts and their generalizability. A 
larger longitudinal study, using data from nine European countries involving 329,391 
participants who were followed-up for five years, reported an average weight gain of 
0.44 kg CI (0.36- 0.52) for men and 0.46 kg CI (0.41- 0.52) for women (Travier et al., 
2012). This averaged to nearly 2.8kg after 5 years, with only 5% gaining more than 
12kg for the same period, less than the results of other studies.  
In a more recent meta-analysis of 62 clinical papers, Aubin, Farley, Lycett, Lahmek, 
and Aveyard (2012) reported a mean weight gain of 4-5kg at one year on post quit. 
Thirteen per cent gained more than 10kg during the same period. Weight gain was 
reported to be highest within the first three months (average 1kg per month). Unlike 
in previous studies (O'Hara et al., 1998; Williamson et al., 1991), this study was 
limited to participants in a clinical trial setting. Often participants in this setting are 
smokers who are more dependent, have greater needs and have attempted to quit 
multiple times. This study also found that between 16-21% of smokers actually lost 
weight on quitting. The authors provided no explanation for the study findings. There 
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is a possibility that the findings indicate that some individuals are destined to gain 
weight while a minority might actually lose weight during their quit attempt.  
In summary, quitting smoking is associated with weight gain. Moreover, a minority of 
patients can also gain 10kg or more as a result of their quit attempt. 
5.5 Mechanism for Smoking Cessation Weight Gain 
Weight gain happens when there is an imbalance in energy consumption and energy 
intake. Nicotine plays a significant role in suppressing appetite both directly and 
indirectly through the POMC as explained earlier in section 4.2.2. The removal of 
nicotine may lead to weight gain through the reduction of resting metabolic rate which 
results in an increase in appetite. The latter is believed to happen through the 
reduction of ghrelin. This leads to inhibition of the POMC by NPY. The removal of 
nicotine also stops nicotine’s action directly on the α2β3 nicotinic receptor at the 
POMC. This then reduces both leptin and serotonin release, and their subsequent 
reduced action on the POMC. All of this leads to increased appetite and possibly 
impending weight gain as a result. 
Another possible mechanism for gaining weight is behavioural factors such as 
sedentary lifestyle. Tobacco smoking has been termed a “gateway behaviour” 
whereby smokers often make unhealthy behaviour choices such as poor exercise 
and poor food choices, apart from increased use of other drugs such as alcohol 
(Kaufman, Augustson, & Patrick, 2011; Prochaska, Spring, & Nigg, 2008). A study 
using the NHANES 1999-2006 data reported that those who were classified as 
having moderate sedentary behaviour were 1.34 times more likely to be obese. 
Those with high sedentary behaviour were at greater risk. They were 1.78 times 
more likely to be obese than those with low sedentary behaviour and had noticeably 
higher BMI (Kaufman et al., 2011). Current smokers with higher levels of sedentary 
behaviour were also heavier than those with lower levels. Former smokers were also 
found to be more sedentary than those who had never smoked, and this led to the 
notion that sedentary behaviour developed during the smoking years and continued 
following smoking cessation. Therefore, these may be explanations for the role of 
nicotine cessation and behavioural factors in weight gain post quit.  
Another mechanism which is beginning to receive attention is the possibility of 
substituting addictions (Ogden, 1994; Sussman et al., 2011). There is growing 
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evidence that food, especially hyper-palatable foods with various combinations of fat, 
sugar and salt, may act in a similar manner in their action to drugs of abuse 
(Gearhardt & Corbin, 2011). Neuroimaging studies have found certain foods to 
release dopamine in the limbic system, in a similar fashion to addictive substances 
(Volkow, Wang, Tomasi, & Baler, 2013). Smokers who quit often report the need for 
sweet foods (Rodin, 1987). Sugar, independent of fat, has been shown to be 
responsible for weight gain and can account for a proportion of the weight gained on 
smoking cessation (Te Morenga, Mallard, & Mann, 2013). The use of food in the past 
has often been reported as being more as ‘food desire’ to replace the desire for 
cigarettes (Ogden, 1994). This was before food, particularly food which contains 
certain contents such as sugar, was known to mimic other addictive substances. 
Even then, before the concept of food addiction was introduced, some have written 
about food reinforcement being greater than food desire, but somewhat mediated by 
dopaminergic activity (Epstein & Leddy, 2006). Currently, food addiction is gaining 
acceptance within the scientific community (Brownell & Gold, 2012; Ashley, 
Gearhardt, Corbin, & Brownell, 2009a) and may be an alternative mechanism to 
explain weight gain after smoking cessation (Audrain-McGovern & Benowitz, 2011). 
This concept, however, has not been clinically researched to date in smoking 
cessation. 
 Predictors of Weight Gain among Those Wanting to Quit 
There are a number of risk factors which may lead to individuals gaining weight on 
smoking cessation. For clarity, these risk factors are classified as general, smoking 
and weight factors. 
 General Factors 
Those in the younger age group were often reported to be at risk for weight gain as a 
result of smoking cessation. O'Hara et al. (1998), using the Lung health Study, 
reported mean ages of 48 years for male and 49 years for female of those quitting 
smoking who are more likely to gain weight. Using the NHANES I, Williamson et al. 
(1991) reported those under 55 were more likely to develop weight gain.  
When weight gain risk was investigated in terms of gender, women appeared to be at 
greater risk (Flegal, Troiano, Pamuk, Kuczmarski, & Campbell, 1995; Klesges, 1997; 
Pistelli, Aquilini, & Carrozzi, 2009; Williamson et al., 1991). Aubin et al. (2012), 
however, were unable to come to the same conclusion in their meta-analysis 
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investigating weight gain and gender, due to insufficient information in the 
publications used for their study. 
Studies examining ethnicity and weight gain on smoking cessation are limited. In 
their study, Williamson et al. (1991) reported that those of African American descent 
were three times more likely to gain weight (>13kgs) than Caucasian Americans. 
Among Asians, studies have been restricted to Japanese men, and the reported 
weight gain is around 2kg post quit. These findings are below the generally 
anticipated weight gain of 4-5kg reported by other researchers (Kadowaki et al., 
2006; Tamura et al., 2010). 
 Smoking Factors 
A significant factor which appear to be the most consistent predictor for weight gain 
are smoking factors. A high number of cigarettes smoked per day (25 of more) 
appears to be positively associated with weight gain in a number of studies 
(Caponnetto & Polosa, 2008; John, Hanke, Rumpf, & Thyrian, 2005; O'Hara et al., 
1998; Williamson et al., 1991). In a study of 7,124 German participants recruited from 
a national health examination survey, a proportion of overweight and obese were 
associated with the number of cigarettes per day for both male and female (John et 
al., 2005). In this study, when age, education level, alcohol and exercise confounders 
were controlled, male former smokers smoking the highest number of cigarettes per 
day were five times more likely to be obese than current smokers. This was not seen 
in women former smokers. In a Williamson et al. (1991), study, men were 5.7 times, 
and women 4.7 times, more likely to gain weight with an increased number of 
cigarettes per day (25 or more) compared to current smokers. The Lung Health 
Study, O'Hara et al. (1998) reported an inverse relationship between cigarettes per 
day and weight loss among current smokers. 
 Weight Factors 
Weight history has also been associated with weight gain, although there is little 
agreement on baseline weight predicting weight gain and obesity. John, Meyer, 
Rumpf, Hapke, and Schumann (2006), in a study of 4075 participants recruited from 
Lubeck, Germany, found those with increased appetite or weight at baseline were 
associated with a higher BMI amongst former smokers compared to current smokers. 
Participants were part of the Transitions in Alcohol Consumption and Smoking 
(TACOS) study, and the authors concluded that those with increased appetite or 
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weight as a withdrawal symptom were at higher risk of having a higher BMI at 3 
years.  
A fear of weight gain has been shown to discourage smoking cessation in women. 
Similarly, men have also been reported as attributing a fear of weight gain as a 
reason not to quit (Clark et al., 2004; Spring et al., 2009). Although weight concerns 
have been attributed to an increase in relapse to smoking (Meyers et al., 1997; Wee, 
Rigotti, Davis, & Phillips, 2001), these similar concerns are not associated with 
increasing weight. White, McKee, and O'Malley (2007) found that those who reported 
using cigarettes to control weight were not seen to gain actual weight. In another 
study examining weight concerns and body image (Pomerleau et al., 2001), all 
participants who reported having very high concerns about weight gain on quitting 
tended to be heavier than those who reported to be somewhat concerned or not 
concerned at all about their weight (157.3 +/- 35.8 vs 149.0 +/- 36.1 vs 130.2 +/- 26.0 
pounds respectively). Those who were highly concerned also had a distorted image 
of self in multiple dimensions of body image measurements. The women in the study 
were also found to smoke more cigarettes and thus were more addicted to nicotine, a 
situation most likely to perpetuate further their weight gain on cessation. Considering 
that participants who endorsed high concerns about weight gain on quitting were 
different from participants who were either somewhat concerned or not concerned, 
this group may be uniquely different from the others, an area that will likely benefit 
from further study. 
In summary, those with an increased appetite or weight at baseline and those highly 
concerned about their weight were a high risk of gaining weight when attempting to 
quit smoking. 
5.6 Treatment Availability 
Although increased appetite and weight have been recognised for some time as 
withdrawal phenomena of smoking cessation, the development of treatment to 
address this has been limited (Tobacco Use and Dependence Guideline Panel, 
2008). Some guidelines report weight gain as an undesirable consequence which 
may discourage initiating a smoking cessation attempt, or as a cause of early relapse 
(Ministry of Health, 2007; Zwar N et al., 2011) whilst others do not mention it at all 
(CAN-ADAPTT., 2011).  
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Pomerleau et al. (2001) reported that smokers who rated highly on concerns about 
weight gain on quitting were different from those without similar concerns, and 
understanding this population might be important in assisting in the management of 
their quitting. These smokers are often highly addicted, unlikely to quit on their own 
and have a distorted view of their body image. These individuals may benefit from 
behavioural intervention, together with pharmacological treatment. Unfortunately, 
treatment for weight control has been mixed in terms of smoking cessation. Newer 
agents such as rimanobant, which was initially found to show promise in both 
assisting in quitting smoking and reducing post cessation weight gain, have 
subsequently been deemed unsafe in other studies and have therefore been 
withdrawn from use for smoking cessation (Caponnetto et al., 2012). A newer agent, 
which has been shown to be useful in both smoking cessation and weight 
management, is Lorcaserin, a selective serotonin inhibitor (Shanahan et al., 2015). In 
a recent clinical trial of 603 smokers with an average of 4 quit attempts, the 
abstinence rates, both continuous and 7-day point prevalence, were better compared 
than placebo, and the weight gain was comparable (+0.73 vs +0.76). However, this is 
the only study so far investigating the role of Lorcaserin for smoking cessation and 
too early to recommend further. 
A meta-analysis by Spring et al. (2009) investigated the role of behavioural treatment 
and successful quitting in reducing post cessation weight. This meta-analysis 
included ten from the 779 publications found in their final analysis. The authors found 
that combined smoking and weight related behavioural control was associated with 
both increased cessation, OR 1.29 CI (1.01 - 1.64, p = 0.041) and weight reduction in 
the short term, OR -0.30 CI (-0.057 - -0.02, p = 0.035). In the long term, however, 
combination treatment has not been shown to be effective. In the Spring et al. study, 
short term cessation was defined as outcomes at less than 3 months and long term 
as more than 6 months. Where possible, abstinence was considered to be 
continuous abstinence whereas other studies have often reported abstinence criteria 
as a 7-day point prevalence. These findings indicated that combination treatment 
was useful for the duration of highest risk of weight gain post cessation, which was 
early (as early as 2 weeks) and usually within 3-months. This meta-analysis was 
unable to provide long term (>6 months) outcome conclusions as the duration of the 
current available studies was not long enough. The study with the longest duration 
period was 16 weeks (Spring et al., 2009).  
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The Cochrane group recently released a study aimed at assisting in the treatment of 
smokers with post cessation weight gain (Farley, Hajek, Lycett, & Aveyard, 2012). 
The two main objectives of this study were to ascertain the effectiveness of 
treatments to address post cessation weight gain, and to identify treatments for 
smoking cessation which might affect post cessation weight gain. Unlike the previous 
study (Spring et al., 2009), outcomes were measured at six and twelve months, as 
opposed to three and six months. For the first objective, sixteen studies were 
identified. There was no evidence that pharmacological treatments including 
dexdenfluramine, naltrexone and phenylpropanolamine assisted post cessation 
weight gain. However, these treatments were not shown to affect smoking cessation 
rates either. Behavioural treatment outcomes were mixed, with more intensive 
treatments appearing more effective than general weight management, although 
effectiveness varied in duration. Some of these treatments also affected abstinence 
outcomes (personalised weight management and cognitive behavioural therapy) and 
others (very low calorie diet) did not show better outcomes at 12 months. These 
findings, however, were limited by the small number of studies for analysis (N = 1-2) 
in each intervention reported. 
The most widely studied smoking cessation intervention was of treatments using 
NRTs. Farley (2012), reported effectiveness at reducing weight gain [-0.45kg CI (-
0.66 to-0.27)] at end of treatment but this was not found to be sustained at 12 
months. Other treatments such as bupropion, fluoxetine and varenicline were all 
shown to influence post cessation weight gain; however, effects were not sustained 
at either 6 or 12 months. In the studies assessed, the use of fluoxetine showed no 
weight gain in participants, which was in keeping with the understanding of 
serotonin’s role in weight control (refer to section 4.2.2), but fluoxetine was also not 
found to be an effective smoking cessation treatment (refer to section 3.7.3). 
However, as mentioned previously, the new agent lorcaserin, which acts on the 
serotonin 5HTc receptor, appears from one study both to have a weight neutral 
property and to assist in smoking cessation (Shanahan et al., 2015). 
Considering that weight gain is also attributed to energy imbalance, exercise together 
with smoking cessation may assist as a behavioural intervention and may also aid 
weight reduction (Bush, Lovejoy, Deprey, & Carpenter, 2016). When the available 
data is pooled, the effect of exercise on post-cessation weight gain at end of 
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treatment, not seen initially, was found significant at 12 months [-2.07kg CI (-3.78 to -
0.36)] (Farley et al., 2012). 
5.7 New Zealand Studies 
There have been two published studies addressing the role of weight gain and 
smoking cessation using the New Zealand population. Both are population based 
studies and have attempted to understand the current obesity situation in conjunction 
with smoking status. Both studies had a good response rate (>70% for each study). 
The first study used three cross-sectional surveys in Auckland totalling 3,074 
participants over three time points from 1982 to 1993-4 (Simmons, Jackson, 
Swinburn, & Yee, 1996). This study, however, excluded both Māori and Pacific 
people in their analysis. The investigators reported on the steady rise in overweight 
and obesity amongst both men and women during this period. The mean change in 
smoking status in both genders between these two time points only increased the 
body mass index by 0.06kg/m2 with a decrease in smoking of 7% and 10% 
respectively for men and women in the same time period. Current smokers were 
lightest and ex-smokers were heaviest in this study for both genders. Exercise did 
not change these findings. The authors of this study reported that the rise in BMI over 
the ten plus years was more likely caused by external factors rather than a drop in 
cigarette smoking. This study, however, was limited in its generalizability, being more 
representative of the European and Asian populations of New Zealand.  
Using the 2002/3 New Zealand Health Survey, Martin Tobias, Yeh, and Jackson 
(2007) attempted to describe the co-occurrence and aversion/clustering of tobacco 
use and obesity. Clustering was measured when the observed prevalence of both 
smoking and obesity exceeded the expected prevalence, given the independent 
distribution of the risk factors was the product of individual risk factors. Aversion, on 
the other hand, was the opposite i.e. when the observed prevalence of the 
combination is less than the expected prevalence of individual risk factors. For this 
study (Martin Tobias et al., 2007), unlike Simmons et al. (1996), Māori made up a 
third of their sample. The study reported Māori, compared with non-Māori, as having 
co-occurrence of tobacco smoking and obesity by a ratio of 2.7 (10% Māori vs 3.7% 
non-Māori). Māori were also reported to be more likely obese and to smoke tobacco 
compared with non-Māori. No clustering was reported in this study. Being cross-
sectional, the study was unable to address trends of smoking on obesity rates and 
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vice-versa. The study, however, used self-reports for smoking status which can lead 
to an underestimation of smoking status. Also, neither New Zealand study included 
any dietary assessment; it was therefore not possible to determine dietary intake and 
its potential impact on obesity. 
5.8 Summary  
Despite the interest and research in the relationship between weight and smoking 
cessation, there is still much that is not understood about the relationship between 
the two variables. More recent studies have found that those who quit smoking do 
gain weight as opposed to losing weight, and for some individuals this weight gain 
can be more than 10kgs (13%). For others, actual weight gain, or the fear of weight 
gain, complicates smoking cessation. There is limited local information on this issue, 
despite New Zealand having a significant proportion of the population being 
overweight. 
The concept of switching of addiction is an interesting idea which is increasingly 
being studied of late. Although earlier researchers have observed a possible 
relationship between quitting smoking and comfort eating, the idea of food as a 
possible addiction is rather new and has been studied minimally in those with 
nicotine addiction.  
More studies are warranted in this area of research to understand better the 




 CHAPTER 6 – Literature Review: Smoking Cessation, 
Depression and Weight Gain 
6.1 Chapter Overview 
This chapter will bring together the three variables that are focussed by this thesis – 
quit smoking, depression and weight – and investigate the relationship between 
them. At the end of this chapter, the study rationale and the objectives of the study 
will be stated. 
6.2 Overview 
A literature review was conducted in February 2016 using the MEDLINE (From 1946 
till current), EMBASE and PsycINFO online database. Search terms used were 
‘smoking cessation or smoking’ AND ‘weight’ AND ‘major depression or depression 
or depress*’. Searches were limited to humans and English publications. A second 
search through the references of these publications was conducted to identify 
publications that were missed using the databases mentioned. Publications were 
excluded if they did not include information on these topics. 
There are very few studies which investigate the three conditions together (Frederick, 
Hall, Humfleet, & Muñoz, 1996), and studies investigating the inter-relationship 
between depression, weight gain and smoking cessation are equally limited (Levine, 
Marcus, & Perkins, 2003). 
The association between depression and obesity has been shown to be significant 
(Stunkard, Faith, & Allison, 2003), similar to the relationship between depression and 
smoking. The direction of this relationship, however, is still debatable. There appears, 
though, to be a difference between male and female association with depression and 
obesity (Stunkard et al., 2003) which was explored in chapter five. In a meta-analysis 
involving 17 studies of depression and obesity (de Wit et al., 2010), the association 
between depression and weight were significant, and became increasingly significant 
when outlier studies was removed. This same study also found depressed females to 
be more affected by weight gain leading to obesity compared to males, pooled OR 
1.31 CI (1.23-1.4). Another meta-analysis of 16 studies with longitudinal designs 
found that having depression at baseline was associated with a 1.8 times greater risk 
for obesity (Blaine, 2008). After controlling for confounders, this relationship was still 
significant; however, the magnitude was reduced and the estimated effect size was 
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OR 1.18 CI (1.13-1.23). This study compiled data from 33,000 participants with a 
mean follow-up time of 7.6 years, and included both adolescents and adults. 
Females were also twice more likely to develop weight gain and become obese if 
they have had depression in the past, OR 2.57 CI (2.27-3.91) (Blaine, 2008). One 
explanation for this may be related to the self-medication hypothesis. Instead of using 
tobacco, food is used as a replacement. This phenomenon has been called comfort 
eating (Stunkard et al., 2003). In section 5.4 certain foods were reported to act 
similarly to drugs of abuse, allowing the release of certain neurotransmitters such as 
serotonin and dopamine, both of which can assist in reducing depression. The 
neurotransmitter serotonin itself has also been implicated in appetite regulation. As 
seen in Figure 4.1, serotonin acts at the POMS to regulate eating behaviour. A 
reduction of serotonin may lead to feeding dysregulation, and this was reported to be 
corrected with SSRIs (Shanahan et al., 2015; Spring et al., 1995). 
Conversely, obesity leading to depression has also been found to be significant. In a 
study of 9000 participants recruited from the NHANES, an association between 
obesity and depression was found for women but not for men (Onyike, Crum, Lee, 
Lyketsos, & Eaton, 2003). Women were nearly two times more likely than men to be 
depressed within the past month, OR 1.82 CI (1.01-3.3). This association increased 
when severely obese women were studied. This study found that women who were 
severely obese were nearly five times more likely to develop depression, OR 4.98 CI 
(2.07-11.99) compared to those who were overweight and obese but with BMI < 35. 
This association was found, however, to be weaker in a systematic review of 24 
publications, which included both longitudinal and cross-sectional studies (Atlantis & 
Baker, 2008). 
In another meta-analysis involving 15 studies of >50,000 participants using studies 
which had outcomes for both overweight and obesity, a bi-directional causality was 
reported (Luppino et al., 2010). In this study, baseline obesity increased risk for 
depression more than being overweight [OR 1.55 CI (1.22-1.98) vs. OR 1.27 CI 
(1.33-1.87)]. In this same study, baseline depression was also associated with 
obesity, OR 1.58 CI (1.33-1.87). Possible explanations may be a shared effect, of 
either genetics or environment. In a study of 993 female twins from the University of 
Washington Twin Registry (Afari et al., 2010), a modest association was reported. 
This study found a 12% shared genetic component between depression and obesity 
using a best-fit bi-variate model. A shared environment between the two conditions 
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may also play a part due to unhealthy lifestyle choices. Often, depression and obesity 
have been associated with lower socioeconomic status which can lead to unhealthy 
choices, including the lack of exercise and poor food choices. It can be presumed 
that obesity can lead to depression, and depression can therefore lead to increased 
obesity, and thus a vicious cycle ensues. 
Among the few studies attempting to investigate the inter-relationship between 
smoking, depression and weight gain, one involves tobacco smokers who were 
classified as depressed and concerned with weight (Vickers et al., 2003). The study, 
comprising 618 university students, found that participants who were considered 
depressed, based on the CES-D were likely to have greater weight concerns. This 
was also associated with a maladaptive coping skill, namely an increase in tobacco 
smoking in response to their negative mood. In another study, comparing smokers 
with a positive lifetime history of depression with those without that history, those with 
a positive history endorsed higher scores for the use of cigarettes to control their 
weight (p<0.05) (Weinberger, George, & McKee, 2011). In a third study (Addicott, 
Gray, & Todd, 2009), 82 women smokers were recruited from the local community. 
The aim of the study was to investigate the women’s dieting status, self-efficacy, and 
temptation to smoke after mood induction. Using a series of pessimistic statements to 
induce a depressed mood, and optimistic statements to induce an elated mood, the 
researchers were able to show reduced self-efficacy, and therefore reduced dietary 
restraint, during depressed mood states and increasing cigarette use at the time. 
Therefore, smokers with depression either past or current were more likely to have 
higher weight concerns, and were seen to use smoking as a method for coping 
compared to smokers without a similar mood condition.  
There is one study which investigated smoking, depression and weight as the main 
objective. Leventhal et al. (2010) reported tobacco smoking and tobacco dependence 
moderated the depression and obesity connection. In this study, participants were 
recruited face to face through the National Epidemiologic Survey on Alcohol and 
Related Conditions (NESARC; Wave 1, 2001–2002), a population based survey of 
non-institutionalised residents in the United States of America. Depression status 
was determined using DSM-IV criteria, similarly for tobacco dependence using the 
Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS-IV). 
BMI was objectively measured through self-reporting of weight and height. Logistic 
regression analysis found that tobacco smoking was found to moderate significantly 
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the predictive influence of depression in the past year on current obesity and body 
mass index (P<0.0001). This interaction remained after adjusting to demographic 
factors and psychiatric status. Moreover, supplemental analysis found tobacco use 
remained to influence the interaction on depression and BMI. The role of tobacco 
was postulated to either influence mood, therefore reduce food consumption 
(depression might increase caloric intake) or compete with food at the brain reward 
sites and reduce consumption. However, despite these promising findings, this study 
was limited to a cross-sectional design which might increase bias, self-reporting of 
weight and no biochemical verification of smoking status. This study also did not take 
into account physical activities and strategies to cope with mood which might 
confound the study results. Nevertheless, this study did show there was an 
interaction between smoking, depression and weight, however more studies were 
needed to replicate the findings. 
Pomerleau et al., (2001) in their study on body image and smoking attempted an 
analysis using variables of body mass index, smoking status and depression status 
recorded using the CES-D and found no significant inter-group relationship. 
However, this study highlighted the plausible inter-relationship between depression, 
smoking cessation and post-cessation weight gain; and the authors suggested more 
research to investigate this be conducted. 
6.3 Does Weight Gain and Depression Influence Smoking 
Cessation Outcomes 
There has been little on the inter-relationship between depression, weight gain and 
smoking cessation outcomes in the literature. One study, aimed at developing an 
algorithm using a signal detection method and focused on the interval from end of 
treatment to 24-months, involved a longitudinal cohort of 1,044 smokers who 
completed a smoking cessation trial (Killen et al., 1996). Four hundred and twenty 
participants remained abstinent for three months from trial completion. The analysis 
focused on nicotine dependence, and investigated the impact of depression 
symptoms and weight change independently on smoking cessation relapse. Four 
subgroups were identified at 24 months with abstinence rates of 33% to 79%. The 
researchers reported that those who were identified with high depression scores on 
CES-D, and gained weight during that period, were nearly three times more likely to 
have less relapse at 24 months, OR 2.90 CI (1.41 – 5.96). The study findings indeed 
contradicted current understanding on this matter. However, the authors have 
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suggested that, should patients with depression develop weight gain, advising them 
to temporally accept their weight gain may be a treatment worth investigating. 
Another study (Widome et al., 2009) involving only women aged 40-65, who were 
recruited through a population based survey, examined the association between 
smoking cessation and depression in women of different weight. Of the 4,640 
participants, obese and depressed smokers had more difficulty in quitting smoking 
and were unlikely to quit within the year of study, OR 2.48 CI (1.26-4.88). The 
researchers also reported current and lifetime depression prevalence increased with 
increasing BMI categories (p<0.001). Current depression was also associated with 
obese women only. Limitations of this study were that information of non-
respondents was not assessed, and height and weight were self-reported. In a study 
by Levine, Marcus, Kalarchian, Houck, and Cheng (2010), of pregnant smokers who 
had quit and who were followed-up to investigate post-partum relapse, mood and 
weight were associated with possible relapse. Pregnant women who associated 
strongly with increased weight gain concerns also associated smoking with weight 
management and were reported to relapse earlier (p=0.007). Those with positive 
affect using the perceived stress scale were also found to have decreased relapse 
rates. The main study’s limitation, however, was a high attrition rate. Only just over 
half of the initial participants were accounted for at the end of the study. 
A study of 219 women with post-cessation weight concerns, who were recruited to 
participate in a smoking cessation clinical trial, found no difference between those 
who had a history of lifetime depression compared to those without, in terms of 
successful quit attempts (Levine et al., 2003). They were, however, more likely to 
drop out from the study, if they had lifetime depression, by a factor of three, OR 2.9 
CI (0.99-8.5). The study also found a much higher prevalence of lifetime depression 
in those with post-cessation weight concerns. All participants for this study underwent 
standard cognitive behavioural therapy and intervention included either an additional 
behavioural weight control program, additional cognitive behavioural therapy to 
promote acceptance of modest weight gain, or non-specific support. There was also 
no difference in weight gain between those with a lifetime history of depression and 
those without. This study recommends additional research to further understand the 
relationship between smoking cessation, weight gain and mood. 
In summary, when extrapolated from the studies where depression and weight gain 
are studied independently, it is postulated that having both depression and weight 
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gain together will hinder successful smoking cessation. From the three studies that 
have been mentioned, there is still a lack of understanding between the three 
variables of interest and therefore further studies which take into account the 
limitations are needed. 
6.4 Study Rationale 
Smoking cessation programs have varied in their approach, and also in the 
interventions which have been offered. These programs have received recognition by 
being incorporated in the Framework Convention on Tobacco Control as an effective 
strategy and an integral aspect in tobacco control. There is, however, limited 
information in understanding if these programs work in people with depression and 
weight gain particularly in a clinical setting. 
Both depression and weight gain in smoking have been studied rather extensively, 
the former more so. However, there appear to be gaps in the research in terms of 
descriptive and predictive information. There are obvious gaps in investigating the 
relationship between both depression, weight and smoking cessation, and even less 
information on the inter-relationship between the three. 
The literature reviewed has also highlighted what limited information is available in 
New Zealand for smoking cessation, especially on the consequences of quitting. 
There is a definite lack of available information on the relationship between 
depression, weight and smoking cessation. Information on both service users and 
providers is also limited, and no study using mixed-methods research, investigating 
smoking cessation, has been found. This may be an obstacle to achieving a smoke 
free New Zealand by 2025, as the pool of smokers in need of assistance becomes 
increasingly ‘hardened’ and are from the ‘under-served’ population. It is the 
recognition of the scarcity of, and the many uncertainties in, the studies on smoking 




6.5 SCeMES Aims and Objectives 
The SCeMES is aimed to investigate the relationship between smoking cessation, 
depression and weight gain, exploring the experiences of participants attending a 
smoking cessation program in Christchurch. The objectives are: 
1. To determine the association between depression and smoking cessation 
outcomes 
a. by investigating the prevalence of depressive symptoms amongst 
patients in a smoking cessation program 
b. by investigating depression and its association with quitting smoking 
amongst patients in a smoking cessation program 
c. by determining the predictors for depression and their variables and 
quitting smoking amongst patients in a smoking cessation program 
2. To determine the association between weight and smoking cessation 
outcomes 
a. by investigating weight variables associated with quitting smoking 
amongst patients in a smoking cessation program 
b. by determining the predictors for weight variables and quitting smoking 
amongst patients in a smoking cessation program 
3. To determine the association between depression, weight gain and smoking 
cessation outcomes 













 CHAPTER 7 - Methodology: Introduction, Concept and 
Rationale of use 
7.1 Chapter Overview 
This chapter describes the SCeMES methodology, a mixed methods research (MM) 
study comprising SCeMES-Quantitative (QN) and SCeMES-Qualitative (QL) 
methods. It also provides a brief outline on MM as a methodology, and highlights 
current issues pertaining to this methodology. The researcher’s worldview is also 
included in this chapter to better explain his position within the research. The MM 
research design of choice is introduced, together with the justification for its use. An 
MM purpose statement is provided and the chapter ends with an outline of the 
subsequent sections for this thesis.  
7.2 Description of Mixed Methods Research 
 Introduction 
Although not described as MM per se, the discussion on mixing different types of 
data has been around for a number of decades, through the idea of mixing multiple 
quantitative data (Campbell & Fiske, 1959) and quantitative and qualitative data 
(Jick, 1979). However, MM as presently understood was introduced by Patton 
(1980), whereby he suggested utilizing both experimental and naturalistic data 
together and described the possible ways of doing so. MM has since been discussed 
widely over the past 25 years and used in various disciplines, not only in education 
and evaluation, but also in health (Tashakkori & Teddlie, 2010b). Within the past 
decade, MM has increasingly been recognised as a methodology, with some 
researchers calling it the third methodology after quantitative and qualitative research 
(Johnson & Onwuegbuzie, 2004; Tashakkori & Teddlie, 2010b). Other researchers, 
however, have been less convinced. Although agreeing that MM is a research 
method, they have not concurred that it meets the ideals of a methodology as such 
(Gorard, 2010). Despite the above, there has been increasing interest in the use of 
MM as a methodology for research theses, publication in the sciences and MM 
research has also been increasingly funded by research grant bodies (Clark, 2010; 
Tashakkori & Teddlie, 2010b). 
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 Definition of Mixed Method 
The definition of MM since its introduction has been actively debated. Initial 
proponents of MM understood it to be the basis for studies in which mixed research 
methods were used (Creswell & Clark, 2007; Greene, Caracelli, & Graham, 1989). 
Others took MM to mean the mixing of various specific methodologies which 
produced its own paradigm or worldview, language and technique (Tashakkori & 
Teddlie, 2003). A landmark study attempting to define MM, reported on the interviews 
of 19 leading MM methodologists from an initial sample of 31 (Johnson, 
Onwuegbuzie, & Turner, 2007). The researchers reported on five themes which 
defined MM: the mixing of quantitative and qualitative research; the place at which 
the research was mixed i.e. at the beginning, middle or end; the breadth of mixing i.e. 
the mixing of data only or mixing at all stages; the purpose of mixing; and the 
orientation of the mixing i.e. whether the research question drove the mix, or whether 
the participants or researcher were driven to mixing the research approaches. The 
above findings can be summarised as follows: 
Mixed methods research is the type of research in which a researcher or 
team of researchers combines elements of qualitative and quantitative 
research approaches (e.g. use of qualitative and quantitative viewpoints, 
data collection, analysis, inference techniques) for the broad purposes of 
breadth and depth of understanding and corroboration (R. B. Johnson et 
al., 2007). 
 
This was subsequently followed by the notion that MM was not only a method for 
conducting research, but an approach to understand the social world. Newer 
definitions have since included a philosophical emphasis, while others have included 
research design within their definition (Tashakkori & Teddlie, 2010b). Creswell and 
Clark (2007) defined MM using core characteristics which emphasised and included 
MM as a method, philosophy and research design. More recently, Tashakkori and 
Teddlie (2010b) reported on eight contemporary characteristics of MM: 
methodological eclecticism; paradigm pluralism; an emphasis on diversity at all levels 
of the research; an emphasis on continuum as opposed to dichotomy; an iterative 
approach to research; a focus on the research question; a set of standard research 
designs and analytical processes; and a tendency to balance and compromise. 
These eight characteristics were summarised in the findings by Johnson et al. 
(2007). In addition, the leading journal for MM (Creswell & Tashakkori, 2007) defined 
MM as follows:  
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Mixed methods research is defined as research in which the investigator collects 
and analyses data, integrates the findings, and draws inferences using either 
qualitative and quantitative approaches or methods in a single study or program 
of inquiry. 
 
This definition is in keeping with the characteristics reported by Tashakkori and 
Teddlie (2010b) and the findings and summary by Johnson et al. (2007). This 
definition is also the preferred definition of MM for this thesis. 
 Paradigm or World View 
Paradigm, also known as worldview, has been described as “a set of generalizations, 
beliefs and values of a community of specialist” (Kuhn, 1970). Of the two terms – 
‘paradigm’ or ‘worldview’ – the term used in this review, and the one preferred by 
Creswell (2009), is ‘worldview’. As described by Creswell (2009), ‘worldview’ is 
understood to be what the researcher brings to their research in the quest for 
knowledge. This includes both the researcher’s combined beliefs and assumptions 
about knowledge which, in turn, further inform the study being undertaken. 
There are four worldviews often reported when the issue of paradigms is discussed. 
Often these same worldviews are linked to a certain type of research design or 
method. The four worldviews are: positivism, or post-positivism, which is often linked 
to quantitative research design; constructivist to qualitative research design; 
participatory; and pragmatism. The latter two are considered to work best with MM. In 
positivism/postpositivism, the research question often includes rigorously testing a 
hypothesis which, through a quantitative method, is often numerical in nature. With 
constructivism, the meaning of the research is determined by the researcher and 
data is often collected in the narrative form. For the participatory and pragmatism 
worldviews, absolutes are avoided, and the stance is taken that some research 
questions are better answered though the numerical form while others are better 
answered though the narrative form. What is paramount for this final approach is the 
importance of the research question posed, and the best method used to answer it. 
These worldviews were, however, initially believed to be mutually exclusive and 
therefore were unable to be combined. This ‘incompatibility’ was due to the nature of 
the philosophy of knowledge these worldviews were aiming to discover.  
Quantitative research has often been described as gaining knowledge deductively 
and objectively, and is meant to be generalizable, whereas qualitative research is the 
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opposite, in which knowledge is achieved through an inductive approach, and is 
subjective and context based, among other things (Tashakkori & Teddlie, 2010b). 
The “paradigm wars” were the consequence of the belief that worldviews are unable 
to be mixed. The beliefs were maintained by “purists” in both fields of quantitative 
and qualitative research, due to the researchers’ inflexibility in accepting any 
alternative possibility for their respective arguments (Creswell & Clark, 2007; 
Tashakkori & Teddlie, 2010b; Teddlie, 2009). It is now generally accepted that the 
“paradigm wars” are over. This acceptance has come to light as MM has become 
increasingly more accepted, and also with it having a wider reach (Tashakkori & 
Teddlie, 2010b). It is now more accepted to think of worldviews as the shared beliefs 
between researchers (Morgan, 2007), moving away from a dichotomy as described 
earlier, and moving more towards thinking in terms of a continuum (Tashakkori & 
Teddlie, 2010b). At this present moment, MM is accepted as a research methodology 
in between quantitative and qualitative methodologies (Teddlie, 2009; Teddlie & Yu, 
2007). Refer to Figure 7.1 below (with permission). 
 
Figure 7.1: The Purposive-Mixed Probability Sampling Continuum 
 
Of the four often mentioned worldviews, pragmatism is regarded, however, as the 
worldview of choice for MM. Greene and Hall (2010) have argued that although 
pragmatism appears to be the worldview most often reported when using MM, it is 
not the only worldview. They explain that pragmatism has many interpretations, 
including being thought of as “what works” in practice (Greene & Hall, 2010), which 
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Biesta (2010) has referred to as “everyday pragmatism”. Creswell (2009), has 
identified four basic characteristics of the pragmatism worldview: it focusses on the 
consequence of research, it is problem centred, it is pluralistic, and it takes into 
consideration real world practice. This worldview has been described as leading to 
problem solving, and to active oriented research questions, and to being progressive 
and fair in its execution (Denzin & Lincoln, 2011).   
 Types of Mixed Method Research Designs 
As MM has become widely accepted and used as a method, it has developed its own 
language or terminology (Creswell & Clark, 2007; Tashakkori & Teddlie, 2010b; 
Teddlie & Tashakkori, 2011). A common language is useful to ensure uniformity 
(Creswell, 2009; Teddlie, 2009; Wolff et al., 2013) in understanding concepts of MM 
(Tashakkori & Teddlie, 2010b). As a result of this, some common types of research 
design have often been referred to when conducting MM. However, they are not 
exclusive to MM. Therefore, this has allowed for flexibility in the conduct of other MM 
research designs for researchers of the future (Greene, 2007). MM research design 
depends on the research question, the level of interaction between the two different 
methodologies, the priority of quantitative and qualitative contribution to the research, 
timing, the skill set of the researcher, and possibly funding (Creswell, 2009; Creswell 
& Clark, 2007; Teddlie & Tashakkori, 2011).  
Despite the good intentions of MM proponents to develop a typology or a 
classification of research designs exclusively for MM, this endeavour has been 
challenging, if not elusive (Tashakkori & Teddlie, 2010b). MM, having both a 
quantitative and qualitative underpinning, due to the latter being an iterative 
component, allows flexibility in answering a broad range of research questions. 
Nastasi, Hitchcock, and Brown (2010), after reviewing the literature, have 
summarized existing typologies based on six criteria. The typologies are classed into 
types of MM research designs – Types I–VI – , which refer to I) the number of 
elements; II) types, mixing and priority of data; III) the stages in which the mixing 
occur; IV) a focus on an integrated approach; V) an involved iterative approach; and 
VI) the dealing with synergistic design approaches. These have subsequently been 
divided further into two main designs which Nastasi and colleagues (2010), have 
termed as basic (involving criteria types I-III) and complex (types IV-VI) designs. 
Creswell (2009) has also identified four basic designs (convergent parallel, 
explanatory sequential, exploratory sequential and embedded) and two which are 
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more complex (having multiple elements) which he refers to as transformative and 
multiphase designs. Teddlie (2009), has referred to quasi-mixed designs, including 
MM, which have little mixing between both quantitative and qualitative research 
elements.  
 Benefits 
Teddlie (2009), has observed three major benefits attributed to MM: the ability to 
tackle research questions which are both confirmatory and exploratory in nature; the 
ability to provide better inference or understanding on the subject matter; and the 
ability to provide various inputs and views based on expertise of both quantitative 
and qualitative concepts. MM is able to provide information using both numbers and 
narrative which has allowed findings to be reported with more context compared to 
using either quantitative or qualitative methodologies on their own (Creswell & Clark, 
2007; Jick, 1979). Moreover MM has allowed the researcher to provide extensive 
research findings as a result of being able to mix the different types of methodologies 
available (Tashakkori & Teddlie, 2010b). The possibility of using multiple worldviews 
previously mentioned has also provided various inputs (breadth and depth) in the 
research discussion. It has given the researcher the ability to answer research 
questions, which would otherwise have been difficult through the use of either 
research methodology, sometimes known as a mono-method, on its own. Gorard 
(2010), has stated as a matter of fact that using MM is only logical. Using the 
argument of daily life situations, he has gone on to explain MM research in everyday 
practice as being likened to buying a house or car where one would not only look at 
the numbers (specifications for examples), but also interview people who have used 
or purchased the item of interest. MM is also practical, in the sense that MM allows 
the researcher to use various research methods to conduct research, and to express 
the result findings in both numbers and words (Creswell, 2009).  
 Controversies and Critiques 
Ever since the possibility that various methodologies and methods can be mixed, MM 
has been open to various critiques and controversies. The most common criticism of 
MM is the “incompatibility thesis”, raised earlier, between quantitative and qualitative 
worldviews in conducting research. This has been, however, harmonized through the 
continuous work and efforts of the major proponents of MM (Creswell & Clark, 2007; 
Greene, 2007; Tashakkori & Teddlie, 2010b) and has increasingly been accepted by 
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early critics (Denzin & Lincoln, 2011). Yet much work is still required within the field 
as MM becomes an increasingly popular research methodology. 
For some qualitative researchers, MM has been viewed in the past as a methodology 
which has subjugated qualitative research under the quantitative research heading 
(Denzin & Lincoln, 2011). These concerns, however, have been unfounded, with 
most authors on MM emphasising equal consideration for both quantitative and 
qualitative contribution (Tashakkori & Teddlie, 2010b; Teddlie, 2009). An equal 
mastery of both research methodologies has been encouraged to allow the best 
possible conclusions for the data collected (Creswell & Clark, 2007).  
Due to its research design, MM, has often been seen as more time consuming, and 
therefore more expensive, than conducting research using either quantitative or 
qualitative methodologies on their own (Creswell & Clark, 2007). This has been 
especially noted when there has been a need to be proficient in both research 
methodologies (Creswell & Clark, 2007). This has not gone unnoticed by leading 
proponents of MM. They recommend that MM be conducted only if the research 
enquiry necessitates the use of MM rather than either quantitative or qualitative 
research on their own (Creswell, 2009; Creswell & Clark, 2007; Greene, 2007; 
Tashakkori & Teddlie, 2010b; Teddlie & Tashakkori, 2011). 
Lately, more recent issues which have appeared to dominate the MM field are the 
need for MM exclusive language, typology and research questions (Tashakkori & 
Teddlie, 2010b; Teddlie & Tashakkori, 2011). Although most innovators of MM are in 
agreement on the need for MM language to ensure meaning between researchers, 
they are more accommodating towards typology compared to other areas within MM 
which might also require attention, such as ‘rigor’ in MM (Creswell, 2009; Greene, 
2007; Tashakkori & Teddlie, 2010b). The issue regarding the best method to state an 
MM research question has been fairly recent. This sudden need for a more exclusive 
method to state such a question is most likely the consequence of the increasing use 
of MM. Newer researchers to MM are believed to have required greater guidance in 
conducting proper MM research (Creswell, 2009). Also, a uniform research question 
for MM would also strengthen MM as a methodology for certain researchers as 
opposed to using mono-methodology for their research enquiry (Creswell & Clark, 
2007).  
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Together with the increasing acceptance and usage of MM, attention on the “how to 
do” has become increasingly important. More and more, questions are being raised 
on various aspects of MM, such as which phases within the research should the 
methods be mixed: during the analysis, the interpretation of result findings, or during 
the presentation and reporting of the research (Greene & Hall, 2010), amongst 
others. These issues have since intensified but have progressively been addressed 
by MM proponents (Creswell & Clark, 2007; Tashakkori & Teddlie, 2010b). With MM 
being used more widely, collaborative and cross-cultural issues are also emerging 
within the field (Tashakkori & Teddlie, 2010b).  
7.3 Applying Mixed Methods to the SCeMES 
The researcher has taken a pragmatic worldview in undertaking this research project. 
In keeping with pragmatism, the research has been driven purposefully by the 
research question which includes both the understanding of the relationship between 
the researched variables, and also the need to explore the ‘lived experiences’ of 
these same participants in their journey. Pragmatism, being a problem centred 
approach, is flexible and orientated to real-world practice. As a result, it allows a 
more definitive conclusion based on the evidence obtained (Creswell & Clark, 2007). 
It is not committed to any one worldview, and therefore is able to adapt to the 
research situation. In this same notion, pragmatism as a worldview allows for 
“freedom of choice” and “what works” at the time (Creswell, 2009). 
In keeping with the pragmatist worldview on “what works”, a quantitative study was 
used for research questions which attempted to find a cause-and-effect relationship; 
this is termed as SCeMES-QN in the main SCeMES. This quantitative phase of the 
SCeMES focused on selected variables of interest, detailed observations of 
measured variables, and tested theories through the literature review which, in 
essence, has a postpositivist slant (Creswell & Clark, 2007) to the research enquiry 
often linked to quantitative research. Knowledge for the SCeMES-QN, thus, was 
gathered deductively.  
For the second phase of the study, involving the exploration of the experiences of 
participants who were quitting through a smoking cessation program, also known as 
the ‘lived experience’, a qualitative study was considered as the best approach to 
investigate this phenomenon. Information was obtained inductively, meaning there 
was no prior hypothesis for the possible conclusions; and knowledge for the subject 
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matter was obtained from the evidence provided by the researched participants. This 
qualitative component of the SCeMES is referred to as the SCeMES-QL and has an 
interpretative or constructivist slant. Knowledge was acquired through the 
understanding of meaning of an event; this was obtained from participants of the 
research from their subjective views on a certain issue of interest (Creswell & Clark, 
2007).  
7.4 Research design 
For the SCeMES, a sequential explanatory mixed methods research design was 
employed (Creswell, 2009). The follow-up explanatory variant was preferred, 
emphasising the quantitative phase of the MM (Creswell & Clark, 2007). Using the 
model proposed by Creswell and Clark (2007), this research design consisted of two 
parts: a quantitative phase (SCeMES-QN) followed by a qualitative phase (SCeMES-
QL). The qualitative element of the design was implemented to assist in explaining 
the findings of the initial phase of the study. Refer to Figure 7.2 below for flow of 
study. 
 
Figure 7.2: Flow of MM Research Design  
(Creswell & Clark, 2007) 
 
 Areas of Mixing 
The mixing or integration of both quantitative and qualitative elements was decided to 
take place during the research question formulation phase where both an 
investigative and exploratory study was determined for the research. This closely 
follows Creswell and Clark (2007). In explaining the sequential explanatory MM 
studies, Creswell and Clark (2007) referred to studies in which the qualitative phase 
built on the initial quantitative phase.  
The main reasoning underpinning this study was that the quantitative data and its 
analysis addressed the research question. The qualitative data and its analysis 










‘purposively’ selected participants in more depth. Both sets of results were then 
integrated at the end of the study. This allowed the discussion and conclusions of 
MM to consist of both numerical and narrative descriptions which in turn allowed for a 
better ‘picture’ of the phenomena under study (Creswell & Clark, 2007).  
 Justification for Using Sequential Explanatory Mixed Method 
The use of MM in this type of study design is useful especially for researchers who 
are quantitative orientated (Creswell & Clark, 2007). This design allowed the 
researcher to investigate the relationship between variables and at the same time to 
explore other possible explanations for the trends or initial findings. For a new 
researcher in MM, the sequential explanatory MM design was considered to be direct 
in its implementation, in that two separate studies were conducted one after the 
other, and the reporting was able to be done in the same sequence (Creswell, 2009; 
Creswell & Clark, 2007). There was also an emergent element to this type of study 
where findings or experiences from the initial study were allowed to influence the 
other (Ivankova, Creswell, & Stick, 2006). This in turn may provide a greater 
understanding of the results for discussion.  
 Ethics 
This study was approved by the Central Health and Disability Ethics Committees 
(HDEC), Ethics Reference CEN/09/08/055. The SCeMES was an amendment to the 
Zonnic and Patch Study (ZAP) mentioned later in this chapter. Further ethical 
considerations for the qualitative element, pertaining to the methods for the 
SCeMES-QL study, will be discussed in chapter nine. 
7.5 The Researcher’s Role 
Qualitative research, being interpretive in nature, exposes the researcher to potential 
strategic, ethical and possibly personal issues in the conduct of the research (Locke, 
2007). In order to reduce the impact of these potential biases to the research 
findings, the researcher often state his/her position within the research. Examples of 
this can include researchers explicitly stating their worldview in the conduct of the 
study, and providing information with regards to their biases, values and also 
personal background (Creswell, 2009). 
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 The Researcher 
The researcher is a Malaysian who has lived his life in equal proportions in the 
United States of America, New Zealand and Malaysia. He graduated with a medical 
degree from New Zealand but decided to practise and specialise in psychiatry in 
Malaysia before returning to New Zealand to complete his doctoral studies. He has 
never smoked, nor experimented with cigarettes; however, some of his immediate 
family members do smoke. 
As a psychiatrist in Malaysia, his role is in general psychiatry. He is also part of the 
addiction psychiatry clinical team in his hospital. Tobacco control is not a major 
consideration in psychiatry in Malaysia. His interest arose from the observation of the 
number of patients under his care who were smokers. In Malaysia, 22.8% of the adult 
population smokes; and more men than women smoke (43.9% vs. 1.4%) (Hum, 
2016). However, data on underserved populations, such as mental health, is very 
limited (Amer Nordin Amer Siddiq, 2012). 
During his doctoral study, the researcher was involved with the ZAP study, a clinical 
trial for a new smoking cessation treatment, which allowed him to assist smokers to 
quit. Involvement in the ZAP study led to his interest in his current doctoral study, the 
SCeMES. In addition, during this period and in the following years he became 
involved with advocacy work, both in New Zealand and Malaysia, in tobacco control, 
particularly among mental health clients (Amer Siddiq, 2012, 2013; Amer Siddiq & 
Bullen, 2014). 
Of significant importance during the period of the doctoral study were the 
earthquakes of September 2010 and February 2011, the latter earthquake being the 
most devastating natural disaster experienced by Christchurch. His experience of the 
earthquakes has transformed his outlook on life, and also strongly affected the 
conduct of the study. 
 The Christchurch Earthquakes 
Christchurch is the largest city in the South Island of New Zealand with a population 
of 376,700 as at June 2010 (Statistics New Zealand, 2010). On September 4 2010 at 
4.35am, Christchurch experienced one of the worst disasters in the history of New 
Zealand, an earthquake measuring 7.1 on the Richter scale. While the city sustained 
significant damage to property, land and infrastructure during the September 
earthquake, there was no loss of human life. The Christchurch region has since 
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experienced more than eighteen thousand earthquakes or aftershocks, 4,400 of 
these occurring within the six months following the September earthquake, including 
28 aftershocks greater than magnitude 5. Further major seismic events occurred in 
December 2010, and February, June and December 2011.  
The February 22 2011 earthquake, however, was the most devastating. A magnitude 
6.3 earthquake struck Christchurch at 12.51pm, killing 185 people and with damage 
totalling an estimated NZD40 billion for insurers (New Zealand News, 2013). Many 
landmarks in Christchurch were lost as a result of this catastrophe, and this event did 
not spare disruption to the researchers and their participants. The National Addiction 
Centre (NAC), where the study took place, was closed for approximately twelve 
weeks, meaning researchers and participants were displaced, and subsequently 
many participants were lost to follow-up as a result. The following earthquakes and 
aftershocks only made it harder for Christchurch residents, and particularly those 
involved with the SCeMES, to continue with life as it had been prior to the 
earthquake. However, over the next 12 months, things slowly improved.  
7.6 Mixed Method Purpose Statement 
This study was conducted to address the relationship between smoking cessation 
and both depressed mood and weight gain among smokers who wanted to quit, and 
also for the researcher to understand the perspective of these smokers in their quit 
attempts. An explanatory sequential mixed methods design was used. This involved 
collecting quantitative data (SCeMES-QN), and subsequently explaining the 
quantitative results by using in-depth qualitative data (SCeMES-QL) gathered in 
focus groups and individual interviews. In the SCeMES-QN, a prospective cohort was 
involved to collect data from smokers participating in a smoking cessation program at 
the National Addiction Centre. The goal was to test whether smoking cessation was 
related to either depression or weight gain, or both. The SCeMES-QL was conducted 
as a follow-up to the SCeMES-QN results to assist in explaining the quantitative 
results. In this exploratory follow-up, the tentative plan was to explore the “lived” 




 CHAPTER 8 - Smoking Cessation, Mood and Eating Study 
Quantitative (SCeMES-QN) Methodology 
8.1 Chapter Overview 
This chapter will describe the details of the quantitative aspects of the Smoking 
Cessation, Mood and Eating study. The research design, site and the population 
studied will be introduced. The inclusion and exclusion criterias will be described and 
the data that participants will be providing is also reported. Finally, the analysis for 
this study will be discussed.  
8.2 Research Design 
The SCeMES-QN was an observational, longitudinal cohort prospective study 
consisting of smokers wanting to quit smoking in a smoking cessation program. 
8.3 Zonnic™ and Patch (ZAP) Study 
The ZAP study was a smoking cessation trial which took place in Christchurch and 
Wellington from 2010 to 2012. There were three major sites for the ZAP study: two in 
the North Island of New Zealand and one in the South Island (where this present 
study occurred). The study involved smokers who wanted to quit smoking and who 
consented to receive either a placebo spray or Zonnic™, the active treatment for the 
study. Zonnic™ is an NRT which is delivered through a mouth spray. At the time of 
the study, the mouth spray was a new form of delivery device for NRT. The 
procedure for taking Zonnic™ was that participants squirted two squirts of the 
treatment into their mouths and left it there for at least 15-30 seconds to allow the 
treatment to be absorbed by the buccal mucosa. After that, the participants were 
allowed to swallow the treatment. Both the placebo and the active treatment were 
taken in the same manner. Details regarding the ZAP study and its findings have 
been reported elsewhere (Caldwell, Adamson, & Crane, 2014).  
8.4 Duration 
The data collection period for this study was initially scheduled for nine months from 
October 2010 to June 2011. However, as a result of the major Christchurch 
earthquake of February 22 2011, recruitment into the study was extended for another 
three months. The last participant for baseline recruitment was obtained in 
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September 2011, and the last participant for follow-up therefore was in September 
2012. 
8.5 Recruitment and Site 
Participants for the SCeMES-QN were recruited from Christchurch-based participants 
attending the ZAP study. The method used for recruiting participants was the 
consecutive sampling method, chosen because of the limitation of the sample, time 
constraints due to an on-going ZAP study, and the continuous Christchurch 
earthquakes. A variety of strategies were used to recruit participants for the study. 
The main method was through the use of newspaper advertisements. Participants 
were also recruited through newspaper articles and television interviews on smoking 
where the study was mentioned at the end to assist with recruitment. Advertisements 
were placed on prominent noticeboards within the Christchurch Hospital, in areas 
accessible to the public including the elevators. Local health practitioners, such as 
general practitioners in Christchurch, were also sought to help with referrals to the 
study. The health practitioners were sent personalised letters in the mail to 
encourage them to refer potential participants for the study. A small minority of 
participants were also noted to have been recruited from the social media entity 
Facebook. All participants who had agreed to participate in the Christchurch ZAP 
study were approached to participate in the SCeMES-QN. This is considered to be 
the best recruitment method considering the limitations mentioned (Endacott & Botti, 
2005). 
All study participants were assessed and followed up face-to-face at the National 
Addiction Centre (NAC). The NAC was located opposite the Christchurch Hospital. 
Three researchers were involved in assisting with recruiting participants and 
assessing baseline and follow-up visits. 
8.6 Inclusion and Exclusion criteria 
Participants were eligible if they: 
1. wanted to quit smoking 
2. smoked nine or more cigarettes per day 
3. were aged between 18 and 70 
4. resided in Christchurch 
5. intended to complete the study by attending baseline and follow-up visits 
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Patients were excluded if they: 
1. were allergic to nicotine replacement therapy  
2. had a serious medical condition including high blood pressure, cardiovascular 
health problems (including fast or irregular heart rhythm, angina, chest pain, a 
history of previous myocardial infarct); having had a cerebrovascular event 
such as a stroke; a history of previous stomach ulcer; heartburn; kidney 
disease; liver disease; an over active thyroid; pheochromocytoma and 
uncontrolled diabetes 
3. were pregnant, intended to get pregnant during the study period, or hetero-
sexually active and not using a reliable form of contraception 
4. consumed alcohol above the low risk drinking guidelines of 21 standard drinks 
per week 
5. were using illicit drugs at the time of study 
6. were on medications known to interact with the nicotine replacement therapy, 
of particular note theophylline, insulin, imipramine and pentazocline 
Participants were asked twice about their history of serious medical conditions, once 
on screening and again at baseline visit. Participants were not excluded if they were 
experiencing mental health difficulties. 
8.7 Measures 
 Objective Measurements: 
1. Weight in kilograms (using a digital weighing scale) 
2. Blood pressure and pulse rate 
3. Height in centimetres 
4. Carbon monoxide (CO) monitoring 
Weight was obtained by using a digital weighing machine. Participants were weighed 
in street clothing without shoes prior to the start of assessments during each visit. 
After weight, height was measured using a mounted stadiometer. Body mass index 
(BMI) was subsequently calculated as weight (kg)/height (m)2. 
Blood pressure monitoring and pulse rates were obtained using an OMRON 5 series 
blood pressure device.  
CO monitoring was obtained using the Compact™ Smokerlyzer® by Bedfont 
Scientific Ltd. CO monitoring instruments by Bedfont Scientific Ltd have often been 
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reported in scientific publications (Jarvis, 1986). This particular instrument is ideal for 
brief intervention to monitor smoking status in various settings. It also allows wider 
access and use (Pearce & Hayes, 2005). The Compact™ Smokerlyzer® is also the 
most popular type of CO monitoring instrument due to its size and portability. There is 
a seven level indicator on this device which spreads over the colours green, amber 
and red. The non-smoking cut-off is ten parts per million (ppm) corresponding to 
levels below two on the instrument. These cut-off scores might differ depending on 
different devices and their make. 
 Questionnaires: 
A number of questionnaires were used for this study to assess variables of interest. 
The Fagerström Test for Cigarette Dependence (FTND), Brief Questionnaire of 
Smoking Urges (QSU-brief) and the Brief Wisconsin Inventory of Smoking 
Dependence Motives (Brief WISDM) were the questionnaires originally used in the 
ZAP trial, and also used for the SCeMES study. The remaining questionnaires were 
introduced as part of the SCeMES. In total, nine questionnaires were used, one 
socio-demographic, three smoking related, two depression and three eating/food 
related questionnaires. 
Data was collected using the following: 
1. Socio-demographic questionnaire 
The socio-demographic questionnaire included questions about age, gender, 
ethnicity, current occupation and employment status. The smoking status 
segment asked questions about the initial age of smoking, number of cigarettes 
smoked, duration of smoking and the number of quit attempts. The mood 
segment asked for information on previous personal and family history of 
depression.  
2. Fagerström Test for Cigarette Dependence (FTND) 
The FTND was developed in 1978 as an eight-item scale, known as the 
Fagerström Tolerance Questionnaire (FTQ), to provide a measure of nicotine 
dependence which was short and able to be self-reported (Heatherton, 
Kozlowski, Frecker, & Fagerström, 1991). The FTQ subsequently became the 
Fagerström Test for Nicotine Dependence (FTND) with only six items 
(Heatherton et al., 1991). Recently, the FTND was renamed the Fagerström Test 
for Cigarette Dependence; however, the same acronym FTND was kept, the 
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author contending that FTND better reflected the current knowledge on tobacco 
(Fagerström, 2012). The FTND is one of the most commonly known and used 
questionnaires to measure nicotine dependence, and has been reported to be 
useful in various settings and amongst a variety of different populations 
(Courvoisier & Etter, 2010). The six items of the FTND take less than five 
minutes to complete. Reliability testing with Cronbach α is reported to be 
between 0.64-0.91 (Heatherton et al., 1991). 
3. Brief Questionnaire of Smoking Urges (QSU-brief) 
The QSU-brief was developed from a 32-item questionnaire, the Questionnaire of 
Smoking Urges (QSU), and first published in 1991 (Cox, Tiffany, & Christen, 
2001). The brief version (QSU-brief) maintains the two-factor item structure of the 
longer QSU. These two factors are 1) a desire and intention to smoke, with 
smoking anticipated as pleasurable, and 2) an anticipation of relief from the 
negative affect of nicotine withdrawal, with an urgent desire to smoke. The QSU-
brief has ten items and takes less than two minutes to complete. The QSU-brief 
also reports high internal consistency, very similar to the longer QSU (Cronbach 
α 0.76-0.96) (Cox et al., 2001).  
4. Brief Wisconsin Inventory of Smoking Dependence Motives (Brief WISDM) 
The brief-WISDM was developed from the 68 item Wisconsin Inventory of 
Smoking Dependence Motives (WISDM), first published in 2004 (Piper et al., 
2004). The brief version contains 11 subscales as opposed to the 13 in the 
original WISDM (Smith et al., 2010). It measures a variety of theoretically derived 
smoking motives which allows an understanding of the mechanism for 
compulsive drug use. The brief-WISDM, containing 37 items and 11 subscales, is 
as psychometrically sound as the original WISDM (Smith et al., 2010). A total of 
nine out of 11 subscales have Cronbach α >0.8 and the remaining two subscales 
are >0.7. Correlation between the original WISDM is similar to the brief-WISDM 
(Smith et al., 2010). Scoring for this questionnaire involves using means of the 
subscale, and also the sum of the means for total scoring. Responses are 
collected using a seven-point likert scale whereby 1 corresponds to “not true of 
me” and 7 corresponds to “extremely true of me”. 
5. Beck Depression Inventory second edition (BDI-II) 
The Beck Depression Inventory (BDI) was first published in 1963 and a second 
edition (BDI-II) was introduced in 1996 (Beck, Brown, & Steer, 1996). The BDI-II 
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is an instrument to detect symptoms of depression but can also be used to 
diagnose depression. At present the BDI-II is the gold standard amongst self-
assessment rating instruments for depression (Cusin, Yang, Yeung, & Fava, 
2010). The BDI-II has 21 items and is easy to use with minimal training. On 
average, a little more than 5 minutes is required to complete the questionnaire. 
The BDI-II is designed to detect depression in both the psychiatric and general 
population. Reliability testing is good at Cronbach α 0.92-0.93 and concurrent 
validity has also been reported to be high (Dozois, Dobson, & Ahnberg, 1998). 
To score the BDI-II, items in the scale are summed and the cut off scores are 
determined at 0-10 (no depression), 11 – 16 mild mood disturbance, 17 – 20 
(borderline clinical depression), 21-30 (moderate depression), 31 – 40 (severe 
depression) and above 41 (extremely severe depression) (Beck et al., 1996). The 
BDI-II has been used in other studies among the New Zealand population without 
problems (Roberts, Bushnell, Collings, & Purdie, 2006). 
6. Hospital Anxiety and Depression Scale (HADS) 
The HADS was developed by Zigmond and Snaith and first published in 1983 
(Zigmond, 1983; Zigmond & Snaith, 1994). The HADS questionnaire is designed 
to detect symptoms of depression and anxiety. The HADS is also designed to be 
brief, acceptable and easy to understand. It is primarily a screening instrument 
and concentrates on the psychological aspects of depression. The instrument is 
targeted for use by clinicians in busy practices, and therefore takes less than 5 
minutes to complete. The target client group are those in non-psychiatric 
hospitals;, however, the HADS has been found to be effective in both the primary 
care setting and also in the general population (Bjelland, Dahl, Haug, & 
Neckelmann, 2002). Reliability using Cronbach α is reported to be 0.90 for the 
depression subset and validity is established at 0.79 (Bjelland et al., 2002). The 
HADS has been translated into many languages and is widely used (Snaith, 
2003; Zigmond & Snaith, 1994). The instrument has been used on a population 
in Christchurch without any limitations (Dowson et al., 2001). To score the HADS, 
items in the depression and anxiety subscales are summed and the cut-off 
scores have been determined to be at 0-7 (no depression), 8-10 (mild), 11-14 
(moderate) and 15-21 (severe) (Zigmond & Snaith, 1994).  
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7. Non-Essential Energy Dense Nutritionally Deficient Food List (NEEDNT) 
The NEEDNT Food List was developed by the team in the New Zealand National 
Addiction Centre and first published in 2012 (Elmslie, Sellman, Schroder, & 
Carter, 2012). The list is designed to “start a conversation on eating”. It has 
subsequently been operationalised into the questionnaire used in this current 
research to give the number of times a person consumes, over the past month, 
each of the food items listed. The 50 food items have been compiled using the 
National Heart Foundation and Diabetes New Zealand “Foods to Avoid”, “Stop 
Eating” and “Optional Foods” lists; the Canterbury District Health Board 
“Supermarket Shopping Guide”; and the United States Dietary Association 
(USDA) population guidance on discretionary calories.  
For the current study a modified 44 item questionnaire was used by merging 
certain food items from the original 50 item. This was done through consultation 
with one of the original authors of the paper (Personal communication with RS). 
The duration of “over the past month” was changed to “over the past week” and 
the NEEDNT for this study was used as a food diary alternative. A reliability study 
has reported the Cronbach α to be between 0.82-0.85 (Eder, 2013). For the 
SCeMES study, scoring was by summing up all 44 items. The higher the number 
of NEEDNT foods scored and the greater the frequency of consumption, the 
worse the diet.  
8. Questionnaire on Craving for Sweet or Rich Foods Scale (QCSRF) 
The QCSRF was developed by Toll and colleagues and first reported in 2008 
(Toll, Katulak, Williams-Piehota, & O'Malley, 2008). The QCSRF is designed to 
assess perceptions about the ability of certain foods to relieve negative affect, 
and about self-control over eating; and also to assess the urge of smokers 
wanting to quit. The original publication has a 14-item scale, adapted from the 
Alcohol Urge Questionnaire (Toll et al., 2008). The QCSRF is used as a self-
assessment tool and takes less than 5 minutes to complete. Reliability is reported 
at Cronbach α 0.87-0.90, and the QCSRF has been found to have good 
predictive validity. The QCSRF used for this study had nine items as opposed to 
the 14 in the original published version. This was provided by the primary author 
(personal communication with BT), reported to be the improved version. There 
are two subscales for this instrument: a craving scale and a reinforcement 
subscale. The scale was scored using the means of the subscales and also the 
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summation of the total. Exploratory factor analysis showed two factors similar to 
the original 14-item scale and the coefficient alpha was 0.82, indicating very good 
internal reliability (Amer Nordin Amer Siddiq, Adamson, Schroder, & Sellman, 
2013). In the same study, the QCSRF was also found to correlate with the 
NEEDNT (rs= 0.273, N = 256, p <0.01).  
9. The Yale Food Addiction Scale (YFAS) 
The YFAS, designed as a diagnostic tool for food addiction, was first reported in 
2008 (Gearhardt, Corbin, & Brownell, 2009b). There are 27 items which include 
both likert and dichotomous items. The content was developed from the DSM-IV 
TR (American Psychiatric Association, 2000) with scales used to assess 
behavioural addictions such as gambling, exercise and sex. Questions were 
adapted to relate to the consumption of high fat and sugary items. Reliability 
testing is good at Cronbach α 0.81 and adequate internal validity (Gearhardt et 
al., 2009b). For this study, the modified YFAS (mYFAS) was used (Flint et al., 
2013). The mYFAS uses a core of nine questionnaire items. The mYFAs has 
good validity (construct) and high sensitivity and therefore provides a valid 
measure of food addiction (Mason, Flint, Field, Austin, & Rich‐Edwards, 2013). 
While the original study took into account the past year, this study used the 
duration of the previous month, in keeping with the SCeMES’s visit timetable. 
8.8 Data Collection 
Table 8.1: Phases of Data Collection 
Phase Activity 
One Training of researchers 
Two Pilot 
Three Data Collection 
 
 Phase One 
Three researchers were trained to assist in data collection for the SCeMES-QN. This 
session was conducted by the primary researcher. The training session took place at 
the National Addiction Center and lasted for two hours. The session included a brief 
description of the study protocol and the objectives of the study, an introduction to 
the variables of the study, and a brief training session on the use of the various 
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questionnaires. A thirty-minute session on clarifying concerns related to data 
collection was also included and these concerns were discussed and resolved.  
 Phase Two 
The baseline SCeMES-QN data protocol was trialled on 10 participants. This pilot 
was conducted to obtain feedback from both the researchers and participants. The 
pilot was also conducted to test the ease of use and timing of the questionnaires 
used for the study. From the pilot, the SCeMES-QN was found to take one hour and 
ten minutes to complete for the baseline data collection. No complaints were reported 
from either the researchers or the participants involved during enrolment and in 
completing the SCeMES-QN.  




- Smoking related 




























Figure 8.1: Flow for the SCeMES-QN Data Collection 
 
Data was collected on five occasions during the period of one year. The five visits 
corresponded to baseline and four subsequent visits at one, three, six and 12 months 
from the initial planned quit attempt which was at week two after baseline. On 
Baseline Early Visit Late Visit
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average, it took 75 minutes to collect data at baseline and 30 minutes for each 
subsequent follow-up visit. 
Participants who agreed to participate in the ZAP study and fulfilled inclusion criteria 
were invited to participate in the SCeMES-QN. Informed consent was obtained, and 
baseline data, comprising two sections was collected. The first section included a 
brief explanation of the study; signing of the consent form; recording socio-
demographic data and objective measurements such as weight, height and blood 
pressure monitoring; and completing the set of questionnaires. Expiratory carbon 
monoxide levels were measured at the time. In the second section, participants were 
asked to complete the set of questionnaires on their previous smoking status and 
smoking cessation management, on their mood, and on their craving for, or addiction 
to, food. Food intake over the previous week was taken using the NEEDNT to 
measure current eating habits. A quit date was arranged within a two week period, 
and details of a contact person were also recorded. The remaining four follow-up 
visits were subsequently arranged. For visits two, three, four and five a recording of 
quit rate within the last week (7 days) was also taken. This was the main outcome 
measure. All questionnaires were repeated as per Figure 8.1. 
Two methods of data collection were used for the SCeMES-QN. Data was collected 
using both computer and paper and pen. For the data collected using the computer, 
data was recorded directly into the computer to minimise data entry error and data 
loss at the time of data collection. For paper and pen, the questionnaires were 
provided after completing the computer questionnaires. Either participants were 
allowed to enter their responses in the computers on their own, or the researcher 
could read the questions and record the relevant responses. In the case of the 
former, researchers were present together with the patients to ensure all questions 
were answered. The information was stored in a Microsoft Access database 
designed for the study. This database was linked to a server hosted and maintained 
by the University of Otago to ensure that the data was stored safely. In the case of 
the paper and pen questionnaires, all answers were filed together with the 
demographic data and stored in the NAC to ensure safe keeping and confidentiality. 
All attempts were made to collect data for all five time points and various measures 
were put in place to ensure this. Among the strategies were early reminders of 
upcoming visits either by email messages or phone calls. Patients were contacted 
three times if they had missed their appointment visits, and a call to their listed 
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significant other was also made among one of the three calls. At the end of twelve 
months, participants who had not attended any late visits were called three times in 
order to invite them for a face to face visit where possible, or a phone call interview. 
At the end of data collection, when it became clear that there was much missing 
data, thought to be largely due to the earthquakes, follow-up data was aggregated 
into three time points - baseline, early and late. Early visits included visits at one and 
three months after a quit attempt, and late visits included both six and 12 months 
from the initial quit attempt 
For telephone interviews, only a limited set of questions was employed for data 
collection due to time constraint. The HADS was used to assess mood and the 
mYFAS for food addiction. The total time for the data collection by telephone was 
under ten minutes. 
8.9 Analysis 
Analysis was performed using the Statistical Package for Social Sciences (SPSS) 
version 20. Descriptive statistics were performed for all demographic, smoking, 
mood, weight and food variables. Mean and standard deviations were obtained for 
continuous variables, and median and mode for categorical variables. Continuous 
variables were subsequently analysed for skewness using both histogram and the 
one-sample Kolmogrov-Smirnov test. Where normal distribution was not found, 
analysis using non parametric tests was performed. For normal distribution, 
parametric tests were performed. Univariate analysis was performed between groups 
using an independent t-test; Fisher’s test was used for continuous variable; and chi 
square for dichotomous variables. Variables which had multiple categories were 
analysed using ANOVA. The significance level was set at p< 0.05 and the confidence 
interval at 95% interval. Multivariate analysis was performed to predict quit attempts. 
For continuous variables, linear regression was performed, and for non-parametric 
datasets log regression was done. The dependent variable was quit rates at both 
early and late time lines, and independent variables were mainly mood, weight and 
food variables. 
The SCeMES-QN involved a baseline and four follow-up visits as described earlier in 
the methods chapter. The earthquake disruption brought about a higher rate of non-
attendance at the various follow-up appointments. Therefore, for analysis, two time 
points were used, baseline and early follow-up (EARLY); and baseline and late 
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follow-up (LATE). EARLY combined follow-up visits one and two, while LATE 
combined visits three and four. For participants who attended both visits in either 




 CHAPTER 9 - Smoking Cessation, Mood and Eating Study 
Qualitative (SCeMES-QL) Methodology 
9.1 Chapter Overview 
This chapter will describe the components of the methodology for the qualitative 
aspect of the Smoking Cessation, Mood and Eating Study. In this chapter, the 
research design and justifications are described. The recruitment strategy and 
methods of data collection is reported together with methods to ensure rigor during 
data collection. Finally, methods of analysis is reported. 
9.2 Research Design 
The SCeMES-QL was conducted sequentially on completion of the SCeMES-QN. 
This was a qualitative study using interviews for data collection.  
Qualitative research is difficult to define but has been reported as being a “field of 
inquiry of its own” (Denzel & Lincoln, 2011). It has attempted to study the world in its 
natural setting. Conclusions are, therefore, often based on the experiences and 
understanding of the participants (Denzin & Lincoln, 2011).  
9.3 Recruitment and Sampling 
Participants for the SCeMES-QL were recruited from the SCeMES-QN. They were 
purposively sampled, meaning they were chosen for a specific reason and not 
sampled at random (Tashakkori & Teddlie, 2003). Purposive sampling is unique to 
qualitative research and often referred to as “qualitative sampling” (Teddlie & Yu, 
2007). Cases are often related to the research question and described as 
“information rich” or, simply, cases with the most to learn from (Tashakkori & Teddlie, 
2010b). Sampling of this nature is typically small in sample size, often only including 
30 or fewer participants. Cases are usually selected through the “expert judgement” 
of either the researcher or the informant (Tashakkori & Teddlie, 2010a). In 
accordance with Patton (2002), multiple purpose sampling techniques were 
employed in the SCeMES-QL. This sampling technique used a combination of two or 
more sampling strategies. Using this technique allowed for the inclusion of cases 
which were either representative or comparable across types of cases on a 
dimension of interest, with unique or “extreme” cases being included in the sampling 
frame (Patton, 2002). 
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Participants were eligible to be included in the SCeMES-QL if they:  
1. had completed the baseline visit and one other visit for the SCeMES-QN 
2. were willing to be interviewed either individually or in a group 
3. agreed to sign an informed consent form 
4. were able to converse in English 
One hundred and forty participants met the criteria of at least two recorded visits in 
the SCeMES. Of these, 94 were able to be contacted at the end of the SCeMES-QN. 
However, for 20 of these participants, the ‘visits’ were telephone interviews, which left 
74, who had presented in person for two visits, who were able to be contacted and 
were therefore eligible for interviews. Forty-one of the 74 agreed to be interviewed; 
nine of them were interviewed individually. These nine were either identified as 
‘unique cases’ and therefore would not be suitable for groups which had a more 
homogenous grouping; they were unable to attend any of the focus groups planned; 
or they were unwilling to participate in a focus group, but were willing to participate by 
being interviewed. 
 
Figure 9.1 : Recruitment for SCeMES-QL 
9.4 Data Collection 
 Technique 
For the SCeMES-QL, qualitative interviews were used as the main research 
technique to gather information.  
Interviews are able to capture the actual experience of individual’s more than general 
beliefs and opinions (King & Horrocks, 2010). Interviews also allow the researcher 
and interviewee to interact and seek understanding on the questions posed 
(Tashakkori & Teddlie, 2010b). This interaction between interviewee and interviewer 
is crucial in ensuring the success of an interview (King & Horrocks, 2010). Kvale and 
Sven (2009), use 12 terms to describe the qualitative research interview. The 
interview must include the “lived world” of the interviewee and have “meaning” which 











“descriptive”, “specific”, and “focussed” on a central theme. Although the theme is 
focussed, the interviewer’s questions can be “ambiguous” to allow deliberation by the 
interviewee, and can also “change” during the course of the interview, i.e. flexibility. 
“Sensitivity” is another aspect of the interview and the research interview might lead 
to a “positive experience”, although the knowledge gleaned is through the 
“interpersonal situation” of the interviewee. Finally, the interviewer needs to allow 
himself/herself the freedom of judgement and allow acceptance of the information 
with an open mind, termed “deliberate naïveté”. 
The qualitative research interview is different from the therapeutic interview, which 
some have confused it with. Aspects of the qualitative interview discussed earlier 
might also be similar in therapeutic interviews, such as ambiguity and change, but 
the aim of these interviews is very different. The qualitative research interview is 
aimed at seeking qualitative knowledge, whereas the therapeutic interview is aimed 
at changing, and its main purpose is to heal (Kvale & Sven, 2009). As a result, health 
care providers, who are involved with qualitative research through the use of 
interviews, should be careful not to confuse the therapeutic interview with the 
research interview during data collection (Dickson-Swift, James, Kippen, & 
Liamputtong, 2006).  
Patton (2002), has described three types of interview styles: the informal 
conversational interview, the interview guide, and the standardized open-ended 
interview. Hansen (2006), has described three other types: structured, unstructured 
in-depth, and informal interviews. A fourth, called semi-structured and mentioned by 
Hansen (2006), is similar to Patton’s (2002), ‘interview guide interviews’. Both 
informal and semi-structured interviews use open-ended questions, allowing 
interviewees to express themselves without undue influence from the researcher’s 
assumptions or biases. Unstructured or informal type of interviews allow for more 
freedom of expression than either semi-structured or structured, and are usually 
conducted in ethnographic type studies. Often, more skill and time is required for this 
type of interview due to its “go with the flow” approach (Patton, 2002). Semi-
structured interviews, on the other hand, often use an interview guide. The latter 
contains a broad range of questions which have been predetermined before the 
interview is conducted. These questions should be open-ended and allow flexibility in 
terms of the questioning sequence. These questions should also be broad enough to 
provide some structure to the topic of the interview, while at the same time allowing 
 117
the participants to introduce their own ideas and areas of interest about the issue 
being studied. Using an interview guide, a customary line of inquiry is followed for 
each interviewee and often have a topic or subject area which the interviewer is 
interested in pursuing. These interviews might lead to a slightly different path or 
conversation on the interested topic. According to Kvale and Sven (2009), interview 
guides should be balanced thematically, meaning that the questions should be 
related to the topic being studied. It should also be dynamic enough to promote a 
positive interactive experience, allowing motivations and experiences to be shared.  
The SCeMES-QL employed the semi-structured interview using an interview guide 
for data collection. 
 Data Collection Strategies 
Two main strategies for data collection were used in the SCeMES-QL: the semi-
structured focus group interviews (FG), and the semi-structured individual interviews. 
Focus group interviewing is a common interviewing strategy employed to collect data 
by using both a group approach and group interviewing techniques. The main 
strengths in using FG interviewing is that it allows observation during the interviewing 
process and therefore enables the collection of both verbal and visual data. For the 
SCeMES-QL, verbal data was the main data gathered using FG. Interviews are also 
interactive and allow for group dynamics to operate during the interviewing. Through 
this interaction, different types of information can be collected which might not be 
present during a routine one-on-one interview. FG interviews are also very useful in 
gathering opinions (Krueger and Casey, 2009). This technique is often used in 
marketing research and is increasingly used in health education research (Basch, 
1987). 
Focus groups are different from other forms of group interviews in that they are 
focussed, have a specific topic to discuss, and are moderated (King & Horrocks, 
2010). A moderator, who is usually the interviewer, allows groups to run smoothly, in 
an ‘ordered’ fashion and often is tasked to put the group at ease. Krueger and Casey 
(2009) include size, composition and procedure as other aspects of a FG. Having a 
moderator is crucial to a FG, and is considered to be one of the main characteristics 
differentiating it from other group interviews (Krueger & Casey, 2009; Morgan, 2001). 
Hennink and Diamond (2000) have even suggested that a FG team should have not 
only a moderator, but also an assistant and housekeeper. Moderators play a central 
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role in any FG; however, the setting and set up for the interview is equally important 
(Basch, 1987). The characteristics of a FG have been described by Krueger and 
Casey (2001), as each group having five to ten members; being somewhat 
homogenous, meaning group members have something in common in relation to the 
research topic; allowing qualitative data collection; being focussed in their discussion 
and each session lasting less than two hours. The optimum number of participants 
within a group has been reported to be 6-10 (Morgan, 1997). In recent times, Krueger 
and Casey (2009) have advocated for five to eight participants per group, and have 
reported that smaller groups of five to six participants are acceptable and, not 
surprisingly, have been observed to be increasingly popular. Having too few in a 
group reduces the meaningfulness of FGs. Too many participants, on the other hand, 
make the group too difficult to control. An adequate number in the group has been 
reported to bring out group dynamics, one of the reasons why FGs are popular and 
useful (Krueger & Casey, 2009). The number of groups on the other hand requires 
flexibility. The number often depends on theoretical data saturation, meaning groups 
will have a tendency to report similar themes on interviewing (O’Reilly & Parker, 
2013). 
Semi-structured individual interviews are frequently organized in a one-on-one 
approach, and best conducted face-to-face. They are qualitative research interviews 
and fulfil the criteria discussed previously (Krueger & Casey, 2009). In the SCeMES-
QL, individual interviews were used for those participants who were unable to 
tolerate group interviews, or who were unable to attend the focus groups but were 
still keen to participate in the study. For the latter individuals, every effort was made 
to include them in a group i.e. the timing of the group was flexible and frequent 
reminders were sent out. However, when this failed, and these individuals were still 
interested in participating, an individual interview was offered. Those categorised as 
unique or ‘extreme’ cases, and those who showed interest, but were too few to make 
up a group, were also interviewed individually using this strategy (MacDougall & 
Fudge, 2001).  
For the SCeMES-QL, a total of five FGs were initially planned. A total of 41 
participants had initially agreed to participate and were grouped accordingly. The 
decision to group participants into groups with some commonality was an attempt to 
homogenise the group to obtain better qualitative research interviews. Participants 
were purposively grouped according to their quit smoking status, their experience 
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with depression and their experience with weight gain during the course of the 
SCeMES. All FG participants had experienced the Christchurch earthquakes in both 
September 2010 and February 2011.  
Of the five FGs initially planned, only three eventuated. Two of the five groups were 
unable to proceed due to poor turnout (Group 1, 2 of 6 could attend and in Group 2, 3 
of 5 could attend), and a decision was made to cancel them. Efforts to re-run the two 
groups failed, as a specified time could not be agreed on by the group members. 
One group included those with a history of depression who had successfully quit, and 
the other group included those who had completed the SCeMES but were not 
successful in quitting smoking. Individual interviews were subsequently arranged with 
participants from these two groups.  
In total, nine individual interviews were conducted which comprised participants that 
were not included in the two cancelled groups and others who were considered to 
meet the term ‘extreme case’ and believed to be able to provide more context to the 
research questions. 
 Development of Interview Guide 
A three-step approach was followed in developing the interview guide, as described 
by King and Horrocks (2010), for the SCeMES-QL.  
Step One 
The first step involved developing the initial questions for the study and the scope for 
the line of inquiry. King and Horrocks (2010), have suggested three main sources for 
identifying topics for inclusion: personal experience, literature review, and conducting 
a preliminary study. The information obtained using these strategies may assist to 
shape the comprehensiveness of the interview guide. The information will also assist 
in deciding which types of questions are to be asked, the sequence of the questions, 
possible probes and how best to incorporate new information as it becomes available 
during the course of the interview, i.e. the level of flexibility. An interview guide 
encourages new information to emerge during the interview which is then used to 
further develop the interview guide (Hansen, 2006; King & Horrocks, 2010). Interview 
guides can be dynamic and might change during the course of the FGs. For the 
SCeMES-QL interview guide, topics were sourced from the primary researcher’s role 
as both a clinician and psychiatrist in teaching and in treating smokers with tobacco 
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dependence. Further information was sourced from the experience gained through 
the SCeMES-QN. In that study, both participants and researchers (those assisting 
with data collection) were interviewed through informal interviews during the 
consultation process i.e. when the participants were asked to answer the various 
questionnaires such as the BDI-II or the NEEDNT for example. Hansen (2006), has 
described interviews conducted through an unplanned or opportunistic method, such 
as when “opportunity arose”, as informal interviewing. Further information was also 
collected from discussions with the supervisory team (for the SCeMES) and also the 
ZAP team members. The supervisory team was not directly involved with the ZAP 
study and therefore provided information which mainly related to the research 
questions of interest, whereas those involved with the ZAP study were able to relate 
more experiential information from their day-to-day involvement in assisting smokers 
to quit smoking.  
Following on from these discussions, a total of five themes and 34 questions were 
initially developed. The five themes were related to quitting smoking in a program 
such as the SCeMES, mood, weight, resilience, and new treatment. The questions 
were grouped into these themes, and sequenced to be asked in this exact order. It 
was anticipated that through this sequence, the main information to be gleaned in 
response to the research questions would be gathered first, before moving onto other 
areas of interest such as the impact of the earthquakes on quitting smoking. During 
the course of the interviews, flexibility was employed to gather data. If, during the 
interviews, the interviewee gave related information sought from the interview guide 
but not in the order planned, to allow less disruption during the interviewing process, 
the interviewer facilitated the discussion in the direction of the interviewee rather than 
holding rigidly to the interview guide. Moreover, all questions developed were open-
ended questions which allowed exploring the “lived experience” of participants in the 
SCeMES. The interview questions were initially pre-tested with two colleagues from 
the NAC, who were familiar with the SCeMES, to ensure that the questions were 
clear, easily understood and that the sequencing was easy to follow.  
Step Two 
The second step involved a pilot interview. This pilot interview had three objectives. 
The first was to pilot the interview guide for ease of use, relevancy, clarity, the timing 
and to identify themes or questions which might have been missed. The second 
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objective was to conduct a dry run of a FG which was the main interviewing method 
used for the SCeMES-QL (Krueger & Casey, 2009). The third was to ensure that the 
“quality of the interviewer” was established and maintained (Kvale, 1996; Kvale & 
Sven, 2009). A total of ten people were recruited for the pilot study and invited to the 
FG interview. Five confirmed their attendance, but only three attended the session. 
The primary researcher was the moderator, while an experienced qualitative 
researcher in the supervisory team was assistant and scribe. The qualitative 
researcher also assessed the moderator and provided feedback about the 
moderator’s interviewing technique at the end of the session. This exercise was 
important to ensure the moderator showed competence in qualitative interviewing 
skills as “the quality of the information obtained during the interview was largely 
dependent on the interviewer” (Patton, 2002). The interview took 45 minutes in total 
and a debriefing session was conducted at the end. In keeping with 
recommendations on guideline development, allowance was made to address 
emerging questions during the course of the interview and improve the interview 
guide accordingly (Hansen, 2006; King & Horrocks, 2010). 
Step Three 
The third step involved finalising the semi-structured questionnaire. A total of four 
themes were included in the final questionnaire and included 39 questions for those 
in the groups who had quit smoking at the time of the interview, and 45 for those who 
were still smoking. The four themes of interest were: the participants’ experience in 
quitting using a structured programme how mood, especially depression, affected 
their quit attempt; how weight gain affected their quit attempt; and their experience of 
quitting through the aftermath of an earthquake.  
 Data Collection Site 
According to King and Horrocks (2010), the setting of an interview plays a major role 
in the interview. This has been echoed by others (Basch, 1987; Krueger & Casey, 
2009). Three main aspects that might lead to a successful interview are comfort, 
privacy and quiet (King & Horrocks, 2010). Therefore, all interviews were conducted 
at the NAC. For FG interviews, sessions were conducted in a meeting room that was 
able to comfortably accommodate up to ten participants. This room also had a small 
kitchen area which allowed for light refreshments to be provided at the end of the 
sessions. The sessions were arranged for after working hours and lasted between 60 
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to 90 minutes. The decision for choosing times outside of general working hours was 
to increase participation, and also to ensure that the sessions were private and quiet. 
For the individual interviews, sessions were conducted at the primary researcher’s 
clinical room. Flexible timing was arranged to allow for all interested participants to 
participate in the study; therefore some interviews were held during office hours and 
others were not. Similarly, each session lasted approximately 90 minutes.  
 Recording the Data 
All interviews were recorded using two digital recording devices. These devices were 
supported with two professional microphones to ensure conversations were clearly 
recorded. 
For each group interview, an assistant was present and acted as scribe. The same 
assistant was used for all the group interviews. The scribe documented placement of 
participants during the interview and also provided descriptive observations during 
key moments, items which may have been missed when using the recording devices 
on their own.  
After completing each interview, the primary researcher (who was also the 
moderator) recorded his thoughts and experiences of the interview. After the primary 
researcher had recorded his interview, he and the scribe also had a debriefing 
session on areas that worked, and areas to improve on. These sessions allowed 
reflection on the recently concluded interviews. 
9.5 Ethical Considerations 
A number of steps were undertaken to ensure that the SCeMES-QL was of a high 
ethical standard. Among these steps were the following: 
1. The study was approved by the Central Health and Disability Ethics 
Committee (Refer to 7.4.3).  
2. All participants were asked twice about their interest in participating in the 
interview, both at the beginning, and nearing the completion, of the initial 
SCeMES-QN. In the first instance, the interviews were mentioned at the start 
of the SCeMES, informing participants that this study had two parts in which 
they could participate; and, second, an expression of interest in participating 
was required in the written informed consent form. Participants who showed 
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an interest were subsequently followed up with a phone call prior to the start of 
the SCeMES-QL. Those who had initially declined to participate when asked 
at the beginning of the SCeMES, but after completing the SCeMES-QN 
decided to participate, were also included. At the last follow-up for the 
SCeMES-QN, participants were asked if they were still interested in 
participating in the interviews; and those who did not complete the SCeMES-
QN were asked during the telephone interviews. 
3. Participants were re-informed about the SCeMES-QL on the day of the 
interview. Information on the study objectives and the role of anonymity were 
both stressed at the beginning of both FG and individual interviews. Both 
interviews required a second informed consent form, specific to participating in 
the qualitative interviews, to be completed.  
4. For FG participants, group rules were discussed at the start. As part of this 
discussion, the issues of respecting others, and the need for confidentiality 
outside of the group, were raised.  
5. Participants for the group sessions were also provided with light refreshments 
at the end of the interview. All participants were reimbursed for their time with 
a NZD20 Motor Trader Association (MTA) voucher, which was to cover 
transport to and from the interviewing site. For the few that were interviewed 
individually, an MTA voucher was given and coffee and tea were provided. 
6. On completion of the interviews, all participants were provided with the 
opportunity to read the completed transcripts. This was in keeping with 
member checking (this will be expanded on later). Transcripts were only 
directed to the participants’ personal email accounts, and any names or 
identifying descriptions were carefully altered to ensure anonymity. For those 
who did not want to participate in this exercise, transcripts were not sent to 
them. 
7. All interviews were recorded and transcribed verbatim. Recordings were 
initially transcribed by the primary researcher for the pilot and two individual 
interviews. This task, however, was subsequently outsourced to a professional 
transcribing service. A confidentiality agreement was signed by the 
transcribing service at the beginning of the service, to ensure that all 
recordings were safely stored during transcribing and destroyed on completion 
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task. All transcripts were ensured not to include any identifying records which 
may allow other people to identify individual participants. Careful consideration 
was given to other items such as working history and details, names of spouse 
or children, and any reference to relationships.  
8. Transcripts and analysis were kept at the NAC under lock and key during the 
period of analysis. For transcripts which were digital, the documents were 
secured in a password protected computer, which was able to be accessed by 
the primary researcher, All transcripts were subsequently kept in the NAC 
under lock and key on completion of the study. Digital documents were kept 
on a password protected hard disk. 
9.6 Methods of Rigor 
Rigor is necessary to ensure that a study is of sound quality and of a certain 
standard. In quantitative research, this is referred to as either reliability or validity. 
Reliability simply refers to the ability of a given instrument to measure the same thing 
at every use. Validity, conversely, entails that the instrument measures what it is 
supposed to measure. Although important, both methods of rigor are not easily 
applied in a qualitative study, as it often follows a constructivist paradigm as its 
theoretical model. Guba and Lincoln (1989) have therefore proposed parallel terms 
for reliability and validity. These are referred to as credibility and transferability. 
However, according to Morse, Barrett, Mayan, Olson, and Spiers (2008), this action 
has resulted in confusion within the field. Since the shift to the use of parallel 
terminologies, there has been a move away from emphasising rigor in the conduct of 
a study in favour of ensuring ‘trustworthiness’ in the reporting of the study. Both, 
however, do not necessarily mean the same thing (Morse et al., 2008). This 
alternative terminology has been especially favoured by North American researchers, 
Morse et al. (2008) have therefore suggested maintaining both initial terminologies 
(validity and reliability) to ensure some level of standardization, particularly for written 
reports. This approach had been adopted for the reporting of both components of the 
SCeMES. 
9.7 Reliability 
This term, or its equivalent dependability, is concerned with how precise a variable is 
measured. For qualitative research, this refers both to the interview and to 
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subsequent transcription. The SCeMES-QL employed two techniques to ensure 
reliability of the data. The first was ensuring investigator responsiveness (Morse et 
al., 2008) through activities likened to ‘calibration’ of the interviewer. The interviewer 
was essentially the main instrument in conducting qualitative research. The primary 
researcher, who was the interviewer, was observed under direct supervision on two 
occasions for his interviewing skills, and was then debriefed on both sessions. The 
interviewer was also required to record both interviews, which were then discussed 
during supervisory sessions to enhance the quality of the interviewing for the best 
possible data collection.  
The second technique to ensure data reliability was during the course of transcribing 
the interview recordings. The transcripts were re-read with the recordings to ensure 
that the information was not missed and that the transcription was as accurate as 
possible. 
9.8 Validation 
Validity or trustworthiness, which encapsulates terminologies such as credibility and 
transferability, was important to ensure that the method of measurement measured 
what it was supposed to. Onwuegbuzie and Leech (2007) have reported on the use 
of a model, referred to as the Qualitative Legitimation Model (QLM), to illustrate areas 
which might compromise internal and external validity of a qualitative study. The QLM 
identifies 12 internal threats, including researcher bias, reactivity, and effect size; and 
14 external threats, which include items such as action validity and evaluative 
validity. Through the identification of these threats to validity, methods to reduce 
them are discussed. The authors have suggested a number of actions such as 
prolonged engagement, persistent observation, triangulation, leaving an audit trail, 
member checking, weighting the evidence, checking for representativeness of 
sources of data, checking on researcher effect, contrast and comparisons, theoretical 
sampling, checking the meaning of outliers, using extreme cases, ruling out spurious 
relations, replicating a finding, referential adequacy, following up surprises, structural 
relationship, peer debriefing, rich and thick descriptions, the modus operandi 
approach, assessing rival explanations, negative case analysis, confirmatory data 
analyses and effect sizes. Morse et al. (2008), however, have noted the need to use 
these actions earlier in the study, during the development or conduct of the study, 
rather than only in the reporting, which is often as the end of what is currently being 
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performed. The various actions suggested by the identification of QLM also vary 
depending on the type of qualitative study being conducted. Validity is also not 
dichotomous, a ‘yes’ or a ‘no’, but a continuum, described as having a degree of 
validity (Morse et al., 2008). 
The SCeMES-QL incorporated a number of suggested methods to increase validity 
for the study. One of these methods included the use of member checking, referred 
to by Guba and Lincoln (1989) as one of the most important methods to increase 
validity. Member checking for this study involved participants being provided with 
their transcripts after transcribing, for clarification prior to analysis. This was to ensure 
that the spoken interview was not lost of its meaning, and that what was provided in 
the interview was how participants meant it to be (Liamputtong, 2009). Of the 25 
interviewed, 18 agreed to their transcripts being sent to them. Only one participant 
made slight changes to the interview by omitting certain statements. This person was 
one of the seven who were interviewed individually. The other participants for both 
FG and individual interviews found no issues with their respective transcripts. In one 
individual interview a recording malfunction occurred. This resulted in the loss of half 
the interview. The researcher, however, managed to salvage the situation as best as 
possible by recalling what was remembered during the interview, and immediately 
informing the participant through a phone call, subsequently emailing the transcript to 
the participant on the same morning. The interviewee concurred with the 
researcher’s memory of the events with minimal additions. 
An audit trail was also employed in the study. An audit trail uses documents, 
thoughts, pictures, notes or any item which was used in the study to allow some trail 
of the thought process in reaching to the conclusion of the analysis (Morse et al., 
2008). For this study, the historical development of the interview guide, the pilot and 
test interview recording and notes, the recording of all interviews, and the discussion 
on analysis were kept to provide an audit trail for best practice.  
The use of extreme cases can be useful in analysis, and also to reach a conclusion, 
as it allows the researcher to verify items or issues which might be different in the 
‘general’ population studied (Miles & Huberman, 1994; Miles, Huberman, & Saldaña, 
2013). For the SCeMES-QL, participants who were different, or who experienced 
extreme complications such as severe weight gain or who were admitted to hospital 
due to depression, were included to allow a different perspective for the study.  
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Researcher bias has been described in the QLM, but is defined by Miles and 
Huberman (1994), as including two sources, predominantly the bias of the researcher 
towards the participant, and also the other way round, the bias of the participants 
towards the researcher. Among the steps taken in reducing this threat to validity is a 
declaration of clear intentions of the interviewing process during the start of each 
interview, the signing of the informed consent form, the inclusion of extreme cases to 
allow diversity of information, discussion of research with colleagues, and having the 
research questions firmly in mind throughout (Miles & Huberman, 1994; Miles et al., 
2013; Onwuegbuzie & Leech, 2007).  
In the analysis process, one method to reduce threats to validity is to provide as 
much as possible of the research findings and notes which will allow for a clear 
description of the item of interest, also known as ‘thick and rich descriptions’. This 
process includes a detailed and complete description of the text or data which then 
allows the researcher to maximise the ability to search for meaning (Onwuegbuzie & 
Leech, 2007). What is defined as ‘complete’ or ‘thick’ data is still not well understood 
(Guba & Lincoln, 1989). ‘Thick and rich descriptions’, are undertaken to ensure that 
the meaning of the data is not lost during analysis.  
9.9 Analysis 
To analyse is to draw meaning from the data. Miles et al. (2013) define analysis as 
having three parts: data reduction, data display, and data verification or conclusion. 
The method of analysis chosen for the SCeMES-QL was the general inductive 
approach introduced by Thomas (2006). This analysis consisted of “systematic steps 
in analysing qualitative data in which the analysis was guided by specific evaluation 
objectives” (Thomas, 2006). The general inductive approach allowed the research 
findings to emerge from the data through coding and theme generation which did not 
need to be attached to a set theoretical concept. This method of analysis fitted well 
with the pragmatic worldview adopted by the researcher.  
Thomas (2003) has described five procedures in a general inductive approach: the 
preparation of the data, ‘immersion’ by the researcher in the data, creating categories 
for the data, searching for overlaps, and refining and revising the categorical system. 
No specific methods are mentioned for analysis using the general inductive 
approach, and researchers have reported using thematic analysis and constant 
comparative methods for creating categories and looking for overlaps. Similarly, 
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those using this analysis approach are known to use thematic reporting or the use of 
matrices to present findings (Miles & Huberman, 1994; Miles et al., 2013).   
For the SCeMES-QL, the data was ‘prepared’ by transcribing interviews verbatim, 
and ‘cleaned’ by reviewing transcripts together with audio-recordings to ensure 
transcripts were as accurate as possible. The transcripts were prepared to be 
compatible with the use of NVivo, a computer software which is often used to store 
and assist with categorizing or coding of data in qualitative studies (Welsh, 2002).  
Transcripts were then read and re-read to ensure ‘immersion’ in the data. Immersion 
is the process whereby the researcher immerses himself in the data to allow 
familiarity with the contents (Miles et al., 2013). Coding was subsequently undertaken 
after this stage. Two methods of coding were used. The first, descriptive coding, is a 
method of taking a segment of textual data of interest and inserting a code which is 
descriptive and free of interpretation. The second coding method used is pattern 
coding, which are codes of textual data more explanatory in nature (Miles et al., 
2013). Codes were listed in a sourcebook and discussed with the supervisory team 
before being re-coded if needed (Saldaña, 2013). 
Thematic analysis was then performed whereby codes were read and re-read to look 
for certain repetitive and overlapping categories which were labelled as themes. 
Themes were then named and defined to bring meaning to the data (Liamputtong, 
2009). The themes were then presented in a matrix where possible, or otherwise 
reported thematically (Miles et al., 2013). Both methods of display also included 
appropriate raw data called quotes to give meaning to the information that was 
inductively generated. Where possible, ‘thick description’ of the data was used to 
describe these quotes (Miles et al., 2013). At all stages of analysis, both reliability 
and validity of the data was undertaken as previously described to ensure that the 














 CHAPTER 10 - Quantitative Results (SCeMES-QN) 
10.1 Chapter Overview 
This chapter describes the results for the quantitative study of the SCeMES. A 
general overview of the study participants is described followed by an overview of the 
follow-up participants in the study. The description continues with the description of 
participants who completed the study and those who managed to become abstinent. 
The chapter ends with the findings for the association between quitting smoking and 
depression, quitting smoking and eating, and findings when all three variables were 
analysed together.  
10.2 General Sample Profile 
A total of 1628 participants responded to the ZAP study advertisement in 
Christchurch (method section 8.5). Six hundred thirty-five participants were screened 
out through the online system, and another 416 by telephone screening. Five 
hundred seventy-seven were invited to attend a face-to-face baseline screening. 
Twenty-one participants were subsequently excluded: four failed the mental health 
screening, two were excluded due to heavy alcohol consumption, two due to medical 
complications, and two for smoking fewer than 9 or less cigarettes. Nine were 
excluded because their Fagerstrom Test for Cigarette Dependence (FTND) scores 
were less than 3. Two participants were mistakenly randomised during the face-to-
face screening and were subsequently excluded. Table 10.1 is a summary of the 
sample distribution. In all, 556 participants were eligible for the ZAP study, and 256 
consented to participate in the SCeMES (Figure 10.1). 
 
 













Table 10.1: Reasons for exclusion from the ZAP Study (and SCEMES-QN) 
Reasons Number excluded 
Mental Health 37 
Pregnancy/Contraception 12 
Age >70 years 35 
Logistics 53 
Alcohol use > 21 standard drinks  85 
Contraindication Medication 23 
Contraindication medical problem 82 
Smoking <9 cigarettes 36 
FTND Score <3 82 
Already quit  90 
Declined or not interested 508 
Wrong or changed contact details 23 
Interested, but no appointment suitable 2 
Spoilt randomization 2 
 1,072 
 
10.3 Baseline Sample Description 
 Baseline Smoking Status 
The mean age for initiating smoking was 16.3 years (range 7-43, SD = 4.5 years). 
The mean duration of lifetime smoking was 30 years (range 4-55, SD = 11.9 years), 
and the mean number of cigarettes smoked per day (CPD) at baseline was 19.9 
(range 9-50, SD = 7.1). Participants in this study had attempted to quit on average 
four times (M = 4.2, range 0-100, SD = 7.2) prior to enrolment.  
Nicotine addiction severity was measured using three instruments as described 
previously. The mean scores were FTND 6 (range 3-10, SD = 1.8), QSU-brief 21.8 
(range 10-63, SD = 11.1) and Brief WISDM 48.1 (range 18-73.3, SD = 11.3). The 
mean carbon monoxide level at baseline was 4.5 (range 1-7, SD = 1.3).  
More than half of the sample reported they were not living with another smoker (n = 
154, 60.2%). On completion of the ZAP, 47.7% (n = 122) were found to be on active 
treatment (NRT) compared to 52.3% (n = 134) who were on placebo. 
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 Baseline Sample Demographic Profile 
The mean age of the SCeMES sample was 46.2 years (range 19-70, SD = 12.1 
years) and more than half, 140 (54.7%), were females. The majority identified as 
Caucasians, 233 (91%), while only 19 (7.4%) identified as New Zealand Māori. Of 
the remaining four (1.6%), two identified as Pacific, one as African and one as Asian. 
Nearly a fifth had tertiary level education (n = 44, 17.2%), and a quarter had 
completed secondary schooling, obtaining a school qualification (n = 66, 25.8%). A 
fifth of the participants reported having not completed Form Five (Year 10) (n = 50, 
19.5%) and therefore had no school qualification. The majority of participants (n = 
208, 81.3%) were employed, and most of them were working full time (n = 134, 68%). 
The most common occupation was a tradesperson (n = 60, 23.4%). This was 
followed by people in managerial positions and clerical or administrative positions (n 
= 40, 15.6%) each. Forty-eight (18.8%) participants reported not being employed.  
 Baseline Mood Status 
Ninety participants (35.2%) reported having been diagnosed with depression by a 
doctor in their lifetime. Just over a quarter (n = 70, 27.3%) reported a family history of 
depression, while 15 (5.9%) did not answer, and the remaining did not know of 
anyone with depression in their immediate families. 
The mean score for the HADS depression subset (HADSD) was 1.8 (range 0-12, SD 
= 2.2), and the mean score for the BDI-II was 2.6 (range 0-28, SD = 3.9).  
Using a cut-off score of 8 or greater for the HADSD and 16 or greater for the BDI-II, 
the current prevalence of depression was 2.3% (n=6) and 6.6% (n=17) respectively 
for the instruments, at baseline (Refer to Table 9.16).  
 Baseline Eating Status 
The mean weight in kilograms for the sample was 79.9 (range 40-185, SD = 19.1), 
and the mean BMI (kg/m2) was 27.4 (range 16.41-74.11, SD = 6.2) with a median of 
26.4. Just over a third of the sample, 89 (34.8%), was found to have a normal BMI. 
More than half were overweight (n = 95, 37.1%) or were obese (n = 68, 26.6%), 
whilst a very small number of participants were found to be underweight, (n = 4, 
1.6%).  
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The Questionnaire on Craving for Sweet or Rich Foods Scale (QCSRF) measures 
craving for sweet and rich foods. The mean QCSRF score was 18.1 (range 9-50, SD 
= 8.5) at baseline. The Non – Essential Energy Dense Nutritionally Deficient Food 
List (NEEDNT), a questionnaire used as a proxy to measure consumption of 
unhealthy foods, was found to have a mean score of 76 (range 11- 285, SD = 45.7). 
The prevalence of food addiction using the 9-item modified Yale Food Addiction 
Scale (mYFAS) was less than one per cent (0.8%). Only two individuals met the 
diagnosis at baseline (Refer to Table 9.21). 
 The Association Between Variables 
For smoking variables, the Spearman rho correlation coefficient was as shown in 
Table 9.2. There were a number of variables which were correlated such as FTND 
and CPD, age of smoking, CO level and baseline QSU-brief (p < 0.05).  
For mood variables, the Spearman rho correlation coefficient between baseline 
HADS and BDI-II was rs = 0.557, N = 256, p < 0.001. 
For weight variables, weight was highly correlated with BMI, rs = 0.865, N = 256, p < 
0.001. As a result, BMI was replaced by weight in all eating variable analyses where 
a grouping of eating variables was required. The QCSRF questionnaire, which 
measured craving for sweet and rich foods, was found to correlate with the NEEDNT, 






Table 10.2: Correlation for smoking variables 









FTND 1 .515** -.131* .056 .002 .371** -.094 .212** .110 -.038 
CPD .515** 1 -.062 .207** .024 .395** -.052 .177** .105 -.013 
Age Smoking -.131* -.062 1 -.135* .000 -.086 -.005 -.113 -.152* -.032 
# year 
smoking .056 .207
** -.135* 1 .046 .003 .015 -.039 -.076 -.001 
# quit attempt .002 .024 .000 .046 1 -.021 -.023 .050 .046 -.041 
CO level .371** .395** -.086 .003 -.021 1 -.115 -.173** .042 .004 
WISDM- b -.094 -.052 -.005 .015 -.023 -.115 1 .020 -.041 .138* 
QSU-b .212** .177** -.113 -.039 .050 -.173** .020 1 .130* -.031 
Live with 
smoker .110 .105 -.152
* -.076 .046 .042 -.041 .130* 1 -.026 
Investigative 
treatment -.038 -.013 -.032 -.001 -.041 .004 .138
* -.031 -.026 1 
 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
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10.4 Follow-up Sample Description 
 Follow-up Retention 
This section describes the role of depression and eating variables associated with 
follow-up retention, and determine predictors involved with follow-up retention in a 
smoking cessation program. Follow-up visits are described as EARLY (baseline and 
early follow-up) and LATE (baseline and late follow-up) (details in Section 8.9).  
Of the 256 original participants, 116 (45.3%) attended only the baseline visit. A 
further 140 (54.7%) attended at least one other visit. Of these 140, 78 (55.7%) 
attended baseline, EARLY and LATE, 46 (32.9%) attended baseline and EARLY 
only, and 16 (11.4%) attended baseline and LATE only (Figure 10.2). 
When follow-up visits were re-grouped into EARLY and LATE, 124 (48.4%) were 
categorised into EARLY and 94 (36.7%) were placed into LATE (Figure 9.1). 
 
 
Figure 10.2: Sample recruitment and distribution 
SCeMES 
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Attended any follow-up 
140
Attended baseline + EARLY 
and LATE 78
Attended baseline and 
EARLY
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Attended baseline and LATE 
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 Characteristics of Participants Who Did Not Attend Any Follow-
up (n =116) 
All continuous variables were found to be normally distributed (one-sample 
Kolmogorov-Smirnov (1-KS) test, p > 0.05). 
There were a number of demographic variables between those who attended follow-
ups and those who attended the baseline interviews only (n =116): age (t =-4.60, p < 
0.001), ethnicity (X2 =4.04, df =1, p = 0.044) and employment (X2 =4.04, df =1, p = 
0.044). Participants who attended the baseline visit only were younger than those 
who attended any follow-ups (M =42.6 years, SD =12.8 vs M = 49.3 years, SD =10.6, 
p < 0.001); they were more likely to be from an ethnic minority (12.9% vs 5.7%); and 
they were not working at the time of interview (24.1% vs 14.3%). No differences were 
found for gender and education, p >0.05. 
Participants who attended only the baseline assessment had a longer duration of 
smoking than those who attended any follow-ups (M = 32.9 years, SD = 10.7 vs. M = 
26.6 year, SD =12.4; t = -4.42, p < 0.001). Participants who lived with another smoker 
were associated with attending only baseline visit (48.3%) compared with those who 
went to follow-ups (32.9%), X2 =6.29, df =1, p = 0.012. No differences were found for 
other smoking variables, p > 0.05. 
Those with a positive family history of depression were more likely to attend only the 
baseline assessment (see Table 10.3) while no other depression variable difference 




Table 10.3: Comparison between depression and eating variables for those attending 
baseline visit only (n =116) compared to any follow-up (n =140) 
Variable 
Baseline only 
n = 116 
N (%) 
Attended any follow-up 

























































a = mean (SD), *p < 0.01 
In summary, there were differences in age, ethnicity and employment for 
demographic variables. For smoking variables, living with another smoker (p = 0.012) 
and duration of smoking were found to be statistically significant (p < 0.001). 
However, only a family history of depression was found to be different between the 
two groups (p = 0.009). No differences were found for eating variables between 
participants who attended any follow-up and those who did not. 
10.5 Retention in the Study 
 Characteristics of Participants at EARLY Follow-up (n =124) 
A total of 124 (48.4%) participants attended EARLY follow-up compared to 132 
(51.6%) who were lost to follow-up. A test for normality using the 1-KS test found age 
and the number of years of smoking to be statistically significant, p < 0.05, and 
therefore required analysis with a non-parametric test. 
Using the Mann–Whitney U test, demographic differences for age (p < 0.001) were 
associated with EARLY follow-up. Chi-square test found employment status was also 
associated with EARLY follow-up (X2 = 4.0, df = 1, p = 0.045). Participants who were 
lost to follow-up tended to be younger (M = 42.5, IQR = 20 years) and belonged to 
the group who were not employed at baseline (12.1%) when compared to those who 
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attended EARLY follow-up (6.6%). No association was found for gender, ethnicity 
and education between the two groups (p > 0.05) (Table 10.4). The mean duration to 
attend EARLY was 93 days (range 42-182, SD = 34.3 days) or roughly three months. 
Those who were lost to follow-up tended to be those who had a shorter duration of 
lifetime smoking, median 27.5 (IQR = 20), compared to those attending EARLY 
follow-up, median 34.0 years (IQR = 14); p = 0.001 (Table 10.5). Living with another 
smoker was found to be associated with attendance at EARLY follow-up, X2 = 8.49, 
df = 1, p = 0.004. There were more participants attending EARLY follow-up if no one 
was smoking at home, compared to participants lost to follow-up, (p =0.004). 
No association was found between depression and eating variables and EARLY 
follow-up (Table 10.5). 
In summary, only demographic variables (age, duration of smoking, employment 
status and living with another smoker) were found to be associated with EARLY 
follow-up. There were no depression or eating variables found to be associated with 
EARLY follow-up. The mean duration to attend EARLY was three months for those 
who attended follow-up visits. 
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Table 10.4: Association between demographic and smoking variables for EARLY (n 
=124) and lost to follow-up (n = 132)  
Variables EARLY Retention  
n =124 
N (%) 





Age of Smokingb 
Number of years smokinga 
CPDb 













- Not employed 
- Employed 
Living with another smoker 
 - Yes 





































































Table 10.5: Association between mood and eating variables for EARLY (n=124) and 
lost to follow-up (n = 132) 
Variables EARLY Retention 
n=124 
N (%) 


























































a = Mean (SD) 
 
 Characteristics of Participants at LATE Follow-up (n =94) 
A total of 94 (36.7%) participants attended LATE follow-ups compared to 162 
(63.3%) who were lost to follow-up. Test for normality using the 1-KS test reported 
age and lifetime smoking duration not to be normally distributed, p < 0.05. Both 
variables were therefore analysed using a non-parametric test. 
Using Mann-Whitney U test, differences were found for both age and lifetime 
smoking duration between the two groups (p < 0.001) (Table 10.6). Participants who 
were older and those with a longer lifetime duration of smoking were found to be 
associated with attending LATE follow-ups. No differences were found for mood and 
eating variables (p >0.05). The mean duration to attend a LATE was 380 days (range 
196-664, SD = 84.0 days) or just over a year.  
In summary, only age and lifetime smoking duration were found to be associated with 
LATE follow-ups. No association was found for depression and eating variables; and 
the mean duration to attend a LATE follow-up was one year. 
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Table 10.6: Association between demographic and smoking variables for LATE (n = 
94) and lost to follow-up (n = 162) 
Variables LATE Retention 
n =94 
N (%) 





Age of Smokingb 
Number of years smokinga 
CPDb 







































































a = Median (IQR), b = Mean (SD), *p < 0.001  
 
 Predictors for EARLY and LATE Follow-up 
This study also attempted to determine possible predictors in both depression and 
eating variables for both EARLY and LATE follow-ups in a smoking cessation 
program.  
Logistic regression analysis was conducted using four groups of variables 
(demographic, smoking status, depression and eating). The analysis identified six 
independent predictors for retention at EARLY follow-up from the respective models: 
age (p < 0.001), employment (p =0.008), living with another smoker (p = 0.009), 
duration of smoking (p < 0.001), positive family history of depression (p =0.035), and 
HADSD (p = 0.031) (Tables 10.7, 10.8 and 10.9). 
Logistic regression for LATE follow-up models, also showed age (p <0.001), 
employment (p=0.013) and smoking duration (p < 0.001) as significant predictors. 
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Other predictors found were gender (p= 0.048), and the number of cigarettes smoked 
(p= 0.046) (Tables 10.7 and 10.8). 
For depression variables, groupings were done with depression symptoms scores 
and diagnosis for BDI-II and HADS separately i.e. four separate models for EARLY 
and LATE follow-ups. These models were found to be unstable (p >0.05). A separate 
model using both HADSD and BDI-II symptom scores was found to be reliable for 
EARLY retention, X2 = 10.00, df = 4, p < 0.05; but not LATE retention (Table 10.9). 
None of the models using eating variables grouping were found to be reliably able to 
distinguish between predictors and grouping (p > 0.05) (Table 10.10). 
 Stepwise Logistic Regression for EARLY Follow-up 
When these independent predictors were grouped together, using a stepwise logistic 
regression analysis showed the model grouping age, employment and living with 
another smoker to be reliable, X2 = 30.48, df = 3, p < 0.001. Inclusion of the 
remaining three predictors resulted in an unreliable model and predictors were found 
not to be statistically significant (p > 0.05). Stepwise logistic regression also showed 
age to be the strongest predictor where an increase in one score (1 year) increased 
non-attendance at EARLY, Exp (B) = 1.04 (95% CI = 1.02 - 1.07). Participants who 
were not employed at baseline were also found to attend EARLY, Exp (B) = 0.34 
(95% CI = 0.17 - 0.71), while living with another smoker increased the odds by 2.02 
(95% CI = 1.18 - 3.46) of not attending EARLY. 











































































X2 =27.056 p =0.000 
Nagelkerke’s R2 = 0.134 
N =256 
X2 = 27.058 p = 0.000 
Nagelkerke’s R2 =0.137 
N = 256 
 P < 0.001, ** p < 0.05 
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X2 = 26.694 p = 0.002 
Nagelkerke’s R2 = 0.132 
N = 256 
X2 = 29.039 p = 0.001 
Nagelkerke’s R2 = 0.147 
N = 256 
 P < 0.001, ** p < 0.05 
 
































































X2 = 10.00 p = 0.040 
Nagelkerke’s R2 = 0.051 
N = 256 
X2 = 2.552 p = 0.635 
Nagelkerke’s R2 = 0.014 
N = 256 


































































X2 = 1.401 p = 0.844 
Nagelkerke’s R2 = 0.007 
N = 256 
X2 = 1.914 p = 0.752 
Nagelkerke’s R2 = 0.010 
N = 256 
 
 Stepwise Logistic Regression for LATE Follow-up 
The five independent predictors (age, employment, smoking duration, gender and 
CPD) were grouped, and the logistic regression model was found to be reliable: X2 = 
37.70, df = 5, p < 0.001; however, Negelkerke’s R2 = 0.19. This model found three 
predictors to be statistically significant: gender, employment status and number of 
cigarettes smoked at baseline (p <0.05). When duration of lifetime smoking was 
included in a separate model, it was found equally reliable, X2 = 37.70, df = 4, p < 
0.001.  
Stepwise logistic regression found an increased score for duration of lifetime smoking 
by one (1 year) increased the odds by 1.07 (95% CI = 1.02 – 2.00), and being male 
increased the odds by two times (95% CI = 1.14 – 3.61) of not attending follow-up at 
LATE. A reduction of one score (1 cigarette), and not being employed, was predictive 
of less likely not to attend LATE by odds of 0.93 (95% CI = 0.89 - 0.98) and 0.40 
(95% CI =0.18 - 0.88), respectively. 
 Summary 
To summarise, increasing age and living with another smoker predicted non-
retention, while not being employed predicted retention among the EARLY follow-up. 
For LATE follow-up, being male and longer duration of lifetime smoking predicted 
non-retention for LATE and reducing cigarette use while not employed predicted 
retention. No depression or eating variables were found to predict retention for both 
EARLY and LATE follow-up. 
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10.6 Smoking Cessation Outcome 
The SCeMES-QN was primarily interested in investigating the association between 
depression and eating variables, both individually and together, and their association 
with the outcomes of smoking cessation – either being abstinent or still smoking. In 
this study, attempts were also made to determine predictors from both depression 
and eating variables which might affect the quit attempt. 
Additionally, this study attempted to determine the smoking quit rate, and the 
prevalence of depression and food addiction for both EARLY and LATE follow-up. 
The trends of weight gain and smoking cessation outcome were also investigated. 
 Smoking Cessation Outcome on Follow-up 
The main outcome for the SCeMES-QN was the quit status of participants, – either 
abstinent or still smoking. The 7-day point prevalence was used to define the 
abstinent group. All others were automatically defined as still smoking. Abstinent 
participants did not smoke even a puff of a cigarette during the seven days prior to 
when measurement was taken. Abstinence was further verified with the CO 
recording. Those who were lost to follow-up were included in the still smoking group  
For participants who attended EARLY follow-up, which included regrouping both 
visits 2 and 3, the CO verified quit rate was found to be 14.5% (n=37). For 
participants who attended LATE follow-up, which included regrouping visits 4 and 5, 
the CO verified quit rates was 14.8% (n=38). 
10.7 Mood 
For the SCeMES-QN, the term mood in the acronym SCeMES referred mainly to the 
status of depression in the participants. The diagnosis of depression was made using 
the agreed cut-off scores for both the HADS and the BDI-II, determined to be >7 and 
>16 respectively. This study investigated the prevalence of depression in smokers 
wanting to quit smoking, and their trend over the course of the program. The study 
was also interested in investigating the associating factors between the depression 
variables and smoking cessation outcomes; and determining variables which may 
influence the outcomes. 
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 Depression Diagnosis and Quit status 
Table 10.11 illustrates the prevalence of depression at each follow-up visit. Baseline 
depression was reported as 2.3% to 6.6% depending on the instrument used for 
detection. In general the BDI-II showed a much higher figure of those with depression 
across all visits except the final visit. A number of participants did not answer the 
BDI-II questionnaire at visit five. 
Table 10.11: Prevalence of depression at four visits 
Timeline Baseline  n (%), 256 
Visit Two  
n (%), 103 
Visit Three 
n (%), 67 
Visit Four  
n (%) 49 
Visit Five  





































0 (0), 38 
 
 Depression Diagnosis at EARLY and LATE Follow-up Visits 
The prevalence of depression measured, using both measurements, are shown in 
Table 10.12. Overall, there was a trend of improving depression at both follow-up 
visits. This trend was also seen for depression scores on both instruments  
Table 10.12: Prevalence of depression for EARLY and LATE follow-up 
Timeline Baseline  n (%), 256 
Early 
n (%), 124 
Late 
n (%), N 
Hospital Anxiety Depression 
Scale (cut-off >7) 
 










1 (1.0), 94 
 
 
2 (3.6), 55 
 
As shown in Figure 10.2, there was an improvement for the HADSD score from 
baseline (M = 1.94, SD = 2.20) to EARLY follow-up (M = 1.41, SD = 2.15) of 0.53, 
which was statistically significant on paired t-test (t (123) = 2.54, p = 0.012). Similarly, 
an improvement in score was also seen between baseline (M = 1.81, SD = 2.05) and 
LATE follow-up (M = 1.24, SD = 1.98) HADSD scores by 0.57, the difference being 
statistically significant (t (93) = 2.29, p = 0.024).In Table 10.12, improvement in the 
score by 0.03 was also found for the BDI-II instrument from baseline (M = 4.63, SD = 
5.34) to EARLY follow-up (M = 4.60, SD = 5.67); however, this was not found to be 
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statistically significant (t (123) = 0.05, p =0.959). There was a greater improvement 
for baseline (M = 4.53, SD = 5.33) and LATE follow-up (M =3.15, SD = 5.03) BDI-II 
scoring of 1.38 scores. However, this too was not statistically significant (t (55) = 
1.90, p = 0.06).  
Although there was a change between total mean scores from baseline to EARLY, 
andbaseline to LATE follow-ups for the HADSD, both EARLY and LATE scores were 
not found to be statistically significant: F (1, 121) = 3.38, P > 0.05 and F (1, 91) = 
1.14, p > 0.05. 
 
* p = 0.012 ** p = 0.024 
Figure 10.1: HADSD mean score trend between baseline and follow-ups 
 
 Baseline Mood and Smoking Cessation Outcomes 
There was no difference in mood variables between those who quit and those who 
were smoking at EARLY and LATE using 1-KS test (p >0.05).  
On independent t-test, no association between the means of both HADSD and BDI-II 
at baseline and quit smoking outcomes at EARLY (p >0.05) were found. There was 
also no association between quit smoking outcomes and smoking to relieve negative 
mood using the WISDM subset for affect (p >0.05) (Table 9.13). When both HADSD 
and BDI-II were used to detect presence or absence of depression, chi-square test 
found no association with EARLY quit smoking outcomes, p > 0.05. 
Analysis using the subset for WISDM-brief which assesses for affective enhancement 
also found no association with EARLY quit smoking outcomes, p >0.05.  
0 0.5 1 1.5 2
Mean Score
Mean Score







No association was found between mood variables and LATE quit smoking outcomes 
(p > 0.05) (Table 10.13). When both HADS-D and BDI-II were used as diagnostic 
tools for presence or absence of depression, no association was found between 
depression diagnoses and LATE quit smoking outcomes (P > 0.05). The subset for 
WISDM-Affect was also not found to be associated with LATE quit smoking 
outcomes (p > 0.05). 
Logistic regression was not tested, as no variables in both follow-up periods were 
found to be associated with a smoking cessation outcome in this study. 
Table 10.13: Association between baseline mood variables and EARLY (n = 124) quit 
smoking outcome and LATE (n=94) 


















































































a = Mean (SD) Dep. = Depression 
 
9.6.4 Summary 
In summary, no association was found between depression and smoking cessation 
outcomes at both EARLY and LATE follow-ups. Logistic regression models for both 
EARLY and LATE depression variables were not tested as no variables were found 
to be significant. 
10.8 Eating 
The SCeMES-QN attempted to investigate the trend of eating variables, in particular 
weight and food addiction at EARLY and LATE follow-ups. The eating variables were 
also investigated to determine any association with smoking cessation outcomes at 
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both follow-up periods. Finally, predictors at both EARLY and LATE follow-ups for 
eating variables were also investigated. 
 Weight Status on Follow-up 
Figure 10.3 below illustrates the mean weight increase over time from baseline to 
EARLY and also LATE follow-ups. During the same period both QCSRF and 
NEEDNT scores decreased as shown in both Figures 9.4 and 9.5. 
 
*p < 0.001 
Figure 10.2: Mean weight at baseline, EARLY and LATE follow-up 
 
Table 10.14: Paired t-test Eating Variables Between Baseline and Follow-up 
Pair Mean SD t-test P value 
Baseline weight – EARLY weight (kg) 
Baseline weight – LATE weight (kg) 
Baseline QCSRF – EARLY QCSRF score 
Baseline QCSRF-LATE QCSRF score 
Baseline NEEDNT- EARLY NEEDNT score 

























*P < 0.01, ** P < 0.001 
 
The mean score change of 1.85 kg over a period of three months between baseline 
(M =79.33, SD = 16.91) and EARLY follow-up (M = 81.15, SD = 17.26) was found to 



















addition, an increase of 3.03 kg from baseline (M = 82.01, SD = 17.26) to LATE 
follow-up (M = 85.05, SD = 17.86) also showed the mean score change to be 
statistically significant using the paired t-test, (t (87) = -6.11, p < 0.001). Therefore, 
there was a noticibly increasing trend for mean weight gain over time for participants 
of the SCeMES. 
For both NEEDNT and the QSCRF, the mean score changes between baseline and 
EARLY, and baseline and LATE, were to reduce over time. However, only the 
change between baseline (M = 17.15, SD = 8.67) and LATE follow-up (M = 13.98, 
SD = 5.51) for the QSCRF of -3.17 was found to be statistically significant (t (55) = 
2.79, p = 0.007) on the paired t-test (Table 10.14). The change between scores for 
the QSCRF from baseline (M = 17.75, SD = 7.98) to EARLY follow-up (M = 17.33, 
SD = 7.35) of -0.42 was found not to be statistically significant on t-test (t (124) = 
0.60, p = 0.547). Using a similar analysis for the NEEDNT, the improving change in 
score of – 4.1 from baseline (M = 73.58, SD = 41.40) to EARLY follow-up (M = 73.32, 
SD = 46.67) was not statistically significant (t (124) = 0.33, p = 0.739). At LATE 
follow-up, a smiliar improving trend was also found not to be statiscally significant (p 
= 0.094) (Table 10.14, Figures 10.4 and 10.5). 
 
* P < 0.05 


















P > 0.05 
Figure 10.4: Mean score NEEDNT between baseline, EARLY and LATE follow-up 
 
 Baseline between Weight and Quit Smoking 
Figure 10.3 illustrated that the mean weight between baseline and subsequent 
follow-ups was indeed increasing over time and found to be statistically significant at 
p < 0.001. When the sample was separated according to their quit smoking 
outcomes, an increase was also found in both the abstinent group and also in those 
still smoking (Figures 10.6 and 10.7). 
For EARLY follow-up, those who were abstinent gained more weight rapidly, 3.3 kg 
in the first three months, while those who were smoking were found to gain 1.1 kg 
over the same period. This increase was found to be statistically significant using 
univariate ANOVA at p < 0.001 (Figure 10.6).  
This weight gain was found to continue for LATE follow-up quit smoking outcome; 
however, the gain was not as rapid. Those participants who were abstinent were 
found to have a mean weight gain of 4.5kg after a year. For participants who still did 
not quit at the LATE follow-up period, the weight gain was 1.8kgs. Similar to EARLY 
follow-up, this was found to be statistically significant, F (1, 84) =8.35, p = 0.005 













* P < 0.001 
Figure 10.5: Baseline and EARLY weight (kgs) and quit smoking outcome  
 
 
* P < 0.01, ** P < 0.001 
Figure 10.6: Baseline and LATE weight (kgs) and quit smoking outcome 
 
 Association between Eating Variables and EARLY (n = 124) Quit 
Status 
Testing for normality of distribution found no differences between the two groups at 
EARLY and LATE follow-ups (p > 0.05).  
Data analysed showed no association was found between baseline weight variables 

































based on the WISDM subset were not found to be associated with smoking status at 
EARLY follow-up (p >0.05). They were as likely to be abstinent compared to smoking 
at three months (Table 10.15). 
No association was found between eating variables and LATE quit smoking 
outcomes (Table 10.15). Similarly, when WISDM-Weight subscale was analysed 
against LATE quit smoking outcomes, no association was found (t1.25, p > 0.05).  
Logistic regression was not tested as no variables in both follow-up periods were 
found to be associated with the smoking cessation outcome in this study. 
Table 10.15 Association between baseline eating variables and EARLY quit smoking 
outcome 




































































a = N (%) 
 
 Food Addiction Status on Follow-up 
The modified-YFAS questionnaire was used to detect cases of food addiction in the 
sample over the data collection period. As shown in Table 10.16, there were no 
significant cases detected over the study period of five visits. When visits were 
regrouped to EARLY and LATE follow-up, no cases were detected at EARLY follow-
up on analysis. For LATE follow-up, only one case (1.1%) was detected. 
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Table 10.16: Diagnosis of food addiction at each visit 








n, (%), N 
Yale Food Addiction 
Score (YFAS) 2 (0.8) 2 (1.9) 0 (0.0) 1 (2.0) 1 (1.3), 79 
 
 Summary 
In summary, overall, participants gained weight from baseline at both EARLY and 
LATE follow-ups by 1.3kg and 5.1kg respectively and this was statistically significant 
(p<0.001). Contrary to expectations, there was an improvement in overall scores for 
both craving for sweet and rich foods, and consumption of foods which were energy 
dense but nutritionally deficient. However, only the QCSRF score change from 
baseline to LATE follow-up was statistically significant (p<0.05).  
For participants who were both abstinent or not at follow-ups, the trend of weight gain 
was found. Participants who were abstinent, however, gained more weight at both 
three months and one year compared to those who were still smoking at the time of 
recording (p<0.01). 
No association was found between eating variables and smoking cessation outcome 
at both EARLY and LATE follow-ups. Logistic regression models for both EARLY and 
LATE depression variables were not tested as no variables were found to be 
significant. 
This study found no increase in food addiction diagnosis using the mYFAS at three 
months and at one year. 
10.9 The Association between Mood, Weight and Smoking 
Cessation 
 The Association between Depression, Eating and Quit Smoking 
Outcomes 
There was no correlation between weight at baseline and depression at EARLY (rs = 
0.88, N = 124, p = 0.322) or LATE (rs = 0.05, N = 94, p = 0.961) follow-ups using 
Spearman rho correlation coefficient. There was also no correlation detected 
between weight at EARLY and mood at LATE (rs = -0.51, N = 76, p = 0.664). 
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 Predictors between Depression and Weight towards Quit 
Smoking Outcomes 
Both depression and weight variables at baseline were grouped as a single model to 
predict for both EARLY and LATE quit smoking outcomes. Both models were found 
to be unreliably able to assess if mood and weight variables together were able to 
distinguish between being abstinent or smoking at EARLY follow-up, X2 = 10.28, df = 
9, p 0.329 (Table 10.17) and LATE, X2 = 9.45, df = 9, p = 0.397 (Table 10.18). 
Therefore, when all mood and weight variables were grouped as a model, no 
predictors were found.  
Table 10.17: Logistic regression for mood and eating and EARLY quit smoking 
outcome 
 B S.E. Wald df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
Weight -.014 .013 1.054 1 .305 .987 .961 1.012 
QCSRFTotal .052 .029 3.336 1 .068 1.054 .996 1.115 
NEEDNTtotal .003 .005 .236 1 .627 1.003 .992 1.013 
HADSD -.098 .134 .535 1 .464 .907 .697 1.179 
BDItotalDep -.019 .055 .121 1 .727 .981 .880 1.093 
HxDepression(1) .511 .472 1.171 1 .279 1.667 .661 4.204 
FamilyhxBinary(1) -.638 .499 1.632 1 .201 .528 .199 1.406 
WISDMWt -.165 .137 1.455 1 .228 .848 .648 1.109 
WISDMAffect .043 .136 .101 1 .751 1.044 .799 1.364 
Constant -.328 1.404 .055 1 .815 .720   
a. Variable(s) entered on step 1: Weight, QCSRFTotal, NEEDNTtotal, HADSD, BDItotalDep, HxDepression, 
FamilyhxBinary, WISDMWt, WISDMAffect 
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Table 10.18: Logistic regression for mood and eating and LATE quit smoking outcome 
 
B S.E. Wald df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
Weight -.009 .013 .507 1 .476 .991 .965 1.017 
QCSRFTotal .010 .030 .111 1 .740 1.010 .952 1.072 
NEEDNTtotal -.003 .006 .207 1 .649 .997 .986 1.009 
HADSD .118 .140 .710 1 .399 1.125 .856 1.479 
BDItotalDep -.076 .059 1.655 1 .198 .927 .825 1.041 
HxDepression(1) .715 .503 2.021 1 .155 2.044 .763 5.476 
FamilyhxBinary(1) -.400 .552 .526 1 .468 .670 .227 1.978 
WISDMWt -.028 .136 .042 1 .838 .973 .744 1.271 
WISDMAffect -.238 .153 2.398 1 .122 .789 .584 1.065 
Constant 1.488 1.559 .910 1 .340 4.427   
a. Variable(s) entered on step 1: Weight, QCSRFTotal, NEEDNTtotal, HADSD, BDItotalDep, HxDepression, 
FamilyhxBinary, WISDMWt, WISDMAffect. 
 
Analysis using forward conditional logistic regression with depression variable and 
each independent weight variable, and subsequent weight variable with each 
independent depression variable did not find independent predictors with each model 
(p > 0.05).  
There appeared to be no predictors in both depression and weight variables which 
could reliably predict quit smoking status at EARLY and LATE follow-up for this 
population. 
 Summary 
In summary, there was no association between mood and eating variables, and 
smoking cessation, found in this analysis. 
10.10 Key Findings 
Among the key findings reported were: 
1. A total of 256 participants were recruited for the SCeMES-QN. The mean age 
was 46.2 years; there were slightly more females than males (54.7%); 91% of 
participants were Caucasian; 81% were employed; and 25.4% had completed 
secondary schooling. 
2. The mean age of smoking initiation was 16.3 years and the average lifetime 
smoking duration was 30 years. The participants reported smoking an average 
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of 20 cigarettes a day and having attempted four quit attempts in their lifetime. 
The average FTND score was 6, QSU-brief 21.8 and WISDM-b 48.1. 
3. Slightly over a third (35.7%) reported a history of previous depression. The 
mean score for HADSD was 1.8 and the BDI-II was 2.6. Using the agreed cut-
off of >7 for the HADSD and 16 for the BDI-II, the prevalence for depression 
was 2.3% and 6.6%, respectively. 
4. The mean weight was 79.9kgs and the average BMI 27.4. The average score 
for the QCSRF was 18.1 and for the NEEDNT 76. Only 0.8% of the 
participants were considered to fulfil the criteria for food addiction at baseline. 
5. The retention rate at EARLY follow-up (M = 94 days) was 48.4% and LATE 
follow-up (M = 380) was 37.6%. 
6. The only differences between those who attended any follow-up and those 
who attended only baseline follow-up apart from age (t =-4.60, p = 0.000), 
ethnicity (X2 =4.04, df =1, p = 0.044) and employment (X2 =4.04, df =1, p = 
0.044). 
7. Only demographic variables (age, duration of smoking, employment status 
and living with another smoker), not mood or eating variables, were found to 
be associated with EARLY follow-up.  
8. Only age and lifetime smoking duration were found to be associated with 
LATE follow-ups. No association was found for mood and eating variables. 
9. Age and living with another smoker predicted non-retention, while non-
employment predicted retention among the EARLY follow-up. For LATE 
follow-up, gender and duration of lifetime smoking predicted non-retention, 
while cigarettes per day and non-employment predicted retention. 
10. The quit rate at 3 months was 14.5% for EARLY follow-up and 14.8% at one 
year for LATE follow-up. 
11. Using the HADSD and BDI-II instrument, depression detection was 3.2% and 
6.5% at EARLY follow-up and 1% and 3.6% at LATE follow-up. No 
deterioration mood trend was found. 
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12. No association was found between mood variables and smoking cessation 
outcomes at both EARLY and LATE follow-ups. Logistic regression models for 
both EARLY and LATE mood variables found no predictors for smoking 
cessation outcomes at these two follow-up visits. 
13. Overall, participants gained weight from baseline at both EARLY and LATE 
follow-ups by 1.3kg and 5.1kg respectively, and this was statistically significant 
(p <0.001). For participants who were both abstinent or not at follow-ups, the 
trend of weight gain found showed participants who were abstinent gained 
more weight at both three months and one year compared to those who were 
still smoking at the time of recording (p<0.01). 
14. There was an improvement in overall scores for both craving for sweet and 
rich foods, and consumption of foods which were energy dense but 
nutritionally deficient. However, only the QCSRF score change from baseline 
to LATE follow-up was statistically significant (p<0.05).  
15. No association was found between eating variables and smoking cessation 
outcome at both EARLY and LATE follow-ups. Logistic regression models for 
both EARLY and LATE eating variables found no predictors for smoking 
cessation outcomes at these two follow-up visits. 
16. There was no increase in food addiction diagnosis using the mYFAS at three 
months and at one year. 
17. There was no association between mood and eating variables, and smoking 




 CHAPTER 11 - Qualitative Results (SCeMES-QL) 
11.1 Chapter Overview 
This chapter describes the results for the qualitative study of the SCeMES. A general 
introduction is provided on the overall data collected and the participants who 
participated in the qualitative arm of the SCeMES is reported. The qualitative findings 
are reported in a matrix together with relevant quotations. This chapter ends with a 
summation of the findings. 
11.2 Introduction 
The SCeMES-QL is the qualitative study in the SCeMES. It follows on from the 
SCeMES-QN reported earlier. In this sequential type MMR, the qualitative study is 
connected to the quantitative study. The SCeMES-QL was conducted using a semi-
structured questionnaire which was developed from the experience of the SCeMES-
QN. The use of this questionnaire allowed the interview to be more focussed in 
collecting specific information. This same interview aid, however, was flexible enough 
to allow newer issues or agendas to emerge during the course of the interviews.  
Qualitative studies are often reported in the first person. However, to provide 
consistency with the remainder of the thesis, this chapter, similar to the previous 
chapters, will use the third person narrative or ‘voice’. The sole interviewer, who is 
also the main researcher, will be identified in the chapter as “the researcher”, while 
the interviewees will be identified as “the participants”. Where appropriate, 
participants will be identified as individuals to denote their “voice”; this allows them to 
share their quit smoking lived experience in the SCeMES. Where the individual 
participant is part of a focus group, this will be stated. Through this method of 
description, the researcher hopes to promote the “voice” of the participant and allow 
them to be ‘heard’. 
11.3 Setting the Scene 
A total of 25 participants agreed to be interviewed for the SCeMES-QL. Of the 25, 16 
of them participated in the focus group interviews, while the remaining were 
interviewed individually. Three focus groups were formed for this study: FG1 (5 
participants), FG2 (6 participants) and FG3 (5 participants). (Refer to Figure 11.1)  
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The participants were chosen purposively with the aim of providing a meaningful 
representation of participants’ perspectives of quitting smoking in the SCeMES. As 
described in chapter 9 all participants were interviewed at the National Addiction 
Center (NAC) by the researcher.  
Results for the SCeMES-QL will be displayed using the matrix display method. The 
general induction approach method of labelling, describing and quoting relevant 
concepts or themes elucidated from the respective transcripts of all participants was 
used to share the findings for this study. 
 
 
Figure 11.1: Progression to Interviews 
11.4 Participant Characteristics 
A total of 140 participants from the SCeMES were eligible to be interviewed. Those 
eligible for interview had completed baseline and one other visit for the SCeMES-QN, 
they were willing to be interviewed, they agreed to sign the consent form, and they 
were able to converse in English. Of these, only 94 were able to be contacted. 
Seventy-eight of the total 140 participants met criteria (attending two or more visits). 















able to be interviewed. Two of the seven declined, three were not in Christchurch to 
attend interviews, and the remaining two decided that they preferred to be 
interviewed individually. Of the remaining 41 participants who consented, five groups 
were initially planned. Two of these focus groups were cancelled due to poor 
participation (unable to meet a minimum of five participants) and the participants who 
attended were offered to be interviewed individually instead. Three focus groups 
were successfully completed. 
Twenty-five participants initially agreed to participate in the three focus group 
interviews; however, only 16 participants attended on the day.  
Nine participants were interviewed individually. Five were from the groups which 
were cancelled and four were chosen purposively for the study. 
Of the 25 participants that were interviewed, the mean age was 51.4 years old (range 
33-70, SD = 8.7), 13 (52%) were females, 22 (88%) were employed, and 9 (36%) 
had a school qualification. Fourteen (56%) had a history of lifetime depression and 
just over two-thirds, 18 (72%), gained weight in the SCeMES – an average of 4kgs 
(M = 4.2, range 0-11). The mean cigarettes per day (CPD) was 20.4 (range 10-30, 
SD = 6.7), and most had a high level of tobacco dependence score with mean FTND 
of 6.1 (range 3-9, SD = 1.8). The average number of years smoking was 35.2 years 
(range 18-54, SD = 8.6). Of the 25 participants interviewed, only one (4%) met 
criteria for food addiction diagnosis based on the mYFAS. Just over half, 13 (52%), 
were still smoking at the time the interviews were conducted. 
On baseline demographic parameters, there was also little difference between those 
who participated in the qualitative study compared to the total population studied 
(Table 11.1). Smoking cessation, weight gain and food addiction outcomes were not 
included as they were analysed by either early or late which will be difficult to 
compare descriptively between groups. 
11.5 Demographic Description Interview Type 
There was little difference descriptively, in terms of age and smoking status (CPD, 
FTND and duration smoking), between those who were interviewed individually and 
those interviewed using focus groups. The one individual reported in the SCeMES-
QN as having a diagnosis of food addiction, using the mYFAS, was purposively 
recruited for the SCeMES-QL. Purposive sampling allowed the collective numbers of 
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participants with issues of interest, namely weight and depression, to be represented 
in the SCeMES-QL. Refer to Table 11.1. 
Table 11.1: Description of participants interviewed individually compared to those 
interviewed in FG 
Variable Individual Interview 
n = 9 
N (%) 
Focus Group  




n = 256 
Agea 52.0 (11) 51.1 (7.5) 46.2 (12.1) 
Gender 
- Male 


































CPDa 19.6 (7.5) 20.9 (6.4) 19.9 (7.1) 
FTNDa 5.8 (1.8) 6.3 (1.9) 6 (1.8) 
# Years Smokinga 35.3 (10.3) 35.1 (6.8) 30 (11.9) 
Quit Status 
- Abstinent 
































Amount Weight Gaina (kg) 5.2 (4.6) 3.6 (2.8)  










a = Mean (SD) 
 
11.6 Demographic Description of Focus Group 
Focus groups were made up of participants who shared certain characteristics, to 
avoid the participants feeling uncomfortable about their smoking, mood and weight 
issues. By being comfortable, this encouraged the participants to have meaningful 
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discussions during the interviews. Participants grouped in focus group 1 (FG1) (n = 
5) were all smoking and had no history of depression. FG1 participants did not 
complete all of SCeMES whereby they attended either an EARLY or LATE follow-up. 
Focus group 2 (FG2) (n = 6) participants consisted of those who were abstinent from 
smoking and had no history of depression. This session was unexpectedly attended 
by only the male invitees. This group also comprised participants who had completed 
the full SCeMES. Focus group 3 (FG3) (n =5) was a group of participants who were 
still smoking at the time of the interview and had a history of lifetime depression.  
FG1 was predominantly female, with participants who were employed, had minimal 
tertiary education, smoked 20 cigarettes per day, and smoked on average for 31.8 
years. All were still smoking at the time of interview and none had a history of lifetime 
depression. Just over half gained weight, the average weight gain being 2.2kg. 
FG2 was a men’s only group with participants who were all abstinent from smoking. 
This group also consisted of an older population with a mean age of 54.8 years, the 
majority being employed, and none having had tertiary level education. Among the 
three groups, those in this group smoked the most on average, at 21.7 cigarettes per 
day, and had a longer mean history of smoking – 40.7 years. There was no one with 
a history of lifetime depression in this group, but all participants reported weight gain 
and the average weight gain being 6kgs.  
The final group, FG3, consisted of participants who all had a history of lifetime 
depression and all of them were still smoking at the time of interview. This group was 
the youngest group with an average age of 46.2 years. The majority were female, 
employed, but with no history of tertiary level education. Participants in the focus 
group smoked on average 21 cigarettes per day and smoked for 31.8 years on 
average. Just over half of them reported weight gain during the study; the average 
weight gained was 2kgs. 
All participants in the focus groups had similar levels of nicotine dependence and no 
one was diagnosed with food addiction during the study. 
11.7 Demographic Description Based on Quit Smoking Outcomes 
Table 11.2 highlights the differences and similarities between participants who were 
abstinent and those who were still smoking at the time of interview. There were 
almost equal numbers of abstainers and smokers amongst those interviewed. The 
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participants who were abstinent were seen to be older; they had fewer cigarettes per 
day but higher FTND, and longer lifetime smoking. In keeping with SCeMES-QN 
findings, those who reported being abstinent also reported more weight gain. 
Table 11.2: Abstainers compared to smokers in SCeMES-QL 
Variable Abstinent n = 12 
N (%) 
Smoking n = 13 
N (%) 
Agea 54 (8.7) 49 (8.2) 
Gender 
- Male 

























CPDa 19.3 (7.2) 21.6 (6.3) 
FTNDa 6.3 (1.5) 5.9 (2.1) 
# Years Smokinga 39 (9.3) 31.7 (6.3) 


















Amount Weight Gaina (kg) 5.9 (3.1) 2.5 (3.2) 









a = N (Mean) 
 
In summary, Tables 11.1 and 11.2 and the description of participants in all three 
focus groups were representative of those in the larger SCeMES. Differences that 
were present indicated the purposive nature of the sampling technique for the 
SCeMES-QL.  
11.8 SCeMES-QL Interview Findings 
Three domains, consisting of five major themes, emerged during data analysis to 
express a participant’s experience in quitting smoking in the SCeMES.  
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The participants in the SCeMES-QL (both focus groups and individual interviews) 
described the SCeMES as being more of a ‘journey to quitting’ rather than being 
outcome orientated i.e. being abstinent or not. This was very much different from how 
the researcher thought of quit smoking experiences. Nevertheless, the participants 
continued to aim to achieve abstinence from smoking at some point in their life.  
So it’s a constant thing, it’s not... like I admire the people who just make a clear 
cut decision and they don’t have an addictive gene and so for them it’s the end of 
the journey, it’s over. But for those of us who’ve struggled, it’s like… I don't know 
for the rest of you, but...it's like when you get to the end of the first three weeks 
you wanna stand on a rooftop. In fact, you can stand on a roof top and say, “Look 
at me.” Because you’re so proud of yourself within yourself… cause you know 
what a battle it’s been, that you want everybody to know that you’re very clever 
just now. Of course you’re not gonna tell them a month later when you’ve fallen 
off again (laughter). (FG1, female, 65)  
 
 Journey towards Smoking Cessation 
The first domain was the experience of smoking cessation itself. This was 
conceptualised by three major themes which were labelled as: 
a. The outlook of quitting  
b. The process of quitting and  
c. Support.  
The themes were subsequently expanded to categories and subcategories which 
were supported by relevant codes to illustrate the iterative development of each 
theme. Each code, or cluster of codes, was further supported by explanations or 
quotes to provide context and meaning to the theme. A matrix table is also included 
at the end of each domain presentation. 
a. The Outlook to Quitting 
The first of three themes under ‘journey towards smoking cessation’ is the ‘outlook to 
quitting’. This theme attempts to describe the participant’s expectations of trying to 
quit smoking. There were two categories found from the interview which attempted to 
explain this theme. They were labelled as ‘matched expectations’ and ‘mismatched 
expectations’ (Table 11.3). 
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 Matched Expectations 
The category ‘matched expectations’ was associated with a positive experience or it 
matched the participant’s expectations to quit smoking. For the matched expectation 
category, four subcategories were reported: readiness, information, accountability, 
and identity. Participants who reported a positive experience in quitting smoking were 
found to describe a sense of ‘readiness’ in their experience. Another way to describe 
this was being prepared mainly for the quit smoking journey. Participants who 
reported this subcategory also reported feeling determined about their chances in 
getting rid of their smoking. The quotation below from one participant, who was 
abstinent at the time of the interview, illustrates what readiness to quit meant to her. 
So I think my mind was made up pretty strongly that I was giving up, and it didn’t 
matter what was thrown in my direction, I was giving up, and that’s all there was 
to it. (Individual5, female, 56) 
 
The participants categorised as having ‘matched expectations’ were also described 
in this subcategory of ‘readiness’ as having the ability to cope well with any given 
situation during the course of their journey to quit smoking. This ability was either 
learnt from a previous quit attempt or was the result of the current quit attempt. Often, 
these participants were aware of their surroundings and therefore able to adjust 
accordingly. This inevitably influenced their ‘outlook to quitting’ as a result. 
The participants who reported having ’matched expectations’ also reported acquiring 
a deep sense of what was expected of them during the smoking cessation program. 
They reported a clear understanding of the treatments that were available and were 
clear with the instructions on how to use the available or given treatments. This 
‘matched expectation’ in terms of ‘information’ was often accompanied with a more 
positive experience in quitting. 
Another subcategory of the ‘outlook to quitting’ was ‘accountability’. Accountability 
was reported to be for both the participant who was attempting to quit smoking, and 
to other people who were supporting their quit attempt. These other people usually 
included family, friends or the treating healthcare provider. The sense of 
accountability allowed the participants to feel in charge of their own health, which 
allowed them to be more accepting of their outcomes. 
No, I’d been thinking about it and I’d seen it advertised, I forget where I’d seen it 
now, but as soon as I committed myself to become part of it I knew then that I 
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was on the way to giving up. But as (sic) it didn’t work out for me, the way I 
thought it would, but I carried on because you made me think about it more. 
(Individual3, male, 58) 
 
For some participants, being accountable to another person, such as their own 
therapist, motivated them to continue their quit smoking journey. 
I think it’s cemented…. Hmmm, it’s cemented the idea in my head that hey look, 
you can quit. Because people like yourself [their therapist] wouldn’t be constantly 
doing these things if it wasn’t actually achievable. If something is not achievable, 
then hey you just don’t go there, do ya? It’s obviously achievable. (Individual7, 
male, 33,) 
 
The final subcategory reported was ‘identity’. This subcategory was related to how 
the participants viewed themselves and their ability to adapt to change. The 
participants who reported a more positive experience in their quit attempt were often 
more flexible in their approach to quitting, and eager to learn skills to be successful in 
quitting either through their own self-reflections or from the SCeMES. Below is a 
description of an individual who had managed to quit smoking at the time of the 
interview. 
I took it a day at a time for a start. And then I went to a week at a time and then I 
got a couple of weeks and I’d say to my wife, you know, ‘Two weeks I haven’t 
had a cigarette.’ And I was so proud of myself because I’ve always been a 
smoker. I mean I'm nearly 60 years of age, I’ve smoked for 45 years I would say 
and I just… it was just… it’s easier to smoke than to give up. It’s a lot easier to 
carry on smoking, pay the money [to buy cigarettes] and carry on because it’s 
hard work to give up, very hard. And I think I'm so proud of myself that I’ve made 
it and I won’t go back again, touch wood. (Individual3, male, 58) 
 
 Mismatched Expectations 
The category of ‘mismatched expectations’, the opposite of ‘matched expectations’ 
was related to a more negative quit smoking experience. Participants in this category 
reflected a mismatch of what was expected from them to quit smoking and what they 
thought they needed to do. The subcategories were similar to ‘matched expectations, 
namely readiness, information, accountability and support. However, the experience 
was more often negative. 
Those who reported negative experiences were often not ready to quit smoking. 
They were ill-prepared for the quit attempt and related that their main motivation for 
quitting was to please other people and not themselves. These same participants 
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also appeared to express ambivalence and indifference towards their quit attempt as 
described below. The participant identified as Individual1, was still smoking at the 
time of the interview. 
Um... Again, it’s the sort of concentration, the sort of determination to stick 
through it and go to the grouting and break all the habits that you normally do 
things anyway. Which I’ve done, putting off easier for the zonnic and the 
[something]. (Individual1, female, 49) 
 
Participants categorised as having ‘mismatched expectations’ reported being 
overwhelmed with any level of stressors. These stressors were either described as 
internal, such as anxiety feelings, or external, such as work pressures or events 
surrounding them. These participants also reported a lack of prioritization to quit 
smoking, although they were involved in a quit attempt at the time. As a result, the 
participants in this category were likely to relapse at the slightest pressure. This can 
be demonstrated in two participants who were still smoking below. 
I think it became an excuse for me, anything over about a four [relating to 
earthquake aftershocks], I thought, ‘I need to…’ I think it did, it became a bit of a 
game I think. It was like just an excuse. You had to get and have one. (FG1, 
female, 51) 
 
You know, I was… Yeah. So, yes a little bit… cos there was too much to cope 
with –I was having a new job, um, and all that sort of stuff, so it was just too 
much, too hard to quit really. That’s why I’ve said to you I’ve got it all under 
control and things are more settled. (Individual1,female, 49) 
 
The participants with a mismatch in their expectations to quit smoking were also 
often less informed on their quit smoking interventions. This lack of understanding of 
their treatments resulted in a more negative quit smoking experience. For example, 
the participant might have expected the new quit smoking treatment, Zonnic™, to 
work immediately, a “snap fix” as one participant described, which unfortunately 
might not be the case. As a consequence of these mismatched expectations, 
participants in this category also related a sense of frustration when using the 
available quit smoking treatments provided to them.  
Participants who reported a more negative experience also appeared to be more 
inflexible in their responses during the interviews. They were less enthused about 
what was offered to them, and they appeared to be more rigid in their thinking 
regarding the reasons for their smoking and the quit smoking treatment provided. 
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They were also least likely to report gaining any new experiences during the 
SCeMES to assist in their quit smoking attempt. 
Well, it would be nice to be a non-smoker. After 30 years, it’s part of who you are 
and whatever, but we all know it’s really bad for you. So it would be nice to be a 
non-smoker but the reality of it, that’s the ideal to be giving up, but the reality is 
far, far, far from it. (Individual1, female, 49) 
 
In terms of accountability, they were often less committed to themselves or to what 
was required to assist with their quit attempt. Those with ‘mismatched expectations’ 
reported less commitment to themselves or to a significant other to quit smoking. This 
resulted in earlier episodes of lapse in each quit attempt. 
Cold turkey, oh twice, that was when I was pregnant. And funnily enough I found 
that really easy, as soon as the doctor said, ‘You’re pregnant,’ that was it. And 
back when I had my kids, it probably wasn’t high pressure to give up, it was 
probably more of a suggestion. But then it wasn’t for me either. I was giving up 
for somebody else, so whether that made it easy. Or the time I gave up just cold 
turkey, and lasted probably about six-seven months, but my marriage split up 
then. (Individual5, female, 56) 
 
In summary, it appeared that the participants’ quit smoking experience was related to 
their ‘outlook to quitting’. This outlook comprised two categories which were the 
opposite of each other and termed as ‘matched’ or ‘mismatched expectations’. Both 
expectations were further explained by similar subcategories: readiness, information, 







Table 11.3: Matrix display for the theme ‘The Outlook to Quitting’ 
Categories Subcategories Codes Explanation for category 





Related to the preparation (psychologically) in 
relation to quitting smoking 
Information Understood information 
Clear instructions 
Clear expectations of limits 
Related to the information and understanding of 
what was required to quit smoking in terms of the 
smoking cessation program 
Accountability Self 
Others 
Related to the responsibility to self or another 
person during smoking cessation 
Identity Flexible 
Willing to learn 
Related to individual uniqueness of the participant 
which may affect their outlook to quitting 
Mismatched 
Expectation 




Related to the preparation (psychologically) in 
relation to quitting smoking 
Information Quick fix 
Unclear instructions 
Poor understanding information 
Related to the information and understanding of 
what was required to quit smoking in terms of the 
smoking cessation program 
Accountability Self 
Others 
Related to the responsibility to self or another 
person during smoking cessation 
Identity Inflexible 
Set in own ways 
Poor self-esteem 
Related to individual uniqueness of the participant 
which may affect their outlook to quitting 
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b. The Process of Quitting 
Another major theme which emerged from the SCeMES-QL and conceptualised the 
meaning of smoking cessation for the participants was the ‘process of quitting’. This 
theme reported procedures experienced by the participants which they described as 
their quit smoking experience. Two major categories which emerged from the data to 
further expand on this theme were labelled as ‘the particularities of quitting smoking; 
and ‘the undesired spin-offs of quitting smoking’.  
 The Particularities of Quitting Smoking 
The ‘particularities of quitting smoking’ was one of the two categories which emerged 
in the understanding of the ‘process of quitting’. This category included the steps and 
procedures to quit smoking, from the moment the participants entered the program 
up till the end of the program.  
This category was illustrated by four subcategories which were labelled as provider, 
treatment, follow-up and outcome (Table 11.4). Each subcategory will be dealt with 
individually below to allow a better understanding of the category and how it affected 
the experience of quitting smoking for the participants. 
11.8.4.1 Provider 
The participants described five major quit smoking providers during their quit attempt 
in the SCeMES. These providers shaped their experience of a quit smoking program 
(both directly and indirectly). Of the five, general practitioners and the Quitline service 
were mentioned the most often, followed by nurses, hospital physicians and finally 
dentists. Irrespective of who was providing treatment, the participants who reported a 
more positive experience in their current journey to smoking cessation, related 
dealing with providers who had traits of being respectful, non-judgmental and 
supportive.  
Oh, I took it [quit smoking brochure] because even at that time, well it was last 
year, it was… I’d already decided that this year I was going to give up smoking. 
So I was quite happy to take it. But I hadn’t made my mind up what I was going to 
do about it. Yeah, so yeah. No, I was quite pleased to get it, so yeah. 
(Individual6, female, 46) 
 
One hell of a thing because, then they got me antibiotics and what have you, and 
without the smoking... well, funnily enough, I thought... well the Dentist said to 
me; he says, ‘You shouldn’t be smoking, you know, not with that.’ He says, 
‘That's gonna infect it,’ and it did [and] it made it worse. But, he says, ‘Anyway,’ 
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he says, ‘Put another ten years on your life if you stopped.’ Bit of a laughing 
matter. I thought, ‘He's probably bloody right!’ (FG2, male, 67, 10 quit attempts) 
 
The participants who reported a negative experience in their quit attempt related the 
opposite sentiment. The providers they encountered had made them felt unwanted, 
belittled and the feeling of not being trusted during the consultation.  
Absolutely none and almost a negative thing is like, you go back to your GP after 
a lengthy period of time on whatever, and we haven't given up and it’s almost a 
sarcastic, ‘Oh, I didn't think you would,’ but that's getting a little bit sort of... under 
my GP, yeah, oh yeah I knew you wouldn’t. (FG2, male, 56, 3 quit attempts) 
 
Well, I could see that he wasn't prepared to waste the time with somebody who 
was going to smoke every day, drink themselves just about silly every night and 
then expect to be treated. I mean, it doesn’t make sense. You know, why treat 
people if they're just going to continue to abuse their bodies (sic) with smoke or 
alcohol. (Individual8, male, 70, 6 quit attempts) 
 
The participants in the study reported a strong preference for face-to-face 
consultations. This was the type of consultation experienced most during visits to 
general practitioners, with nurses, hospital physicians and even the dentists. The 
experience with Quitline, which was through the telephone, was by contrast 
described by most of the participants interviewed as easier to disengage from.  
Yeah, I had a phone call or emails from Quitline, they’re easy to ignore and just 
palm them off, whereas if you’re coming to see somebody…..it’s hmmm I don’t 
know… like there’s empathy attached to it as well, which helps. (FG1, female, 41, 
2 quit attempts) 
 
The Quitline as an option for quitting smoking was recognised by all the participants 
interviewed. A number of the participants had used the Quitline service in the past. 
Although these participants related to understanding the general aim of the Quitline 
service, they were not fond of it. The main issue reported by these participants was a 
lack of warmth compared to the face-to-face consultations. Often the complaints 
were reported as a lack of empathy due to the nature of the intervention which was 
stated matter of fact by one participant as, “you were talking to a telephone”.  
Yeah, I think it would help a lot of people, I do. I think it would make a big 
difference to some people. (Individual5, female, 56, 4 quit attempts) 
 
Yeah, I mean there’s definitely support. With those things, like the Quitline, they’ll 
call you up, or you can call them. There’s different sorts of things you can get and 




The second subcategory which emerged during the discussion with participants was 
labelled ‘treatment’. This subcategory was associated with mainly the information 
provided on the quit smoking treatments used during the SCeMES. The information 
on treatment was related to the instructions for using the treatment, the explanation 
of the side-effects, and also the understanding of the limitations of the treatment. 
More often than not, a negative experience in smoking cessation was the result of 
unclear information and instructions on the treatment provided. A number of 
participants recounted that the difference between their current quit attempt and a 
previous attempt was associated with the clarity of the treatment information 
provided. A clear understanding of what was expected appeared to lead to a better 
experience. 
So yeah, it was actually your advice that really... just even on how to use the 
patches, it made a big difference. The other options were the GP would give you 
a box or you'd go to a chemist and they'd give you a box and you’re like, ‘Mate, 
you'll be fine. Away you go...’. (FG2, male, 44) 
 
Well, obviously there were.. hmm….certainly having the patches, the 
understanding of the patches using seven days before can effect it was a big 
thing that I learnt. It did help once you explained about the build up [of the 
medication dose], that was very helpful, so I didn’t have the expectation from day 
one it working. I felt that when it did kick in later, that was a big help. Normally 
when you get the patches, they don’t tell you that. You kind of stick one on and 
be expecting that it be working straight away. (Individual1, female, 48) 
 
Clear information on treatments used to assist in quitting smoking was as important 
as the understanding of the possible side-effects, and what was able to be 
anticipated by the given treatments. The participants who related to being provided 
with clear information on their treatment often related a more positive experience and 
were more likely to think fondly of their quit attempt.  
I quite liked using the patches, and even the mouth spray, even though I didn’t 
use it all that often. At the start, I think the first six weeks, it was really quite good. 
I know it sounds really silly, but the patches, I always remember Jeela saying 
right at the start that it could cause vivid dreams, and I had some really vivid 
dreams (Individual6, female, 46) 
 
Both a lack of information, and therefore limited understanding of the treatments, 
were more likely to lead to a more negative experience in quitting. One example of a 
lack of information was expecting the treatment to work in an unexpected fashion, in 
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the words of the patient, ‘a snap fix’. This lack of information leads to mismatched 
expectations (Table 11.3) highlighted earlier.  
Another code to describe the subcategory ‘treatment’ was options. If the participants 
were presented with options during their quit smoking management they were more 
likely to report a more positive quit attempt. Being provided with treatment options 
meant having some level of control (autonomy) in the participants’ management, 
which they saw as a positive experience; participants who reported the opposite had 
a more negative quit smoking experience. 
Not really. Having the options….Zonnic™ helped to give…for me it works 
because I had the patches on as well and having one or the other I’m not sure if it 
will work. (Individual1, female, 48) 
 
11.8.4.3 Follow-up 
‘Follow-up’ was the third subcategory for the category of ‘particularities of quitting 
smoking’. The following-up of smokers in a smoking cessation program was part of 
the greater management of these participants. Follow-up care can be further 
represented either by the type of follow-up received – face-to-face, correspondence 
or by phone; or by the frequency of follow-up. 
During the interviews, the participants reported preferring personal follow-ups such 
as face-to-face, compared to impersonal follow-ups such as the Quitline calls.  
And I found that coming and having the meetings and doing the tests here was a 
big boost to ringing the Quitline; getting seen, the prescription and this last year 
did pretty much. (FG1, male, 52) 
 
Emerging from the data in exploring follow-up preferences was the suggestion of 
group based therapy as one alternative form of treatment. Compared to Alcoholics 
Anonymous for example, two participants felt that smoking cessation was neglected 
somewhat, as there was no group therapy provided. Group therapy, to these 
participants, allowed more interaction amongst those attempting to quit. The 
participants related that being part of a group of people, all of whom were involved 
with the same trials and tribulations of trying to quit smoking, provided some level of 
support between them. 
I could be wrong, but in my knowledge, there’s no weekly group meeting thing for 
quitting cigarettes. You know, it’s there for drugs and alcohol. Even though 
cigarettes are classed as a drug now, right. But as far as I know, there’s no CC 
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Anonymous, or CS Anonymous, you know Cigarette Smokers Anonymous; and I 
really do believe that because, it’s a smaller amount of people compared to how 
many… I mean this is my own belief; but I think the bulk of people can eventually 
work that out. (Individual7, male, 33) 
 
A second important code which represented the subcategory for follow-up was the 
frequency of visits. Frequency of visits was proportionate to the time to attend 
treatment and the duration of the follow-up visit. The ideal duration and number of 
visits was not determined; however, those who felt that the duration and frequency of 
visits were adequate coped better and had a more positive quit smoking experience. 
Those participants who felt that their visits were short or not as frequent as they 
expected reported a more negative quit smoking experience. To further illustrate the 
schism of this code, one participant summed it nicely by stating that everyone is 
different and what works for one person may not work for another.  
And I think that some of those things have to be taken in when you’re doing 
something like that and if somebody needs... I need constant checks on 
everything I do, I need people and you’re still doing that, you know. Where other 
people need to be probably left alone, but given a longer; you know, like if you 
were told, ‘Okay, you’re not ready, so how about we extend that out to more 
weeks?’ (FG3, female, 49) 
 
11.8.4.4 Outcome 
The final subcategory identified was the desired outcome of the program itself. All 
participants wanted to quit according to one participant. However, from the 
interviews, it was clear that some were satisfied to have reduced the number of 
cigarettes smoked per day instead of abstinence; this was often the main aim and 
outcome of any quit smoking program or study. For some participants, a reduction to 
a lower number of cigarettes compared to their initial baseline smoking was regarded 
as a successful outcome.  
I mean… I still think, um… I’m not smoking as much as before I started the study. 
Even now I’m not smoking as much as I was. It’s up… It’s gone up again. 
Probably just over 20, but it’s not back over 30. (Individual6, female, 46) 
 
For others, reduction was not an option as it was not abstinent and therefore 
indicated failure. This inability to accomplish the expected outcome led to a sense of 
guilt and a more negative experience in their quit smoking attempt.  
But I just think more of the fact of, like if it was a study... what was it, was it once 
a month, or it started off monthly and then it went into spreading that apart. And I 
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did actually notice that I seem to get back into smoking when I wasn’t coming in 
here as frequently. Because I’ve definitely, I’m still nowhere near smoking what I 
used to smoke. But the fact is I’m still having a bloody cigarette, and that’s still as 
bad as anything. (Individual7, male, 33) 
 
 The Undesired Spin-offs of quitting smoking 
The next category in the ‘process of quitting smoking,’ was categorised as the 
‘undesired spin-offs’. The concerns within this category were from the participants’ 
responses to dealing with, or managing, the consequences of quitting smoking 
whereby the majority voiced their experiences with unwanted consequences.  
Two main subcategories were reported by the participants when this issue was 
explored. The two subcategories best to explain the experience of the participants 
were labelled as ‘mood changes’ and ‘weight concerns’ (Table 11.4).  
11.8.5.1 Mood Changes 
The SCeMES was interested in the relationship between smoking cessation and 
mood, in particular, depression. As a result, the researcher, over the course of the 
interviews, emphasised depression as a consequence of quitting using the semi-
structured interview script developed. The interviews, however, did not suggest that 
depression exerted any major impact during the SCeMES quit smoking attempt. 
Depression was found to be a feature of withdrawal and an unpleasant experience 
for some participants, but not a major concern by the majority of those interviewed.  
The participants with a previous history of depression did not relate that their mood 
was anything like how they felt when they were suffering from clinical depression in 
the past. The interviews did find, however, that the participants related experiencing 
depressed mood instead of clinical depression. Below are some examples from the 
participants who have had clinical depression in the past. 
No… If I… if I happened to be depressed, giving up smoking, then it would’ve 
been a lost one… (Individual1, female, 48) 
 
Oh, I guess emotionally, because I think; and the previous times, I mean I can 
recall easily sort of being quite….. having suicidal thoughts. Nothing like that this 
time. Even went to brief counselling, ‘cause one episode was while I was at 
University, so I withdrew from studies, but I did go and have some counselling. 
But nothing like that this time. (Individual6, female, 46) 
 
That’s why I mentioned earlier that I don’t think it was me not quitting, or me 
quitting smoking, or going onto... I don’t think it was the fact I was trying to quit 
smoking that contributed to me getting depression, but I think if I really did think 
about it, I think it might have contributed a wee bit in the way, like I was saying 
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before, there was all those triggers when you have a cigarette, why you want to a 
cigarette. (Individual7, male, 33) 
 
Participants with a history of clinical depression found it difficult to continue quitting smoking 
in case their depression reappeared. One participant put it simply:- 
Smoking was the last (sic) of my problems at that time. (Individual6, female, 46)  
 
Other participants also supported this statement by saying that there would be almost no 
consideration to even consider a quit attempt when they had clinical depression. 
So… then I’ve got depression under control and I’m functioning –and I’m 
functioning well – mean I can cope with not smoking. But if I’m in a dark place 
and I’m not even coping with sort of getting out of bed in the morning and, you 
know, communicating and all I want to do is, sort of, wither away and die…well I 
don’t want to (nervous laugh) I don’t want to have to be thinking about smoking at 
the same. It would just be too much of a pressure. That’s my opinion (clears 
throat). (Individual1, female, 48) 
 
I mean I look at things totally differently now that I haven’t got depression and so I 
don’t need that crutch. (Individual8, male, 70) 
 
Although the focus was on depression, the participants also related other mood 
changes which were experienced during the whole smoking cessation process. One 
of the reported mood changes was anxiety which was described in many forms such 
as feeling irritable, feeling anxious, feeling stressed and also feeling fearful.  
Grumpy, bad tempered; lose the plot so easily. Yeah, stupid little things would set 
you off. I'm damned if I know why but just the dumbest of things when you look 
back on it, would set you off and away you'd go. (FG2, male, 56) 
 
Hugely for me because when I feel my anxiety and my stress building; cigarette, 
cigarette, cigarette and as soon as I have it, it drops. (FG3, female, 45) 
 
I'm losing my cool or getting angry about things that wouldn’t normally anger me. 
(FG3, female, 41) 
 
For some participants, the mood change experienced was a feeling of grief. This 
emotion was probably in response to discontinuing their cigarette use. Further 
analysis suggested that this feeling of grief was in relation to the participant’s 
perception that this quit attempt was to be their last. As a result, this was the finale in 
using cigarettes. On further exploration, it was unclear if the participants considered 
withdrawal symptoms as a reason for these mood changes.  
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And I think… that just was a head thing; that was just a psychological perhaps 
partly avoidant thing. I don’t know. But yeah, now I don’t get that kind of, you 
know, sort of feeling of, you know, my best friend’s died. (Individual4, female, 46) 
 
Yeah, I think even with this time, I think I did go through a small wee patch where, 
it sounds stupid, it’s almost like you’ve lost a friend, yeah. And it’s not when I first 
gave up, it’s sort of after a wee bit that yeah, you suddenly think, ooh you know, 
that security thing that you reach for when things weren’t right, or whatever, it’s 
not there anymore. Yeah. (Individual5, female, 56) 
 
One unexpected response was the reporting of elevated mood compared to 
depression or depressive mood. Further clarification regarding this experience found 
that the elevated mood was in response to the participant’s ability to become 
abstinent or reduce their cigarette use. It was not in response to any known 
physiological consequences of nicotine withdrawal. 
I think I feel better not smoking, because I have a bit of control in my life, so I 
think I felt more elevated, yeah. (FG1, female, 48) 
 
11.8.5.2 Weight Concern 
Another focus of the SCeMES-QN was the role of weight in smoking cessation. The 
data suggested that the participants were concerned with their weight prior, during, 
and after the smoking cessation program. In general, unlike depression, weight gain 
was a greater concern. Only a small minority reported no weight gain during the 
course of smoking cessation, whereas the majority gained weight. 
Weight concerns were a major reason for not wanting to quit smoking for a few 
participants, a reason to consider stopping their quit attempt midway for others, and a 
reason to totally relapse back to smoking for yet others. More importantly, these 
concerns were mainly related to gaining weight. 
So I don’t know why, I have no idea why, ‘cause that was my fear, that I was just 
gonna keep putting it on. So I don’t know the answer to that. I mean I'm sitting 
here now and I'm really thinking, ‘I’d really love a cigarette’ and it’s been a month, 
you know three weeks since I’ve had one. (FG1, female, 51)  
 
Yeah, and so I did, I put on three kg very quickly, very quick and it’s very 
distressing. It was, I hated it and I, then my mind starts saying, ‘Oh my God, I’d 
rather be a smoker than fat’. (FG3, female, 41) 
 
Yes. I keep on thinking to myself that I should start again. I might lose all this 
weight, but I don’t want to do that. I don’t want to start again because there is a 
price anyhow. The price of smokes puts me off. (Individual2, female, 48) 
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When the participants were asked about reasons for their weight gain, the majority of 
the participants reported that it was mainly the result of increasing food intake. There 
was little emphasis on what types of foods were involved in this weight gain. The 
data appeared to suggest that the participants understood weight gain was the result 
of increasing consumption of any type of food during their quit smoking attempt in the 
SCeMES. When the researcher probed further on this experience, the participants 
reported enjoying food more after quitting smoking due to the return of the senses of 
taste and smell, and an increased appetite to eat.  
And if anything, in those months, especially the recent months when I have 
been… I’ve actually found my diet improved dramatically ‘cause I could taste 
food. (FG1, female, 65) 
 
…and it was a real hard effort not to have two helpings of that. (FG2, male, 56) 
 
…but the flavours of some foods; what did kumara or yams taste like before, I 
have no damn idea. Now, wow. (FG2, male, 56) 
 
Hmmm….yes and no. sometimes but sometimes not. Yes, probably are, I was 
eating proper foods now but whereas before I was eating junk foods. I could eat a 
big huge, king size,…bigger than a king size cake of chocolate before… 
(Individual2, female, 48) 
 
During the interviews there was little mention of craving which is defined as an 
intense desire for a certain item. For this study, the item of interest was the craving 
for food in general, or for a particular food item, such as sugar.  
Although the participants appeared to be more aware of sweet foods when weight 
was discussed, there was not much else which suggested the participants who did 
gain weight were craving for sweet foods.  
I think what changed for me was everything. I found I was eating more which put 
my weight on, not so much snacking. I was actually really conscious of my 
chocolate bars and things like that, you know. I thought, ‘No, no, I don’t want to 
go there.’ I don’t want to, you know, replace it… but the quantity of food I was 
eating, increased and that’s why I think my weights gone [up] so that’s what I’m 
trying to reverse now. It’s down to the quantity again but yes, you’re right, the 
taste of food is just incredible [which was not there before]. (FG2, male, 44) 
 
The participants did not report increasing their energy output by increasing activity 
levels or exercising, despite their awareness of the impact this may have on their 
weight gain in the SCeMES. Some participants had made great efforts to incorporate 
this transformation (quitting smoking and eating healthy). However, the majority of 
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participants interviewed had concentrated on quitting smoking solely. One 
respondent explained this inaction to be because “quitting smoking required a lot of 
concentration”; this revealed the possibility that participants needed to concentrate 
on one lifestyle change at a time. 
The researcher’s interest in substitution of food being a reason for weight gain was 
not reported by the majority of the participants. The one individual with a diagnosis of 
food addiction related that there was a clear relationship between the two; others felt 
that this connection was plausible. However, the majority disagreed with this 
hypothesis. The participants reported that if there was a substitution phenomenon 
happening, it was in response to stress, as in ‘comfort eating’, rather than a direct 
switching from nicotine to food.  
I think I’m using food as an excuse to… I don’t know. I mean eating, I love food, 
it’s a pleasurable thing. But there are so many sort of, I don’t know, I suppose 
negative things, like my broken house, and then there’s, I’m so busy at work that I 
never have any time, so it’s just easier to get take-out, and I don’t know. Eating 
has that sort of immediate effect of, oh it feels really good. But then as soon as 
you stop, as soon as I stop, I think, whoa I’ve eaten too much, and of course the 
feeling goes away. It’s almost like a compulsion, and an addiction in itself. 
(Individual6, female, 46, met criteria for food addiction) 
 
Yeah, well just lollies or something like that, just as a comforter. (Individual9, 
male, 63) 
 
An emerging issue of importance, in relation to weight concerns, were reports that 
the participants were using the questionnaires for assessing food intake, craving and 
addiction as a form of treatment. Some participants reported becoming more aware 
of their eating habits as a result of the questionnaires used. This was similar to the 
use of the smoke analyser, another assessment tool, which had also inadvertently 
become a treatment tool by the participants of the study. Some participants reported 
a change in behaviour as a result. 
I’ve been particularly careful, knowing that when you stop you’re inclined to eat 
more. And it was good that that set of questions about ….hmmm…for example, 
“Do you avoid going somewhere where there’s going to be for example pavlovas 
because you can’t stop eating pavlova?” you know that sort of thing. And so I’m 
very particular about my weight. I mean I know I’m about 80 to 82kg. (Individual8, 
male, 70) 
 
Your eating habits, which was quite comprehensive, although before I’d gone on 
this programme I have been over a long period of time, looking at my eating 
habits. And with quitting I haven’t put on any weight, if anything I’ve got down to 
my target weight. So yeah it’s … it has made me stop and think and look at going 
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through the questionnaires what I actually am eating. So yeah I have made a big 







Table 11.4: Matrix display for the theme Process of Quitting 
Categories Subcategories Codes Explanation for category 
















Type of follow-up 




Describing the end goal expected by participants when 
participating in smoking cessation 
The undesired spin-offs 
of quit smoking 
Mood changes Emotional responses Mood changes during smoking cessation which included feeling depressed, anxious, or feelings of grief or elevation 
Weight concerns 
Weight gain The experience of gaining weight after quitting smoking or attempting to quit smoking 





The third theme in conceptualizing the term ‘journey towards smoking cessation’ for 
the participants was labelled ‘support’. The theme ‘support’ was raised by the 
majority of those interviewed individually and in the focus groups. It appeared to link 
the themes ‘outlook to quitting’ and ‘the process of quitting’ together. The theme, 
‘support’, was reported to exist even before a quit attempt, often setting the scene or 
influencing the ‘outlook to quitting’. In trying to define support, one participant from 
the study described it as “that hand that was, you know, was there…”. This was 
mentioned in reference to how support “meant a new start” or “it meant, well having 
tried a lot of times to quit smoking and it was an opportunity, to try something 
different”, quipped another two participants. Having support when the participant was 
ready to quit related to the theme ‘outlook to quitting’ and led to a more positive 
experience. 
What attracted me to… when I saw an ad for the programme, was the duration. 
Because when I’ve done things in the past through the GP, it’s take it home and 
they may contact you a few weeks later and that’s it, once, and it’s within the first 
month or six weeks. This programme offered three-pronged support but for a 
year. And it’s the year bit that really made me think that I could not give this 
opportunity up. (FG1, female, 51) 
 
For others, support was reported to be important at the end of a successful quit 
attempt. This allowed continuous motivation and encouragement for the participants 
to remain abstinent. Without this level of support at the end of the smoking cessation 
program, the participants reported that some faltered, felt abandoned and eventually 
relapsed.  
But you really would just like that somebody would acknowledge that you’ve 
worked so hard to reach that point. (FG1, female, 51) 
 
I wasn’t meaning to say the other person wasn’t nice, it was just that it was 
psychologically that one person and that was secure in my mind, you know and 
then when it swaps to another person, it was just an excuse for me to think 
otherwise [to consider smoking again]. (FG1J, female, 41) 
 
The participants reported in the interviews that one major reason for participation in 
the SCeMES was the perceived support which was to be provided throughout the 
course of the program. This was reported to be different from previous attempts 
which some of the participants had made, and a major source of positive experience 
for the current quit attempt.  
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I agree with you, I think it was the support and, for me personally… (FG1, female, 
48) 
 
So to be fair, I had XXX (name of therapist) and I found her very, very good too. 
So it was just everybody on it, although we had different people, it was 
supportive. (FG1, male, 52) 
 
It just sort of gave me... because it was being studied it gave me an incentive to 
say, ‘Well actually, somebody’s gonna check up on what I'm doing.’ So that's 
what it’s done for me, it gave me that sort of boost to say, ‘Stay quit this time’. 
(FG2, male, 44) 
 
When this perception was negated as related by FG1J above earlier, the experience 
of the program was more negative.  
Two major categories which summed up the theme ‘support’ were whether the 
support was general or specific. General support was directly related to what the 
SCeMES program was able to provide in general terms in supporting the participants 
towards a successful quit attempt. A few of the reported SCeMES supporting 
features were the face-to-face nature of the program, the non-judgmental attitude, 
the professional demeanour of the therapist, the checking on their quitting, and the 
encouragement given during times of adversity. For some, the clear and concise 
structure of the SCeMES provided that indirect support: it was a year-long program, 
undertaken by trained staff, with a clear number of visits aimed at assisting them to 
quit smoking. When this structure was compromised as a result of staffing issues, 
which occurred suddenly as reported earlier by FG1J, the experience was less 
positive. 
So I thought yeah, I really wanted to, yeah, I was quite committed to the idea of 
giving up smoking. And I think I was attracted by the fact that there were 
interviews and sort of like support that I could call if I wanted to talk, and there 
were I think was it five, five visits throughout the year, and I like the idea of that. 
So yeah. (Individual6, female, 46) 
 
Yeah. Yeah, I think it comes down to more the overall effect that having that 
contact part of it, the spray and yeah the tone that gets you right from the start it’s 
been a different attitude of making the attempt. So I thought about it for quite a 
while and then you’ve done something and you’ve talked about it. Yeah, it’s 
another process. (Individual9, male, 63)  
 
Specific support refers to specific providers of support such as family, friends, the 
therapist who was responsible for the care of the participants, and the community at 
large. Each specific support played a cumulative effect in motivating the participants 
to either initiate a quit attempt; continue in the program attempting to maintain their 
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quit attempt; or try another quit smoking attempt. For those participants who were 
abstinent, the specific support provided motivated them to continue abstinence.  
When the discussion involved the SCeMES providers, the participants often 
compared the therapist they had had in the past with the ones they were assigned to 
in the SCeMES. Negative experiences with each quit smoking attempt were reported 
by the participants to be related strongly to a non-supportive, judgmental and often 
uncaring provider. Questions were also raised about why the government persisted 
with care (systems) which the participants felt to be unsupportive. A positive 
experience was when the participants related being cared for by the opposite type of 
therapist i.e. caring, non-judgmental etc.  
Absolutely none and almost a negative thing is like, you go back to your GP after 
a lengthy period of time on whatever, and we haven't given up and its almost a 
sarcastic, ‘Oh I didn't think you would,’ but that's getting a little bit sort of... under 
my GP, yeah, oh yeah I knew you wouldn’t. (FG2, male, 56) 
 
No, no, no; given it’s the same, I agree with you, they've got an awful lot and it’s... 
I know in the practices I've been involved in with the... you know giving up 
smoking, it was more like, ‘Well, go and see my nurse and they'll sort you out,’ so 
and it was, ‘Yeah, here’s your box.’ Then you'd go back to your next box and it 
was, ‘Have you smoked while you've been on it?’ And you either sat there and 
lying to her or you know, whatever; and it was at the end of the day you think, 
‘Oh... no.’ ‘Oh well that's good, then here’s your prescription.’ It was like, so if you 
weren’t truthful with her, she wasn't able to help you, whether she smoked or not; 
as you say but yeah, it was more... yeah, there's important things to do and 
smoking is a decision people make. Maybe, that's how you were made to feel 
and I think now... I know now, going back to the doctor and they'll say, ‘Are you 
still smoking?’ ‘Well no, actually I've been, not since June last year.’ ‘Oh good.’ 
And that's it, because it’s not like, ‘Oh, congratulations.’ It’s like, ‘well you 
certainly knock off.’ So yeah. (FG2, male, 44) 
 
..and you didn’t make us actually feel… I didn’t feel guilty that I was a smoker 
when I came in because you were running this to try and get us to give up 
smoking and help us, I almost had this perception before I met you was that I’m 
gonna in there and you’ll probably smell that I’ve just had a cigarette [Laughter] 
yeah and you’re probably gonna be like everybody does looking down at 
(muffled) you know and I really did have that thought until I met you and then I 
was okay. (FG1, female, 51) 
 
It was all there, the genuineness of her helping; keep telling us, ‘You're doing 
fine,’ and that was the bit, the reassurance. (FG2, male, 56) 
 
Support by both family and friends drew mixed responses. On the one hand it was 
mentioned as being helpful in initiating and maintaining the quit attempt; on the other 
hand, some reported that it was a source of stress.  
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Participants who experienced both general and specific support found them to be 
equally effective in assisting them quit smoking. Family and friends, however, needed 
to be sensitive to the participant’s needs in terms of encouraging them to continue 
staying abstinent.  
Hmm…I get real shitty, upset at any little thing that happens…hmm… but then 
again, I’m more laid back to what I use to be. People don’t reckon I am. My family 
don’t reckon I am. I don’t know. But I’ve really had no help with my family. They 
have not encouraged me. (Individual2, female, 48,) 
 
As a result of their mood changes during withdrawals, a couple of participants 
reported on overly-supportive friends or family which they considered to be 
counterproductive in their quit attempt. Some had even lapsed as a result of this 
counterproductive support. 
My own case, yeah, I did have a wee bit of mood swings. Felicity (pseudonym for 
wife) said to me on occasion you know where I would snap or say something and 
she’d say to me, which helped as well, she’d say to me, “Go and have a 
cigarette. (Individual3, male, 58) 
 
I had times where I run out of cigarettes, where I was, say, on a shooting trip with 
me mates and me cigarettes got wet or something and we’re away for a few 
days. And then I’d say, ‘Oh well, I haven’t had any for a couple of three days, I’ll 
not have any more from now on.’ But I mean it never worked, you’d end up 
popping out somewhere, meeting up with the friends and what have you and 
they’d all be smoking. Someone would offer you one, ‘Oh, all right.’ And back to it 
I went. Yeah, so that’s about it. (Individual3, male, 58) 
 
There were, however, opposite reports of both family and friends who were protective 
of the participants’ current quit attempt and allowed them to stay abstinent for a 
longer period than they normally would last. 
Oh good, yeah. I have a friend, and just as a joke I said… oh, it was a few 
months ago, we went out and I think she’d been smoking quite a lot, and I said, 
‘Oh give me one.’ And she looked at me, but she didn’t bat an eyelid and she 
gave me the packet. I said, ‘No, I was only kidding.’ And I said, ‘You would have 
let me have one?” She said, ‘Make your own decision.’ She said, ‘I would have 
been disappointed, but I wouldn’t have said anything.’ I thought, ‘Oh that’s 
interesting’. (Individual6, female 46) 
 
Well, I tell you what, there’s been a few times when I said, ‘God I wished I had a 
smoke.’ My daughter said, ‘Well if you start that again mate you’ll be out’. 
(Individual9, male, 63) 
 
The final subcategory to illustrate what specific support meant to the participants was 
community support. The community at large was found to play their part in either 
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supporting the participant to stay abstinent or relapse. The participants reported that 
encouraging words were felt to be more helpful than disparaging ones. Also, 
continuous support was raised during the interviews. More often than not, the non-
smoking public in particular, were keen to assist smokers to quit smoking, but were 
less responsive to their successes when they had quit. For some participants, having 
the continuous encouragement was reported to be useful for them to maintain 
abstinence. 
Even after February the 22nd, after that quake I was in town, I didn’t make a 
conscious decision to smoke. But a smoker brought me one up and said, ‘You’ll 
need this’. (FG1, female. 48) 
 
Well that’s the only thing people have said to me, they never said, ‘Good on you,’ 
or, ‘Well done,’ or anything, they just said, ‘Oh, so have you put on weight?’ ‘Oh 








Table 11.5: Matrix display for the theme Support 
Category Subcategory Codes Explanation for the category 
General Structure SCeMES  
In relation to the support structure of the SCeMES 
which the participants felt was either helpful or 
unhelpful during their quit attempt 
Specific 
Community  
In relation to the specific support which the 
participants felt was either helpful or unhelpful during 
their quit attempt 
Family  
Friend  




 Summary for Smoking Cessation 
The study found that the participants’ experience of smoking cessation in the 
SCeMES-QL consisted of three major themes, labelled thematically as ‘the outlook to 
quitting’, ‘the process of quitting’ and ‘support’. All three interacted together to enable 
either a positive or negative experience of quitting smoking to occur. This experience, 
however, did not necessarily dictate the smoking cessation outcome. Instead, a 
positive or negative experience was found in the study to be important, for possible 
future quit attempts for those who failed to become abstinent in their current attempt. 
This was seen in the case of the participant (FG3, female, 47) who was smoking at 
the time of the recruitment for SCeMES-QL, but then made a new quit attempt during 
the course of the interview period. This was as a result of her more positive 
experience in quitting. On the contrary, another participant (FG3, male, 49) was not 
considering a quit attempt anytime in the near future as a result of his more negative 
experience. 
The themes ‘outlook to quitting’ and ‘process of quitting’ were linked with the theme 
‘support’. Both initial themes, nonetheless, were able to shape the smoking cessation 
experience on their own. If the participant was thought to have a ‘match expectation’ 
in terms of their readiness to quit and had adequate information, it was likely that the 
participant related more positive quit smoking experience irrespective of the process 
of quitting smoking. Similarly, a positive experience through the ‘process of quitting’ 
might be reported, despite a negative experience at the stage of ‘outlook to quitting’. 
In the ‘process of quitting’, the undesired consequences of quitting were also 
explored. There was however little suggestions that depression was a considerable 
factor in the quit smoking process. Weight gain in particular, however, was of more 
concern with more respondents reacting to the issue. It appeared to feature strongly 
within the participants as reasons not to quit smoking in the first place and also a 
factor in both discontinuation of the smoking cessation program and falling back into 
reinstating their smoking. Nevertheless, there was little indication to suggest that the 
weight concerns were related to food addiction. In spite of that, an issue which 
emerged was the use of the NEEDNT to monitor their diet as opposed to assessing 
their food intake and this might have changed their behaviour somewhat. A third 
theme which emerged was ‘support’. If the theme ‘support’ was less than desired, it 
appeared that the determining factor for the two themes resulted in a contradicting 
experiences for the participants. This was seen to be the case for a participant (FG1, 
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female, 41) who had a negative experience at the beginning, but a positive 
experience during the ‘process for quitting’, but was not supported. As a result of the 
perceived lack of support provided to her, her experience in smoking cessation was 
considered negative as she felt abandoned midway and she therefore subsequently 
relapsed. The difference and determining factor for her whole ‘journey towards 
smoking cessation’ experience was the theme ‘support’. This theme played a larger 
role than the other two themes that conceptualised what was meant by ‘smoking 
cessation’ by the participants in the SCeMES-QL.  
11.9 Prejudice 
The second domain, which emerged from the data when exploring the lived-
experience of smokers quitting in the SCeMES-QL, was labelled as ‘perceived 
prejudice’. The theme ‘perceived prejudice’ was associated with the participants 
recounting their experience and encounters of being judged during their smoking 
cessation journey. This experience was in response, not only to the decision to 
smoke, but also the decision to quit smoking.  
I guess the one thing that really, really annoys me and you won’t die wondering 
this.... if you do, but I smoke and I get ostracized for smoking by people who don’t 
smoke. (FG1, male, 52) 
 
But I don’t know, part of me thinks poor old smokers are getting picked on a little, 




Perceived prejudice was noticed to be shown not only by non-smokers within the 
community, but also by ex-smokers. There were also participants who related that 
they themselves had started to discriminate against other smokers once they had 
become ex-smokers. 
FG1a: “Or an ex-smoker.”  
FG1b: “Oh, they’re worse.”  
FG1a: “They’re worse are they?” 




From the interviews, three major categories emerged from the SCeMES-QL to 
support and further illustrate this domain. The first category which emerged was ‘the 
appraiser’. This category was divided into multiple subcategories: smokers, ex-
smokers and non-smokers. The participants related that with ‘appraisers’ labelled as 
smokers or ex-smokers in the subcategory, the ‘perceived prejudice’ was not only 
seen, but it was also felt. From the interviews with the participants, often smokers 
were more critical of other smokers when they attempted to quit smoking. On the 
other hand, there were also those (smokers) who did encourage other smokers to 
quit, but this was not experienced as frequently by the participants in this study.  
Unexpectedly, however, there were participants who reported to personally becoming 
one of these individuals (‘the appraiser’) once they became abstinent. For some of 
these participants, they related to becoming “holier than thou”, much to their chagrin.  
I can understand that. My son, I have got a little bit holier than thou with him. He’s 
18. (FG2, male, 55) 
 
So my friends, all my mates I say to them you know, if I hear them coughing and 
spluttering I say, ‘You should give those bloody things away.’ But I suppose I 
shouldn’t, but I do. (Individual3, male, 58) 
 
At the extreme end, a number of the participants became advocates and champions 
of quitting smoking. Some appeared to do advocacy for quit smoking even more so 
than the non-smokers. For those still smoking, this advocacy was not taken very well 
at times despite the good intentions.  
Smokers in the study who were interviewed reported feeling a sense of judgement 
upon them, especially amongst those who were unable to quit smoking as easily as 
some of their peers. 
I had one son that carried on smoking, you know, and he’d smoke and he’d 
smoke and it would come into my house and I don’t think that was fair, you know. 
Now he’s come back….well, he’s moving out shortly but he won’t…he’s not 
allowed to smoke. Well, he came back just before Christmas in November and I 
set the rules, no smoking in my property. No one is allowed to smoke in my 
property because I don’t see why they should. I’ve still got to get over this. Once 
I’m over two years, I think I should be right… touch wood (laughter). (Individual2, 
Female, 48) 
 
I think to be honest, I think they need, whoever it is, whether it be Zonnic, 
Quitline, whatever, I think they need to be full frontal, full on and go straight for it 
and show graphic pictures and people with asthmas and really turn it on. 
Because people… and then you’ll have people saying; you need everyone 
saying; everyone who’s a non-smoker needs to say to a smoker, ‘Put that 
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stinking thing out.’ You know I think it would be a big help if non-smokers said to 
smokers, ‘Give up, get out of it.’ (Individual3, male, 58) 
 
In the subcategory non-smokers, ‘perceived prejudice’ was reported to be both seen 
and unseen. Similar to the ‘perceived prejudice’ reported by ex-smokers towards 
those still smoking, the unseen ‘perceived prejudice’ was felt through the use of 
tobacco control policies on them (the participants). The participants related to being 
“an easy target” by policies implemented by ‘”big brother known also as the 
government”. For some of them, the latest policy, Smoke-free 2025 initiative, was 
especially felt. This initiative had ‘targeted’ them through multiple avenues such as 
tobacco taxes, smoke free public places, pictorial warnings and point-of-sale bans to 
name a few. As New Zealand moves towards a smoke-free nation, it was in the 
minds of the participants that the current feeling will increase. 
 
It’s like, I don’t know… its saying, right, you do wrong and you do right, sort of 
thing, but we could break that down into everybody’s habits, but... so probably on 
the anti-side. It’s like me; I work at the University, now we've gotta walk off the 
grounds. I mean, it’s got that bad. So, it’s... um. (FG3, male, 49) 
 
I really can’t see that, that… if you want a packet of smokes you’re going to buy 
them, whether you can see them or not. Like even giving up, if I’d gone into a 
service station and couldn’t see the smokes, it would be no different seeing them, 
then walking in and seeing the cupboard, and knowing that the smokes are 
behind that cupboard, just thought, temptation’s still there. I just think it is 
pointless. But they’ve obviously got their reasons for it, so yeah. (Individual3, 
female, 56)  
 
Well, I think they are, because they have to be. I think boxed-in in the sense… 
you’re not talking about (hospital name) staff aren’t you? (Individual6, female, 46) 
 
Those who had quit and were now abstinent (ex-smokers) reported understanding 
the reasoning behind such policies, while others (those still smoking) related to being 
pushed into a corner and having no place to go.  
Certainly when I would hear things like, they want to bring in a more… or it would 
be illegal to smoke in your car with children, or would I read or did I hear that 
they, that duty free cigarettes were going to be stopped, something like that. I 
would feel profoundly irritated, yeah. (Individual6, female, 46) 
 
The next subcategory was labelled ‘response’ to denote the response of the 
participants towards the prejudice meted out to them. The initial response was often 
reported as a wave of emotions from anger to annoyance, frustration, guilt and 
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feeling like a failure. This was identified as the subcategory ‘emotional roller-coaster’ 
and one participant summed up how most of them all felt: “society hates us!” 
It’s just… people’s opinion…..they just try and make themselves right and us 
wrong. That’s where I get anti because you haven't looked at the whole situation. 
FG3, male, 49) 
 
What annoys me about it is they say, ‘We’re doing this to save your health ’cause 
our hospitals are full and it’s costing millions of dollars.’ Well, I’ve never been to 
the public hospital for anything. (FG1, male, 52) 
 
You’re a leper. Without them being behind the wall. (FG1, female, 48)  
 
…that’s at work. I got no issues with my new job, they think I'm a non-smoker. 
And I think I'm gonna keep it up, I'm doing well. (FG1, female, 65) 
 
For some, their response was more physical; they felt they needed to do something, 
to rebel. As a result of the perceived prejudice against them, the participants reported 
to be “more anti it (tobacco control messages)”, as one participant stated, which 
further illustrated the feelings of anger and frustration. Some of the participants 
reported that they were planning to grow their own tobacco, and one participant 
responded defiantly by saying “migrate to another country”. 
FG3a: I’ve got a lifestyle block; I might have to start growing them there. I’d make 
a fortune here. 
FG3b: Can I join you there? 
(Response by two participants, FG3, male, 49 and FG3, female, 47) 
 
The final subcategory, which emerged was labelled as ‘repercussion’. This 
subcategory related to the effects of prejudice towards the participants. The main 
repercussion was the sense of being persecuted for smoking.  
Well, it’s like discriminating somebody... Well, they just judge us all the time. 
(FG3, male, 49) 
 
The researcher: ‘And when you said that smokers were being picked on… 
 
Individual6: ‘Oh it’s not so much picked on, but they’re targeted!’ (Individual6, 
female, 46) 
 
Just in the fact of ….ah... what, are you doing mate? You know, you get sick of 
the comments, ‘Oh you stink of smoke.’ ….Or you spend so much money on the 
actual cigarettes itself and it’s not sort of doing any good for you either. 
(Individual7, male, 33) 
 
 194
Alcohol was seen by the participants to be as dangerous, if not more dangerous, to 
society as tobacco smoking. Despite this, the participants reported that the 
government was targeting the “passive” smoker. This feeling of injustice increased 
towards the authorities, particularly the government, regarding the perceived double 
standards with alcohol use in New Zealand. 
Family violence and others...full of people that have done things under the 
influence of alcohol. (FG1, female, 48) 
 
The hospital’s full of people that are sick and you know and it’s not us ‘cause 
we’d go privately, but there’s… well, I say there is more people in hospital as a 
result of alcohol related traffic accidents, or whatever than there is smoking. 
(FG1, male, 52) 
 
But I do think that the more products, if you like, that are available that don’t cost 
the earth… but I still have trouble today with the fact that alcohol is allowed to be 
advertised on television. And they’re showing you on the Good Morning show 
how to make some drink with vodka, which I think is absolutely disgusting. That 
they can advertise in the paper the alcohol, which we know kills brain cells, to 
excess if you’re drinking it to excess. (Individual8, male, 70) 
 
I mean I’ve written to Tariana Turia (Minister of Health) recently, or emailed her, 
to say when did you last hear of somebody driving and smoking and killing 
someone; compared to somebody drinking and driving and killing someone. So 
which is the worst? (Individual8, male, 70) 
 
No. And you know, the Government gets kickbacks from it so they trying to, on 
one hand stop us but look at the taxes they’re collecting and it’s wrong. If they 
really want this out of people’s faces, change it. (FG3, female, 47) 
 
As a result of these perceived prejudice and double standard practices, those 
interviewed reported that smokers (within the study and outside) tended to stick 
together. This inadvertently created more ‘perceived prejudice’ when participants 
attempted to quit smoking. 
In summary, ‘perceived prejudice’ as a domain emerged from the data and was an 
unexpected but important finding in the ‘journey towards smoking cessation’ of the 
SCeMES-QL participants. The sense of discrimination was present and felt 
throughout the ‘journey towards smoking cessation’, happening even before their quit 
attempt but continuing long after quitting smoking. More importantly, the 
understanding of perceived prejudice in this journey was crucial, considering the role 







Table 11.6: Matrix display for the theme Prejudice 
Category Subcategory Codes Explanation 
The appraiser Smoker Seen Included all participants who were smokers at the start of the 
study and those who were still smoking during the SCeMES-
QL 
Ex-smokers Seen Those participants who were abstinent as a result of their 
participation with the SCeMES-QL 
Non-smoker Seen 
Unseen 
Non-smokers who were not part of the SCeMES-QL but whom 
the participants had made contact with in their lifetime 





Feeling like a failure 
Guilt 
The emotions reported by the participants in response to 
prejudice 
Rebel Grow own 
Migrate 
The physical response reported by the participants in response 
to prejudice 
Repercussion Ganging up  The description of smokers who stick together as a response 
to prejudice in society against them 
Persecution Double standard The description of the injustice towards smokers by mitigations 
of prejudice  
 196
11.10 Unprecedented Life Event 
The SCeMES, and the participants attempting to quit smoking in it are unique, as the 
study crossed paths with the Christchurch earthquakes of 2010 and 2011. As this 
event was prominent, and an issue which was not able to be ignored in every 
interview whether FG or individual interviews, it was considered to be the third and 
final domain in understanding what it meant to quit in the SCeMES. The domain was 
labelled ‘unprecedented life event’ as it was meant to reflect the period of the 
Christchurch earthquakes, which was unprecedented, and also those who attempted 
to quit smoking during this period. 
This domain was further explained by two categories which were based on the period 
of quitting for the participants of the SCeMES: during, and after, the periods of 
earthquakes.  
During the periods of earthquakes, the first category for the domain “unprecedented 
life event”, the major theme which emerged was ‘confusion’. Confusion during this 
unprecedented event was understood by the participants to mean uncertainty during 
the earthquakes. The earthquake of interest was primarily the earthquake of 
February 2011, although participants were involved with the September 2010 
earthquake as well. During the much reported earthquake of February 2011, a large 
number of the participants reported lapsing either because of themselves, or 
indirectly by other people.  
For most participants and the researcher, this period was confusing, as it was 
essentially the first time that both the participants and the researcher were involved 
in, and directly affected by, an earthquake in Christchurch as this area had not 
experienced such a severe earthquake before. 
Um… I think probably just the stress of the situation. It wasn’t… I mean, I wasn’t 
in the position where I lost my home or lost anybody or anything like that. But I 
think the sort of uncertain nature. (Individual1, female, 48) 
 
I could have [quit smoking], but I didn’t want to. I guess it was really sort of just 
the shock of, this has actually happened to us in Christchurch, and how lucky I 
guess I felt that I came away unscathed, and yeah. And of course everything, 
everything was sort of turned upside down. (Individual6, female, 46) 
 
It was, that’s exactly what it was. It was a break, think about what you’re doing 
and well I guess I'm a policeman and as soon as you put on that police jacket, 
especially in the February quake everybody looks to you for, they know what to 
do; they know how to do it. And we get no training down at ….and I've gotta… I 
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mean we did really, really well, but I found it really, really stressful, being 
responsible for everybody else as well. (FG1, female, 51) 
 
The second category was ‘post-earthquake’, the period after the earthquakes of 
February 2011. This phase included the subsequent and continuous aftershocks, and 
the two earthquakes of June and December of the same year. The main theme to 
emerge during this phase was described as ‘earthquake fatigue’. This was related to 
the interference of daily life in Christchurch as a result of both the thousands of 
aftershocks, and also the damage and destruction that these constant mini-
earthquakes caused. This damage included damage to both personal homes and 
neighbourhoods, and also damage to local infrastructure such as roads and 
buildings. This damage resulted in the participants having difficulties going to work, 
conducting their normal daily commute, and also visiting the NAC for follow-up 
appointments. This same theme of ‘earthquake fatigue’ has continued during the 
Christchurch rebuild phase – an enormous project of fixing the damage caused by 
the earthquakes. 
Not too bad, but just the timing that the earthquakes as well, I don’t think you 
could give up smoking when you’re also dealing with very traumatic thing. And 
my house was a rebuild in September, so I mean I’m still no further on now, two 
years down the track, and I’m no closer to anything than what I was then. Yeah, 
so you know it’s not just giving up smoking, you’ve got a lot else going on as well. 
Not as bad as some people, don’t get me wrong, I’ve been very lucky compared 
to some people. But yeah. (Individual5, female, 56) 
 
Both the stressful period of the earthquake and the period after, which included 
aftershocks, were explained with a theme labelled as ‘earthquake tension’. This 
theme described the strain which the earthquakes and their consequences had on 
each of the participants. The effects of this experience later resulted in the presence 
or absence of what was described by the participants as “a new look to life”. This 
‘new look to life’ or new thinking could be likened to both mental toughness and 
staying power. All participants who continued with the SCeMES-QL interviews 
reported the strength to keep on going as a factor in their continued interest in the 
study.  
No, no. But I do believe it’s played a major part in it here for us, and it’s been a 
big help in some ways, but it’s the wanting to give up that's the biggest thing. 
(FG2, male, 60) 
 
Hugely for me. Basically I thought, ‘Bugger this. If this is what life is going to be 
like then who knows what’s going to happen tomorrow, I’m going to smoke.’ And I 
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kind of got this attitude and I know it sounds stupid but that I’m going to smoke 
until the end of 2012. And if we all wake up, we’re fine with it, first of January 
2013 then I might look at giving up in the end, but I just think, ‘Why put myself 
through this huge stress when tomorrow I could be crushed by a falling building?’ 
You know, and I know that’s a horrible way to think but that is how I feel very 
strongly. (FG3, female, 41) 
 
I think adversity, a wee bit of… I mean my house is buggered, in bits and pieces 
like this well I just... the smoking part of it I could have let go and carried on 
smoking but I had to be strong with that as well. I mean I’ve got a lot of damage 
to my house and I’ve still got issues with that as I speak. Just smoking wasn’t 
helping either, you know, I mean it just… it was just another thing you know. 
(Individual5, female, 56) 
 
To summarise, the earthquakes, although a major event for all participants, did not 
appear to be a major contribution for blame towards their success or failure to quit 
smoking. The participants reported this major life event as being unprecedented 
without adding too much emotive connotation with regards to smoking cessation. 
This approach, therefore, allowed the participants to remove blaming the 
earthquakes for the success or failure to be abstinent at the end of the study. The 
participants, however, acknowledged the earthquakes played a big part in their quit 
smoking journey. 
No, no. But I do believe it’s played a major part in it here for us, and it’s been a 
big help in some ways, but it’s the wanting to give up that's the biggest thing. No, 
I can’t say that with the earthquakes, that it made me feel that I wanted to go 
back to smoking, yeah. But in saying that, prior to everything, there was no way 
in the world, I would have thought, that I could give up through something like 








Table 11.7: Matrix display for the theme Prejudice 
Timeline Category Codes Explanation for category 
During the earthquake The Christchurch earthquake  How the Christchurch earthquake directly affected 
the lives of the participants 
Confusion  
 
To describe the confusion and uncertainty as a result 
of the earthquake 




To describe the effects of the aftershocks on the 
participants 
Post-quake recovery Road works 
House renovation 
Work 
To describe the effects of the recovery or activities 
after the earthquake on the participants 
Throughout the earthquake 
experience 
A new look at life Earthquake tension 
Mental toughness 
Resilience 
To explain how the earthquake had changed the way 




11.11 Summary of “Journey Towards Smoking Cessation” 
The SCeMES-QL found the ‘lived experience’ to quit smoking consisted of three 
domains and five major themes. The three domains were labelled as ‘smoking 
cessation’, ‘perceived prejudice’ and ‘unprecedented life event’. For the domain 
smoking cessation, the interviews found three themes each labelled as ‘the outlook 
of quitting’, ‘the process for quitting’ and ‘support’. The latter theme ‘support’ bonded 
the three themes together and explained the experience of what it was like to quit 
smoking by the participants in the study. 
For the participants, the experience to quit smoking through the SCeMES was 
likened to a journey rather than a destination, i.e. obtaining an outcome of abstinent 
from smoking or not. This finding was different from what the researcher had 
anticipated at the beginning of the conduct of the study. 
The three variables of interest, namely quitting, depression and weight did not find 
much inter-relationship in this qualitative study. There was little information on the 
role of depression in a quit attempt, but more issues on weight gain. However, there 
was also little on the role of food addiction as a cause for weight gained. 
From the information gathered, it appeared that the experience of quitting smoking 
for the participants in the SCeMES-QL comprised of the domain smoking cessation 
which was the main reason to participate in the first place. This domain, if imagined 
as the core of the experience, is surrounded by the second domain, perceived 
prejudice. The second domain is all inclusive as the participants reported this theme 
to be felt prior, during and after their attempt to quit smoking. More importantly, it was 
not only seen and felt directly by some of the participants, but was also reported to 
be unseen and felt indirectly by all the participants of the study.  
To complete the experience of quitting smoking for the participants, both domains 
‘smoking cessation’ and ‘perceived prejudice’ are covered by the final domain, 
‘unprecedented life event’. It is more likened to an umbrella rather than a complete 
circle encircling the two earlier domains. An umbrella analogy is probably best 
because, although the Christchurch earthquakes were a major life event for 
participants in this quit smoking journey, there were other issues which were also 
happening at the time, which may not be linked to the earthquakes. The earthquakes 
were a major unprecedented life event not only for the participants of the study but to 
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DISCUSSION, IMPLICATIONS FOR 





 CHAPTER 12 – Discussion  
12.1 Chapter Overview 
This is the final chapter for the SCeMES and attempts to explain the research 
findings from both the quantitative and also the qualitative components. The main 
objectives are highlighted and discussed in this chapter. Finally this chapter ends 
with a discussion on the limitations and strengths of the SCeMES before suggestions 
on both future research and implications for practice. 
12.2 Introduction 
This study was mainly aimed at investigating the role of depression, weight and 
smoking cessation amongst a population in Christchurch who were involved in a quit 
smoking program in New Zealand. It was the objective of this thesis to find the rate of 
depression and its association with quitting smoking, to find any relationship between 
the eating variables in particular weight, and its role towards quitting smoking and 
finally to investigate the inter-relationship between the three variables. This study 
was a mixed method research study which was sequential in design, meaning, it had 
two methodological philosophies organised in a linear fashion with the quantitative 
study at the fore followed by a qualitative study. The latter was designed to explore 
and document the ‘lived experience’ of the participants in their quit attempt through 
the SCeMES. This study allowed insight into what it meant to quit smoking in the 
SCeMES, to quit smoking in New Zealand after the Māori Affairs Select Committee 
report and to quit smoking in Christchurch during the period of the Christchurch 
earthquakes. A total of 556 participants were eligible for the SCeMES and 256 
participants were recruited into the SCeMES-QN. Of these, 78 participants were 
subsequently eligible to participate in the SCeMES-QL, however, nearly a third 
(n=25) participated as interviewees in both the face-to-face or group interviews.  
12.3 Main Findings 
 Outcome Measures 
This study had two measurable outcomes for success which were retention and 
abstinence. Most smoking cessation studies measure abstinence, however, it was 
felt that retention was equally important considering that from a clinical perspective 
retention ensured that treatment was able to be given adequately. Although useful, 
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an abstinence only outcome measure might not be able to give that information. For 
the SCeMES two follow-up periods was proposed namely EARLY and LATE follow-
ups. For EARLY follow-up, the average duration was three months (M = 93, SD = 
34.3 days) and for LATE follow-up, the average duration to follow-up was a year (M = 
380, SD = 84 days). The retention rate was found to be 48.4% and 36.7% 
respectively, at both follow-up periods. Abstinence on the other hand was measured 
using the 7-day point prevalence, an often used measure of abstinence in a clinical 
setting. Abstinence was further validated with a carbon monoxide monitor at < 10 
ppm. For the SCeMES, the abstinence rates were 14.5% and 14.8% respectively for 
EARLY and LATE follow-up.  
 Depression and Smoking Cessation Outcomes 
One of the major thesis findings of interest was the rate of depression amongst 
smokers who were planning to quit smoking in Christchurch, New Zealand. The rate 
of depression was reported as lifetime depression and current depression. 35.7% of 
participants were found to have lifetime depression and the findings from the 
SCeMES was higher than the national average reported to be between 14-16% 
(Ministry of Health, 2012; Oakley et al., 2006). These findings were in keeping with 
the current understanding of mentally ill patients smoking at least double the rates of 
those without any mental illness (Ziedonis et al., 2008), and also in keeping with the 
rates of smoking in those with clinical depression reported globally in Table 4.2. 
Another study in New Zealand by Glover (2005), also reported a prevalence of 30% 
in her sample of 130 Māori smokers. In that study, however, the diagnosis of 
depression was made using the Māori worldview, the 4 realms of the Te Whare Tapa 
Wha (Glover, 2005), for defining depression. Unlike the conventional diagnosis of 
depression made using the DSM-IV or ICD-10, the Māori worldview model included 
four categories of experience, namely the physical element, the psychological 
component which included feelings and thoughts, a spiritual component and that his 
condition was closely related to family and the wider community for which these 
people belonged to. It is unclear whether both methods were correlated and this 
made direct comparison of the findings difficult. In another study by Tobias et al. 
(2008), involving a general community sample of 12,992 adults using the New 
Zealand Mental Health Survey, 33% of smokers had a mental illness. These findings 
again was supportive of both the findings in this study and Glover (2005). In the study 
by Tobias et al. (2008), however, it was estimated that those with mental illness were 
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50% more likely to smoke compared to those without mental illness during the study 
period. The similarities with the SCeMES for this study was that Tobias et al. (2008) 
used the CIDI, an instrument which was based on the DSM-IV, a conventional tool to 
diagnose depression.   
Compared to lifetime depression, the rate of current clinical depression was found to 
be much lower (Oakley et al., 2006). It is worth highlighting that between the two, 
current depression is often studied less compared to lifetime depression. Current 
depression is also less affected by socioeconomic wealth and was often more similar 
from country to country (Kessler & Bromet, 2013). In the SCeMES-QN, the rate of 
depression at enrolment differed depending on the instrument to detect depression 
that was being used. In this study, current depression was reported to be 2.3% and 
6.6% respectively using the HADSD or the BD-II respectively. This was significantly 
lesser compared to lifetime depression among smokers reported earlier, however, it 
was still within the wide range of 2 - 34.3% reported elsewhere (Table 4.2).  
Nevertheless, the rate reported in the SCeMES is within the lower end of the 
spectrum in Table 4.2, but is clearly at the lower end of the range. The rates of 
current depression in the SCeMES was almost similar to current depression within 
the general population (6.9%) (Oakley 2006) if BDI-II was used (6.6%), and lower 
with HADSD (2.3%). It was possible that those with current depression in this study 
were those with mild depression and therefore more likely to be able to participate in 
the study. Those with moderate to severe depression were unlikely to want to make a 
quit attempt. One significant statement by a participants of the SCeMES-QL (Refer to 
11.8.5.1), where she describes that if she were in a ‘dark place’ with her depression, 
it would be unlikely that she will consider quitting as opposed to when her depression 
is controlled. 
One other interest in this research was the possibility of an increase in depression 
during the quit smoking process. It was initially anticipated that depression 
prevalence would increase over time, however, this was not found in this study. The 
SCeMES did not support the idea that smoking cessation increases depression rates 
as there was no increase in depression over the three months or at one year follow-
up. This was similar to the study by Tsoh et al. (2000), which found no increase in 
rates of depression in either those who were abstinent or not at 12 month follow-up. 
Community based studies also found no increase in rates of depression in both those 
abstinent or not at <3, 3 or 6 to 9 months follow-up (Bolam et al., 2011; Shahab et al., 
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2013).  Further insight into this finding can be found in the qualitative component of 
the SCeMES. Amongst the participants interviewed, clinical depression did not 
feature prominently at all as a consequence of quitting. Participants did report having 
depressive symptoms as a symptom of withdrawal and this was reported more so in 
the early stage of quitting. Even those participants with a previous history of clinical 
depression did not report that their depression worsened or reappeared during the 
course of the SCeMES -QL. This is important and reiterate the need to encourage 
and treat people with depression for their smoking. The recent study by Anthenelli et 
al. (2016), reports that there are no neuropsychiatric complications with any of the 
currently available smoking cessation treatment. Furthermore, Taylor et al. (2014) 
found in their review that smoking cessation reduces depression and increases 
positive mood apart from quality of life. Therefore, our negative findings further 
supports treating people with depression who smoke. 
Apart from the rate of depression amongst smokers, this study aimed to investigate if 
depression had any effect on successful quitting and whether there were predictors 
which were identified to assist in future quit attempts. The SCeMES-QN unfortunately 
did not find any association between having depression and the measured outcomes 
for smoking cessation in the SCeMES at both three months and one year 
respectively. When lifetime depression and current depression were analysed for any 
association with smoking cessation outcomes, there were no associations found 
between these two variables with either successful smoking cessation or retention in 
the study. These findings were in line with an earlier study by Hitsman et al. (2003), 
which found no association between lifetime depression and smoking cessation 
although in their more recent re-analysis of the same studies together with the 
addition of newer studies there appeared to be a modest effect of depression 
predicting lower quit rates (Hitsman et al., 2013). The findings in SCeMES although 
negative, is helpful considering much of the current information on depression and 
smoking cessation is based on clinical trial information which often includes strict 
protocols and may not mimic the real-world clinical setting. The SCeMES being a 
primarily longitudinal observational cohort study is possibly more generalizable and 
can provide additional information since observational and cohort studies are often 
less studied in investigating the role of depression and smoking cessation (Ziedonis 
et al., 2008). The SCeMES-QL also did not find support that depression or 
depressive symptoms experienced during the study period affected the outcome for 
the participants interviewed, despite the high rates of lifetime depression (56%) in the 
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qualitative sample. Rae, Pettey, Aubry, and Stol (2015) reported similar findings in 
their study. However, participants of SCeMES-QL did report of grief feeling as a 
result of quitting. This was also found in another study investigating smoking 
cessation within a community psychiatric setting (Lawn et al., 2002). In this particular 
study, the feeling was attributed to loss and was not reported to be clinical 
depression in any way. In order to explain the SCeMES findings, it was possible that 
the population who were interviewed, whom comprised mainly of those still present in 
Christchurch after the many earthquakes were different in features such as coping 
mechanisms, and therefore attributed little of their depression to their smoking 
outcome.  Adams-Hutcheson (2015) reported that inhabitants of Christchurch who 
moved away from Christchurch after the earthquakes were found to suffer more from 
post-traumatic disorders, compared to those who stayed back. They were also more 
unsure about their future. Both factors may lend support to the notion that those who 
stayed back in Christchurch were slightly different from those who had left 
Christchurch after the earthquake. To further support the idea that participants in the 
SCeMES may be different was the study by Wilson (2013), describing resilience in 
the ‘survivors’. These survivors were reported to appear to have better individual 
resilience compared to community resilience. Resilience according to Wilson (2013), 
described the capacity to absorb disturbances and reorganize while still undergoing 
change to retain essentially the same function, structure, identity and feedback. It 
was possible that from the description by Wilson (2013) those remaining in 
Christchurch were a more resilient group which accounted for some of these 
negative findings in both the quantitative and qualitative study.   
 Eating and Smoking Cessation 
The SCeMES measured weight and other eating variables, including the possibility of 
food addiction as a result of weight changes in the study. The baseline weight was 
80kg and the average BMI was 27.4, by definition considered overweight. Observing 
the BMI of those with BMI >25, almost two thirds of the study participants had 
excessive weight to begin with. These findings mimic the current situation in New 
Zealand in terms of weight (University of Otago & Ministry of Health, 2011) and 
therefore representative of the general population. 
There was a positive relationship between weight gain and smoking cessation in this 
study. The majority of the participants were found to be heavier at both follow-up 
periods compared to their baseline weight. For those who were abstinent, their 
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weight was significantly greater at both three month (3.3kg) and one-year (4.5kg) 
follow-ups compared to those who did not quit at the follow-up assessment periods 
(1.1kg and 1.8kg respectively). These changes were also found to be statistically 
significant and in keeping with other studies reported elsewhere (Filozof, Fernández 
Pinilla, & Fernández-Cruz, 2004; Mohammad Siahpush et al., 2013).  
In addition, compared to their initial baseline weight, participants were found to be 
heavier overall at follow-up irrespective of their smoking status. One possibility might 
be any level of abstinent period, whether complete (7-day point prevalence) or 
incomplete between baseline visit and either EARLY or LATE follow-up period 
resulted in weight gain, although the mechanism for this was not well understood.  
Another possible hypothesis postulated was ‘gateway behaviour’ whereby Kaufman 
et al. (2011) argued that smokers in general were prone to unhealthy lifestyle 
options. These options include poor eating habits and a sedentary lifestyle and more 
importantly, were often difficult to change within a short period. Considering that the 
current study was a observational study where no intervention was given, it was 
possible that weight gain might have happened as a result of these unhealthy 
choices. Furthermore, this population which was heavier to begin with, might already 
be susceptible to weight gain (John et al., 2006). One other possibility was that 
frequent attempts to quit within the current study period may have increased the 
weight incrementally and was picked up during the frequent follow-ups conducted in 
the SCeMES. Alternatively, the weight gain seen could be the result of normal aging. 
Mozaffarian, Hao, Rimm, Willett, and Hu (2011), found in their study of >100,000 
participants that both men and women gained weight over a four year period but the 
weight gain was lesser compared to those within the study cohort who quit smoking. 
Apart from metabolic changes (Finkel, 2015), weight changes were the 
consequences of lifestyle factors (Mozaffarian et al., 2011). 
The SCeMES-QL found that participants when discussing weight often mentioned 
that food tasted better during quit attempts (particularly in those who were abstinent). 
One even mentioned, “taste that I never knew was there”, particularly in those who 
were abstinent. This was supported in other qualitative studies as a negative 
consequence of quitting which participants had experienced (Bommele et al., 2014; 
Twyman, Bonevski, Paul, & Bryant, 2014). In the SCeMES-QL, the participants 
mentioned that they ate more, irrespective of whether they were abstinent or still 
smoking as reported in the SCeMES-QN. It was possible that participants consumed 
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more food in general and not specifically just NEEDNT type foods as a result of this 
change in taste as the NEEDNT scores reduced over time. Together with the minimal 
mention of any increase in physical activities through exercise for example, this 
energy imbalance may be another factor for the general weight gain in both groups 
(Rupprecht, Donny, & Sved, 2015). The ‘gateway behaviour’’ hypothesis (Kaufman et 
al., 2011) might also provide an alternative explanation considering behavior change 
takes a longer period of time than just the follow-up period of the study. 
Another possibility for weight gain which had been postulated (Audrain-McGovern & 
Benowitz, 2011) but never formally studied was the substitution of nicotine for food. 
There was no evidence of this found in this study. Hardly any participants met the 
diagnosis for food addiction (<1%) at baseline and there was no increase at both 
follow-up period of 3 month and one year. Two possible reasons to explain this 
finding were 1) there was no co-morbidity with food addiction amongst current 
smokers and 2) there was no substitution in addiction between nicotine and food. It is 
possible that even though food addiction shares the same aetiology for addiction i.e. 
the dopamine theory (N. D. Volkow et al., 2013), the mechanism of action or the 
neurotransmitters affected might be different. These findings, however, were 
preliminary and more studies were needed to understand the possibility of 
substituting addiction for smoking cessation. 
This study was also interested in investigating the role of eating, in particular weight 
gain, and its association with quit smoking and possible predictors for future smoking 
cessation attempts. There was no association found between any of the studied 
eating variables and quitting smoking in this study. Analysis of weight particularly did 
not find any association with either abstinence or retention in this study. In light of the 
retention rate reported at <50% in both EARLY and LATE follow-ups, findings in 
relation to quit rates needed to be interpreted with caution. It is possible that those 
who had the greatest weight gains dropped out earlier from the study and therefore 
significantly reduced the power to detect changes during analysis. Alternatively, 
further inclusion of other predictors for eating variables such as fear of weight on 
initial assessment might have been useful as a predictive factor. Additional analysis 
of the WISDM weight subsets did not find any association to successful quitting in 
this study. The WISDM weight subset questions were assessing the role of weight in 
initiating and sustaining smoking behaviour. 
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This study, however, found an interesting observation on eating behaviour as 
measured by the two food-related instruments in this population. The researchers 
had initially anticipated that the scores of both the NEEDNT and QSCRF 
questionnaires would rise over time, however, this was not observed. In fact, the 
opposite was seen whereby the scores reduced over time, although important to note 
that only the change between baseline and LATE follow up was statistically 
significant (P <0.05). The findings for QSCRF, which looked mainly at craving for 
sweet and savoury foods, nevertheless might explain the lack of support for 
substitution of one addiction for another in this study. Craving is a hallmark for 
addiction and is often reported to be significant if a diagnosis of addiction is to be 
made (Baker, Breslau, Covey, & Shiffman, 2012). It might, however, provide an 
alternative explanation for the low to absent diagnosis of food addiction. The lower 
NEEDNT scores was in keeping with the low craving for such food (sweet and 
savoury) which was reassuring but did not explain the weight gain observed overall in 
this population. One explanation was that other foods which were not recorded could 
also be high in calories and lack nutrition. The increase consumption of these food 
items overall together with the lack of any physical activity could also cause a weight 
imbalance and might explain the weight gain observed in this study. Future studies 
might need to take a detailed eating history which included exercise or energy 
expenditure history, though this record keeping must be balanced to avoid participant 
burden.  
The qualitative study was able to support some of the anomalies found in the 
quantitative study on why weight gain might be a result of an increased in 
consumption in other types of food apart from those recorded by the NEEDNT which 
focused on energy dense but nutritionally deficient type food. Although the current 
study did not aim to intervene, it was possible that the frequent use of the NEEDNT, 
QSCRF and also the mYFAS instruments could have unintentionally change the 
behaviour of this population. Evidence included detailed reporting of foods during the 
SCeMES-QL interviews where participants appeared to be mindful of the NEEDNT 
foods when they responded as such; “I was really conscious of my chocolate bars 
and things like that”, “I’ve been particularly careful, knowing when to stop…it was 
good that the set of questions….for example, do you avoid going to somewhere 
where you know there was going to be pavlovas…”, which indicated that the 
participants might have taken the assessments tools as a form of treatment. Although 
these were essentially assumptions by the researchers, frequent mentions of such 
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experience in the qualitative study might indeed indicate to something more. Should 
this be true, using these questionnaires as a type of treatment might be a useful way 
to encourage weight control in a smoking cessation program as it is cheap and non-
invasive. However, more studies need to be conducted to ensure the validity of this 
hypothesis.  
 The Interrelationship between Depression, Weight and 
Smoking Cessation Outcomes 
Similar to other studies (Killen et al., 1996; Michele D. Levine et al., 2003), the 
SCeMES did not find any inter-relationship between depression, weight and smoking 
cessation. This is in contrast to the study by Adam M Leventhal et al. (2010) which 
found that tobacco smoking moderated depression and weight. Unlike, Leventhal et 
al. (2010), however, the SCeMES included the presence or absence of food 
addiction.  Nevetheless no relationship was found between this food addiction, 
depression and quitting smoking. Though food addiction was included as a variable, 
the numbers were small with only two participants fulfilling the diagnosis at baseline. 
The low retention at both EARLY and LATE follow-up (< 50%), and limited successful 
quitters in both follow-ups might have also affected the outcome of this study. The 
current study might have been underpowered to detect changes. The study by 
Leventhal et al. (2010) in comparison had more than 50,000 samples in three 
national cohorts, therefore a bigger sample size might have found a difference in the 
SCeMES.  
In the summary of Chapter 6, there was limited research in this area to the best of 
our knowledge. However unlike previous studies, this study included food addiction. 
Nevertheless, those with this diagnosis in the SCeMES were minimal with only two 
participants who met the criteria at baseline and no further increase was seen at 
follow-ups. Having a small number of successful quitters at the EARLY and LATE 
follow-ups might have also affected the analysis by not being able to detect changes 
between the analysed variables. 
 The Experiences of Smoking Cessation in the SCeMES 
The qualitative study of this mixed method research was aimed to assist in providing 
additional insight into the quantitative variables of interest and also to explore the 
lived experience of the SCeMES smoking cessation program. The qualitative study 
was able to support the quantitative study beyond providing context to the study. 
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Unlike the expectations of the researcher, a quit attempt had a different meaning for 
the participants. Participants related a quit attempt to be a form of journey, whereas 
the researcher was understanding the quit attempt to be more like a destination with 
clear outcome expectations.  For the participants in general based on the SCeMES-
QL, they reported to feeling happy and successful with any improvement in their 
smoking reduction. This included a reduction in cigarettes smoked per day for 
example as opposed to abstinence from smoking. The latter, being the desired 
outcome for the researcher as a measure of success. Nevertheless, a recent study 
found that reduction of cigarettes precluded abstinence to smoking (Klemperer & 
Hughes, 2016) whilst others report that it might only predict future abstinence 
(Lindson‐Hawley, Shinkins, West, Michie, & Aveyard, 2016). A review of 26 
qualitative publications (Graham, Flemming, Fox, Heirs, & Sowden, 2014), indicate 
that cutting down might be a viable option, particularly in special populations (the 
study was on pregnant women), however requires more acceptance by healthcare 
providers considering that current understanding still recommends that total 
abstinence proffers the best result for health (Klemperer & Hughes, 2016; Lindson‐
Hawley et al., 2016).  
This study found that for those who participated in the SCeMES, the smoking 
cessation experience could be explained to have three parts or domains. The first 
was related to the ‘outlook to quit smoking’ which was a theme related to the 
participants’ views on their quit attempt. A quit attempt which included suggestions of 
preparation, information, some level of accountability to self or others and a 
willingness to learn often led to a more pleasant quit smoking journey. Contrary, a 
quit attempt which was poorly planned or the attempt was ambivalent, the information 
on the attempt less clear, the quitting attempt was for others as opposed to self and 
where the attempter had a lack of self-esteem and a rigid plan led to an unpleasant 
quit smoking journey. Twyman et al. (2014) reported those who were more motivated 
have been found to be more successful in their quit attempts whereas those with low 
self-esteem appear to be less successful. Often, low self-esteem is a consequence of 
both previous failures to quit or as a result of poor quit smoking experience in the 
past, making the participant rebellious towards quitting smoking. 
In the process of exploration through semi-structured interviews, the participants in 
the SCeMES-QL related additional information regarding their smoking cessation 
experience which was not initially anticipated. For the participants, the smoking 
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cessation program which they experienced consisted of three parts. The initial part 
described the participants’ views on their quit attempts, their ‘outlook to quit smoking’, 
whether it was their own expectation or a consequence of another person such as a 
loved one. It was found that for those who were more motivated to quit, able to 
understand what was expected of them and were willing to learn from this quit 
smoking experience, often reported a more pleasant quit smoking experience. Those 
who quit smoking for reasons other than themselves, reported ambivalence about 
their experience and expected that quitting smoking would be easy. This led to 
quitters in this category to have an unpleasant smoking cessation experience. The 
domain outlook to quit is linked to the ‘process to quit smoking’, the second domain. 
This domain is divided into two categories described as the particularities of quitting 
and the consequences of quitting. The latter is further divided into mood and weight 
concerns which were the main research questions, whereas, the former related to the 
smoking cessation provider, treatments available, follow-ups and outcomes. Previous 
studies have reported the particularities to quit as potential barriers to smoking 
cessation and more work needs to be done in this area to identify and subsequently 
address this issue. This study was in keeping with other studies in terms of provider-
related complaints, particularly by general practitioners who were either too busy, 
inadequately trained in smoking cessation or were not emotionally present during 
consultation. The lack of training is not new and was reported as a factor for lack of 
support and adequate care (Ditchburn, 2012). Moreover, training is accessible and 
studies have found them to increase knowledge and competency (Abdul Kadir et al., 
2013). The final domain in completing what participants in the SCeMES reported as a 
successful quit smoking journey was ‘support’. Support was divided into general and 
specific support. For the latter, specific type of support included support by specific 
groups of people such as the community, family, friends and also the healthcare 
provider assisting in the quit attempt. In their review, Twyman et al. (2014) reported 
one of three main barriers to quit smoking was support, and this was particularly 
seen in all major groups in their study. One of the limitations identified by Ditchburn 
(2012) was the lack of psychological support in smoking cessation. The authors 
argued that a clinic would be best in ensuring that this form of support and treatment 
was provided. In addition, the SCeMES found participants were keen to explore the 
use of group based treatment. A Cochrane review (Lindsay Stead & Lancaster, 2005) 
has also reported that it is at least equal to individual treatment, however there was 
insufficient evidence to say it was more cost effective. Participants were also keen to 
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partake in group based treatments compared to Quitline, possibly due to the 
perceived lack of support and engagement. A Canadian study on pregnant mothers 
(Nadia et al., 2016), found that blogging about quitting increases engagement and 
support and can be an addition to current group based support practice. 
Both the fourth and fifth domain reported were unexpected and emerged from the 
data collected during the SCeMES-QL. Although not intentional, the quit attempts 
made by all participants in the SCeMES was across two major local issues 
happening in New Zealand and also Christchurch more specifically. The first issue 
was the national agenda for New Zealand to be smoke-free by 2025. This agenda 
became both a local and also a global commitment towards the Endgame model for 
tobacco control. New Zealand became the first country in the world to declare an end 
to tobacco smoking by the year 2025 where smoking prevalence was expected to be 
< 5%. The international community looked towards New Zealand for guidance and 
leadership in this area. As a result, during the course of the interviews, a domain 
termed ‘prejudice’ emerged to express the participant’s experience in quitting 
smoking in New Zealand during this time. This domain was divided into three 
categories which looked at the appraiser or those causing the feelings of discomfort, 
the response of the participants towards this prejudice and finally the repercussions, 
or how the participants responded or retaliated to the prejudicial activities felt. This 
feeling of being judged or even stigmatize had been reported in the past in 
Christchurch amongst the lower socioeconomically deprived group in the low income 
Christchurch suburb Aranui by Thompson, Pearce, and Barnett (2007), however, the 
current experience was more generalized to all groups studied as a result of the 
nationwide call to be smoke-free. Notwithstanding, these same feelings are not 
uncommon. Other studies exploring the role of increasing tobacco control policies 
found the same sentiments being expressed by smokers in both the UK during their 
clean air policy as well as in Canada (Bell et al., 2010; Louka et al., 2006). Canada 
had early on in their legislation towards smoking adopted tough tobacco control 
measures which made some smokers feel marginalized (Bell et al., 2010). In a recent 
review, Evans-Polce, Castaldelli-Maia, Schomerus, and Evans-Lacko (2016) 
concluded that it was important that tobacco control advocates take into account the 
possible role of stigma as it can derail the intention of available policies through 
resistance and rebellion by smokers already feeling pushed by current policies which 
were meant to assist them.  
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The second local issue which was closer to the population studied was the 
Christchurch earthquakes which started in September 2010 and continued over the 
next three years with significant after-shocks in February, June and December 2011 
and persistent smaller after-shocks till late 2013. To the best of our knowledge, this 
was probably the only mixed method research study on smoking cessation 
conducted throughout a period of devastating earthquakes. There were two major 
timelines in which the participants often referred to, these were during and after the 
February 2011 earthquakes. Many participants reported reinstating their smoking 
during this period as a result of stress towards the consequences of the earthquake. 
This was supported by a study conducted in December of the same year which 
indicated both initiation and reinstatement of smoking happened as a result of the 
earthquakes (Erskine, Daley, Stevenson, Rhodes, & Beckert, 2013). The closest 
experience of a similar life event was reported by Forman-Hoffman, Riley, and Pici 
(2005), whereby the authors investigated relapse to smoking as a result of the 
September 11, 2001 terrorist attacks of participants from Washington DC. The 
participants were then involved in a clinical trial examining the effectiveness of a 
nicotine inhaler. These authors found no statistically significant change in smoking or 
relapse rates compared to rates prior to the event in the study. For the SCeMES, the 
post-earthquake experience was more important. Studies that were related to natural 
disasters or a life-event often looked at a single event, which was different from what 
the participants in SCeMES-QL related. This repetitive stress due to repetitive 
aftershocks was also noted by G. A. Wilson (2013) in his study. Participants in the 
SCeMES-QL reported an experience which was termed as ‘earthquake fatigue’. This 
terminology attempted to express their general feeling and their feeling of exhaustion 
towards the various difficulties which arose as a result of on-going destruction on 
public and personal infrastructure from the aftershocks. This destruction left a 
sensation of perpetual stress to the participants involved. Despite this, the 
participants shared their experience of hope and optimism termed as a ‘new look to 
life’ and some, even cited this, as a reason behind why they continued to participate 




12.4 Limitations and Strengths 
 Limitations 
One of the main limiting factors was the retention rate of participants for this study. At 
3 months, the default rate was estimated to be 51.6% and at 12 months this 
increased to 63.3%. Other studies have reported default rates of between 20 – 50% 
(Backinger et al., 2008; Ferguson, Bauld, Chesterman, & Judge, 2005; Lee et al., 
2013; Wee, Shahab, Bulgiba, & West, 2011) in their smoking cessation programs 
within community samples and lesser within clinical trials for smoking cessation 
(Gilbody et al., 2015). This study was a prospective cohort conducted during a 
difficult period in New Zealand’s history. Every effort was made to increase retention 
at both follow-up periods, particularly the later follow-ups including phone call 
reminders for both follow-ups, flexible consultation hours including after hour access, 
a token transportation reimbursement, and data collection through the telephone for 
participants who could not attend the final follow-up at the one year period, however, 
the retention was still reported < 50% at 3 months and 1 year. The qualitative study 
provided further information regarding what might have transpired during the period 
to explain this low retention rate. Those who attended EARLY follow-up were seen 
just prior to the February 2011 earthquake and recruited across the June 2011 
earthquakes which affected Christchurch. This was the period with the most 
destruction towards both private and public infrastructure. Moving around 
Christchurch in general was extremely challenging. In exploring the participants’ 
experiences in quitting smoking through the SCeMES, the participants reported these 
difficulties when relating to the period of the earthquakes. The primary researcher 
was similarly affected by the Christchurch earthquakes. For the period of nearly three 
months after the February earthquake, the National Addiction Centre was not 
operational and follow-up visits were a challenge due to logistic reasons. Later in the 
course of the study, public and private repairs made follow-up visits unappealing as it 
was difficult to move within the area where the National Addiction Centre was located 
and individual participants had also reported their own personal situational concerns 
such as awaiting insurance reviews, a lack of transport and support during the 
period. This was on top of permanent displacement for some and relocation to other 
parts of Christchurch and New Zealand by others. It was reported that over the 12-
month period post-earthquake, 70 000 people had moved within Christchurch or 
elsewhere, causing both patient tracing and contact tracing difficult (Love, 2011). 
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These experiences understandably made retaining participants difficult in the 
SCeMES.  
The second notable limitation was the reduced abstinence rate at both early and late 
follow-up. Accordingly, the abstinent rate for the SCeMES was 14.5% and 14.8% 
respectively, at three months and at one year which were in the lower end of most 
treatment studies for smoking (Ferguson et al., 2005; Walker et al., 2011; Wee, 
West, et al., 2011). More recent studies have reported better abstinence in those 
using smoking cessation aid compared to those without. This study however was not 
focused on abstinence other than to compare between those with depression and 
weight gain compared to those without. A study by Erskine et al. (2013) supports the 
difficulty in quitting smoking during the period of the SCeMES. In their study 
conducted just after the December 2011 earthquake, it was reported that nearly 
58.1% of ex-smokers had started smoking again as a result of the Christchurch 
earthquake. More importantly, 27% of those surveyed were non-smokers prior to the 
earthquakes but had started the addiction post-earthquake. The SCeMES-QL 
reported participants experiencing the same where comments such as; “I don’t think 
you could give up smoking when you’re also dealing with a very traumatic thing”; 
“bugger this, if this is what life is going to be like then who knows what’s going to 
happen tomorrow, I’m going to smoke!” were often reported during the interviews. 
Erskine et al. (2013), also found this to be true as nearly all the participants surveyed 
reported stress as a major precipitant towards their smoking. Non abstinence 
therefore can lead to default as a result of guilt which had been reported in other 
studies (Twyman et al., 2014) which might explain further the higher default rate 
above. Possible mood and weight changes, which were undetected in those who 
defaulted might have further precipitated non abstinence and study attrition (Leeman 
et al., 2006). It is important to take note of these reasons as participants who 
continue attending follow-ups might be different compared to those who did not and 
therefore may affect the study’s conclusions (Borrelli et al., 2002). 
A third limitation was the study design which was a prospective cohort without a 
control group. This study therefore was unable to measure effectiveness of treatment 
between those with smoking cessation aid compared to those without. However, the 
objectives of the study were not to measure treatment effectiveness but was more to 
investigate depression and weight variables within the cohort. Therefore, a control 
although useful was not required for this objective. Moreover, this study wanted to 
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also explore the lived experience of participants quitting their smoking and therefore 
a mixed method design incorporating both quantitative and qualitative study was 
more appropriate to answer the research question provided.  
A fourth limitation was the small sample size for the SCeMES-QL of 25 participants. 
Qualitative samples often are recruited purposively which is one explanation for the 
limited number of recruits, however, in qualitative research what is more important is 
data saturation whereby further interviews did not provide additional information than 
what is already known which had happened in the SCeMES-QL. Therefore, although 
the sample size is small, relevant information was obtained adequately to provide 
relevancy to the results. 
 Strengths 
This was one of very few mixed method research studies investigating the role of 
depression, weight and smoking cessation whilst exploring the ‘lived experience’ of 
smokers quitting in smoking cessation program. The use of mixed method research 
as a study design allowed the investigation of quantitative variables and at the same 
time explore the possible qualitative explanations for the findings. Also the qualitative 
study allowed more understanding on the experiences of quitting smoking which will 
improve further current existing understanding in this matter. 
This study was also one of few studies in the country which investigated clinical 
depression using a validated instrument for current depression. Prior studies have 
either used a Māori worldview instrument or a single item within an on-going study. 
This study improved on these limitations by capturing those with depression using 
both the HADSD and also the BDI-II instruments to diagnose depression.  
This study was one of very few studies which attempted to investigate the role of 
food addiction as a cause of weight gain. Research in food addiction is growing at an 
exponential rate, however, there is not as much work investigating food addiction and 
more so, food addiction as a cause of weight during smoking cessation. Although this 
study had a negative finding, it augurs well for the research community within New 
Zealand and beyond to investigate further the potential role of switching of addictions 
with a larger sample size and better instruments among others. 
The qualitative study complements the quantitative study for the SCeMES. More 
importantly, this study was able to capture the experience of quitting qualitatively 
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during the two periods of interest in Christchurch and New Zealand namely the 
Christchurch earthquakes and also Māori Affairs Select Committee report for a 
smoke free New Zealand. The use of a qualitative study allowed exploration even 
further than the topic at hand as had happened in the SCeMES. Although both were 
not primary objectives for the qualitative study, it was included as the signal for it was 
too hard to ignore during the interviews. As with qualitative data collection which is 
iterative, this opportunity was possible in keeping with the philosophy of the naïve 
inquirer. Therefore, there was a greater opportunity for learning from both events 
during the course of the study. 
 Future Research 
The results of the two studies in this thesis further contributed to the understanding 
on smoking cessation. More importantly, the two studies complement each other and 
therefore allowed for better understanding on the findings of both types of study. An 
issue for this study was retention, which was lower than expected. Similarly, lower 
retention at the end of follow-ups might affect the detection of a positive predictor for 
both mood and eating variables, both of which were not found in this study to be 
predictors for smoking cessation. 
Chapter 2 described in length the various types of factors which might be predictive 
for smoking cessation. Unfortunately, this study was not able to include the many 
associating factors and its relationship with smoking cessation. Therefore, it is 
recommended that future research try to include as many of these factors as 
possible. As the SCeMES recruited participants from the ZAP study, there was 
strong concern for respondent burden. This study required assessments to take up to 
one hour in total at the beginning and the baseline was often done during office 
hours. Subsequent follow-ups were shorter but they can still take up to 30 minutes. 
Therefore, a balance is needed to ensure that participants were not put off by the 
duration of the assessment and the questions asked. 
This study found for participants who had completed follow-up irrespective of 
smoking status gained weight. Participants who were abstinent gained more weight 
compared to those who continued to smoke, though the reason remains unclear in 
this study. The qualitative findings pointed towards general increase in food 
consumption, rather than specific food choices leading to weight gain. Future studies 
attempting to investigate this might need to conduct more comprehensive monitoring 
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of food, for example, monitoring not only the type of food but possibly frequency and 
amount too. The monitoring of energy input needs to be balanced with the monitoring 
of energy expenditure. 
Contrary to prior expectations, this study hardly found anyone with a diagnosis of 
food addiction. There was also no further change over time for participants to 
develop this condition. Before any conclusion are made, these findings would need to 
be replicated, preferably in a larger population with a lower mean age i.e. younger 
group since addiction often starts during the adolescent period. Therefore having an 
older population could lead to missing cases. Furthermore, it is recommended that 
future studies include smokers who were quitting for the first time. The SCeMES 
participants reported an average of four quit attempts and it was not known how the 
participants coped with their withdrawals during their quit attempts. It is possible that 
the participants had learnt coping mechanisms to reduce their withdrawal to nicotine.  
An example could be stress, and the role of eating to alleviate this stress as a coping 
mechanism. Using a population quitting in only their first or second attempt might 
have the potential to remove this confounding factor. 
This study had a qualitative component which found that participants related their quit 
attempts more as a journey rather than as a destination. At present smoking 
cessation studies used the 7-day point prevalence of not even a puff over seven days 
to determine abstinence. Future studies might want to look into retention in the 
program or repeated attempts to quit smoking after relapse to determine the 
outcomes because they better reflected the idea of supporting quit attempts rather 
than focusing on treatment success as an outcome. 
Future qualitative studies might want to consider replicating the SCeMES-QL as this 
study was unique given the influence of not only an unprecedented life event which 
was the earthquake, but also that it was conducted during a period of rapid and 
evolving implementation of tobacco control measures nationally. It is possible that 
some of the qualitative findings which represented these environmental factors might 
make transferability of knowledge more difficult between societies.     
Consideration of future research directions has highlighted the need for replication of 
the current findings with increased sample sizes to investigate the role of mood 
specifically depression and eating especially weight in relationship to smoking 
cessation. Continued work needs to also be done in investigating the inter-
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relationship between the three variables considering that this and other previous 
studies had been inconclusive. The negative findings reported need to be considered 
in light of the limitations reported, although a number of positive findings may be able 
to assist in current and future policies. This area of research is still evolving and 
further research is warranted.  
 Implications for Practice 
There are a number of suggested implications for practice which this study can 
contribute in the area of smoking cessation. This study found that depression rates 
for both lifetime and current in smokers was similar to those reported elsewhere. 
More importantly this study also found that over time, there was no worsening of their 
depression for those who have had a previous history or those which were found to 
have active symptoms in the study. Therefore, this study provides continued 
reassurance that smoking cessation does not worsen the depression of individuals 
who are affected by this medical condition. Furthermore, this study encourages 
practitioners to continue treating all smokers irrespective of their mental health status 
which will in turn improve the health of those with mental illness. 
The second implication for practice is the use of the NEEDNT questionnaire as a 
clinical tool. As was found, it appears that although this questionnaire was meant to 
be use as an evaluation questionnaire for certain food items, the participants in this 
study had used this instrument as a form of treatment. As a result there was 
evidence that, particularly in the qualitative study, eating habits and behaviours had 
changed as a result of repeated exposure to the NEEDNT. Considering this tool was 
easy to administer and did not take too much time to use, in future clinical practice it 
could possibly be used to start the discussion about healthy eating which will assist in 
weight management for smokers who plan to quit. This was important as this study 
found that smoking cessation did indeed increase weight compared to continued 
smoking. 
The third implication for practice from this study was the role of food addiction which 
was not seen as a consequence of quitting smoking and reason for weight gain. 
However, as discussed, further studies using larger samples are more likely need to 
fully appreciate the role of sweet and rick foods as a cause for weight gain in those 
susceptible, however at this point of time, there is limited evidence to suggest that 
food addiction is the cause of weight gain post quitting. 
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12.5  Conclusion  
This study was aimed at investigating the association between depression, weight 
and smoking cessation using a mixed method research approach. This study was 
also interested in exploring the ‘lived experiences’ of the participants who attended 
this smoking cessation program in Christchurch.  
This study found a lifetime prevalence of depression amongst current smokers was 
similar to studies reported elsewhere. In general it was double compared to the 
general population studied. Current depression on the other hand was in the lower 
range of what other studies had found. The diagnostic instruments used also played 
a part in these results. Nevertheless, both results provided the much needed 
baseline information using standard diagnostic tools which were not reported before 
in New Zealand to the best of our knowledge in smoking cessation research. 
This study, however, was unable to find any association between depression and 
smoking cessation outcomes as was initially expected. It is possible that this was 
affected by the lower than expected retention rate at both follow-up periods and also 
a lower than expected successful abstinence from smoking at the same follow-up 
periods. The SCeMES qualitative study suggested that the low retention and 
abstinence might be the result of the stress reported as a result of the earthquakes 
which had happened during the study period. Without a control group, however, this 
could only be speculated. Nonetheless, it appeared that environmental factors which 
were described as ‘unprecedented’ might have affected the outcome. It would be of 
interest to replicate this study with attention towards these issues, though, it would be 
impossible to predict such an event ever happening again during a similar smoking 
cessation study. 
This study found weight gain was an issue for all participants who attempted to quit 
smoking. Participants who were abstinent gained more weight compared to those 
who were still smoking at the same time period at follow-up. This finding was 
reassuring as it was similar to the current literature. This study however found no 
association between eating variables which included weight and smoking cessation. 
This study, however, went a step further and postulated if weight gained on quitting 
smoking was the result of switching of addictions from nicotine to food. This 
hypothesis, however, was not substantiated in this study. There was hardly any 
participants diagnosed at baseline with food addiction and there was no increase 
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over time. The qualitative results did reveal that the appetites of nearly all participants 
interviewed increased although this was not captured using the NEEDNT 
questionnaire in the quantitative study. It was possible that the weight gained was the 
result of a general increase in consumption with a lack of energy expenditure and 
therefore caused weight gain in this population. This was further supported by 
reduction in the QCSRF and the NEEDNT which were correlated. Both 
questionnaires measured craving for sweet and savoury foods and consumption of 
energy heavy but nutritionally deficient foods. A reduction meant that energy intake 
was from other sources which were not explained in this study.  
When all three variables were investigated together, this study did not find any 
relationship between the three variables of interest. Other studies reported elsewhere 
did not find any relationship between the three variables of interest either. 
Nevertheless, this study was unique with the inclusion of food addiction which was 
never reported before. It was possible though that the small number of those 
diagnosed with food addiction and the final sample size might have affected the final 
analysis and thus, future studies would need to ensure this was addressed. 
This study was also interested in exploring the lived experience of the participants 
quitting in a smoking cessation program which was observational in nature. Two 
major findings were reported: the experience of quitting smoking, and the role that 
the environment played towards this experience. This qualitative study found that 
participants were more interested in the experience of quitting rather than the 
outcome of either success or failure to stop smoking. A more positive experience 
might result in a successful quit attempt, retention in the study and a further attempt 
to quit if they had relapsed during the program period. A negative experience was 
often reported with the opposite results. For those attempting to quit through the 
SCeMES, these experiences were influenced by the environment at the time when 
the Christchurch earthquakes occurred, as well as the implementation of increasingly 
restrictive tobacco control policies as the nation moved towards Smokefree 2025. 
Therefore, although the participants reported their quit attempt as a ‘journey’, this 
journey might not be transferable to another population with a different environment. 
As reported earlier, future studies would need to replicate this study in different 
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Appendix B - Ethics 
 
15 November 2010 
Sonia Scott 
Administrator 
Central Regional Ethics Committee 




Re: Amendments to Zonnic Trial CEN/09/08/055 
I am writing to you in reference to the request by Professor Julian Crane, emailed on 
the 5th November 2010. As mentioned by Prof. Crane, I am a psychiatrist currently 
doing work with the ZAP Study at the National Addiction Centre site in Christchurch. I 
am keen to do my PhD research with the study sample in Christchurch looking at the 
role of depression and weight towards a successful quitting in a smoking cessation 
trial. 
Essentially, my study will involve additional questionnaires looking at the items of 
interest, which are depression and weight including food craving. I will also invite a 
number of participants to focus groups or individual interviews to better understand 
their experiences taking part in a smoking cessation programme.  
As requested, I am enclosing together with this letter a brief outline of my study, the 
questionnaires that will be used, the patient information sheet and the informed 
consent forms (both amendment to the current one used in Christchurch and also for 
focus groups). 
My study will be supervised by Prof. Doug Sellman and Dr Simon Adamson in the 
National Addiction Centre. For the focus groups section, I will be in consultation with 
Dr Ria Schroder, a Research Fellow in the National Addiction Centre. 
I hope that the committee will consider my application for an amendment. 
Finally, thank you again for your time and consideration. 
 
Kind regards 
Dr Amer Siddiq Amer Nordin 
PhD Student 












Appendix C - Consent 
Participant Information Sheet 
 
Only ten percent of people who use nicotine replacement therapy (NRT) to quit 
smoking will be successful at 12 months. Therefore new, more effective, nicotine 
replacement therapies are needed. 
This study aims to test Zonnic (a nicotine mouth-spray) taken together with nicotine 
patches. 
Nicotine patches give you a small continuous dose of nicotine via your skin which 
helps reduce withdrawal symptoms from stopping smoking (such as irritability, 
restlessness, poor concentration etc). 
Nicotine patches do not completely stop you from craving cigarettes. 
Zonnic is likely to help more people to quit because when they get cravings to smoke 
they can use Zonnic instead of smoking a cigarette to get rid of the craving. 
Zonnic is a nicotine mouth-spray that is squirted in your mouth between your cheek 
and gum.  It has a peppermint flavour and causes an immediate mild peppery tingle 
in your mouth (caused by nicotine).  It helps reduce your craving to smoke within 
minutes but not as fast as smoking a cigarette does, so you will still have to rely a lot 
on your determination and strength of will not to smoke.   
In this study, you will use nicotine patches each day for 5 months and Zonnic for 6 
months.   
You will take one patch per day and can use Zonnic as often as you like (within the 
recommended dose range). 
To make the study scientific, half of participants will get active Zonnic and half will get 
inactive (placebo) Zonnic.  All participants will receive active nicotine patches.   
Whether you receive the active or inactive Zonnic will be determined by chance 
(computer randomisation). 
We will inform you of whether you were taking the active or placebo-Zonnic at the 
end of the study. 
You can keep smoking for the first three weeks that you take the Zonnic and 
patches, but we ask that you reduce the amount you smoke, so that you quit 
smoking at the end of the third week.  We ask you to remain quit from smoking 
from then on.  But if you do smoke after the third week, please continue to take part 
in this study – try to increase the amount of Zonnic that you use and try to smoke as 
little as possible, and try to quit again as soon as you can. 
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You can choose whether to take part in this study in Wellington or Christchurch.  In 
Wellington you can choose between the University of Otago, Wellington, next to the 
hospital in Newtown or Tu Kotahi at the Kokiri Marae in Seaview.  In Christchurch 
you can take part via the University of Otago, Christchurch, at the National Addiction 
Centre on Oxford Terrace near Hagley Park. 
 
Who can take part in this study? 
Anyone who is aged between 18 and 70 and who smokes 9 or more cigarettes per 
day. 
 
Who cannot take part in this study? 
People who are allergic to nicotine patches.  Those with a serious medical condition 
and/or high blood pressure, and/or something wrong with their heart or blood vessels 
(fast or irregular heart rhythm, angina, chest pain, had a heart attack or stroke within 
the last 3 months), and/or who have ever had a stomach ulcer, heartburn, a stroke, 
kidney disease, liver disease, over-active thyroid, phaeochromocytoma (tumour of 
the adrenal gland).  Pregnant women and women who are not using appropriate 
contraception (for heterosexual contact, appropriate contraception includes use of 
condoms by men or oral contraceptive by women).  People who regularly exceed the 
recommended guideline amount of alcohol, and/or use illegal drugs.  Those taking 
medicines such as: theophylline, imipramine, pentazocline.   
 
How to use the mouth-spray 
Spray onto the inside of your cheek between the cheek and the gum, using one to 
two sprays at a time.  If you use two sprays, spray one onto the left-hand cheek and 
one onto the right-hand cheek to ensure as much of the nicotine gets absorbed 
across your cheek and that you swallow as little as possible.  In order for the nicotine 
to be absorbed into your blood, it needs to be absorbed across your cheek.  If you 
swallow the nicotine only a small amount will get into your blood because your liver 
will remove most of it.  One spray delivers 1 mg of nicotine.  The maximum dose 
recommended by the manufacturer is 30 sprays per day.  If you use too much 
mouth-spray you will feel nauseous and dizzy, so if you feel these symptoms, reduce 
the amount of sprays you take. 
 
What side effects does Zonnic have? 
Side effects that occur with 1% or more of people: dizziness, headache, 




Side effects that occur in 1% to 0.1% of people: fast heart rate, red blotches on skin, 
hives. 
Side effects that occur less than 0.01% of the time: irregular heart beat, allergic 
reactions (e.g. swelling and redness of skin). 
If you have these symptoms, reduce the number of sprays of Zonnic that you take.  If 
these symptoms persist and/or become bothersome, inform us and/or your doctor.  
Notify us and/or your doctor if you develop: breathing difficulties, chest pain, irregular 
heartbeat, nervousness, anxiety, tremors. If you notice other effects not listed above, 
contact us and/or your doctor 
 
What side effect do patches have? 
Side effects that occur within 2% or more of people: abdominal pain, heart burn, acid 
reflux, indigestion, stomach upset, nausea skin allergy, coughing, abnormal 
dreaming, joint pain, headaches, dizziness, light headedness. 
Side effects that occur within 1 to 2% of people: insomnia, sleepiness, impaired 
concentration, vomiting, chest pain, fatigue, pain, blood pressure changes. 
Side effects that occur in less than 1% of people: hot flushes, swelling of the skin 
near the patch, weight gain, extra heart beats, high blood pressure, rapid irregular 
heart beat, stomach ulcer, dry mouth, flatulence, inflamed gums, pain upon 
swallowing, abnormal stool, change in your sense of taste, abnormal vision, 
shortness of breath, increased appetite, leg cramps, migraine, itchiness, increased 
sweating, red blotches on skin, acne. 
Most side effects will go away in the first few days as your body adjusts to the 
medication. If these symptoms persist or become bothersome, inform us and/or your 
doctor.  If the area around the patch becomes red, itchy or irritated, remove it and try 
a new site. If the irritation continues or becomes worse, notify us and/or your doctor.  
When you notify us we can talk with you about the possibility of using a lower dose 
patch, or using it for fewer hours of the day.  Notify us and/or your doctor if you 
develop: breathing difficulties, chest pain, irregular heartbeat, nervousness, anxiety, 
tremors. If you notice other effects not listed above, contact us and/or your doctor.   
 
Do I get paid to take part? 
No, you do not get paid.  We are not able to cover any costs that you may incur by 





What is involved in taking part in this study? 
x Less than one hour per week!!!! 
x 5 visits to the University of Otago (Wellington or Christchurch) or Kokiri Marae 
(20 – 60 minutes per visit).  Week 1 visit will be the longest and may take up to 
60 minutes.  Further visits will be at weeks 8, 16, 29 and 55. 
x The visits involve answering questionnaires (smoking and related issues such 
as mood and weight), blowing into a machine that can detect whether you 
have smoked, checking your blood pressure and receiving counselling from 
the researchers. 
x At the last visit (Week 55) we will ask for a small hair sample from your head 
to see if you smoked in the previous month. 
x Record on diary cards how much you smoke and how much Zonnic you use 
each day during the study. 
x Week 1 - 3:  start using patches and Zonnic and reduce your smoking each 
week so you quit by the end of week 3. 
x Week 4 - 18:  continue using patches daily and Zonnic as often as you like, 
but do not smoke from this point onwards.  If you do smoke, please record it.  
If you start smoking regularly, please let us know and we can offer you further 
assistance.  We will phone you around the time that you quit smoking to offer 
you brief counselling and advice. 
x Week 19 - 22:  use lower doses of patches so you stop patches by end of 
Week 22; continue using as much Zonnic as you like during this period. 
x Week 23 - 26:  use less Zonnic each week so that you have stopped Zonnic 
by end of Week 26.  Keep some Zonnic with you so you can use Zonnic 
instead of smoking if you have a strong urge to smoke. 
x Week 26 - 55:  stay smoke free, phone or email researchers if you have 
concerns.  You will keep a bottle of Zonnic to use, just in case you still get a 
strong urge to smoke (but only use Zonnic if you really have to during this 
time).  If you smoke regularly, please let us know because you may need 
more assistance.  In Week 42 we will phone you to catch up with how you are 
doing and provide brief counselling and advice. 
x You may also be invited to attend a focus group session at a later date to talk 
about your experience in the programme. 
 
The up-side of taking part in this study: 
x The study is FREE; 
x Five visits with researchers to help you to quit smoking; 
x Active nicotine patches to everyone to help you quit smoking; 
x Active Zonnic for half the participants to help quit smoking; and 
x You will gain a better understanding of why you smoke and how to quit. 
 
The down-side of taking part in this study: 
x The hassle of 5 visits to the medical school (we can do visits on weekends 
and after work-hours); 
x The time involved in recording your smoking and use of Zonnic on diary cards; 
x The Zonnic and patches will not be a perfect solution, it will still be hard to quit 
(but not as hard as going cold-turkey); and 
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x The study has a very long duration of 13 months (55 weeks), and we would 
ask that you remain available for clinic visits on the scheduled dates. 
 
You can stop taking part in the study whenever you want.   
 
Future Availability of Zonnic 
Zonnic is not currently licensed as a medicine in New Zealand.  It may take a year or 
more to license it for sale as a medicine in New Zealand.   
 
Compensation 
In the unlikely event of a physical injury as a result of your participation in this study, 
you may be covered by ACC under the Injury Prevention, Rehabilitation and 
Compensation Act.  ACC cover is not automatic and your case will need to be 
assessed by ACC according to provisions of the 2002 Injury Prevention and 
Compensation act.  If your claim is accepted by ACC, you still might not get any 
compensation.  This depends on a number of factors such as whether you are an 
earner or non-earner.  ACC usually provides only partial reimbursement for costs and 
expenses and there may be no cover for mental injury unless it is a result of physical 
injury.  If you have ACC cover, generally this will affect your right to sue the 
investigators.  For more details, refer to http://www.acc.co.nz.  
 
Confidentiality and Privacy 
All information collected will be held confidentially by our research staff.  
All records will be securely stored in the research facility. 
We aim to have the results of the study published in the international medical 
literature and we will send you a copy of the paper once it becomes available. No 
identifying data will be included in any publications.  When the study is complete we 
will remove your name from all the data and leave only the identification number 
remaining.  We will keep this anonymous data securely in locked files for future 
analysis.  We would have to gain additional ethical approval if we were to use these 
anonymous data in the future. 
 
Ethical Approval 
This study has been reviewed and approved by the Central Region Ethics 
Committee.  If you have any concerns about the study, please contact them by 





If you have any queries or concerns regarding your rights as a participant in this 
study you may wish to contact a Health and Disability Advocate, telephone Mid and 




If you have any questions about this study, please contact the Research Team.  The 
primary contacts are: 
Free phone – 0800 318 167 or  
Wellington - Brent Caldwell (04) 918-6041 or 021 872-264;  
Lower Hutt - Cheryl Davies (04) 939-4629;  
Christchurch - Marie Ditchburn (03) 364-0480;  





Participant Consent Form 
 
 
The purpose of this study has been explained to me.  I understand the nature of the 
test procedures to be carried out.  All of these aspects have been explained to my 
satisfaction, and I have had the opportunity to discuss them with the investigators 
and have had time to consider whether to take part. 
I understand that my participation in this study is entirely voluntary, and that at any 
stage I can withdraw from the study and this will not interfere with my future 
treatment. 
I understand that I will be required to attend the Wellington School of Medicine or the 
National Addiction Centre (Christchurch) on 5 occasions by arrangement, but that at 
any time during the study I may withdraw from further participation.   
I understand that I will NOT be paid for participating in this study, and that my 
expenses (such as parking) will NOT be reimbursed. 
I understand that I will be asked to provide a small hair sample (5-10 strands of hair) 
at the end of the study, to test for nicotine.  This test procedure dissolves the hair, so 
that it becomes liquid.  The liquid is disposed of as soon as the test is completed. 
I understand that information obtained during this study is confidential and will not be 
used in any way that could identify me, or for any other purpose than fulfilling the 
aims of the study.   
I understand that my participation will be stopped if it should appear to be harmful to 
me. 
 
I give permission for my general practitioner to be informed that I will be taking 
part in this study:  .................................................................................................... YES / NO 
I give permission for an anonymous version of my data (data with my name removed) 
to be retained in a secure location at the medical school, for use in future studies, as  
long as they have gained ethical approval:  ............................................................ YES / NO 
I wish to receive a copy of the results: .................................................................... YES / NO 
I wish to participate in a focus group discussion at a later date: .............................. YES / NO 
 
I ……………………………………….…………… hereby consent to take part in this study. 







Participant Information Sheet (Focus Group) 
 
THE ROLE OF DEPRESSION AND WEIGHT ON SUCCESSFUL QUITTING IN A 
SMOKING CESSATION TRIAL 
You may recall completing questionnaires regarding mood changes and food craving. You 
may also recall that some of the participants in the ZAP Study will be invited to take part in a 
focus group discussion regarding these issues and also their experiences within a smoking 
cessation program like the ZAP study. 
I am writing to invite you for such a focus group discussion. The focus group discussion will 
involve a small group of 6-8 participants and will be held in the seminar room on the 3rd Floor 
of Terrace House, where you are currently coming for visits. It will last between an hour or 
two. These sessions will be moderated by myself and Dr Ria Shroder, a Research Fellow at 
the National Addiction Centre (NAC). Sessions will be recorded with a digital audio player to 
ensure good data collection and completeness. 
Your input into this research will be invaluable in assisting us to understand further the issues 
involved with quitting smoking in order to improve smoking cessation programs in the future. 
You will receive a fuel voucher of NZD20 to partly compensate your time. 
Your participation in this study is strictly confidential. Participants involved will be provided a 
pseudonym e.g. Ms A, Mr A, Ms B etc. to identify individual input during the course of the 
interview and on transcribing the digital audio taped discussions. N information that could 
personally identify you will be used in any forms, reports or publications based on this study 
and no information will be passed onto any other individual or group. 
 







Dr Amer Siddiq Amer Nordin    Prof Dr Doug Sellman 




Consent Form (Focus Group) 
 
THE ROLE OF DEPRESSION AND WEIGHT ON SUCCESSFUL QUITTING IN A 
SMOKING CESSATION TRIAL 
 
1. I have read and understood the information outlining a study designed to gather 
information regarding mood, food craving and the experience in partaking in a 
smoking cessation programme. 
 
2. I understand that taking part in this study is voluntary (my choice) and I have not been 
influenced in any way to participate. 
 
3. I have had adequate time to consider whether to take part in this study. 
 
4. I understand that my participation in this study is strictly confidential and no material 
which could identify me will be used in any reports or publication based on this study. 
 
5. I understand that I may withdraw from this study at any time. 
 
I………………………………………………………………………(full name) hereby consent to 








Principal investigator: Dr Amer Siddiq Amer Nordin, MBChB (Otago), M. Psych Med (Malaya) 





Appendix D - Questionnaires 
 
Mood Questionnaire 1 
Doctors are aware that emotions play an important part in most illnesses and if your 
doctor knows about these feelings he/she will be able to help you more. This 
questionnaire is designed to help your doctor know how you feel. 
Read each item and place a firm tick to the statement that comes closest to how you 
have been feeling in the PAST WEEK. 
Don’t take to long to think the answer, your immediate reaction to each item will 





A. I feel tense or ‘wound up’: 
3 Most of the time 
2 A lot of the time 
1 Time to time, occasionally 
0 Not at all 
 
D. I still enjoy the things that I used to 
enjoy: 
0 Definitely as much 
1 Not quite so much 
2 Only a little 
3 Hardly at all 
 
A. I get a sort of frightened feeling as if 
something awful is about to happen 
3 Very definitely and quite badly 
2 Yes, but no too badly 
1 A little, but it doesn’t worry me 
0 Not at all 
 
D. I can laugh and see the funny side of 
things: 
0 As much as I always could 
1 Not quite so much now 
2 Definitely not so much now 
3 Not at all 
 
A. Worrying thoughts go through my 
mind: 
3 A great deal of the time 
2 A lot of the time 
1 From time to time but not often 
0 Only occasionally 
 
D. I feel cheerful: 
3 Not at all 
2 Not often 
1 Sometimes 
0 Most of the time 
 
A. I can sit at ease and feel relaxed: 
0 Definitely 
1 Usually 
2 Not often 
3 Not at all 
 
 
D. I feel as if I’m slowed down: 
3 Nearly all the time 
2 Very often 
1 Sometimes 
0 Not at all 
 
A. I get a sort of frightened feeling like 
“butterflies” in my stomach: 
0 Not at all 
1 Occasionally 
2 Quite often 
3 Very often 
 
D. I have lost interest in my 
appearance: 
3   Definitely 
2   I don’t take as much care as I should 
1    I may not take as much care 
0   I take just as much care as ever 
 
A. I feel restless as if I have to be on the 
move:  
3 Very much indeed 
2 Quite a lot 
1 Not very much 
0 Not at all 
 
D. I look forward to enjoyment to 
things: 
0 As much as I ever did 
1 Rather less than I used to 
2 Definitely less than I used to 
3 Hardly at all 
 
A. I get a sudden feeling of panic: 
3 Very often indeed 
2 Quite often 
1 Not very often 
0 Not at all 
 




2 Not often 







Mood Questionnaire 2 
This questionnaire consists of 21 groups of statements. Please read each group of 
statements carefully, and then pick out the one statement in each group that best 
describes the way that you have been feeling during the PAST TWO WEEKS 
including today. If several statements in the group seem to apply equally well, circle 
the highest number for that group. Be sure that you do not choose more than one 
statement for any group including item 16 (changes in sleeping pattern) or item 18 





0 I do not feel sad 
1 I feel sad much of the time 
2  I am sad all the time 




0 I am not discouraged about my future 
1  I feel more discouraged about my 
future than I used to be 
2 I do not expect things to work out for 
me 
3  I feel my future is hopeless and will 
only get worse 
 
3. Past failure 
0 I do not feel like a failure 
1 I have failed more than I should have 
2 As I look back I see a lot of failures 
3 I feel I am a total failure as a person 
 
4. Loss of Pleasure 
0 I get as much pleasure as I ever did 
from the things I enjoy 
1 I don’t enjoy things as much as I used 
to 
2 I get very little pleasure from the things 
I used to enjoy 
3 I can’t get any pleasure from the things 
I used to enjoy 
 
5. Guilty Feelings 
0 I don’t feel particularly guilty 
1 I feel guilty over many things that I 
have done or should have done 
2  I feel quite guilty most of the time 
3 I feel guilty all the time 
 
6. Punishment Feelings 
0 I don’t feel that I am being punished 
1 I feel I may be punished 
2 I expect to be punished 
3 I feel I am being punished 
 
7. Self Dislike 
0 I feel the same about myself as ever 
1 I have lost confidence in myself 
2 I am disappointed in myself 
3 I dislike myself 
 
8. Self Criticalness 
0 I don’t criticize or blame myself more 
than usual 
1 I am more critical of myself than I used 
to be 
2 I criticize myself for all of my faults 
3 I blame myself for everything bad that 
happens 
 
9. Suicidal Thoughts or Wishes 
0 I don’t have any thoughts of killing 
myself 
1 I have thought of killing myself but I 
would not carry them out 
2 I would like to kill myself 
3 I would kill myself if I had the chance 
 
10. Crying 
0 I don’t cry anymore than I used to 
1 I cry more than I used to 
2 I cry over every little thing 
3 I feel like crying but I can’t 
 
11. Agitation 
0  I am no more restless or wound up 
than usual 
1  I feel more restless or wound up than 
usual 
2 I am so restless or agitated that it’s 
hard to stay still 
3 I am so restless or agitated that I have 
to keep moving or doing something 
 
12. Loss of Interest 
0 I have not loss interest in other people 
or activities 
1 I am less interested in people or things 
than before 
2 I have lost most of my interest in other 
people or things 
3  It’s hard to get interested in anything 
 
13. Indecisiveness 
0 I make decisions about as well as ever 
1  I find it more difficult to make decisions 
than usual 
2 I have much greater difficulty in 
making decisions than I used to 





0 I do not feel I am worthless 
1 I don’t consider myself as worthwhile 
and useful as I used to 
2 I feel more worthless as compared to 
other people 
3 I feel utterly worthless 
 
15. Loss of Energy 
0 I have as much energy as ever 
1  I have less energy than I used to have 
2 I don’t have enough energy to do very 
much 
3 I don’t have enough energy to do 
anything 
 
16. Changes in Sleeping Pattern 
0 I have not experienced any change in 
my sleeping pattern 
1a I sleep somewhat more than usual 
1b I sleep somewhat less than usual 
2a I sleep a lot more than usual 
2b I sleep a lot less than usual 
3a I sleep most of the day 
3b I wake up 1-2 hours early and can’t get 
back to sleep 
 
17. Irritability 
0  I am no more irritable than usual 
1 I am more irritable than usual 
2 I am much more irritable than usual 
3 I am irritable all the time 
18. Changes in Appetite 
0 I have not experienced any change in 
my appetite 
1a  My appetite is somewhat less than 
usual 
1b  My appetite is somewhat more than 
usual 
2a  My appetite is much less than before 
2b  My appetite is much greater than 
before 
3a I have no appetite at all 
3b I crave food all the time 
 
19. Concentration Difficulty 
0 I can concentrate as well as ever 
1 I can’t concentrate as well as usual 
2 It’s hard to keep my mind on anything 
for very long 
3 I find I can’t concentrate on anything 
 
20. Tiredness or Fatigue 
0 I am no more tired or fatigued than 
usual 
1 I get more tired or fatigued more easily 
than usual 
2 I am too tired or fatigued to do a lot of 
things I used to do 
3 I am too tired or fatigued to do most of 
the things I used to do 
 
21. Loss of Interest in Sex 
0 I have not noticed any recent change 
in my interest in sex 
1 I am less interested in sex than I used 
to be 
2 I am much less interested in sex now 




Food Questionnaire 1 
Non-Essential Energy Dense Nutritionally Deficient (NEEDNT) Foods 
 
This questionnaire consist of 44 examples of food or food groups. We will be 
monitoring your consumption over the course of the study.  
Please write down HOW MANY TIMES you have eaten these foods in THE LAST 7 
DAYS 
 
Food Examples Number of times 
1. Alcoholic drinks   
2. Biscuits  
3. Butter (used as a spread or in baking/cooking etc.)  
4. Cakes  
5. Chocolate  
6. Coconut Cream   
7. Corn chips  
8. Cream   
9. Packet chips/crisp (both potato and vegetable)  
10. Desserts / puddings  
11. Doughnuts  
12. Energy drinks   
13. Flavoured milk   
14. Food tinned in syrup (even lite syrup!)   
15. Fried food   
16. Frozen yoghurt   
17. Fruit juice (except tomato juice and unsweetened blackcurrant juice)  
18. High fat (≥ 10g fat per 100g) crackers   
19. Honey  
20. Hot chips  
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21. Ice cream  
22. Jam  
23. Marmalade   
24. Mayonnaise  
25. Muesli bars  
26. Muffins  
27. Nuts roasted in fat or oil   
28. Pastries  
29. Pies  
30. Popcorn with butter   
31. Quiches   
32. Reduced cream   
33. Regular Luncheon sausage   
34. Regular powdered drinks (e.g raro, reflex, hot chocolate, milo)  
35. Regular Salami   
36. Regular Sausages   
37. Regular soft drinks   
38. Sour Cream   
39. Sugar (added to anything including drinks, baking, cooking etc)  
40. Sweets/Lollies  
41. Syrups such as Golden Syrup, Treacle , maple syrup  
42. Takeaways (e.g. fish & chips, McD, KFC, Chinese, Thai, Indian)  
43. Toasted muesli   















Food Questionnaire 3 
 
Yale Food Addiction Scale (Short Version)          Gearhardt, Corbin, Brownell, 
2009 
               Contact: ashley.gearhardt@yale.edu 
 
This survey asks about your eating habits in the PAST 1 MONTH. People sometimes have difficulty controlling their intake of certain foods such as:   
       -  Sweets like ice cream, chocolate, doughnuts, cookies, cake, candy, ice cream 
       -  Starches like white bread, rolls, pasta, and rice 
       -  Salty snacks like chips, pretzels, and crackers 
       -  Fatty foods like steak, bacon, hamburgers, cheeseburgers, pizza, and French fries 
       -  Sugary drinks like soda pop 
When the following questions ask about “CERTAIN FOODS” please think of ANY food similar to those listed in the food group or ANY 
OTHER foods you have had a problem with in the past 1 month                     
 
 
     
IN THE PAST 1 MONTH: NO YES 
8. I kept consuming the same types of food or the same amount of food even though I was having emotional and/or physical problems. 0 1 
9. Eating the same amount of food does not reduce my negative emotions or increase pleasurable feelings the way it used to. 0 1 
 
 












1. I find myself continuing to consume certain foods even though I am no longer hungry 0 1 2 3 4 
2. I worry about cutting down on certain types of food 0 1 2 3 4 
3. I feel sluggish or fatigued from overeating 0 1 2 3 4 
4. I have spent time dealing with negative feelings from overeating certain foods instead of spending time in 
important activities such as time with family, friends, work or recreation 
0 1 2 3 4 
5. I have had physical withdrawal symptoms such as agitation and anxiety when I cut down on certain foods.  (Do 
NOT include withdrawal symptoms caused by cutting down on caffeinated beverages such as soda pop, 
coffee, tea, energy drinks, etc.) 
0 1 2 3 4 
6. My behavior with respect to food and eating causes me significant distress. 0 1 2 3 4 
7. Issues related to food and eating decrease my ability to function effectively (daily routine, job/school, social 
activities, family activities, health difficulties). 








1. Focus or structured programme versus adhoc or on your own 
2. One on one versus group or on your own 
3. Hard core smokers need more intense program 
4. Programme expectations 
5. Comparing to previous attempts 
6. Any role for present model for smokefree NZ 2025 
 
Depression 
1. Mood changes or symptom relapse/ worsening 
2. Different programme more effective for smokers with depression 
3. Using smoking as a treatment 
4. Smoking enables inclusion to a group 
5. Cigarettes as a friend 
6. Understanding on depression on smoking cessation 
 
Weight  
1. Is weight still important in quitting smoking 
2. Is there an acceptable limit of weight gain 
3. Weight affecting contemplation/action/ relapse in smoking cessation 
4. Understanding of weight gain on smoking cessation 
 
Resilience 
1. Earthquake affecting quit attempt 
2. Reasons to continue stopping/strategies that helped cope/ any role of programme 
3. First response of earthquake day 
4. Why were some managing to stay quit and others relapse 
5. Why did some lapse but re-quit whilst others continue to smoke  
 
